P-value | ln(P) | Term | GO Tree | GO ID | # of Genes in Term | # of Target Genes in Term | # of Total Genes | # of Target Genes | Common Genes |
6.513e-09 | -18.85 | integrin-mediated signaling pathway | biological process | GO:0007229 | 96 | 7 | 18204 | 49 |
DAB2,ITGAL,ITGAV,FYB1,ITGB2,HCK,TLN1 |
1.575e-08 | -17.97 | PH-like_dom_sf | interpro domains | IPR011993 | 431 | 11 | 18521 | 50 |
GAB1,TLN1,ARHGAP24,ARAP1,PREX1,DNM2,DAB2,ARHGEF18,AKAP13,WDFY3,SH2B3 |
1.085e-07 | -16.04 | regulation of small GTPase mediated signal transduction | biological process | GO:0051056 | 306 | 9 | 18204 | 49 |
PREX1,ARAP1,AKAP13,DOCK8,DOCK2,ARHGAP24,ARHGEF18,ARHGAP45,ITGAV |
1.206e-07 | -15.93 | Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB) | gene3d domains | 2.30.29.30 | 431 | 11 | 14470 | 48 |
DAB2,SH2B3,DNM2,WDFY3,ARHGEF18,ARAP1,GAB1,PREX1,TLN1,ARHGAP24,AKAP13 |
1.295e-07 | -15.86 | signal transduction | biological process | GO:0007165 | 4637 | 30 | 18204 | 49 |
DNM2,RGL1,GAB1,PTPN6,RXRA,DISC1,PLXND1,ARAP1,ITGB2,HCK,SPI1,ZFP36L1,ARHGEF18,DAB2,ITGAL,CD74,MCOLN2,DOCK8,AKAP13,RBPJ,DOCK2,PTGIR,FYB1,TLN1,TMSB4X,PREX1,SH2B3,ITGAV,ARHGAP45,ARHGAP24 |
1.385e-07 | -15.79 | regulation of cell adhesion | biological process | GO:0030155 | 807 | 13 | 18204 | 49 |
RBPJ,PTPN6,CD74,DOCK8,SH2B3,SPI1,ITGAV,DAB2,DISC1,PLXND1,ITGB2,PREX1,TLN1 |
1.388e-07 | -15.79 | T cell activation | biological process | GO:0042110 | 315 | 9 | 18204 | 49 |
ITGAL,ZFP36L1,PTPN6,SPI1,DOCK2,PREX1,DOCK8,ELF4,CD74 |
1.480e-07 | -15.73 | signaling | biological process | GO:0023052 | 4968 | 31 | 18204 | 49 |
PTGIR,RBPJ,DOCK2,DOCK8,AKAP13,MCOLN2,CD74,ARHGAP45,ITGAV,ARHGAP24,SH2B3,STAB1,TMSB4X,TLN1,PREX1,FYB1,RXRA,PTPN6,GAB1,RGL1,DNM2,ARHGEF18,DAB2,ITGAL,ZFP36L1,SPI1,ARAP1,PLXND1,DISC1,ITGB2,HCK |
1.821e-07 | -15.52 | cell communication | biological process | GO:0007154 | 5010 | 31 | 18204 | 49 |
DNM2,RGL1,GAB1,PTPN6,RXRA,ITGB2,HCK,DISC1,PLXND1,ARAP1,SPI1,ARHGEF18,DAB2,ZFP36L1,ITGAL,CD74,MCOLN2,DOCK8,AKAP13,DOCK2,RBPJ,PTGIR,FYB1,PREX1,TLN1,TMSB4X,STAB1,SH2B3,ARHGAP24,ITGAV,ARHGAP45 |
2.848e-07 | -15.07 | PLCG1 (phospholipase C gamma 1) | protein interactions | 5335 | 258 | 8 | 19454 | 50 |
PTPN12,GAB1,DISC1,TLN1,PTPN6,EHD4,HCK,SH2B3 |
3.458e-07 | -14.88 | cell activation | biological process | GO:0001775 | 725 | 12 | 18204 | 49 |
TLN1,PREX1,ITGB2,ELF4,ITGAL,ZFP36L1,SPI1,DOCK8,CD74,PTPN6,DOCK2,RBPJ |
4.176e-07 | -14.69 | leukocyte activation | biological process | GO:0045321 | 599 | 11 | 18204 | 49 |
SPI1,ITGAL,ZFP36L1,ELF4,ITGB2,PREX1,RBPJ,PTPN6,DOCK2,CD74,DOCK8 |
4.478e-07 | -14.62 | lymphocyte activation | biological process | GO:0046649 | 476 | 10 | 18204 | 49 |
DOCK8,PREX1,ELF4,CD74,ZFP36L1,ITGAL,RBPJ,SPI1,DOCK2,PTPN6 |
5.191e-07 | -14.47 | PH_domain | interpro domains | IPR001849 | 266 | 8 | 18521 | 50 |
ARHGEF18,AKAP13,GAB1,ARAP1,ARHGAP24,PREX1,DNM2,SH2B3 |
6.280e-07 | -14.28 | GTPase regulator activity | molecular function | GO:0030695 | 491 | 10 | 18094 | 49 |
ARAP1,DOCK2,PREX1,ARHGAP24,DOCK8,RGL1,PTGIR,ARHGAP45,AKAP13,ARHGEF18 |
6.280e-07 | -14.28 | nucleoside-triphosphatase regulator activity | molecular function | GO:0060589 | 491 | 10 | 18094 | 49 |
ARAP1,DOCK2,PREX1,ARHGAP24,DOCK8,RGL1,PTGIR,ARHGAP45,AKAP13,ARHGEF18 |
6.285e-07 | -14.28 | cell migration | biological process | GO:0016477 | 921 | 13 | 18204 | 49 |
DOCK8,MCOLN2,DOCK2,BTG1,GAB1,DISC1,PLXND1,PREX1,ITGB2,HCK,ITGAV,ARHGAP24,ITGAL |
6.889e-07 | -14.19 | endocytosis | biological process | GO:0006897 | 499 | 10 | 18204 | 49 |
DOCK2,STAB1,DAB2,ITGAL,ITGAV,MYO1F,EHD4,HCK,DNM2,ITGB2 |
7.874e-07 | -14.05 | response to stimulus | biological process | GO:0050896 | 7803 | 38 | 18204 | 49 |
MCOLN2,CD74,AKAP13,DOCK8,DOCK2,RBPJ,CCND2,CD68,PTGIR,FYB1,ME1,TLN1,TMSB4X,PREX1,SH2B3,PTPN12,STAB1,ARHGAP24,ARHGAP45,ITGAV,FKBP5,RGL1,DNM2,PTPN6,GAB1,RXRA,EHD4,HCK,ITGB2,ARAP1,DISC1,PLXND1,SPI1,TFEB,ITGAL,DAB2,ZFP36L1,ARHGEF18 |
8.058e-07 | -14.03 | PTK2 (protein tyrosine kinase 2) | protein interactions | 5747 | 296 | 8 | 19454 | 50 |
ITGB2,DNM2,HCK,TLN1,PTPN6,FKBP5,PTPN12,ITGAV |
1.167e-06 | -13.66 | cell periphery | cellular component | GO:0071944 | 6020 | 32 | 19108 | 49 |
ITGB2,HCK,ARHGAP45,HEPHL1,ARAP1,PTPN6,CD74,PLXND1,RGL1,STAB1,SEPTIN9,AKAP13,ITM2B,DAB2,DNM2,MYO1F,CD68,ITGAV,TLN1,SH2B3,SLC9A7,DOCK2,ITGAL,ARHGEF18,PTGIR,FYB1,DOCK8,PREX1,WDFY3,EHD4,ANTXR2,MCOLN2 |
1.606e-06 | -13.34 | import into cell | biological process | GO:0098657 | 687 | 11 | 18204 | 49 |
DOCK2,MYO1F,DNM2,STAB1,DAB2,ITGAL,ITGAV,EHD4,HCK,ITGB2,SLC9A7 |
1.906e-06 | -13.17 | immune system process | biological process | GO:0002376 | 1991 | 18 | 18204 | 49 |
FYB1,ELF4,HCK,ITGB2,PREX1,SPI1,SH2B3,ZFP36L1,ITGAL,TFEB,CD74,MCOLN2,DNM2,DOCK8,DOCK2,PTPN6,RBPJ,CD68 |
2.520e-06 | -12.89 | guanyl-nucleotide exchange factor activity | molecular function | GO:0005085 | 228 | 7 | 18094 | 49 |
AKAP13,ARHGEF18,DOCK8,RGL1,DOCK2,PTGIR,PREX1 |
2.650e-06 | -12.84 | plasma membrane | cellular component | GO:0005886 | 5538 | 30 | 19108 | 49 |
DOCK2,SLC9A7,ITGAL,ARHGEF18,PTGIR,ITGAV,TLN1,SH2B3,MCOLN2,FYB1,ANTXR2,PREX1,WDFY3,EHD4,DOCK8,CD74,PTPN6,PLXND1,ITGB2,HCK,ARAP1,ARHGAP45,HEPHL1,DNM2,DAB2,ITM2B,CD68,MYO1F,STAB1,RGL1 |
3.057e-06 | -12.70 | cellular response to stimulus | biological process | GO:0051716 | 6307 | 33 | 18204 | 49 |
ARHGAP45,ITGAV,ARHGAP24,SH2B3,TLN1,PREX1,TMSB4X,FYB1,PTGIR,CD68,CCND2,RBPJ,DOCK2,DOCK8,AKAP13,MCOLN2,CD74,TFEB,ZFP36L1,ITGAL,DAB2,ARHGEF18,SPI1,ARAP1,DISC1,PLXND1,ITGB2,HCK,RXRA,PTPN6,GAB1,RGL1,DNM2 |
3.153e-06 | -12.67 | regulation of response to stimulus | biological process | GO:0048583 | 4104 | 26 | 18204 | 49 |
HCK,ITGB2,ARAP1,DISC1,RBM47,SPI1,ARHGEF18,DAB2,PTPN6,RXRA,FYB1,ELF4,PREX1,TMSB4X,PTPN12,SH2B3,ARHGAP24,BMP2K,ARHGAP45,ITGAV,CD74,AKAP13,DOCK8,DOCK2,RBPJ,PTGIR |
3.492e-06 | -12.56 | regulation of developmental process | biological process | GO:0050793 | 2540 | 20 | 18204 | 49 |
ARHGEF18,DAB2,BMP2K,ZFP36L1,ITGAV,SPI1,STAB1,PREX1,ITGB2,HCK,ARAP1,DISC1,PLXND1,RXRA,PTPN6,BTG1,GAB1,RBPJ,DNM2,CD74 |
4.596e-06 | -12.29 | cell motility | biological process | GO:0048870 | 1101 | 13 | 18204 | 49 |
DOCK2,GAB1,BTG1,DOCK8,MCOLN2,ARHGAP24,ITGAL,ITGAV,PREX1,ITGB2,HCK,DISC1,PLXND1 |
4.852e-06 | -12.24 | cytoplasm | cellular component | GO:0005737 | 12081 | 45 | 19108 | 49 |
DISC1,CD74,PTPN12,HCK,CD68,DAB2,DNM2,RBPJ,SEPTIN9,BMP2K,STAB1,PTGIR,ITGAL,RBM47,DOCK2,TLN1,ITGAV,MCOLN2,ARHGAP24,PREX1,DOCK8,FYB1,PTPN6,BTG1,ME1,ARHGAP45,ARAP1,ITGB2,GAB1,MYO1F,TFEB,ITM2B,FKBP5,AKAP13,RGL1,ZFP36L1,CCND2,ARHGEF18,SLC9A7,SH2B3,RXRA,EHD4,TMSB4X,WDFY3,ANTXR2 |
5.347e-06 | -12.14 | regulation of signal transduction | biological process | GO:0009966 | 3114 | 22 | 18204 | 49 |
RXRA,PTGIR,DOCK2,PTPN6,RBPJ,AKAP13,DOCK8,CD74,ARHGEF18,BMP2K,DAB2,ARHGAP24,ITGAV,ARHGAP45,SPI1,RBM47,SH2B3,PTPN12,PREX1,TMSB4X,DISC1,ARAP1 |
6.316e-06 | -11.97 | Hemostasis | REACTOME pathways | R-HSA-109582 | 632 | 11 | 10285 | 36 |
TLN1,PTPN6,SH2B3,TMSB4X,PTGIR,ITGAV,ITGB2,ITGAL,DOCK8,CD74,DOCK2 |
6.442e-06 | -11.95 | integrin alphaL-beta2 complex | cellular component | GO:0034687 | 2 | 2 | 19108 | 49 |
ITGAL,ITGB2 |
6.508e-06 | -11.94 | cytoplasmic vesicle | cellular component | GO:0031410 | 2521 | 19 | 19108 | 49 |
PTPN6,DISC1,SLC9A7,DOCK2,CD74,ITGAL,ITGAV,ITGB2,HCK,ARHGAP45,ITM2B,DAB2,DNM2,MCOLN2,CD68,STAB1,TMSB4X,EHD4,ANTXR2 |
6.741e-06 | -11.91 | intracellular vesicle | cellular component | GO:0097708 | 2527 | 19 | 19108 | 49 |
ANTXR2,TMSB4X,EHD4,STAB1,CD68,MCOLN2,DNM2,DAB2,ITM2B,ARHGAP45,ITGB2,HCK,ITGAV,ITGAL,DOCK2,CD74,PTPN6,DISC1,SLC9A7 |
7.867e-06 | -11.75 | cytosol | cellular component | GO:0005829 | 5475 | 29 | 19108 | 49 |
ME1,DISC1,PTPN6,ARAP1,ARHGAP45,HCK,PTPN12,MYO1F,TFEB,GAB1,DNM2,DAB2,AKAP13,FKBP5,RGL1,ARHGEF18,CCND2,PTGIR,ZFP36L1,DOCK2,RXRA,SH2B3,ITGAV,TLN1,DOCK8,WDFY3,TMSB4X,PREX1,FYB1 |
8.149e-06 | -11.72 | DOK1 (docking protein 1) | protein interactions | 1796 | 50 | 4 | 19454 | 50 |
PTPN6,TLN1,HCK,ITGB2 |
8.629e-06 | -11.66 | Rho GTPase cycle | REACTOME pathways | R-HSA-194840 | 142 | 6 | 10285 | 36 |
AKAP13,ARHGAP45,PREX1,ARAP1,ARHGAP24,ARHGEF18 |
9.075e-06 | -11.61 | cytoplasmic vesicle membrane | cellular component | GO:0030659 | 1230 | 13 | 19108 | 49 |
ITGAL,SLC9A7,CD74,ITGAV,ITGB2,MCOLN2,CD68,DAB2,ITM2B,DNM2,EHD4,ANTXR2,STAB1 |
1.019e-05 | -11.49 | PH | smart domains | SM00233 | 259 | 8 | 9717 | 41 |
PREX1,ARHGAP24,AKAP13,GAB1,ARAP1,ARHGEF18,DNM2,SH2B3 |
1.089e-05 | -11.43 | vesicle membrane | cellular component | GO:0012506 | 1251 | 13 | 19108 | 49 |
ITGAL,CD74,SLC9A7,ITGB2,ITGAV,CD68,MCOLN2,DNM2,DAB2,ITM2B,ANTXR2,EHD4,STAB1 |
1.177e-05 | -11.35 | focal adhesion | cellular component | GO:0005925 | 427 | 8 | 19108 | 49 |
DAB2,DNM2,ARHGAP24,TLN1,PTPN12,ITGAV,HCK,ITGB2 |
1.337e-05 | -11.22 | VAV1 (vav guanine nucleotide exchange factor 1) | protein interactions | 7409 | 204 | 6 | 19454 | 50 |
DOCK2,SPI1,GAB1,PTPN6,HCK,DNM2 |
1.366e-05 | -11.20 | anchoring junction | cellular component | GO:0070161 | 902 | 11 | 19108 | 49 |
FYB1,ARHGAP24,DNM2,DAB2,GAB1,ITGB2,HCK,ITGAV,PTPN12,TLN1,PTPN6 |
1.391e-05 | -11.18 | cell-substrate junction | cellular component | GO:0030055 | 437 | 8 | 19108 | 49 |
PTPN12,TLN1,ITGAV,HCK,ITGB2,DAB2,DNM2,ARHGAP24 |
1.927e-05 | -10.86 | response to external stimulus | biological process | GO:0009605 | 1882 | 16 | 18204 | 49 |
CD74,MCOLN2,FKBP5,DOCK2,GAB1,PTPN6,RBPJ,PTGIR,CD68,HCK,ITGB2,PREX1,DISC1,STAB1,TFEB,ITGAV |
2.152e-05 | -10.75 | ICAM-3 receptor activity | molecular function | GO:0030369 | 3 | 2 | 18094 | 49 |
ITGAL,ITGB2 |
2.358e-05 | -10.66 | lamellipodium membrane | cellular component | GO:0031258 | 22 | 3 | 19108 | 49 |
ITGAV,PLXND1,DOCK8 |
2.622e-05 | -10.55 | SRC (SRC proto-oncogene, non-receptor tyrosine kinase) | protein interactions | 6714 | 624 | 9 | 19454 | 50 |
MCOLN2,RXRA,TLN1,PTPN6,DNM2,HCK,FYB1,GAB1,DAB2 |
3.078e-05 | -10.39 | nef (Nef) | protein interactions | 156110 | 802 | 10 | 19454 | 50 |
RXRA,HCK,EHD4,DNM2,CD74,ITGAL,SLC9A7,TFEB,DAB2,DOCK2 |
3.124e-05 | -10.37 | INPP5D (inositol polyphosphate-5-phosphatase D) | protein interactions | 3635 | 70 | 4 | 19454 | 50 |
DAB2,ARAP1,HCK,GAB1 |
3.430e-05 | -10.28 | PH_DOMAIN | prosite domains | PS50003 | 246 | 7 | 12186 | 46 |
GAB1,DNM2,ARHGEF18,AKAP13,ARHGAP24,ARAP1,PREX1 |
3.515e-05 | -10.26 | regulation of cell shape | biological process | GO:0008360 | 139 | 5 | 18204 | 49 |
PLXND1,ARAP1,HCK,ITGB2,ARHGEF18 |
3.643e-05 | -10.22 | regulation of cellular component organization | biological process | GO:0051128 | 2455 | 18 | 18204 | 49 |
SEPTIN9,ITGAV,ARHGAP24,ARHGEF18,BMP2K,DAB2,EHD4,ARAP1,PLXND1,DISC1,TMSB4X,PREX1,TLN1,HCK,BTG1,DOCK2,AKAP13,DNM2 |
3.907e-05 | -10.15 | cell surface receptor signaling pathway | biological process | GO:0007166 | 1992 | 16 | 18204 | 49 |
PLXND1,DISC1,ITGB2,TLN1,HCK,TMSB4X,FYB1,ITGAV,DAB2,ITGAL,SH2B3,SPI1,CD74,RBPJ,GAB1,PTPN6 |
4.014e-05 | -10.12 | MET (MET proto-oncogene, receptor tyrosine kinase) | protein interactions | 4233 | 248 | 6 | 19454 | 50 |
HCK,CCND2,SH2B3,ITM2B,ITGAV,GAB1 |
4.083e-05 | -10.11 | Integrin_dom_sf | interpro domains | IPR032695 | 25 | 3 | 18521 | 50 |
ITGAL,ITGAV,ITGB2 |
4.197e-05 | -10.08 | positive regulation of cell adhesion | biological process | GO:0045785 | 486 | 8 | 18204 | 49 |
PTPN6,DAB2,ITGAV,CD74,PREX1,ITGB2,DISC1,DOCK8 |
4.233e-05 | -10.07 | regulation of molecular function | biological process | GO:0065009 | 2005 | 16 | 18204 | 49 |
ARAP1,PLXND1,DISC1,PREX1,TMSB4X,ITGB2,HCK,ARHGAP45,ITGAV,ARHGAP24,DAB2,SPI1,DOCK8,CD74,CCND2,RXRA |
4.284e-05 | -10.06 | regulation of signaling | biological process | GO:0023051 | 3534 | 22 | 18204 | 49 |
PTGIR,DOCK2,RBPJ,AKAP13,DOCK8,CD74,BMP2K,ARHGAP24,ITGAV,ARHGAP45,SH2B3,PTPN12,PREX1,TMSB4X,RXRA,PTPN6,DAB2,ARHGEF18,SPI1,RBM47,DISC1,ARAP1 |
4.389e-05 | -10.03 | NCK2 (NCK adaptor protein 2) | protein interactions | 8440 | 252 | 6 | 19454 | 50 |
GAB1,FYB1,BTG1,DISC1,ARAP1,PTPN12 |
4.422e-05 | -10.03 | regulation of cell communication | biological process | GO:0010646 | 3541 | 22 | 18204 | 49 |
ARHGAP45,ITGAV,ARHGAP24,DAB2,BMP2K,ARHGEF18,SH2B3,PTPN12,RBM47,SPI1,ARAP1,DISC1,TMSB4X,PREX1,PTGIR,RXRA,RBPJ,PTPN6,DOCK2,DOCK8,AKAP13,CD74 |
4.816e-05 | -9.94 | leukocyte migration | biological process | GO:0050900 | 245 | 6 | 18204 | 49 |
ITGAL,MCOLN2,HCK,PREX1,ITGB2,DOCK8 |
5.154e-05 | -9.87 | T cell proliferation | biological process | GO:0042098 | 76 | 4 | 18204 | 49 |
DOCK2,PTPN6,ELF4,DOCK8 |
5.439e-05 | -9.82 | positive regulation of cellular process | biological process | GO:0048522 | 5719 | 29 | 18204 | 49 |
TMSB4X,PREX1,ELF4,ITGAV,BMP2K,DOCK8,AKAP13,CD74,MCOLN2,CCND2,RBPJ,DOCK2,DISC1,PLXND1,ARAP1,HCK,ITGB2,EHD4,ZFP36L1,DAB2,TFEB,SPI1,RBM47,SEPTIN9,DNM2,RXRA,GAB1,BTG1,PTPN6 |
5.476e-05 | -9.81 | specific granule | cellular component | GO:0042581 | 160 | 5 | 19108 | 49 |
ITGB2,DOCK2,ITGAV,PTPN6,ITGAL |
5.952e-05 | -9.73 | regulation of intracellular signal transduction | biological process | GO:1902531 | 1832 | 15 | 18204 | 49 |
CD74,DOCK8,AKAP13,PTPN6,DOCK2,TMSB4X,PREX1,ARAP1,SPI1,SH2B3,ARHGAP24,ARHGEF18,DAB2,ARHGAP45,ITGAV |
6.400e-05 | -9.66 | regulation of vesicle-mediated transport | biological process | GO:0060627 | 516 | 8 | 18204 | 49 |
EHD4,ITGB2,HCK,SPI1,DOCK2,ITGAV,BMP2K,DAB2 |
6.674e-05 | -9.61 | phagocytosis | biological process | GO:0006909 | 159 | 5 | 18204 | 49 |
DNM2,ITGAL,ITGB2,HCK,ITGAV |
6.772e-05 | -9.60 | integrin complex | cellular component | GO:0008305 | 31 | 3 | 19108 | 49 |
ITGAL,ITGAV,ITGB2 |
6.876e-05 | -9.58 | oesophagus-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-carcinoma-squamous_cell_carcinoma | 6486 | 31 | 16828 | 46 |
PTPN12,GAB1,CCND2,SPI1,ITGAL,ME1,ELF4,HEPHL1,WDFY3,DOCK8,PLXND1,TFEB,HCK,ITGAV,PTGIR,TLN1,SLC9A7,ITGB2,RXRA,DNM2,RBPJ,ARHGEF18,FKBP5,AKAP13,ARHGAP24,DAB2,MYO1F,DOCK2,ARAP1,ANTXR2,DISC1 |
7.391e-05 | -9.51 | enzyme binding | molecular function | GO:0019899 | 2086 | 16 | 18094 | 49 |
TMSB4X,ITGB2,PTPN6,PREX1,ITGAV,SH2B3,SPI1,RXRA,DOCK2,AKAP13,DNM2,CCND2,RBM47,TFEB,CD74,BTG1 |
7.735e-05 | -9.47 | receptor complex | cellular component | GO:0043235 | 409 | 7 | 19108 | 49 |
ITGAL,PLXND1,CD74,PTPN6,RXRA,ITGB2,ITGAV |
7.905e-05 | -9.45 | hemopoiesis | biological process | GO:0030097 | 688 | 9 | 18204 | 49 |
SH2B3,RBPJ,PTPN6,RBM47,DOCK2,SPI1,ZFP36L1,CD74,PREX1 |
8.442e-05 | -9.38 | ntegrin, alpha v. Chain A, domain 3 | gene3d domains | 2.60.40.1510 | 26 | 3 | 14470 | 48 |
ITGB2,ITGAL,ITGAV |
9.037e-05 | -9.31 | SRMS (src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites) | protein interactions | 6725 | 34 | 3 | 19454 | 50 |
HCK,FKBP5,HEPHL1 |
9.564e-05 | -9.25 | leading edge membrane | cellular component | GO:0031256 | 180 | 5 | 19108 | 49 |
DOCK8,ARHGAP45,PLXND1,ITGAV,TLN1 |
9.614e-05 | -9.25 | actin cytoskeleton organization | biological process | GO:0030036 | 547 | 8 | 18204 | 49 |
DNM2,TLN1,TMSB4X,PREX1,ARAP1,DOCK2,ARHGEF18,MYO1F |
9.647e-05 | -9.25 | EBNA-2 (nuclear antigen EBNA-2) | protein interactions | 3783761 | 6 | 2 | 19454 | 50 |
RBPJ,SPI1 |
9.684e-05 | -9.24 | regulation of GTPase activity | biological process | GO:0043087 | 278 | 6 | 18204 | 49 |
ARHGAP45,ARHGAP24,ARAP1,PLXND1,DOCK8,PREX1 |
1.006e-04 | -9.20 | positive regulation of multicellular organismal process | biological process | GO:0051240 | 1691 | 14 | 18204 | 49 |
CD74,MCOLN2,DOCK8,RBPJ,GAB1,BTG1,PTPN6,RXRA,PLXND1,DISC1,SPI1,RBM47,ZFP36L1,DAB2 |
1.012e-04 | -9.20 | Rho_GTPase_activation_prot | interpro domains | IPR008936 | 90 | 4 | 18521 | 50 |
ARHGAP45,PLXND1,ARAP1,ARHGAP24 |
1.018e-04 | -9.19 | Cell surface interactions at the vascular wall | REACTOME pathways | R-HSA-202733 | 136 | 5 | 10285 | 36 |
ITGAV,ITGAL,ITGB2,PTPN6,CD74 |
1.034e-04 | -9.18 | regulation of B cell differentiation | biological process | GO:0045577 | 34 | 3 | 18204 | 49 |
ZFP36L1,PTPN6,SPI1 |
1.167e-04 | -9.06 | PTK2B (protein tyrosine kinase 2 beta) | protein interactions | 2185 | 98 | 4 | 19454 | 50 |
ITGB2,PTPN12,TLN1,PTPN6 |
1.221e-04 | -9.01 | lymphocyte differentiation | biological process | GO:0030098 | 290 | 6 | 18204 | 49 |
CD74,PREX1,DOCK2,SPI1,RBPJ,ZFP36L1 |
1.246e-04 | -8.99 | intracellular signal transduction | biological process | GO:0035556 | 1505 | 13 | 18204 | 49 |
PTPN6,DOCK2,RGL1,DOCK8,AKAP13,MCOLN2,ARHGEF18,ZFP36L1,ITGAV,SH2B3,HCK,PREX1,DISC1 |
1.262e-04 | -8.98 | T cell differentiation | biological process | GO:0030217 | 182 | 5 | 18204 | 49 |
PREX1,ZFP36L1,CD74,SPI1,DOCK2 |
1.265e-04 | -8.98 | STK33 (serine/threonine kinase 33) | protein interactions | 65975 | 38 | 3 | 19454 | 50 |
FKBP5,HCK,TLN1 |
1.314e-04 | -8.94 | GRB2 (growth factor receptor bound protein 2) | protein interactions | 2885 | 769 | 9 | 19454 | 50 |
PTPN12,DAB2,BTG1,GAB1,WDFY3,DNM2,ARAP1,PTPN6,SH2B3 |
1.340e-04 | -8.92 | regulation of endocytosis | biological process | GO:0030100 | 295 | 6 | 18204 | 49 |
BMP2K,HCK,DAB2,ITGAV,DOCK2,EHD4 |
1.370e-04 | -8.90 | positive regulation of biological process | biological process | GO:0048518 | 6326 | 30 | 18204 | 49 |
TMSB4X,PREX1,ELF4,FYB1,ITGAV,BMP2K,DOCK8,AKAP13,MCOLN2,CD74,CCND2,RBPJ,DOCK2,ARAP1,PLXND1,DISC1,HCK,ITGB2,EHD4,TFEB,DAB2,ZFP36L1,SEPTIN9,RBM47,SPI1,DNM2,RXRA,PTPN6,GAB1,BTG1 |
1.421e-04 | -8.86 | enzyme regulator activity | molecular function | GO:0030234 | 1305 | 12 | 18094 | 49 |
PREX1,DOCK2,ARAP1,BMP2K,ARHGAP24,ARHGAP45,PTGIR,DOCK8,RGL1,ARHGEF18,CCND2,AKAP13 |
1.483e-04 | -8.82 | regulation of biological process | biological process | GO:0050789 | 12079 | 44 | 18204 | 49 |
AKAP13,PTGIR,CD68,DOCK2,PREX1,TLN1,ME1,FYB1,ARHGAP24,STAB1,SH2B3,GAB1,PTPN6,ITGB2,DISC1,PLXND1,EHD4,TFEB,RBM47,ITM2B,DOCK8,CD74,MCOLN2,CCND2,RBPJ,TMSB4X,ELF4,BMP2K,ITGAV,ARHGAP45,PTPN12,DNM2,RGL1,RXRA,BTG1,HCK,SLC9A7,ARAP1,ZFP36L1,DAB2,ITGAL,ARHGEF18,SPI1,SEPTIN9 |
1.487e-04 | -8.81 | PH_16 | interpro domains | IPR041020 | 7 | 2 | 18521 | 50 |
AKAP13,ARHGEF18 |
1.502e-04 | -8.80 | hematopoietic progenitor cell differentiation | biological process | GO:0002244 | 100 | 4 | 18204 | 49 |
SH2B3,PTPN6,RBM47,SPI1 |
1.531e-04 | -8.78 | FGFR4 (fibroblast growth factor receptor 4) | protein interactions | 2264 | 455 | 7 | 19454 | 50 |
CCND2,DNM2,PTPN6,SEPTIN9,PTPN12,DAB2,GAB1 |
1.546e-04 | -8.77 | PH_16 | pfam domains | PF17838 | 7 | 2 | 17795 | 49 |
AKAP13,ARHGEF18 |
1.581e-04 | -8.75 | THRA (thyroid hormone receptor alpha) | protein interactions | 7067 | 106 | 4 | 19454 | 50 |
RXRA,AKAP13,ARHGAP24,BTG1 |
1.592e-04 | -8.75 | PH | pfam domains | PF00169 | 187 | 5 | 17795 | 49 |
ARAP1,SH2B3,ARHGAP24,DNM2,GAB1 |
1.757e-04 | -8.65 | Focal Adhesion | WikiPathways | WP306 | 195 | 6 | 5310 | 24 |
ITGAV,TLN1,HCK,ITGB2,CCND2,ITGAL |
1.818e-04 | -8.61 | cell adhesion mediated by integrin | biological process | GO:0033627 | 41 | 3 | 18204 | 49 |
ITGAV,ITGAL,ITGB2 |
1.834e-04 | -8.60 | ITGA1 (integrin subunit alpha 1) | protein interactions | 3672 | 43 | 3 | 19454 | 50 |
TLN1,PTPN6,DISC1 |
1.834e-04 | -8.60 | BLNK (B cell linker) | protein interactions | 29760 | 43 | 3 | 19454 | 50 |
GAB1,PTPN6,TLN1 |
1.964e-04 | -8.54 | HOXA10 (homeobox A10) | protein interactions | 3206 | 44 | 3 | 19454 | 50 |
PTPN6,SPI1,RBPJ |
1.967e-04 | -8.53 | regulation of neutrophil degranulation | biological process | GO:0043313 | 8 | 2 | 18204 | 49 |
ITGB2,SPI1 |
2.058e-04 | -8.49 | Integrin_alpha | pfam domains | PF00357 | 8 | 2 | 17795 | 49 |
ITGAV,ITGAL |
2.097e-04 | -8.47 | cellular response to epidermal growth factor stimulus | biological process | GO:0071364 | 43 | 3 | 18204 | 49 |
PTPN12,DAB2,ZFP36L1 |
2.175e-04 | -8.43 | actin filament-based process | biological process | GO:0030029 | 616 | 8 | 18204 | 49 |
ARHGEF18,MYO1F,DOCK2,DNM2,TMSB4X,PREX1,TLN1,ARAP1 |
2.280e-04 | -8.39 | cell differentiation | biological process | GO:0030154 | 3645 | 21 | 18204 | 49 |
ITGAV,ARHGAP24,DAB2,ZFP36L1,SH2B3,RBM47,SPI1,PLXND1,DISC1,ITGB2,HCK,PREX1,ELF4,RXRA,RBPJ,PTPN6,DOCK2,AKAP13,LRMDA,DNM2,CD74 |
2.307e-04 | -8.37 | cellular developmental process | biological process | GO:0048869 | 3648 | 21 | 18204 | 49 |
AKAP13,LRMDA,DNM2,CD74,RXRA,RBPJ,PTPN6,DOCK2,DISC1,PLXND1,HCK,PREX1,ITGB2,ELF4,ITGAV,ARHGAP24,ZFP36L1,DAB2,SH2B3,RBM47,SPI1 |
2.349e-04 | -8.36 | GSK3B (glycogen synthase kinase 3 beta) | protein interactions | 2932 | 831 | 9 | 19454 | 50 |
GAB1,DISC1,FKBP5,SPI1,DAB2,PTPN12,RBPJ,SEPTIN9,RXRA |
2.383e-04 | -8.34 | vesicle | cellular component | GO:0031982 | 4141 | 22 | 19108 | 49 |
PTPN6,DISC1,CD74,HCK,ITGB2,ARHGAP45,ITM2B,DAB2,DNM2,CD68,STAB1,FKBP5,SLC9A7,DOCK2,ARHGEF18,ITGAL,TLN1,ITGAV,MCOLN2,EHD4,TMSB4X,ANTXR2 |
2.513e-04 | -8.29 | positive regulation of GTPase activity | biological process | GO:0043547 | 211 | 5 | 18204 | 49 |
ARHGAP24,PREX1,ARHGAP45,ARAP1,DOCK8 |
2.539e-04 | -8.28 | regulation of multicellular organismal process | biological process | GO:0051239 | 3113 | 19 | 18204 | 49 |
STAB1,SH2B3,SPI1,RBM47,ZFP36L1,BMP2K,DAB2,ELF4,DISC1,PLXND1,TMSB4X,RBPJ,BTG1,GAB1,PTPN6,RXRA,CD74,MCOLN2,DOCK8 |
2.649e-04 | -8.24 | SHC1 (SHC adaptor protein 1) | protein interactions | 6464 | 350 | 6 | 19454 | 50 |
DNM2,ARAP1,PTPN12,PTPN6,GAB1,ITGAV |
2.701e-04 | -8.22 | bounding membrane of organelle | cellular component | GO:0098588 | 2198 | 15 | 19108 | 49 |
ITGAV,ITGB2,ITGAL,SLC9A7,CD74,EHD4,WDFY3,ANTXR2,STAB1,MCOLN2,CD68,TFEB,DAB2,ITM2B,DNM2 |
2.734e-04 | -8.20 | response to epidermal growth factor | biological process | GO:0070849 | 47 | 3 | 18204 | 49 |
ZFP36L1,DAB2,PTPN12 |
2.864e-04 | -8.16 | upper_aerodigestive_tract-head_neck-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-head_neck-carcinoma-squamous_cell_carcinoma | 9263 | 37 | 16828 | 46 |
RXRA,DNM2,ITGB2,PREX1,SLC9A7,TLN1,ITGAV,TFEB,HCK,STAB1,RBM47,PTPN6,ARAP1,DOCK2,ZFP36L1,MYO1F,BTG1,ARHGAP24,DAB2,ARHGEF18,FKBP5,RBPJ,AKAP13,EHD4,ME1,RGL1,SPI1,ITGAL,CCND2,GAB1,PTPN12,MCOLN2,PLXND1,WDFY3,DOCK8,ELF4,BMP2K |
2.978e-04 | -8.12 | regulation of actin cytoskeleton organization | biological process | GO:0032956 | 342 | 6 | 18204 | 49 |
PREX1,TMSB4X,HCK,ARAP1,AKAP13,ARHGEF18 |
3.050e-04 | -8.10 | CD247 (CD247 molecule) | protein interactions | 919 | 51 | 3 | 19454 | 50 |
DOCK2,PTPN6,SH2B3 |
3.150e-04 | -8.06 | positive regulation of monocyte differentiation | biological process | GO:0045657 | 10 | 2 | 18204 | 49 |
ZFP36L1,CD74 |
3.177e-04 | -8.05 | defense response | biological process | GO:0006952 | 1431 | 12 | 18204 | 49 |
MCOLN2,CD74,ITGB2,HCK,RBPJ,STAB1,PTPN6,SPI1,PTGIR,CD68,TFEB,ITGAL |
3.292e-04 | -8.02 | Nef and signal transduction | REACTOME pathways | R-HSA-164944 | 8 | 2 | 10285 | 36 |
HCK,DOCK2 |
3.292e-04 | -8.02 | kidney-carcinoma | COSMIC cancer mutations | kidney-carcinoma | 3720 | 21 | 16828 | 46 |
PTPN6,ELF4,DAB2,ARHGAP24,BTG1,AKAP13,RBPJ,ARHGEF18,FKBP5,BMP2K,RGL1,RXRA,SPI1,ITGB2,CCND2,PREX1,TFEB,HCK,PTPN12,ITGAV,GAB1 |
3.387e-04 | -7.99 | actin cytoskeleton | cellular component | GO:0015629 | 520 | 7 | 19108 | 49 |
DNM2,MYO1F,FYB1,PTPN12,HCK,SEPTIN9,AKAP13 |
3.447e-04 | -7.97 | intracellular signaling cassette | biological process | GO:0141124 | 837 | 9 | 18204 | 49 |
ITGAV,ARHGEF18,ZFP36L1,DOCK2,PTPN6,AKAP13,DOCK8,RGL1,MCOLN2 |
3.613e-04 | -7.93 | LCP2 (lymphocyte cytosolic protein 2) | protein interactions | 3937 | 54 | 3 | 19454 | 50 |
PTPN6,HCK,FYB1 |
3.737e-04 | -7.89 | oesophagus-lower_third-carcinoma-adenocarcinoma | COSMIC cancer mutations | oesophagus-lower_third-carcinoma-adenocarcinoma | 6302 | 29 | 16828 | 46 |
DAB2,EHD4,AKAP13,FKBP5,ARHGEF18,RBPJ,DISC1,ANTXR2,ARAP1,MYO1F,DOCK2,PREX1,ITGAV,TFEB,STAB1,DNM2,RXRA,ITM2B,ITGB2,HEPHL1,ELF4,PLXND1,WDFY3,CCND2,PTPN12,RGL1,SH2B3,ITGAL,SPI1 |
3.784e-04 | -7.88 | protein binding | molecular function | GO:0005515 | 13983 | 47 | 18094 | 49 |
RXRA,PTPN12,HCK,ITGAL,EHD4,AKAP13,ARHGAP45,CD74,TMSB4X,PTPN6,ITM2B,DISC1,WDFY3,DAB2,RBM47,TFEB,GAB1,PREX1,ARAP1,FKBP5,ARHGEF18,PLXND1,RBPJ,TLN1,ME1,BMP2K,DOCK2,CCND2,ZFP36L1,DNM2,ARHGAP24,FYB1,MYO1F,SH2B3,ELF4,CD68,RGL1,DOCK8,SPI1,STAB1,SEPTIN9,MCOLN2,BTG1,ITGB2,ANTXR2,ITGAV,SLC9A7 |
3.801e-04 | -7.88 | regulation of biological quality | biological process | GO:0065008 | 2936 | 18 | 18204 | 49 |
DNM2,PTPN6,PTGIR,SLC9A7,DISC1,PLXND1,ARAP1,TLN1,PREX1,TMSB4X,HCK,ITGB2,SH2B3,RBM47,ITGAV,ARHGEF18,ZFP36L1,DAB2 |
3.844e-04 | -7.86 | positive regulation of chemokine (C-X-C motif) ligand 2 production | biological process | GO:2000343 | 11 | 2 | 18204 | 49 |
MCOLN2,CD74 |
3.844e-04 | -7.86 | pinocytosis | biological process | GO:0006907 | 11 | 2 | 18204 | 49 |
EHD4,DOCK2 |
3.844e-04 | -7.86 | regulation of dendritic cell antigen processing and presentation | biological process | GO:0002604 | 11 | 2 | 18204 | 49 |
CD68,CD74 |
3.868e-04 | -7.86 | DOCKER_Lobe_A | interpro domains | IPR046769 | 11 | 2 | 18521 | 50 |
DOCK8,DOCK2 |
3.868e-04 | -7.86 | DOCK | interpro domains | IPR026791 | 11 | 2 | 18521 | 50 |
DOCK2,DOCK8 |
3.868e-04 | -7.86 | DOCKER_Lobe_B | interpro domains | IPR046770 | 11 | 2 | 18521 | 50 |
DOCK8,DOCK2 |
3.868e-04 | -7.86 | DOCK_C_lobe_A | interpro domains | IPR043161 | 11 | 2 | 18521 | 50 |
DOCK8,DOCK2 |
3.868e-04 | -7.86 | C2_DOCK-type_domain | interpro domains | IPR027007 | 11 | 2 | 18521 | 50 |
DOCK2,DOCK8 |
3.868e-04 | -7.86 | DOCK_C_lobe_C | interpro domains | IPR043162 | 11 | 2 | 18521 | 50 |
DOCK2,DOCK8 |
3.868e-04 | -7.86 | DOCKER_dom | interpro domains | IPR027357 | 11 | 2 | 18521 | 50 |
DOCK2,DOCK8 |
3.868e-04 | -7.86 | DOCKER_Lobe_C | interpro domains | IPR046773 | 11 | 2 | 18521 | 50 |
DOCK8,DOCK2 |
3.868e-04 | -7.86 | regulation of B cell activation | biological process | GO:0050864 | 128 | 4 | 18204 | 49 |
CD74,PTPN6,SPI1,ZFP36L1 |
4.021e-04 | -7.82 | DHR-2_Lobe_A | pfam domains | PF06920 | 11 | 2 | 17795 | 49 |
DOCK8,DOCK2 |
4.021e-04 | -7.82 | DHR-2_Lobe_B | pfam domains | PF20422 | 11 | 2 | 17795 | 49 |
DOCK2,DOCK8 |
4.021e-04 | -7.82 | DOCK-C2 | pfam domains | PF14429 | 11 | 2 | 17795 | 49 |
DOCK2,DOCK8 |
4.021e-04 | -7.82 | DHR-2_Lobe_C | pfam domains | PF20421 | 11 | 2 | 17795 | 49 |
DOCK2,DOCK8 |
4.102e-04 | -7.80 | lymphocyte proliferation | biological process | GO:0046651 | 130 | 4 | 18204 | 49 |
DOCK8,PTPN6,DOCK2,ELF4 |
4.152e-04 | -7.79 | mononuclear cell differentiation | biological process | GO:1903131 | 364 | 6 | 18204 | 49 |
PREX1,CD74,ZFP36L1,RBPJ,DOCK2,SPI1 |
4.207e-04 | -7.77 | protein complex involved in cell adhesion | cellular component | GO:0098636 | 57 | 3 | 19108 | 49 |
ITGAL,ITGAV,ITGB2 |
4.223e-04 | -7.77 | Formation of annular gap junctions | REACTOME pathways | R-HSA-196025 | 9 | 2 | 10285 | 36 |
DNM2,DAB2 |
4.291e-04 | -7.75 | ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase) | protein interactions | 25 | 248 | 5 | 19454 | 50 |
HCK,PTPN12,CCND2,PTPN6,BMP2K |
4.432e-04 | -7.72 | regulation of multicellular organismal development | biological process | GO:2000026 | 1484 | 12 | 18204 | 49 |
BMP2K,ZFP36L1,STAB1,SPI1,PLXND1,DISC1,RXRA,RBPJ,GAB1,BTG1,PTPN6,CD74 |
4.498e-04 | -7.71 | positive regulation of catalytic activity | biological process | GO:0043085 | 868 | 9 | 18204 | 49 |
CD74,PREX1,TMSB4X,ITGB2,ARAP1,DOCK8,CCND2,ARHGAP24,ARHGAP45 |
4.601e-04 | -7.68 | mononuclear cell proliferation | biological process | GO:0032943 | 134 | 4 | 18204 | 49 |
DOCK2,PTPN6,ELF4,DOCK8 |
4.605e-04 | -7.68 | positive thymic T cell selection | biological process | GO:0045059 | 12 | 2 | 18204 | 49 |
DOCK2,CD74 |
4.605e-04 | -7.68 | negative thymic T cell selection | biological process | GO:0045060 | 12 | 2 | 18204 | 49 |
CD74,DOCK2 |
4.660e-04 | -7.67 | non-membrane spanning protein tyrosine phosphatase activity | molecular function | GO:0004726 | 12 | 2 | 18094 | 49 |
PTPN6,PTPN12 |
4.845e-04 | -7.63 | biological regulation | biological process | GO:0065007 | 12501 | 44 | 18204 | 49 |
ELF4,FYB1,TLN1,TMSB4X,PREX1,ME1,STAB1,PTPN12,SH2B3,ITGAV,ARHGAP45,BMP2K,ARHGAP24,CD74,MCOLN2,AKAP13,DOCK8,RBPJ,DOCK2,CD68,PTGIR,CCND2,EHD4,DISC1,PLXND1,SLC9A7,ARAP1,ITGB2,HCK,SPI1,SEPTIN9,ITM2B,RBM47,DAB2,ZFP36L1,ARHGEF18,ITGAL,TFEB,DNM2,RGL1,GAB1,BTG1,PTPN6,RXRA |
4.990e-04 | -7.60 | thyroid-carcinoma | COSMIC cancer mutations | thyroid-carcinoma | 4126 | 22 | 16828 | 46 |
PLXND1,ANTXR2,RBM47,WDFY3,DOCK2,DOCK8,ARAP1,ELF4,AKAP13,RBPJ,CD74,ARHGEF18,DNM2,RGL1,SH2B3,RXRA,ITGAL,SPI1,PREX1,STAB1,MCOLN2,ITGAV |
5.040e-04 | -7.59 | PRKCA (protein kinase C alpha) | protein interactions | 5578 | 395 | 6 | 19454 | 50 |
PTPN12,AKAP13,PTPN6,PTGIR,ITGB2,SEPTIN9 |
5.074e-04 | -7.59 | SNW1 (SNW domain containing 1) | protein interactions | 22938 | 731 | 8 | 19454 | 50 |
TLN1,DNM2,ARAP1,EHD4,RXRA,SEPTIN9,DOCK2,RBPJ |
5.080e-04 | -7.58 | regulation of cell morphogenesis | biological process | GO:0022604 | 246 | 5 | 18204 | 49 |
ARAP1,PLXND1,ARHGEF18,ITGB2,HCK |
5.220e-04 | -7.56 | negative regulation of biological process | biological process | GO:0048519 | 5737 | 27 | 18204 | 49 |
TMSB4X,ELF4,ARHGAP24,ITGAV,SH2B3,PTPN12,STAB1,DOCK8,CD74,CCND2,CD68,PTGIR,RBPJ,HCK,ITGB2,ARAP1,PLXND1,ZFP36L1,DAB2,ARHGEF18,RBM47,ITM2B,SPI1,DNM2,RXRA,PTPN6,BTG1 |
5.225e-04 | -7.56 | KDR (kinase insert domain receptor) | protein interactions | 3791 | 145 | 4 | 19454 | 50 |
PTPN6,DNM2,PTPN12,PLXND1 |
5.267e-04 | -7.55 | Gap junction degradation | REACTOME pathways | R-HSA-190873 | 10 | 2 | 10285 | 36 |
DNM2,DAB2 |
5.281e-04 | -7.55 | lung-carcinoma-small_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-small_cell_carcinoma | 9908 | 38 | 16828 | 46 |
RGL1,SH2B3,ME1,ITGAL,SPI1,CCND2,MCOLN2,PTPN12,GAB1,PLXND1,WDFY3,DOCK8,ELF4,BMP2K,DNM2,ITGB2,TLN1,SLC9A7,PREX1,PTGIR,HCK,STAB1,TFEB,ITGAV,PTPN6,DISC1,RBM47,MYO1F,DOCK2,ARAP1,DAB2,ARHGAP24,BTG1,EHD4,AKAP13,RBPJ,FKBP5,ARHGEF18 |
5.355e-04 | -7.53 | small_cell_carcinoma | COSMIC cancer mutations | small_cell_carcinoma | 9913 | 38 | 16828 | 46 |
PREX1,PTGIR,SLC9A7,TLN1,TFEB,HCK,STAB1,ITGAV,DNM2,ITGB2,ARHGAP24,BTG1,DAB2,RBPJ,FKBP5,ARHGEF18,AKAP13,EHD4,RBM47,PTPN6,DISC1,MYO1F,DOCK2,ARAP1,CCND2,MCOLN2,PTPN12,GAB1,SH2B3,RGL1,ME1,SPI1,ITGAL,ELF4,BMP2K,PLXND1,DOCK8,WDFY3 |
5.382e-04 | -7.53 | human chr4q21.21 | chromosome location | human chr4q21.21 | 18 | 2 | 26134 | 50 |
BMP2K,ANTXR2 |
5.432e-04 | -7.52 | negative regulation of platelet-derived growth factor receptor signaling pathway | biological process | GO:0010642 | 13 | 2 | 18204 | 49 |
PTPN12,PTGIR |
5.432e-04 | -7.52 | negative T cell selection | biological process | GO:0043383 | 13 | 2 | 18204 | 49 |
DOCK2,CD74 |
5.507e-04 | -7.50 | cytokine-mediated signaling pathway | biological process | GO:0019221 | 384 | 6 | 18204 | 49 |
TMSB4X,HCK,CD74,SH2B3,SPI1,PTPN6 |
5.507e-04 | -7.50 | regulation of actin filament-based process | biological process | GO:0032970 | 384 | 6 | 18204 | 49 |
AKAP13,ARAP1,TMSB4X,PREX1,HCK,ARHGEF18 |
5.572e-04 | -7.49 | regulation of anatomical structure morphogenesis | biological process | GO:0022603 | 894 | 9 | 18204 | 49 |
GAB1,BTG1,STAB1,ARHGEF18,ITGB2,HCK,ARAP1,PLXND1,DISC1 |
5.776e-04 | -7.46 | ITGAL (integrin subunit alpha L) | protein interactions | 3683 | 14 | 2 | 19454 | 50 |
ITGAL,ITGB2 |
5.814e-04 | -7.45 | - | gene3d domains | 1.25.40.410 | 11 | 2 | 14470 | 48 |
DOCK2,DOCK8 |
5.814e-04 | -7.45 | - | gene3d domains | 1.20.58.740 | 11 | 2 | 14470 | 48 |
DOCK8,DOCK2 |
5.815e-04 | -7.45 | regulation of supramolecular fiber organization | biological process | GO:1902903 | 388 | 6 | 18204 | 49 |
ARHGEF18,HCK,PREX1,TMSB4X,AKAP13,ARAP1 |
5.877e-04 | -7.44 | mesothelioma | COSMIC cancer mutations | mesothelioma | 4477 | 23 | 16828 | 46 |
ITGB2,PREX1,SLC9A7,TLN1,TFEB,HCK,ITGAV,PTPN6,ARHGAP24,BTG1,DAB2,RBPJ,FKBP5,ARHGEF18,AKAP13,RGL1,SH2B3,SPI1,CCND2,PTPN12,GAB1,ELF4,BMP2K |
6.244e-04 | -7.38 | pleura-mesothelioma | COSMIC cancer mutations | pleura-mesothelioma | 4189 | 22 | 16828 | 46 |
ELF4,BMP2K,CCND2,PTPN12,GAB1,RGL1,SPI1,DAB2,ARHGAP24,BTG1,AKAP13,RBPJ,FKBP5,ARHGEF18,PTPN6,TLN1,SLC9A7,PREX1,TFEB,HCK,ITGAV,ITGB2 |
6.327e-04 | -7.37 | alpha-beta T cell proliferation | biological process | GO:0046633 | 14 | 2 | 18204 | 49 |
DOCK2,ELF4 |
6.327e-04 | -7.37 | immunological synapse formation | biological process | GO:0001771 | 14 | 2 | 18204 | 49 |
DOCK2,DOCK8 |
6.350e-04 | -7.36 | positive regulation of response to stimulus | biological process | GO:0048584 | 2266 | 15 | 18204 | 49 |
SPI1,RBM47,BMP2K,DAB2,ITGAV,FYB1,TMSB4X,ITGB2,HCK,DISC1,PTPN6,RBPJ,RXRA,CD74,AKAP13 |
6.366e-04 | -7.36 | G_DYNAMIN_dom | interpro domains | IPR030381 | 14 | 2 | 18521 | 50 |
EHD4,DNM2 |
6.518e-04 | -7.34 | cell population proliferation | biological process | GO:0008283 | 726 | 8 | 18204 | 49 |
DISC1,DOCK8,ELF4,ZFP36L1,RBPJ,DOCK2,BTG1,PTPN6 |
6.581e-04 | -7.33 | protein-containing complex binding | molecular function | GO:0044877 | 1772 | 13 | 18094 | 49 |
CD74,BMP2K,STAB1,DOCK2,DISC1,ITGAL,RBPJ,ITGAV,SPI1,TLN1,ITGB2,FYB1,MYO1F |
6.654e-04 | -7.32 | TIAM2 (TIAM Rac1 associated GEF 2) | protein interactions | 26230 | 15 | 2 | 19454 | 50 |
DISC1,DNM2 |
6.835e-04 | -7.29 | ERBB2 (erb-b2 receptor tyrosine kinase 2) | protein interactions | 2064 | 583 | 7 | 19454 | 50 |
SH2B3,CCND2,HCK,PTPN6,TLN1,ITGAV,GAB1 |
6.956e-04 | -7.27 | inflammatory response | biological process | GO:0006954 | 559 | 7 | 18204 | 49 |
HCK,ITGB2,RBPJ,STAB1,CD68,PTGIR,ITGAL |
7.004e-04 | -7.26 | cellular response to cytokine stimulus | biological process | GO:0071345 | 734 | 8 | 18204 | 49 |
ZFP36L1,PTPN6,SPI1,SH2B3,HCK,TMSB4X,DOCK8,CD74 |
7.119e-04 | -7.25 | T cell differentiation in thymus | biological process | GO:0033077 | 65 | 3 | 18204 | 49 |
CD74,DOCK2,ZFP36L1 |
7.156e-04 | -7.24 | renal_cell_carcinoma | COSMIC cancer mutations | renal_cell_carcinoma | 4535 | 23 | 16828 | 46 |
HCK,TFEB,ITGAV,PREX1,SLC9A7,TLN1,ITGB2,RBPJ,ARHGEF18,FKBP5,AKAP13,ARHGAP24,BTG1,DAB2,DOCK2,PTPN6,PTPN12,GAB1,CCND2,SPI1,RGL1,BMP2K,ELF4 |
7.156e-04 | -7.24 | kidney-carcinoma-renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-renal_cell_carcinoma | 4535 | 23 | 16828 | 46 |
SPI1,RGL1,GAB1,PTPN12,CCND2,BMP2K,ELF4,ITGB2,ITGAV,TFEB,HCK,PREX1,SLC9A7,TLN1,DOCK2,PTPN6,FKBP5,ARHGEF18,RBPJ,AKAP13,BTG1,ARHGAP24,DAB2 |
7.188e-04 | -7.24 | RhoGAP_dom | interpro domains | IPR000198 | 65 | 3 | 18521 | 50 |
ARHGAP45,ARHGAP24,ARAP1 |
7.284e-04 | -7.22 | cell adhesion molecule binding | molecular function | GO:0050839 | 560 | 7 | 18094 | 49 |
ITGB2,ITGAL,SEPTIN9,PTPN6,ITGAV,EHD4,TLN1 |
7.333e-04 | -7.22 | Dynamin_N | interpro domains | IPR045063 | 15 | 2 | 18521 | 50 |
EHD4,DNM2 |
7.444e-04 | -7.20 | neutrophil migration | biological process | GO:1990266 | 66 | 3 | 18204 | 49 |
ITGB2,PREX1,MCOLN2 |
7.503e-04 | -7.20 | DOCKER | prosite domains | PS51651 | 11 | 2 | 12186 | 46 |
DOCK8,DOCK2 |
7.503e-04 | -7.20 | C2_DOCK | prosite domains | PS51650 | 11 | 2 | 12186 | 46 |
DOCK2,DOCK8 |
7.575e-04 | -7.19 | leukocyte proliferation | biological process | GO:0070661 | 153 | 4 | 18204 | 49 |
DOCK8,PTPN6,DOCK2,ELF4 |
7.592e-04 | -7.18 | ESM1 (endothelial cell specific molecule 1) | protein interactions | 11082 | 16 | 2 | 19454 | 50 |
ITGB2,ITGAL |
7.601e-04 | -7.18 | RhoGAP | pfam domains | PF00620 | 65 | 3 | 17795 | 49 |
ARAP1,ARHGAP45,ARHGAP24 |
7.611e-04 | -7.18 | regulation of actin filament organization | biological process | GO:0110053 | 269 | 5 | 18204 | 49 |
ARAP1,HCK,ARHGEF18,PREX1,TMSB4X |
7.623e-04 | -7.18 | Dynamin_N | pfam domains | PF00350 | 15 | 2 | 17795 | 49 |
EHD4,DNM2 |
7.691e-04 | -7.17 | PECAM1 interactions | REACTOME pathways | R-HSA-210990 | 12 | 2 | 10285 | 36 |
PTPN6,ITGAV |
7.747e-04 | -7.16 | ITGB3 (integrin subunit beta 3) | protein interactions | 3690 | 70 | 3 | 19454 | 50 |
ITGAV,TLN1,DAB2 |
7.851e-04 | -7.15 | lung-carcinoma | COSMIC cancer mutations | lung-carcinoma | 4255 | 22 | 16828 | 46 |
ITGB2,SPI1,RGL1,GAB1,ITGAV,HCK,PTPN12,TFEB,PREX1,CCND2,SLC9A7,TLN1,PTPN6,ARHGEF18,BMP2K,FKBP5,RBPJ,AKAP13,BTG1,ARHGAP24,DAB2,ELF4 |
7.852e-04 | -7.15 | lung-carcinoma-non_small_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-non_small_cell_carcinoma | 5198 | 25 | 16828 | 46 |
PREX1,TLN1,SLC9A7,ITGAV,TFEB,HCK,ITGB2,BTG1,ARHGAP24,DAB2,ARHGEF18,FKBP5,RBPJ,AKAP13,PTPN6,ARAP1,CCND2,GAB1,PTPN12,ME1,RGL1,SPI1,ELF4,BMP2K,PLXND1 |
7.852e-04 | -7.15 | non_small_cell_carcinoma | COSMIC cancer mutations | non_small_cell_carcinoma | 5198 | 25 | 16828 | 46 |
GAB1,PTPN12,CCND2,SPI1,ME1,RGL1,BMP2K,ELF4,PLXND1,ITGAV,TFEB,HCK,SLC9A7,TLN1,PREX1,ITGB2,AKAP13,ARHGEF18,FKBP5,RBPJ,DAB2,BTG1,ARHGAP24,ARAP1,PTPN6 |
7.952e-04 | -7.14 | myeloid leukocyte activation | biological process | GO:0002274 | 155 | 4 | 18204 | 49 |
RBPJ,DOCK2,ITGB2,PREX1 |
8.050e-04 | -7.12 | molecular adaptor activity | molecular function | GO:0060090 | 1138 | 10 | 18094 | 49 |
AKAP13,RBM47,SH2B3,FKBP5,SPI1,BTG1,DAB2,GAB1,SEPTIN9,DISC1 |
8.315e-04 | -7.09 | wound healing, spreading of epidermal cells | biological process | GO:0035313 | 16 | 2 | 18204 | 49 |
ITGAV,ARHGAP24 |
8.356e-04 | -7.09 | GTPase activator activity | molecular function | GO:0005096 | 273 | 5 | 18094 | 49 |
DOCK2,ARAP1,PREX1,ARHGAP45,ARHGAP24 |
8.366e-04 | -7.09 | Integrin_alpha_Ig-like_1 | interpro domains | IPR013649 | 16 | 2 | 18521 | 50 |
ITGAL,ITGAV |
8.366e-04 | -7.09 | Integrin_alpha_C_CS | interpro domains | IPR018184 | 16 | 2 | 18521 | 50 |
ITGAL,ITGAV |
8.410e-04 | -7.08 | ITGB2 (integrin subunit beta 2) | protein interactions | 3689 | 72 | 3 | 19454 | 50 |
ITGB2,TLN1,ITGAL |
8.566e-04 | -7.06 | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-acute_lymphoblastic_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-acute_lymphoblastic_leukaemia | 156 | 4 | 16828 | 46 |
SPI1,HCK,BTG1,ARHGAP24 |
8.696e-04 | -7.05 | Integrin_A_Ig_1 | pfam domains | PF08441 | 16 | 2 | 17795 | 49 |
ITGAV,ITGAL |
8.735e-04 | -7.04 | integrin binding | molecular function | GO:0005178 | 158 | 4 | 18094 | 49 |
ITGAV,ITGB2,ITGAL,TLN1 |
8.753e-04 | -7.04 | ATG9A (autophagy related 9A) | protein interactions | 79065 | 439 | 6 | 19454 | 50 |
DAB2,DISC1,BMP2K,PTGIR,WDFY3,EHD4 |
8.822e-04 | -7.03 | actin filament organization | biological process | GO:0007015 | 278 | 5 | 18204 | 49 |
ARAP1,MYO1F,PREX1,TMSB4X,DNM2 |
8.923e-04 | -7.02 | DH-domain | interpro domains | IPR000219 | 70 | 3 | 18521 | 50 |
ARHGEF18,PREX1,AKAP13 |
9.003e-04 | -7.01 | FGFR1 (fibroblast growth factor receptor 1) | protein interactions | 2260 | 611 | 7 | 19454 | 50 |
ME1,BMP2K,GAB1,ITM2B,RXRA,SEPTIN9,DNM2 |
9.069e-04 | -7.01 | RALBP1 (ralA binding protein 1) | protein interactions | 10928 | 168 | 4 | 19454 | 50 |
BMP2K,SEPTIN9,HCK,RBM47 |
9.069e-04 | -7.01 | Signal regulatory protein (SIRP) family interactions | REACTOME pathways | R-HSA-391160 | 13 | 2 | 10285 | 36 |
FYB1,PTPN6 |
9.299e-04 | -6.98 | DBL_dom_sf | interpro domains | IPR035899 | 71 | 3 | 18521 | 50 |
PREX1,ARHGEF18,AKAP13 |
9.350e-04 | -6.97 | leukocyte differentiation | biological process | GO:0002521 | 425 | 6 | 18204 | 49 |
DOCK2,SPI1,RBPJ,ZFP36L1,CD74,PREX1 |
9.434e-04 | -6.97 | RhoGEF | pfam domains | PF00621 | 70 | 3 | 17795 | 49 |
PREX1,ARHGEF18,AKAP13 |
9.592e-04 | -6.95 | receptor-mediated endocytosis | biological process | GO:0006898 | 163 | 4 | 18204 | 49 |
STAB1,ITGB2,DNM2,DAB2 |
9.738e-04 | -6.93 | positive regulation of cell migration | biological process | GO:0030335 | 592 | 7 | 18204 | 49 |
GAB1,ITGAV,DAB2,CD74,DOCK8,PREX1,TMSB4X |
9.772e-04 | -6.93 | regulation of transport | biological process | GO:0051049 | 1621 | 12 | 18204 | 49 |
SPI1,BMP2K,DAB2,ITGAV,EHD4,ITGB2,TMSB4X,HCK,DOCK2,PTPN6,RXRA,CD74 |
1.016e-03 | -6.89 | cargo receptor activity | molecular function | GO:0038024 | 73 | 3 | 18094 | 49 |
ITGB2,STAB1,DAB2 |
1.033e-03 | -6.88 | NME2 (NME/NM23 nucleoside diphosphate kinase 2) | protein interactions | 4831 | 174 | 4 | 19454 | 50 |
AKAP13,ARHGAP24,DOCK8,PREX1 |
1.040e-03 | -6.87 | cell junction | cellular component | GO:0030054 | 2224 | 14 | 19108 | 49 |
FYB1,DAB2,ARHGAP24,DNM2,GAB1,ITGAV,TLN1,PTPN12,ITGB2,HCK,PTPN6,DISC1,PLXND1,ARHGEF18 |
1.043e-03 | -6.87 | negative regulation of intracellular signal transduction | biological process | GO:1902532 | 599 | 7 | 18204 | 49 |
CD74,TMSB4X,SH2B3,SPI1,PTPN6,DAB2,ARHGAP24 |
1.049e-03 | -6.86 | CDC5L (cell division cycle 5 like) | protein interactions | 988 | 817 | 8 | 19454 | 50 |
PTPN6,TLN1,DOCK8,DNM2,EHD4,SEPTIN9,STAB1,DISC1 |
1.053e-03 | -6.86 | Integrin-mediated Cell Adhesion | WikiPathways | WP185 | 103 | 4 | 5310 | 24 |
TLN1,ITGAL,ITGAV,ITGB2 |
1.054e-03 | -6.85 | blood vessel morphogenesis | biological process | GO:0048514 | 435 | 6 | 18204 | 49 |
PLXND1,RBPJ,GAB1,ITGAV,ZFP36L1,ARHGAP24 |
1.055e-03 | -6.85 | WARS1 (tryptophanyl-tRNA synthetase 1) | protein interactions | 7453 | 175 | 4 | 19454 | 50 |
PTPN12,EHD4,DNM2,SEPTIN9 |
1.056e-03 | -6.85 | regulation of clathrin-dependent endocytosis | biological process | GO:2000369 | 18 | 2 | 18204 | 49 |
DAB2,BMP2K |
1.063e-03 | -6.85 | Integrin_alpha | interpro domains | IPR000413 | 18 | 2 | 18521 | 50 |
ITGAL,ITGAV |
1.063e-03 | -6.85 | Integrin_alpha_Ig-like_2 | interpro domains | IPR048285 | 18 | 2 | 18521 | 50 |
ITGAL,ITGAV |
1.071e-03 | -6.84 | response to biotic stimulus | biological process | GO:0009607 | 1408 | 11 | 18204 | 49 |
PTGIR,CD68,PTPN6,RBPJ,FKBP5,MCOLN2,CD74,TFEB,SPI1,STAB1,HCK |
1.074e-03 | -6.84 | SH3KBP1 (SH3 domain containing kinase binding protein 1) | protein interactions | 30011 | 304 | 5 | 19454 | 50 |
SEPTIN9,ARAP1,DAB2,DNM2,HCK |
1.077e-03 | -6.83 | RIT2 (Ras like without CAAX 2) | protein interactions | 6014 | 19 | 2 | 19454 | 50 |
RGL1,ARHGAP24 |
1.078e-03 | -6.83 | Paxillin-dependent events mediated by a4b1 | Pathway Interaction DB | a4b1_paxdep_pathway | 19 | 3 | 2226 | 25 |
ITGB2,ITGAL,TLN1 |
1.097e-03 | -6.82 | positive regulation of molecular function | biological process | GO:0044093 | 1192 | 10 | 18204 | 49 |
CD74,ITGB2,TMSB4X,PREX1,DOCK8,ARAP1,RXRA,ARHGAP24,CCND2,ARHGAP45 |
1.105e-03 | -6.81 | Integrin_A_Ig_2 | pfam domains | PF20805 | 18 | 2 | 17795 | 49 |
ITGAV,ITGAL |
1.121e-03 | -6.79 | positive regulation of immune system process | biological process | GO:0002684 | 986 | 9 | 18204 | 49 |
HCK,ITGB2,DOCK8,FYB1,CD74,ZFP36L1,SPI1,PTPN6,RBM47 |
1.124e-03 | -6.79 | ERBB4 (erb-b2 receptor tyrosine kinase 4) | protein interactions | 2066 | 178 | 4 | 19454 | 50 |
PTPN6,PTPN12,HCK,SH2B3 |
1.166e-03 | -6.75 | lung-carcinoma-undifferentiated_carcinoma | COSMIC cancer mutations | lung-carcinoma-undifferentiated_carcinoma | 1408 | 11 | 16828 | 46 |
PTPN6,RBPJ,ELF4,BTG1,ITGAL,RGL1,TFEB,GAB1,CCND2,TLN1,PTGIR |
1.175e-03 | -6.75 | NRAGE signals death through JNK | REACTOME pathways | R-HSA-193648 | 60 | 3 | 10285 | 36 |
AKAP13,PREX1,ARHGEF18 |
1.184e-03 | -6.74 | THRB (thyroid hormone receptor beta) | protein interactions | 7068 | 81 | 3 | 19454 | 50 |
RXRA,ARHGAP24,BTG1 |
1.186e-03 | -6.74 | Int_alpha_beta-p | interpro domains | IPR013519 | 19 | 2 | 18521 | 50 |
ITGAV,ITGAL |
1.206e-03 | -6.72 | ILK (integrin linked kinase) | protein interactions | 3611 | 312 | 5 | 19454 | 50 |
ITGB2,FKBP5,SH2B3,ITGAV,TMSB4X |
1.221e-03 | -6.71 | human chr5p13.1 | chromosome location | human chr5p13.1 | 27 | 2 | 26134 | 50 |
FYB1,DAB2 |
1.232e-03 | -6.70 | G_DYNAMIN_2 | prosite domains | PS51718 | 14 | 2 | 12186 | 46 |
DNM2,EHD4 |
1.233e-03 | -6.70 | FG-GAP | pfam domains | PF01839 | 19 | 2 | 17795 | 49 |
ITGAV,ITGAL |
1.236e-03 | -6.70 | undifferentiated_carcinoma | COSMIC cancer mutations | undifferentiated_carcinoma | 1418 | 11 | 16828 | 46 |
RBPJ,TFEB,GAB1,BTG1,PTGIR,ELF4,TLN1,CCND2,ITGAL,RGL1,PTPN6 |
1.238e-03 | -6.69 | intracellular anatomical structure | cellular component | GO:0005622 | 15205 | 47 | 19108 | 49 |
PREX1,DOCK8,FYB1,MCOLN2,ARHGAP24,ELF4,TLN1,ITGAV,PTGIR,ITGAL,DOCK2,RBM47,SEPTIN9,BMP2K,STAB1,CD68,DAB2,RBPJ,DNM2,PTPN12,HCK,DISC1,CD74,TMSB4X,EHD4,WDFY3,ANTXR2,SPI1,SH2B3,RXRA,ZFP36L1,CCND2,ARHGEF18,SLC9A7,FKBP5,AKAP13,RGL1,GAB1,MYO1F,TFEB,ITM2B,ARHGAP45,ARAP1,ITGB2,PTPN6,BTG1,ME1 |
1.240e-03 | -6.69 | HSF2BP (heat shock transcription factor 2 binding protein) | protein interactions | 11077 | 314 | 5 | 19454 | 50 |
HCK,DOCK8,SEPTIN9,ARHGAP45,TMSB4X |
1.245e-03 | -6.69 | GSN (gelsolin) | protein interactions | 2934 | 183 | 4 | 19454 | 50 |
ARHGAP24,DISC1,CCND2,PTPN12 |
1.261e-03 | -6.68 | positive regulation of cell motility | biological process | GO:2000147 | 619 | 7 | 18204 | 49 |
CD74,DOCK8,TMSB4X,PREX1,GAB1,ITGAV,DAB2 |
1.289e-03 | -6.65 | Neutrophil degranulation | REACTOME pathways | R-HSA-6798695 | 487 | 7 | 10285 | 36 |
PTPN6,ARHGAP45,CD68,DOCK2,ITGB2,ITGAL,ITGAV |
1.294e-03 | -6.65 | LGALS1 (galectin 1) | protein interactions | 3956 | 317 | 5 | 19454 | 50 |
FKBP5,HCK,PLXND1,ITGAV,CD68 |
1.307e-03 | -6.64 | regulation of monocyte differentiation | biological process | GO:0045655 | 20 | 2 | 18204 | 49 |
CD74,ZFP36L1 |
1.307e-03 | -6.64 | regulation of chemokine (C-X-C motif) ligand 2 production | biological process | GO:2000341 | 20 | 2 | 18204 | 49 |
MCOLN2,CD74 |
1.307e-03 | -6.64 | regulation of antigen processing and presentation | biological process | GO:0002577 | 20 | 2 | 18204 | 49 |
CD68,CD74 |
1.334e-03 | -6.62 | regulation of cellular process | biological process | GO:0050794 | 11468 | 41 | 18204 | 49 |
PTGIR,CCND2,RBPJ,DOCK2,DOCK8,AKAP13,MCOLN2,CD74,ARHGAP45,ITGAV,ARHGAP24,BMP2K,PTPN12,SH2B3,ME1,PREX1,TLN1,TMSB4X,ELF4,FYB1,RXRA,PTPN6,BTG1,GAB1,RGL1,DNM2,TFEB,ARHGEF18,DAB2,ITGAL,ZFP36L1,RBM47,SEPTIN9,ITM2B,SPI1,ARAP1,DISC1,PLXND1,ITGB2,HCK,EHD4 |
1.354e-03 | -6.60 | Rho GTPase activation protein | gene3d domains | 1.10.555.10 | 66 | 3 | 14470 | 48 |
ARAP1,ARHGAP24,ARHGAP45 |
1.386e-03 | -6.58 | Regulation of KIT signaling | REACTOME pathways | R-HSA-1433559 | 16 | 2 | 10285 | 36 |
PTPN6,SH2B3 |
1.395e-03 | -6.58 | vacuole | cellular component | GO:0005773 | 857 | 8 | 19108 | 49 |
TFEB,CD68,MCOLN2,CD74,DAB2,WDFY3,ARHGAP45,HCK |
1.398e-03 | -6.57 | endoderm development | biological process | GO:0007492 | 82 | 3 | 18204 | 49 |
ITGAV,ZFP36L1,ITGB2 |
1.407e-03 | -6.57 | WAS (WASP actin nucleation promoting factor) | protein interactions | 7454 | 86 | 3 | 19454 | 50 |
FYB1,HCK,PTPN12 |
1.420e-03 | -6.56 | ntegrin, alpha v. Chain A, domain 4 | gene3d domains | 2.60.40.1530 | 17 | 2 | 14470 | 48 |
ITGAV,ITGAL |
1.432e-03 | -6.55 | negative regulation of cell adhesion | biological process | GO:0007162 | 310 | 5 | 18204 | 49 |
SH2B3,CD74,PTPN6,SPI1,PLXND1 |
1.435e-03 | -6.55 | positive regulation of locomotion | biological process | GO:0040017 | 633 | 7 | 18204 | 49 |
ITGAV,DAB2,GAB1,DOCK8,TMSB4X,PREX1,CD74 |
1.442e-03 | -6.54 | regulation of cytokine-mediated signaling pathway | biological process | GO:0001959 | 182 | 4 | 18204 | 49 |
CD74,SH2B3,RBM47,PTPN6 |
1.443e-03 | -6.54 | plasma membrane signaling receptor complex | cellular component | GO:0098802 | 191 | 4 | 19108 | 49 |
ITGAL,ITGB2,ITGAV,PTPN6 |
1.443e-03 | -6.54 | positive regulation of myeloid leukocyte mediated immunity | biological process | GO:0002888 | 21 | 2 | 18204 | 49 |
SPI1,ITGB2 |
1.443e-03 | -6.54 | thymic T cell selection | biological process | GO:0045061 | 21 | 2 | 18204 | 49 |
CD74,DOCK2 |
1.447e-03 | -6.54 | FCGR2B (Fc gamma receptor IIb) | protein interactions | 2213 | 22 | 2 | 19454 | 50 |
PTPN6,GAB1 |
1.452e-03 | -6.54 | FG-GAP | interpro domains | IPR013517 | 21 | 2 | 18521 | 50 |
ITGAV,ITGAL |
1.455e-03 | -6.53 | FGR (FGR proto-oncogene, Src family tyrosine kinase) | protein interactions | 2268 | 87 | 3 | 19454 | 50 |
HCK,DAB2,FKBP5 |
1.455e-03 | -6.53 | PLCG2 (phospholipase C gamma 2) | protein interactions | 5336 | 87 | 3 | 19454 | 50 |
PTPN6,HCK,GAB1 |
1.460e-03 | -6.53 | opsonin binding | molecular function | GO:0001846 | 21 | 2 | 18094 | 49 |
ITGAV,ITGB2 |
1.472e-03 | -6.52 | secretory vesicle | cellular component | GO:0099503 | 1076 | 9 | 19108 | 49 |
DOCK2,DISC1,PTPN6,CD68,ITGAL,ITGB2,ITGAV,ARHGAP45,TMSB4X |
1.489e-03 | -6.51 | localization | biological process | GO:0051179 | 4474 | 22 | 18204 | 49 |
FYB1,EHD4,TMSB4X,ITGB2,HCK,DISC1,SLC9A7,SEPTIN9,STAB1,TFEB,ITGAL,ARHGEF18,DAB2,ZFP36L1,ITGAV,MCOLN2,CD74,DNM2,HEPHL1,DOCK2,CD68,MYO1F |
1.508e-03 | -6.50 | basal_(triple-negative)_carcinoma | COSMIC cancer mutations | basal_(triple-negative)_carcinoma | 2981 | 17 | 16828 | 46 |
RXRA,RGL1,ITGAL,CCND2,TLN1,PTGIR,GAB1,ITGAV,TFEB,PLXND1,PTPN6,RBM47,WDFY3,ELF4,BTG1,ARHGAP24,RBPJ |
1.508e-03 | -6.50 | breast-carcinoma-basal_(triple-negative)_carcinoma | COSMIC cancer mutations | breast-carcinoma-basal_(triple-negative)_carcinoma | 2981 | 17 | 16828 | 46 |
RBPJ,ELF4,BTG1,ARHGAP24,WDFY3,PLXND1,PTPN6,RBM47,ITGAV,GAB1,TFEB,TLN1,CCND2,PTGIR,ITGAL,RXRA,RGL1 |
1.515e-03 | -6.49 | vacuolar membrane | cellular component | GO:0005774 | 490 | 6 | 19108 | 49 |
WDFY3,CD74,DAB2,TFEB,CD68,MCOLN2 |
1.528e-03 | -6.48 | positive regulation of immune response | biological process | GO:0050778 | 640 | 7 | 18204 | 49 |
HCK,ITGB2,CD74,FYB1,SPI1,RBM47,PTPN6 |
1.551e-03 | -6.47 | protein localization | biological process | GO:0008104 | 1954 | 13 | 18204 | 49 |
CD68,DNM2,CD74,MCOLN2,DAB2,ARHGEF18,ITGAL,SEPTIN9,TMSB4X,ITGB2,DISC1,FYB1,EHD4 |
1.587e-03 | -6.45 | MAPK1 (mitogen-activated protein kinase 1) | protein interactions | 5594 | 493 | 6 | 19454 | 50 |
ITGAV,GAB1,ME1,RXRA,ARHGAP45,PTPN12 |
1.594e-03 | -6.44 | Bicelle-embedded integrin alpha(iib) transmembrane segment | gene3d domains | 1.20.5.930 | 18 | 2 | 14470 | 48 |
ITGAL,ITGAV |
1.594e-03 | -6.44 | Integrin domains. Chain A, domain 2 | gene3d domains | 2.60.40.1460 | 18 | 2 | 14470 | 48 |
ITGAV,ITGAL |
1.595e-03 | -6.44 | response to cytokine | biological process | GO:0034097 | 834 | 8 | 18204 | 49 |
SPI1,PTPN6,SH2B3,ZFP36L1,CD74,TMSB4X,HCK,DOCK8 |
1.610e-03 | -6.43 | cellular macromolecule localization | biological process | GO:0070727 | 1962 | 13 | 18204 | 49 |
DNM2,CD74,MCOLN2,CD68,ITGB2,TMSB4X,DISC1,FYB1,EHD4,ITGAL,DAB2,ARHGEF18,SEPTIN9 |
1.617e-03 | -6.43 | INTEGRIN_ALPHA | prosite domains | PS00242 | 16 | 2 | 12186 | 46 |
ITGAL,ITGAV |
1.632e-03 | -6.42 | PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3) | protein interactions | 8503 | 197 | 4 | 19454 | 50 |
DISC1,GAB1,WDFY3,HCK |
1.640e-03 | -6.41 | lymph_node | COSMIC cancer mutations | lymph_node | 1703 | 12 | 16828 | 46 |
DOCK2,WDFY3,ZFP36L1,ELF4,ARHGAP24,BTG1,AKAP13,CD74,DNM2,SPI1,HCK,ITGAV |
1.643e-03 | -6.41 | specific granule membrane | cellular component | GO:0035579 | 91 | 3 | 19108 | 49 |
ITGAL,ITGAV,ITGB2 |
1.655e-03 | -6.40 | SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1) | protein interactions | 6654 | 91 | 3 | 19454 | 50 |
HCK,PTPN6,GAB1 |
1.657e-03 | -6.40 | embryonic placenta development | biological process | GO:0001892 | 87 | 3 | 18204 | 49 |
ZFP36L1,TFEB,RBPJ |
1.671e-03 | -6.39 | Dbl homology (DH) domain | gene3d domains | 1.20.900.10 | 71 | 3 | 14470 | 48 |
PREX1,ARHGEF18,AKAP13 |
1.688e-03 | -6.38 | Integrin cell surface interactions | REACTOME pathways | R-HSA-216083 | 68 | 3 | 10285 | 36 |
ITGAV,ITGAL,ITGB2 |
1.708e-03 | -6.37 | LIMS1 (LIM zinc finger domain containing 1) | protein interactions | 3987 | 92 | 3 | 19454 | 50 |
BMP2K,TMSB4X,FKBP5 |
1.713e-03 | -6.37 | NRAS (NRAS proto-oncogene, GTPase) | protein interactions | 4893 | 683 | 7 | 19454 | 50 |
ITM2B,GAB1,FYB1,RGL1,DOCK8,PREX1,SEPTIN9 |
1.713e-03 | -6.37 | AURKA (aurora kinase A) | protein interactions | 6790 | 683 | 7 | 19454 | 50 |
DAB2,FKBP5,SPI1,ARHGAP45,TMSB4X,CCND2,DOCK8 |
1.725e-03 | -6.36 | SEPTIN7 (septin 7) | protein interactions | 989 | 200 | 4 | 19454 | 50 |
CCND2,DOCK8,TLN1,SEPTIN9 |
1.732e-03 | -6.36 | megakaryocyte development | biological process | GO:0035855 | 23 | 2 | 18204 | 49 |
PTPN6,SH2B3 |
1.743e-03 | -6.35 | Integrin_alpha_N | interpro domains | IPR028994 | 23 | 2 | 18521 | 50 |
ITGAV,ITGAL |
1.752e-03 | -6.35 | response to organic substance | biological process | GO:0010033 | 2498 | 15 | 18204 | 49 |
ZFP36L1,DAB2,SH2B3,SPI1,HCK,TMSB4X,ITGB2,ME1,PTGIR,CD68,RXRA,GAB1,PTPN6,DOCK8,CD74 |
1.775e-03 | -6.33 | lymphoid_neoplasm | COSMIC cancer mutations | lymphoid_neoplasm | 12233 | 42 | 16828 | 46 |
PTGIR,PREX1,SLC9A7,ITGAV,TFEB,STAB1,HCK,RXRA,DNM2,ITM2B,ITGB2,BTG1,ARHGAP24,DAB2,FKBP5,ARHGEF18,CD74,EHD4,AKAP13,RBM47,ANTXR2,PTPN6,ARAP1,DOCK2,MYO1F,ZFP36L1,CCND2,GAB1,MCOLN2,PTPN12,ME1,RGL1,SH2B3,SPI1,ITGAL,HEPHL1,ELF4,BMP2K,TMSB4X,PLXND1,WDFY3,DOCK8 |
1.800e-03 | -6.32 | amyloid-beta binding | molecular function | GO:0001540 | 89 | 3 | 18094 | 49 |
CD74,ITM2B,ITGB2 |
1.809e-03 | -6.31 | signaling receptor binding | molecular function | GO:0005102 | 1493 | 11 | 18094 | 49 |
HCK,ITGAL,DAB2,DOCK2,CD74,ITGB2,FYB1,ARAP1,SH2B3,ITGAV,TLN1 |
1.822e-03 | -6.31 | regulation of response to cytokine stimulus | biological process | GO:0060759 | 194 | 4 | 18204 | 49 |
CD74,SH2B3,RBM47,PTPN6 |
1.829e-03 | -6.30 | RHOU (ras homolog family member U) | protein interactions | 58480 | 507 | 6 | 19454 | 50 |
ITGAV,GAB1,DAB2,ITM2B,DNM2,EHD4 |
1.861e-03 | -6.29 | secretory granule | cellular component | GO:0030141 | 897 | 8 | 19108 | 49 |
CD68,ITGAL,DOCK2,PTPN6,TMSB4X,ARHGAP45,ITGB2,ITGAV |
1.867e-03 | -6.28 | RHOGAP | prosite domains | PS50238 | 65 | 3 | 12186 | 46 |
ARAP1,ARHGAP24,ARHGAP45 |
1.870e-03 | -6.28 | lower_third | COSMIC cancer mutations | lower_third | 7961 | 32 | 16828 | 46 |
HEPHL1,ELF4,WDFY3,PLXND1,PTPN12,CCND2,SPI1,ITGAL,RGL1,SH2B3,FKBP5,ARHGEF18,RBPJ,EHD4,AKAP13,ARHGAP24,DAB2,ARAP1,DOCK2,MYO1F,ANTXR2,DISC1,ITGAV,STAB1,TFEB,PREX1,SLC9A7,TLN1,ITM2B,ITGB2,RXRA,DNM2 |
1.886e-03 | -6.27 | myeloid dendritic cell activation | biological process | GO:0001773 | 24 | 2 | 18204 | 49 |
DOCK2,RBPJ |
1.886e-03 | -6.27 | regulation of platelet-derived growth factor receptor signaling pathway | biological process | GO:0010640 | 24 | 2 | 18204 | 49 |
PTPN12,PTGIR |
1.902e-03 | -6.26 | recycling endosome | cellular component | GO:0055037 | 206 | 4 | 19108 | 49 |
MCOLN2,EHD4,SLC9A7,DNM2 |
1.910e-03 | -6.26 | vesicle-mediated transport | biological process | GO:0016192 | 1283 | 10 | 18204 | 49 |
EHD4,ITGB2,DNM2,HCK,DOCK2,STAB1,ITGAL,DAB2,MYO1F,ITGAV |
1.913e-03 | -6.26 | human chr4q21.23-q21.3 | chromosome location | human chr4q21.23-q21.3 | 1 | 1 | 26134 | 50 |
ARHGAP24 |
1.913e-03 | -6.26 | human chr10q22.2-q22.3 | chromosome location | human chr10q22.2-q22.3 | 1 | 1 | 26134 | 50 |
LRMDA |
1.913e-03 | -6.26 | human chrXp11.3|Xp11.3 | chromosome location | human chrXp11.3|Xp11.3 | 1 | 1 | 26134 | 50 |
SLC9A7 |
1.918e-03 | -6.26 | regulation of plasma membrane bounded cell projection organization | biological process | GO:0120035 | 666 | 7 | 18204 | 49 |
PREX1,PLXND1,DISC1,ARAP1,DAB2,ARHGAP24,SEPTIN9 |
1.949e-03 | -6.24 | endocytic vesicle | cellular component | GO:0030139 | 349 | 5 | 19108 | 49 |
EHD4,STAB1,DNM2,CD74,ITGAV |
1.969e-03 | -6.23 | regulation of apoptotic process | biological process | GO:0042981 | 1518 | 11 | 18204 | 49 |
DAB2,ZFP36L1,ITGAV,HCK,PLXND1,CCND2,PTPN6,BTG1,DNM2,DOCK8,CD74 |
1.993e-03 | -6.22 | negative regulation of response to stimulus | biological process | GO:0048585 | 1760 | 12 | 18204 | 49 |
CD74,PTPN6,PTGIR,ELF4,HCK,TMSB4X,SPI1,SH2B3,PTPN12,DAB2,ARHGAP24,ITGAV |
2.023e-03 | -6.20 | POU2F2 (POU class 2 homeobox 2) | protein interactions | 5452 | 26 | 2 | 19454 | 50 |
ARHGAP24,RXRA |
2.025e-03 | -6.20 | lipid binding | molecular function | GO:0008289 | 861 | 8 | 18094 | 49 |
TLN1,DNM2,ARAP1,FYB1,WDFY3,PREX1,HCK,RXRA |
2.025e-03 | -6.20 | GART (phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase) | protein interactions | 2618 | 209 | 4 | 19454 | 50 |
FKBP5,TLN1,ARHGEF18,ARHGAP24 |
2.052e-03 | -6.19 | INTEGRINA | prints domains | PR01185 | 18 | 2 | 5227 | 20 |
ITGAV,ITGAL |
2.073e-03 | -6.18 | negative regulation of inflammatory response | biological process | GO:0050728 | 201 | 4 | 18204 | 49 |
TMSB4X,HCK,PTPN6,ELF4 |
2.097e-03 | -6.17 | CRKL (CRK like proto-oncogene, adaptor protein) | protein interactions | 1399 | 211 | 4 | 19454 | 50 |
HCK,DOCK2,DNM2,GAB1 |
2.109e-03 | -6.16 | nodular | COSMIC cancer mutations | nodular | 1515 | 11 | 16828 | 46 |
ITGB2,PTPN12,STAB1,TFEB,DOCK2,DOCK8,WDFY3,DISC1,RBM47,AKAP13,FKBP5 |
2.125e-03 | -6.15 | cell projection membrane | cellular component | GO:0031253 | 356 | 5 | 19108 | 49 |
TLN1,ITGAV,PLXND1,DOCK8,ARHGAP45 |
2.141e-03 | -6.15 | regulation of cell-cell adhesion | biological process | GO:0022407 | 500 | 6 | 18204 | 49 |
DOCK8,ITGB2,SH2B3,CD74,PTPN6,SPI1 |
2.149e-03 | -6.14 | negative regulation of cell-cell adhesion | biological process | GO:0022408 | 203 | 4 | 18204 | 49 |
CD74,SH2B3,SPI1,PTPN6 |
2.161e-03 | -6.14 | cell projection | cellular component | GO:0042995 | 2398 | 14 | 19108 | 49 |
DNM2,ARHGAP24,MYO1F,PREX1,DOCK8,SEPTIN9,WDFY3,DISC1,PLXND1,HCK,PTPN12,TLN1,ITGAV,ARHGAP45 |
2.168e-03 | -6.13 | REPS1 (RALBP1 associated Eps domain containing 1) | protein interactions | 85021 | 100 | 3 | 19454 | 50 |
RXRA,BMP2K,DAB2 |
2.168e-03 | -6.13 | HRAS (HRas proto-oncogene, GTPase) | protein interactions | 3265 | 712 | 7 | 19454 | 50 |
ARHGEF18,ITM2B,GAB1,RGL1,DOCK8,DNM2,SEPTIN9 |
2.174e-03 | -6.13 | regulation of localization | biological process | GO:0032879 | 2028 | 13 | 18204 | 49 |
TMSB4X,HCK,ITGB2,EHD4,ITGAV,ZFP36L1,DAB2,BMP2K,SPI1,CD74,RXRA,DOCK2,PTPN6 |
2.176e-03 | -6.13 | response to bacterium | biological process | GO:0009617 | 681 | 7 | 18204 | 49 |
HCK,FKBP5,CD68,PTGIR,TFEB,STAB1,RBPJ |
2.181e-03 | -6.13 | OLIG1 (oligodendrocyte transcription factor 1) | protein interactions | 116448 | 27 | 2 | 19454 | 50 |
PTPN6,HCK |
2.181e-03 | -6.13 | ICAM3 (intercellular adhesion molecule 3) | protein interactions | 3385 | 27 | 2 | 19454 | 50 |
ITGAL,ITGB2 |
2.197e-03 | -6.12 | granulocyte migration | biological process | GO:0097530 | 96 | 3 | 18204 | 49 |
MCOLN2,ITGB2,PREX1 |
2.201e-03 | -6.12 | angiogenesis | biological process | GO:0001525 | 342 | 5 | 18204 | 49 |
GAB1,RBPJ,ARHGAP24,PLXND1,ITGAV |
2.205e-03 | -6.12 | KHDRBS1 (KH RNA binding domain containing, signal transduction associated 1) | protein interactions | 10657 | 358 | 5 | 19454 | 50 |
HCK,DOCK2,PTPN6,ARHGAP24,DISC1 |
2.207e-03 | -6.12 | NCK1 (NCK adaptor protein 1) | protein interactions | 4690 | 214 | 4 | 19454 | 50 |
GAB1,DNM2,ARAP1,PTPN12 |
2.207e-03 | -6.12 | biological process involved in interspecies interaction between organisms | biological process | GO:0044419 | 1540 | 11 | 18204 | 49 |
FKBP5,HCK,MCOLN2,CD74,TFEB,CD68,PTGIR,ITGAV,PTPN6,RBPJ,STAB1 |
2.212e-03 | -6.11 | regulation of cell projection organization | biological process | GO:0031344 | 683 | 7 | 18204 | 49 |
DAB2,ARHGAP24,SEPTIN9,PREX1,DISC1,PLXND1,ARAP1 |
2.214e-03 | -6.11 | ruffle membrane | cellular component | GO:0032587 | 101 | 3 | 19108 | 49 |
ARHGAP45,ITGAV,TLN1 |
2.217e-03 | -6.11 | YWHAZ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta) | protein interactions | 7534 | 1138 | 9 | 19454 | 50 |
TFEB,ARHGEF18,GAB1,DISC1,ZFP36L1,AKAP13,CD74,ITGB2,SH2B3 |
2.217e-03 | -6.11 | vWFA_dom_sf | interpro domains | IPR036465 | 96 | 3 | 18521 | 50 |
ITGAL,ANTXR2,ITGB2 |
2.226e-03 | -6.11 | membrane | cellular component | GO:0016020 | 9220 | 34 | 19108 | 49 |
ANTXR2,EHD4,DOCK8,WDFY3,PREX1,FYB1,MCOLN2,SH2B3,TLN1,ITGAV,PTGIR,CCND2,ITGAL,ARHGEF18,DOCK2,SLC9A7,FKBP5,AKAP13,STAB1,RGL1,CD68,MYO1F,TFEB,DNM2,ITM2B,DAB2,ARAP1,HEPHL1,ARHGAP45,HCK,ITGB2,PLXND1,CD74,PTPN6 |
2.284e-03 | -6.08 | cytoskeleton | cellular component | GO:0005856 | 2412 | 14 | 19108 | 49 |
HCK,PTPN12,TLN1,CCND2,ARHGEF18,DOCK2,DISC1,SEPTIN9,TMSB4X,AKAP13,FYB1,MYO1F,ARHGAP24,DNM2 |
2.286e-03 | -6.08 | chemotaxis | biological process | GO:0006935 | 345 | 5 | 18204 | 49 |
DOCK2,GAB1,ITGAV,ITGB2,PREX1 |
2.288e-03 | -6.08 | FG_GAP | prosite domains | PS51470 | 19 | 2 | 12186 | 46 |
ITGAV,ITGAL |
2.300e-03 | -6.07 | regulation of cell population proliferation | biological process | GO:0042127 | 1790 | 12 | 18204 | 49 |
CD74,HCK,DISC1,BTG1,PTPN6,SH2B3,RBPJ,ZFP36L1,DAB2,CCND2,ITGAV,PTGIR |
2.309e-03 | -6.07 | DH_2 | prosite domains | PS50010 | 70 | 3 | 12186 | 46 |
AKAP13,PREX1,ARHGEF18 |
2.324e-03 | -6.06 | Cell death signalling via NRAGE, NRIF and NADE | REACTOME pathways | R-HSA-204998 | 76 | 3 | 10285 | 36 |
AKAP13,ARHGEF18,PREX1 |
2.344e-03 | -6.06 | positive regulation of signaling | biological process | GO:0023056 | 1794 | 12 | 18204 | 49 |
ITGAV,DAB2,BMP2K,RBM47,SPI1,ARAP1,DISC1,RXRA,RBPJ,PTPN6,AKAP13,CD74 |
2.344e-03 | -6.06 | breast-carcinoma-HER-positive_carcinoma | COSMIC cancer mutations | breast-carcinoma-HER-positive_carcinoma | 2025 | 13 | 16828 | 46 |
DOCK8,WDFY3,PTPN6,RBPJ,BTG1,ELF4,ITGAL,RGL1,GAB1,TFEB,PTGIR,CCND2,TLN1 |
2.344e-03 | -6.06 | HER-positive_carcinoma | COSMIC cancer mutations | HER-positive_carcinoma | 2025 | 13 | 16828 | 46 |
RBPJ,BTG1,ELF4,DOCK8,WDFY3,PTPN6,GAB1,TFEB,PTGIR,TLN1,CCND2,ITGAL,RGL1 |
2.344e-03 | -6.06 | taxis | biological process | GO:0042330 | 347 | 5 | 18204 | 49 |
ITGAV,PREX1,ITGB2,DOCK2,GAB1 |
2.345e-03 | -6.06 | PGAP1 (post-GPI attachment to proteins inositol deacylase 1) | protein interactions | 80055 | 28 | 2 | 19454 | 50 |
DISC1,ITM2B |
2.348e-03 | -6.05 | pleura | COSMIC cancer mutations | pleura | 4914 | 23 | 16828 | 46 |
ELF4,BMP2K,RGL1,SH2B3,SPI1,CCND2,PTPN12,GAB1,PTPN6,ARHGAP24,BTG1,DAB2,RBPJ,FKBP5,ARHGEF18,AKAP13,ITGB2,PREX1,SLC9A7,TLN1,TFEB,HCK,ITGAV |
2.382e-03 | -6.04 | AGR2 (anterior gradient 2, protein disulphide isomerase family member) | protein interactions | 10551 | 930 | 8 | 19454 | 50 |
DOCK2,AKAP13,ME1,TLN1,DNM2,HCK,CD68,SEPTIN9 |
2.386e-03 | -6.04 | Integrin alpha, N-terminal | gene3d domains | 2.130.10.130 | 22 | 2 | 14470 | 48 |
ITGAL,ITGAV |
2.415e-03 | -6.03 | SH2DOMAIN | prints domains | PR00401 | 72 | 3 | 5227 | 20 |
HCK,SH2B3,PTPN6 |
2.430e-03 | -6.02 | RhoGAP | smart domains | SM00324 | 64 | 3 | 9717 | 41 |
ARHGAP45,ARAP1,ARHGAP24 |
2.447e-03 | -6.01 | EGF receptor (ErbB1) signaling pathway | Pathway Interaction DB | erbb1_receptor_proximal_pathway | 25 | 3 | 2226 | 25 |
TLN1,GAB1,PTPN6 |
2.479e-03 | -6.00 | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-desmoplastic | COSMIC cancer mutations | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-desmoplastic | 14773 | 46 | 16828 | 46 |
ITGAL,SPI1,ME1,HEPHL1,TMSB4X,TFEB,STAB1,PREX1,ITM2B,DNM2,AKAP13,FKBP5,ARHGEF18,CD74,DAB2,ARHGAP24,ARAP1,MYO1F,DOCK2,DISC1,GAB1,MCOLN2,PTPN12,CCND2,RGL1,SH2B3,CD68,BMP2K,ELF4,DOCK8,WDFY3,PLXND1,ITGAV,HCK,TLN1,SLC9A7,PTGIR,ITGB2,RXRA,EHD4,RBPJ,BTG1,ZFP36L1,PTPN6,RBM47,ANTXR2 |
2.479e-03 | -6.00 | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma | COSMIC cancer mutations | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma | 14773 | 46 | 16828 | 46 |
MCOLN2,PTPN12,GAB1,CCND2,RGL1,SH2B3,BMP2K,CD68,ELF4,WDFY3,DOCK8,PLXND1,HCK,ITGAV,PTGIR,TLN1,SLC9A7,ITGB2,RXRA,RBPJ,EHD4,BTG1,ZFP36L1,ANTXR2,RBM47,PTPN6,SPI1,ITGAL,ME1,HEPHL1,TMSB4X,TFEB,STAB1,PREX1,ITM2B,DNM2,CD74,FKBP5,ARHGEF18,AKAP13,ARHGAP24,DAB2,MYO1F,DOCK2,ARAP1,DISC1 |
2.479e-03 | -6.00 | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-classic | COSMIC cancer mutations | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-classic | 14773 | 46 | 16828 | 46 |
ZFP36L1,ANTXR2,RBM47,PTPN6,RBPJ,EHD4,BTG1,ITGB2,RXRA,HCK,ITGAV,PTGIR,TLN1,SLC9A7,DOCK8,WDFY3,PLXND1,BMP2K,CD68,ELF4,SH2B3,RGL1,PTPN12,MCOLN2,GAB1,CCND2,DOCK2,MYO1F,ARAP1,DISC1,CD74,FKBP5,ARHGEF18,AKAP13,ARHGAP24,DAB2,ITM2B,DNM2,STAB1,TFEB,PREX1,TMSB4X,HEPHL1,SPI1,ITGAL,ME1 |
2.479e-03 | -6.00 | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | COSMIC cancer mutations | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | 14773 | 46 | 16828 | 46 |
PLXND1,DOCK8,WDFY3,ELF4,BMP2K,CD68,SH2B3,RGL1,CCND2,PTPN12,MCOLN2,GAB1,ANTXR2,RBM47,PTPN6,ZFP36L1,BTG1,RBPJ,EHD4,RXRA,ITGB2,PTGIR,SLC9A7,TLN1,HCK,ITGAV,TMSB4X,HEPHL1,ME1,SPI1,ITGAL,DISC1,DOCK2,MYO1F,ARAP1,ARHGAP24,DAB2,CD74,FKBP5,ARHGEF18,AKAP13,DNM2,ITM2B,PREX1,TFEB,STAB1 |
2.487e-03 | -6.00 | classic | COSMIC cancer mutations | classic | 14774 | 46 | 16828 | 46 |
PLXND1,DOCK8,WDFY3,ELF4,CD68,BMP2K,SH2B3,RGL1,CCND2,GAB1,PTPN12,MCOLN2,PTPN6,RBM47,ANTXR2,ZFP36L1,BTG1,EHD4,RBPJ,RXRA,ITGB2,TLN1,SLC9A7,PTGIR,ITGAV,HCK,TMSB4X,HEPHL1,ME1,ITGAL,SPI1,DISC1,ARAP1,MYO1F,DOCK2,DAB2,ARHGAP24,AKAP13,ARHGEF18,FKBP5,CD74,DNM2,ITM2B,PREX1,STAB1,TFEB |
2.494e-03 | -5.99 | regulation of cellular component size | biological process | GO:0032535 | 352 | 5 | 18204 | 49 |
DISC1,TMSB4X,HCK,DNM2,PREX1 |
2.518e-03 | -5.98 | medulla | COSMIC cancer mutations | medulla | 14778 | 46 | 16828 | 46 |
ELF4,BMP2K,CD68,PLXND1,WDFY3,DOCK8,CCND2,PTPN12,MCOLN2,GAB1,RGL1,SH2B3,BTG1,RBPJ,EHD4,ANTXR2,RBM47,PTPN6,ZFP36L1,PTGIR,SLC9A7,TLN1,HCK,ITGAV,RXRA,ITGB2,HEPHL1,TMSB4X,ME1,SPI1,ITGAL,ARHGAP24,DAB2,CD74,ARHGEF18,FKBP5,AKAP13,DISC1,DOCK2,MYO1F,ARAP1,PREX1,TFEB,STAB1,DNM2,ITM2B |
2.526e-03 | -5.98 | desmoplastic | COSMIC cancer mutations | desmoplastic | 14779 | 46 | 16828 | 46 |
ANTXR2,RBM47,PTPN6,ZFP36L1,BTG1,RBPJ,EHD4,RXRA,ITGB2,PTGIR,SLC9A7,TLN1,HCK,ITGAV,PLXND1,DOCK8,WDFY3,ELF4,BMP2K,CD68,SH2B3,RGL1,CCND2,MCOLN2,PTPN12,GAB1,DISC1,MYO1F,DOCK2,ARAP1,ARHGAP24,DAB2,CD74,FKBP5,ARHGEF18,AKAP13,DNM2,ITM2B,PREX1,TFEB,STAB1,TMSB4X,HEPHL1,ME1,SPI1,ITGAL |
2.546e-03 | -5.97 | SH3-like_dom_sf | interpro domains | IPR036028 | 212 | 4 | 18521 | 50 |
FYB1,DOCK2,HCK,MYO1F |
2.558e-03 | -5.97 | regulation of programmed cell death | biological process | GO:0043067 | 1569 | 11 | 18204 | 49 |
PTPN6,BTG1,CCND2,CD74,DNM2,DOCK8,ZFP36L1,DAB2,ITGAV,HCK,PLXND1 |
2.564e-03 | -5.97 | NOS2-CD74 complex | cellular component | GO:0035693 | 1 | 1 | 19108 | 49 |
CD74 |
2.570e-03 | -5.96 | Prkch (protein kinase C, eta) | protein interactions | 81749 | 1 | 1 | 19454 | 50 |
AKAP13 |
2.570e-03 | -5.96 | Tfap2a (transcription factor AP-2 alpha) | protein interactions | 306862 | 1 | 1 | 19454 | 50 |
DAB2 |
2.570e-03 | -5.96 | Parp1 (poly (ADP-ribose) polymerase 1) | protein interactions | 25591 | 1 | 1 | 19454 | 50 |
RXRA |
2.570e-03 | -5.96 | pparg.L (peroxisome proliferator activated receptor gamma L homeolog) | protein interactions | 397769 | 1 | 1 | 19454 | 50 |
RXRA |
2.570e-03 | -5.96 | ZNF880 (zinc finger protein 880) | protein interactions | 400713 | 1 | 1 | 19454 | 50 |
ARHGAP24 |
2.570e-03 | -5.96 | Kdm5 (Lysine demethylase 5) | protein interactions | 33837 | 1 | 1 | 19454 | 50 |
RBPJ |
2.570e-03 | -5.96 | ZNF729 (zinc finger protein 729) | protein interactions | 100287226 | 1 | 1 | 19454 | 50 |
ARHGAP24 |
2.570e-03 | -5.96 | H (Hairless) | protein interactions | 42445 | 1 | 1 | 19454 | 50 |
RBPJ |
2.570e-03 | -5.96 | ZNF780B (zinc finger protein 780B) | protein interactions | 163131 | 1 | 1 | 19454 | 50 |
ARHGAP24 |
2.570e-03 | -5.96 | EUC1 (Euc1p) | protein interactions | 855138 | 1 | 1 | 19454 | 50 |
DOCK8 |
2.570e-03 | -5.96 | ZNF75D (zinc finger protein 75D) | protein interactions | 7626 | 1 | 1 | 19454 | 50 |
ARHGAP24 |
2.570e-03 | -5.96 | ZNF781 (zinc finger protein 781) | protein interactions | 163115 | 1 | 1 | 19454 | 50 |
ARHGAP24 |
2.570e-03 | -5.96 | NTA1 (amidase) | protein interactions | 853525 | 1 | 1 | 19454 | 50 |
DOCK8 |
2.581e-03 | -5.96 | ETS_fam | interpro domains | IPR046328 | 28 | 2 | 18521 | 50 |
SPI1,ELF4 |
2.581e-03 | -5.96 | Ets_dom | interpro domains | IPR000418 | 28 | 2 | 18521 | 50 |
ELF4,SPI1 |
2.608e-03 | -5.95 | recycling endosome membrane | cellular component | GO:0055038 | 107 | 3 | 19108 | 49 |
MCOLN2,EHD4,SLC9A7 |
2.610e-03 | -5.95 | regulation of phagocytosis | biological process | GO:0050764 | 102 | 3 | 18204 | 49 |
DOCK2,HCK,ITGAV |
2.628e-03 | -5.94 | CHMP2A (charged multivesicular body protein 2A) | protein interactions | 27243 | 107 | 3 | 19454 | 50 |
FKBP5,RBPJ,DOCK8 |
2.629e-03 | -5.94 | regulation of cytoskeleton organization | biological process | GO:0051493 | 521 | 6 | 18204 | 49 |
ARHGEF18,HCK,PREX1,TMSB4X,ARAP1,AKAP13 |
2.630e-03 | -5.94 | SH2 | pfam domains | PF00017 | 100 | 3 | 17795 | 49 |
SH2B3,HCK,PTPN6 |
2.675e-03 | -5.92 | BCAR1 (BCAR1 scaffold protein, Cas family member) | protein interactions | 9564 | 547 | 6 | 19454 | 50 |
TLN1,DOCK2,PTPN12,HCK,FYB1,ITGAV |
2.682e-03 | -5.92 | Ets | pfam domains | PF00178 | 28 | 2 | 17795 | 49 |
SPI1,ELF4 |
2.688e-03 | -5.92 | TGM2 (transglutaminase 2) | protein interactions | 7052 | 226 | 4 | 19454 | 50 |
TMSB4X,DISC1,ITGAV,PREX1 |
2.690e-03 | -5.92 | PECAM1 (platelet and endothelial cell adhesion molecule 1) | protein interactions | 5175 | 30 | 2 | 19454 | 50 |
HCK,PTPN6 |
2.690e-03 | -5.92 | regulation of lymphocyte differentiation | biological process | GO:0045619 | 216 | 4 | 18204 | 49 |
PTPN6,SPI1,CD74,ZFP36L1 |
2.692e-03 | -5.92 | leading edge cell differentiation | biological process | GO:0035026 | 1 | 1 | 18204 | 49 |
DAB2 |
2.692e-03 | -5.92 | macrophage migration inhibitory factor signaling pathway | biological process | GO:0035691 | 1 | 1 | 18204 | 49 |
CD74 |
2.692e-03 | -5.92 | entry into host cell by a symbiont-containing vacuole | biological process | GO:0085017 | 1 | 1 | 18204 | 49 |
ITGAV |
2.692e-03 | -5.92 | memory T cell proliferation | biological process | GO:0061485 | 1 | 1 | 18204 | 49 |
DOCK8 |
2.692e-03 | -5.92 | positive regulation of ephrin receptor signaling pathway | biological process | GO:1901189 | 1 | 1 | 18204 | 49 |
RBPJ |
2.700e-03 | -5.91 | ARHGEF18_PH | interpro domains | IPR037744 | 1 | 1 | 18521 | 50 |
ARHGEF18 |
2.700e-03 | -5.91 | BMP2K_C | interpro domains | IPR028182 | 1 | 1 | 18521 | 50 |
BMP2K |
2.700e-03 | -5.91 | RBM47_RRM2 | interpro domains | IPR034440 | 1 | 1 | 18521 | 50 |
RBM47 |
2.700e-03 | -5.91 | SH2B3_SH2 | interpro domains | IPR035059 | 1 | 1 | 18521 | 50 |
SH2B3 |
2.700e-03 | -5.91 | MHCII_invariant_trimer_sf | interpro domains | IPR036613 | 1 | 1 | 18521 | 50 |
CD74 |
2.700e-03 | -5.91 | RBM47_RRM1 | interpro domains | IPR047044 | 1 | 1 | 18521 | 50 |
RBM47 |
2.700e-03 | -5.91 | Integrin_b-2_sf | interpro domains | IPR015439 | 1 | 1 | 18521 | 50 |
ITGB2 |
2.700e-03 | -5.91 | RGL1_RA | interpro domains | IPR030748 | 1 | 1 | 18521 | 50 |
RGL1 |
2.700e-03 | -5.91 | DISC1 | interpro domains | IPR026081 | 1 | 1 | 18521 | 50 |
DISC1 |
2.700e-03 | -5.91 | HCK_SH2 | interpro domains | IPR035851 | 1 | 1 | 18521 | 50 |
HCK |
2.700e-03 | -5.91 | MHC_II-assoc_invar/CLIP_MHC-bd | interpro domains | IPR015386 | 1 | 1 | 18521 | 50 |
CD74 |
2.700e-03 | -5.91 | Anthrax_toxin_rcpt | interpro domains | IPR017360 | 1 | 1 | 18521 | 50 |
ANTXR2 |
2.700e-03 | -5.91 | DHR2_DOCK2 | interpro domains | IPR026799 | 1 | 1 | 18521 | 50 |
DOCK2 |
2.700e-03 | -5.91 | MHC_II-assoc_invariant_trimer | interpro domains | IPR011988 | 1 | 1 | 18521 | 50 |
CD74 |
2.700e-03 | -5.91 | bHLHzip_TFEB | interpro domains | IPR024098 | 1 | 1 | 18521 | 50 |
TFEB |
2.700e-03 | -5.91 | LRMDA | interpro domains | IPR043313 | 1 | 1 | 18521 | 50 |
LRMDA |
2.700e-03 | -5.91 | MHC_II-assoc_invar_chain | interpro domains | IPR022339 | 1 | 1 | 18521 | 50 |
CD74 |
2.700e-03 | -5.91 | Plexin-D1_Sema | interpro domains | IPR042719 | 1 | 1 | 18521 | 50 |
PLXND1 |
2.700e-03 | -5.91 | Prostglndn_IP_rcpt | interpro domains | IPR000370 | 1 | 1 | 18521 | 50 |
PTGIR |
2.700e-03 | -5.91 | RBM47_RRM3 | interpro domains | IPR034445 | 1 | 1 | 18521 | 50 |
RBM47 |
2.700e-03 | -5.91 | CD74_antigen | interpro domains | IPR043530 | 1 | 1 | 18521 | 50 |
CD74 |
2.700e-03 | -5.91 | PTN12_cat | interpro domains | IPR047251 | 1 | 1 | 18521 | 50 |
PTPN12 |
2.700e-03 | -5.91 | PTN12 | interpro domains | IPR012266 | 1 | 1 | 18521 | 50 |
PTPN12 |
2.700e-03 | -5.91 | FYB_hSH3 | interpro domains | IPR035540 | 1 | 1 | 18521 | 50 |
FYB1 |
2.708e-03 | -5.91 | prostacyclin receptor activity | molecular function | GO:0016501 | 1 | 1 | 18094 | 49 |
PTGIR |
2.708e-03 | -5.91 | MHC class II protein binding, via antigen binding groove | molecular function | GO:0042658 | 1 | 1 | 18094 | 49 |
CD74 |
2.728e-03 | -5.90 | negative regulation of cellular component organization | biological process | GO:0051129 | 709 | 7 | 18204 | 49 |
ARAP1,TMSB4X,DNM2,ITGAV,DAB2,ARHGEF18,ARHGAP24 |
2.754e-03 | -5.89 | MHC2-interact | pfam domains | PF09307 | 1 | 1 | 17795 | 49 |
CD74 |
2.754e-03 | -5.89 | MHCassoc_trimer | pfam domains | PF08831 | 1 | 1 | 17795 | 49 |
CD74 |
2.754e-03 | -5.89 | BMP2K_C | pfam domains | PF15282 | 1 | 1 | 17795 | 49 |
BMP2K |
2.758e-03 | -5.89 | regulation of actomyosin structure organization | biological process | GO:0110020 | 104 | 3 | 18204 | 49 |
AKAP13,ARAP1,ARHGEF18 |
2.763e-03 | -5.89 | immune response | biological process | GO:0006955 | 1349 | 10 | 18204 | 49 |
CD68,TFEB,ITGAL,RBPJ,PTPN6,DOCK2,HCK,MCOLN2,CD74,FYB1 |
2.784e-03 | -5.88 | protein sequestering activity | molecular function | GO:0140311 | 29 | 2 | 18094 | 49 |
TMSB4X,SPI1 |
2.838e-03 | -5.86 | Int_alpha | smart domains | SM00191 | 19 | 2 | 9717 | 41 |
ITGAL,ITGAV |
2.842e-03 | -5.86 | KIT (KIT proto-oncogene, receptor tyrosine kinase) | protein interactions | 3815 | 110 | 3 | 19454 | 50 |
SH2B3,HCK,PTPN6 |
2.862e-03 | -5.86 | blood vessel development | biological process | GO:0001568 | 530 | 6 | 18204 | 49 |
PLXND1,RBPJ,GAB1,ITGAV,ARHGAP24,ZFP36L1 |
2.870e-03 | -5.85 | CSF2RB (colony stimulating factor 2 receptor subunit beta) | protein interactions | 1439 | 31 | 2 | 19454 | 50 |
PTPN6,HCK |
2.874e-03 | -5.85 | regulation of peptidyl-tyrosine phosphorylation | biological process | GO:0050730 | 220 | 4 | 18204 | 49 |
ITGB2,EHD4,CD74,PTPN6 |
2.881e-03 | -5.85 | positive regulation of signal transduction | biological process | GO:0009967 | 1593 | 11 | 18204 | 49 |
RXRA,PTPN6,RBPJ,AKAP13,CD74,DAB2,BMP2K,ITGAV,RBM47,SPI1,DISC1 |
2.889e-03 | -5.85 | RhoGEF | smart domains | SM00325 | 68 | 3 | 9717 | 41 |
PREX1,ARHGEF18,AKAP13 |
2.921e-03 | -5.84 | regulation of cell-substrate adhesion | biological process | GO:0010810 | 221 | 4 | 18204 | 49 |
DISC1,PREX1,DAB2,TLN1 |
2.942e-03 | -5.83 | megakaryocyte differentiation | biological process | GO:0030219 | 30 | 2 | 18204 | 49 |
PTPN6,SH2B3 |
2.969e-03 | -5.82 | MAPK cascade | biological process | GO:0000165 | 222 | 4 | 18204 | 49 |
ITGAV,AKAP13,ZFP36L1,PTPN6 |
2.979e-03 | -5.82 | response to other organism | biological process | GO:0051707 | 1363 | 10 | 18204 | 49 |
TFEB,CD68,PTGIR,PTPN6,RBPJ,STAB1,FKBP5,HCK,MCOLN2,CD74 |
2.985e-03 | -5.81 | locomotion | biological process | GO:0040011 | 367 | 5 | 18204 | 49 |
ITGAV,PREX1,ITGB2,DOCK2,GAB1 |
2.991e-03 | -5.81 | ENAH (ENAH actin regulator) | protein interactions | 55740 | 112 | 3 | 19454 | 50 |
ARHGEF18,ARHGAP24,FYB1 |
3.005e-03 | -5.81 | SH3_domain | interpro domains | IPR001452 | 222 | 4 | 18521 | 50 |
MYO1F,HCK,DOCK2,FYB1 |
3.027e-03 | -5.80 | response to external biotic stimulus | biological process | GO:0043207 | 1366 | 10 | 18204 | 49 |
TFEB,CD68,PTGIR,PTPN6,RBPJ,STAB1,FKBP5,HCK,MCOLN2,CD74 |
3.069e-03 | -5.79 | ETS_DOMAIN_1 | prosite domains | PS00345 | 22 | 2 | 12186 | 46 |
SPI1,ELF4 |
3.102e-03 | -5.78 | large_cell | COSMIC cancer mutations | large_cell | 14845 | 46 | 16828 | 46 |
MYO1F,DOCK2,ARAP1,DISC1,AKAP13,CD74,FKBP5,ARHGEF18,DAB2,ARHGAP24,ITM2B,DNM2,TFEB,STAB1,PREX1,TMSB4X,HEPHL1,ITGAL,SPI1,ME1,ZFP36L1,PTPN6,ANTXR2,RBM47,EHD4,RBPJ,BTG1,ITGB2,RXRA,HCK,ITGAV,SLC9A7,TLN1,PTGIR,WDFY3,DOCK8,PLXND1,CD68,BMP2K,ELF4,SH2B3,RGL1,MCOLN2,PTPN12,GAB1,CCND2 |
3.114e-03 | -5.77 | lytic vacuole | cellular component | GO:0000323 | 762 | 7 | 19108 | 49 |
TFEB,CD68,MCOLN2,CD74,DAB2,ARHGAP45,HCK |
3.114e-03 | -5.77 | lysosome | cellular component | GO:0005764 | 762 | 7 | 19108 | 49 |
DAB2,CD74,MCOLN2,CD68,TFEB,HCK,ARHGAP45 |
3.127e-03 | -5.77 | macromolecule localization | biological process | GO:0033036 | 2376 | 14 | 18204 | 49 |
EHD4,FYB1,DISC1,TMSB4X,ITGB2,SEPTIN9,ARHGEF18,DAB2,ITGAL,ZFP36L1,MCOLN2,CD74,DNM2,CD68 |
3.140e-03 | -5.76 | antigen processing and presentation of exogenous peptide antigen via MHC class II | biological process | GO:0019886 | 31 | 2 | 18204 | 49 |
DNM2,CD74 |
3.161e-03 | -5.76 | stomach-carcinoma-diffuse_adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-diffuse_adenocarcinoma | 4383 | 21 | 16828 | 46 |
AKAP13,EHD4,FKBP5,ARHGEF18,WDFY3,DOCK2,DOCK8,MYO1F,PLXND1,RBM47,ITGAV,STAB1,PTPN12,TLN1,PREX1,ITGAL,ITGB2,ME1,RGL1,RXRA,SH2B3 |
3.161e-03 | -5.76 | diffuse_adenocarcinoma | COSMIC cancer mutations | diffuse_adenocarcinoma | 4383 | 21 | 16828 | 46 |
DOCK8,DOCK2,MYO1F,WDFY3,PLXND1,RBM47,EHD4,AKAP13,FKBP5,ARHGEF18,ITGAL,ITGB2,RXRA,RGL1,SH2B3,ME1,PTPN12,STAB1,ITGAV,TLN1,PREX1 |
3.179e-03 | -5.75 | SH2 | interpro domains | IPR000980 | 109 | 3 | 18521 | 50 |
SH2B3,PTPN6,HCK |
3.195e-03 | -5.75 | Farnesoid X Receptor Pathway | WikiPathways | WP2879 | 19 | 2 | 5310 | 24 |
FKBP5,RXRA |
3.202e-03 | -5.74 | endosome membrane | cellular component | GO:0010008 | 569 | 6 | 19108 | 49 |
ANTXR2,EHD4,ITM2B,SLC9A7,CD68,MCOLN2 |
3.219e-03 | -5.74 | adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-non_functioning | COSMIC cancer mutations | adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-non_functioning | 224 | 4 | 16828 | 46 |
MCOLN2,EHD4,PTGIR,PLXND1 |
3.233e-03 | -5.73 | podosome | cellular component | GO:0002102 | 33 | 2 | 19108 | 49 |
PTPN12,DNM2 |
3.249e-03 | -5.73 | KATNAL1 (katanin catalytic subunit A1 like 1) | protein interactions | 84056 | 33 | 2 | 19454 | 50 |
ARHGAP24,DISC1 |
3.270e-03 | -5.72 | developmental process | biological process | GO:0032502 | 5716 | 25 | 18204 | 49 |
PTPN6,GAB1,RXRA,DNM2,LRMDA,RBM47,ITM2B,SPI1,TFEB,DAB2,ZFP36L1,DISC1,PLXND1,ITGB2,HCK,RBPJ,DOCK2,CD74,AKAP13,PTPN12,SH2B3,ITGAV,ARHGAP24,ELF4,PREX1 |
3.282e-03 | -5.72 | cellular localization | biological process | GO:0051641 | 2660 | 15 | 18204 | 49 |
DOCK2,CD68,MCOLN2,CD74,DNM2,SEPTIN9,ITGAL,ARHGEF18,DAB2,FYB1,EHD4,TMSB4X,HCK,ITGB2,DISC1 |
3.300e-03 | -5.71 | Signaling by Rho GTPases | REACTOME pathways | R-HSA-194315 | 426 | 6 | 10285 | 36 |
ARAP1,ARHGAP45,ARHGEF18,PREX1,ARHGAP24,AKAP13 |
3.315e-03 | -5.71 | cell-cell adhesion | biological process | GO:0098609 | 546 | 6 | 18204 | 49 |
ITGAL,ZFP36L1,ITGAV,PTPN6,ITGB2,TLN1 |
3.317e-03 | -5.71 | - | gene3d domains | 6.20.50.10 | 1 | 1 | 14470 | 48 |
ITGB2 |
3.317e-03 | -5.71 | - | gene3d domains | 1.20.5.2120 | 1 | 1 | 14470 | 48 |
ITGAL |
3.317e-03 | -5.71 | MHC class II-associated invariant chain, trimerisation domain | gene3d domains | 1.10.870.10 | 1 | 1 | 14470 | 48 |
CD74 |
3.331e-03 | -5.70 | PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1) | protein interactions | 5295 | 394 | 5 | 19454 | 50 |
HCK,DNM2,PTPN6,GAB1,RXRA |
3.344e-03 | -5.70 | epiboly involved in wound healing | biological process | GO:0090505 | 32 | 2 | 18204 | 49 |
ARHGAP24,ITGAV |
3.344e-03 | -5.70 | negative regulation of stress fiber assembly | biological process | GO:0051497 | 32 | 2 | 18204 | 49 |
ARHGEF18,ARAP1 |
3.344e-03 | -5.70 | wound healing, spreading of cells | biological process | GO:0044319 | 32 | 2 | 18204 | 49 |
ITGAV,ARHGAP24 |
3.344e-03 | -5.70 | peptidyl-tyrosine dephosphorylation | biological process | GO:0035335 | 32 | 2 | 18204 | 49 |
PTPN12,PTPN6 |
3.345e-03 | -5.70 | positive regulation of developmental process | biological process | GO:0051094 | 1385 | 10 | 18204 | 49 |
RBPJ,BTG1,GAB1,SPI1,RXRA,DAB2,ZFP36L1,CD74,PLXND1,DISC1 |
3.400e-03 | -5.68 | mononuclear cell migration | biological process | GO:0071674 | 112 | 3 | 18204 | 49 |
DOCK8,ITGAL,MCOLN2 |
3.402e-03 | -5.68 | Innate Immune System | REACTOME pathways | R-HSA-168249 | 1285 | 11 | 10285 | 36 |
TLN1,GAB1,ARHGAP45,PTPN6,DNM2,ITGAV,ITGB2,ITGAL,HCK,CD68,DOCK2 |
3.403e-03 | -5.68 | cell adhesion | biological process | GO:0007155 | 942 | 8 | 18204 | 49 |
ITGB2,TLN1,HCK,PTPN6,STAB1,ITGAL,ZFP36L1,ITGAV |
3.436e-03 | -5.67 | vasculature development | biological process | GO:0001944 | 550 | 6 | 18204 | 49 |
GAB1,RBPJ,ARHGAP24,ZFP36L1,ITGAV,PLXND1 |
3.446e-03 | -5.67 | ELMO1 (engulfment and cell motility 1) | protein interactions | 9844 | 34 | 2 | 19454 | 50 |
DOCK2,HCK |
3.446e-03 | -5.67 | PRKCH (protein kinase C eta) | protein interactions | 5583 | 34 | 2 | 19454 | 50 |
AKAP13,ITGB2 |
3.487e-03 | -5.66 | negative regulation of signal transduction | biological process | GO:0009968 | 1393 | 10 | 18204 | 49 |
CD74,TMSB4X,PTPN12,SH2B3,PTPN6,SPI1,PTGIR,ITGAV,ARHGAP24,DAB2 |
3.519e-03 | -5.65 | SH2_dom_sf | interpro domains | IPR036860 | 113 | 3 | 18521 | 50 |
SH2B3,HCK,PTPN6 |
3.523e-03 | -5.65 | regulation of catalytic activity | biological process | GO:0050790 | 1395 | 10 | 18204 | 49 |
ARHGAP24,CCND2,ARHGAP45,CD74,PREX1,TMSB4X,ITGB2,DOCK8,PLXND1,ARAP1 |
3.524e-03 | -5.65 | G alpha (12/13) signalling events | REACTOME pathways | R-HSA-416482 | 88 | 3 | 10285 | 36 |
AKAP13,ARHGEF18,PREX1 |
3.546e-03 | -5.64 | signaling adaptor activity | molecular function | GO:0035591 | 113 | 3 | 18094 | 49 |
AKAP13,SH2B3,GAB1 |
3.553e-03 | -5.64 | epiboly | biological process | GO:0090504 | 33 | 2 | 18204 | 49 |
ITGAV,ARHGAP24 |
3.553e-03 | -5.64 | antigen processing and presentation of peptide antigen via MHC class II | biological process | GO:0002495 | 33 | 2 | 18204 | 49 |
CD74,DNM2 |
3.590e-03 | -5.63 | ITSN1 (intersectin 1) | protein interactions | 6453 | 245 | 4 | 19454 | 50 |
DISC1,DNM2,DAB2,PREX1 |
3.649e-03 | -5.61 | Mbp (myelin basic protein) | protein interactions | 17196 | 35 | 2 | 19454 | 50 |
FYB1,HCK |
3.696e-03 | -5.60 | PICALM (phosphatidylinositol binding clathrin assembly protein) | protein interactions | 8301 | 247 | 4 | 19454 | 50 |
RBM47,DAB2,DNM2,BMP2K |
3.718e-03 | -5.59 | POLR3B (RNA polymerase III subunit B) | protein interactions | 55703 | 121 | 3 | 19454 | 50 |
CD74,RBPJ,FKBP5 |
3.749e-03 | -5.59 | NCOR2 (nuclear receptor corepressor 2) | protein interactions | 9612 | 248 | 4 | 19454 | 50 |
ITGAV,RXRA,RBPJ,CCND2 |
3.769e-03 | -5.58 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | biological process | GO:0002504 | 34 | 2 | 18204 | 49 |
DNM2,CD74 |
3.769e-03 | -5.58 | positive T cell selection | biological process | GO:0043368 | 34 | 2 | 18204 | 49 |
CD74,DOCK2 |
3.794e-03 | -5.57 | breast-carcinoma-ER-PR-positive_carcinoma | COSMIC cancer mutations | breast-carcinoma-ER-PR-positive_carcinoma | 1881 | 12 | 16828 | 46 |
RGL1,ITGAL,TLN1,CCND2,PTGIR,TFEB,PTPN12,GAB1,PTPN6,ELF4,BTG1,RBPJ |
3.794e-03 | -5.57 | ER-PR-positive_carcinoma | COSMIC cancer mutations | ER-PR-positive_carcinoma | 1881 | 12 | 16828 | 46 |
BTG1,ELF4,RBPJ,PTPN6,PTGIR,CCND2,TLN1,TFEB,PTPN12,GAB1,RGL1,ITGAL |
3.803e-03 | -5.57 | ICAM1 (intercellular adhesion molecule 1) | protein interactions | 3383 | 249 | 4 | 19454 | 50 |
ITGAL,SEPTIN9,WDFY3,ITGB2 |
3.826e-03 | -5.57 | CD74ANTIGEN | prints domains | PR01990 | 1 | 1 | 5227 | 20 |
CD74 |
3.826e-03 | -5.57 | PRSTNOIDIPR | prints domains | PR00856 | 1 | 1 | 5227 | 20 |
PTGIR |
3.827e-03 | -5.57 | immune effector process | biological process | GO:0002252 | 389 | 5 | 18204 | 49 |
DOCK2,PTPN6,CD74,HCK,ITGAL |
3.836e-03 | -5.56 | RAC1 (Rac family small GTPase 1) | protein interactions | 5879 | 1005 | 8 | 19454 | 50 |
PREX1,EHD4,ARAP1,DOCK8,ITGAV,GAB1,DOCK2,DAB2 |
3.857e-03 | -5.56 | TBC1D14 (TBC1 domain family member 14) | protein interactions | 57533 | 36 | 2 | 19454 | 50 |
HEPHL1,TFEB |
3.857e-03 | -5.56 | DPP7 (dipeptidyl peptidase 7) | protein interactions | 29952 | 36 | 2 | 19454 | 50 |
HCK,PTPN12 |
3.857e-03 | -5.56 | SGIP1 (SH3GL interacting endocytic adaptor 1) | protein interactions | 84251 | 36 | 2 | 19454 | 50 |
DAB2,HEPHL1 |
3.905e-03 | -5.55 | LIMA1 (LIM domain and actin binding 1) | protein interactions | 51474 | 409 | 5 | 19454 | 50 |
ARHGAP24,DISC1,SEPTIN9,BMP2K,DAB2 |
3.916e-03 | -5.54 | anatomical structure formation involved in morphogenesis | biological process | GO:0048646 | 964 | 8 | 18204 | 49 |
ITGB2,ARHGAP24,ITGAV,PLXND1,GAB1,DOCK2,PTPN6,RBPJ |
3.931e-03 | -5.54 | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | 748 | 7 | 16828 | 46 |
DNM2,BTG1,HCK,ITGAV,CD74,ZFP36L1,WDFY3 |
3.937e-03 | -5.54 | regulation of receptor-mediated endocytosis | biological process | GO:0048259 | 118 | 3 | 18204 | 49 |
ITGAV,DAB2,BMP2K |
3.939e-03 | -5.54 | RA | pfam domains | PF00788 | 34 | 2 | 17795 | 49 |
ARAP1,RGL1 |
3.969e-03 | -5.53 | DCAF15 (DDB1 and CUL4 associated factor 15) | protein interactions | 90379 | 252 | 4 | 19454 | 50 |
TLN1,PTPN12,DOCK2,SEPTIN9 |
3.980e-03 | -5.53 | FLNA (filamin A) | protein interactions | 2316 | 593 | 6 | 19454 | 50 |
PTPN12,DAB2,SH2B3,DISC1,ARHGAP24,BMP2K |
3.990e-03 | -5.52 | negative regulation of actin filament bundle assembly | biological process | GO:0032232 | 35 | 2 | 18204 | 49 |
ARHGEF18,ARAP1 |
4.025e-03 | -5.52 | PRRC2C (proline rich coiled-coil 2C) | protein interactions | 23215 | 253 | 4 | 19454 | 50 |
CD74,FKBP5,TLN1,RBM47 |
4.057e-03 | -5.51 | non_functioning | COSMIC cancer mutations | non_functioning | 239 | 4 | 16828 | 46 |
EHD4,MCOLN2,PLXND1,PTGIR |
4.139e-03 | -5.49 | ovary-carcinoma-serous_carcinoma | COSMIC cancer mutations | ovary-carcinoma-serous_carcinoma | 10710 | 38 | 16828 | 46 |
ITGAL,SPI1,RGL1,SH2B3,ME1,PTPN12,MCOLN2,GAB1,DOCK8,WDFY3,CD68,BMP2K,ELF4,HEPHL1,ITGB2,DNM2,RXRA,TFEB,STAB1,HCK,ITGAV,SLC9A7,TLN1,PTGIR,PREX1,ZFP36L1,MYO1F,DOCK2,ARAP1,ANTXR2,RBM47,AKAP13,EHD4,RBPJ,ARHGEF18,FKBP5,DAB2,ARHGAP24 |
4.252e-03 | -5.46 | Gap junction trafficking | REACTOME pathways | R-HSA-190828 | 28 | 2 | 10285 | 36 |
DNM2,DAB2 |
4.277e-03 | -5.45 | ETS_DOMAIN_2 | prosite domains | PS00346 | 26 | 2 | 12186 | 46 |
SPI1,ELF4 |
4.316e-03 | -5.45 | env (Envelope surface glycoprotein gp160, precursor) | protein interactions | 155971 | 1501 | 10 | 19454 | 50 |
ITM2B,SPI1,CD74,ITGAV,ITGAL,ITGB2,DNM2,HCK,RXRA,ELF4 |
4.352e-03 | -5.44 | ATF7IP (activating transcription factor 7 interacting protein) | protein interactions | 55729 | 128 | 3 | 19454 | 50 |
DISC1,ELF4,DNM2 |
4.382e-03 | -5.43 | lobular_carcinoma | COSMIC cancer mutations | lobular_carcinoma | 763 | 7 | 16828 | 46 |
BMP2K,ITGAV,HCK,CCND2,ZFP36L1,RBM47,ME1 |
4.382e-03 | -5.43 | breast-carcinoma-lobular_carcinoma | COSMIC cancer mutations | breast-carcinoma-lobular_carcinoma | 763 | 7 | 16828 | 46 |
CCND2,BMP2K,ITGAV,HCK,RBM47,ME1,ZFP36L1 |
4.396e-03 | -5.43 | SH3 domain binding | molecular function | GO:0017124 | 122 | 3 | 18094 | 49 |
PTPN12,DNM2,PTPN6 |
4.433e-03 | -5.42 | XRCC6 (X-ray repair cross complementing 6) | protein interactions | 2547 | 810 | 7 | 19454 | 50 |
ARHGAP24,BTG1,DISC1,RBPJ,RXRA,ARAP1,DNM2 |
4.451e-03 | -5.41 | negative regulation of lymphocyte apoptotic process | biological process | GO:0070229 | 37 | 2 | 18204 | 49 |
DOCK8,CD74 |
4.451e-03 | -5.41 | cellular response to low-density lipoprotein particle stimulus | biological process | GO:0071404 | 37 | 2 | 18204 | 49 |
ITGB2,CD68 |
4.451e-03 | -5.41 | response to lipoprotein particle | biological process | GO:0055094 | 37 | 2 | 18204 | 49 |
CD68,ITGB2 |
4.483e-03 | -5.41 | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma | COSMIC cancer mutations | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma | 7205 | 29 | 16828 | 46 |
WDFY3,DOCK8,ELF4,HEPHL1,SH2B3,RGL1,ME1,ITGAL,CCND2,PTPN12,MCOLN2,GAB1,ANTXR2,MYO1F,DOCK2,ARAP1,DAB2,AKAP13,EHD4,FKBP5,ARHGEF18,DNM2,RXRA,ITGB2,SLC9A7,TLN1,PREX1,STAB1,ITGAV |
4.523e-03 | -5.40 | positive regulation of cell-substrate adhesion | biological process | GO:0010811 | 124 | 3 | 18204 | 49 |
DAB2,PREX1,DISC1 |
4.523e-03 | -5.40 | regulation of ossification | biological process | GO:0030278 | 124 | 3 | 18204 | 49 |
RBPJ,RXRA,BMP2K |
4.525e-03 | -5.40 | endomembrane system | cellular component | GO:0012505 | 4764 | 21 | 19108 | 49 |
CD68,MCOLN2,DNM2,ITM2B,DAB2,ANTXR2,EHD4,WDFY3,TMSB4X,CCND2,ITGAL,CD74,DOCK2,SLC9A7,DISC1,PTPN6,ARAP1,ARHGAP45,HCK,ITGB2,ITGAV |
4.557e-03 | -5.39 | The role of Nef in HIV-1 replication and disease pathogenesis | REACTOME pathways | R-HSA-164952 | 29 | 2 | 10285 | 36 |
HCK,DOCK2 |
4.568e-03 | -5.39 | Bacterial invasion of epithelial cells | KEGG pathways | hsa05100 | 76 | 3 | 7161 | 32 |
GAB1,SEPTIN9,DNM2 |
4.568e-03 | -5.39 | Bacterial invasion of epithelial cells | KEGG pathways | ko05100 | 76 | 3 | 7161 | 32 |
SEPTIN9,GAB1,DNM2 |
4.634e-03 | -5.37 | p75 NTR receptor-mediated signalling | REACTOME pathways | R-HSA-193704 | 97 | 3 | 10285 | 36 |
AKAP13,ARHGEF18,PREX1 |
4.674e-03 | -5.37 | cell leading edge | cellular component | GO:0031252 | 428 | 5 | 19108 | 49 |
ARHGAP45,DOCK8,PLXND1,ITGAV,TLN1 |
4.691e-03 | -5.36 | heterotypic cell-cell adhesion | biological process | GO:0034113 | 38 | 2 | 18204 | 49 |
ITGAV,ITGB2 |
4.704e-03 | -5.36 | intestinal_adenocarcinoma | COSMIC cancer mutations | intestinal_adenocarcinoma | 7225 | 29 | 16828 | 46 |
MYO1F,DOCK2,ARAP1,ANTXR2,RBM47,AKAP13,CD74,RBPJ,ARHGEF18,DAB2,ARHGAP24,ITM2B,RXRA,STAB1,ITGAV,SLC9A7,TLN1,PREX1,DOCK8,WDFY3,PLXND1,BMP2K,ELF4,HEPHL1,ITGAL,MCOLN2,PTPN12,GAB1,CCND2 |
4.704e-03 | -5.36 | stomach-carcinoma-intestinal_adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-intestinal_adenocarcinoma | 7225 | 29 | 16828 | 46 |
DOCK8,WDFY3,PLXND1,BMP2K,HEPHL1,ELF4,ITGAL,GAB1,PTPN12,MCOLN2,CCND2,ARAP1,MYO1F,DOCK2,RBM47,ANTXR2,AKAP13,ARHGEF18,CD74,RBPJ,DAB2,ARHGAP24,ITM2B,RXRA,ITGAV,STAB1,SLC9A7,TLN1,PREX1 |
4.705e-03 | -5.36 | plasma membrane region | cellular component | GO:0098590 | 1278 | 9 | 19108 | 49 |
DNM2,PLXND1,ARHGEF18,ITGAV,TLN1,ITGB2,HCK,ARHGAP45,DOCK8 |
4.777e-03 | -5.34 | ACTG1 (actin gamma 1) | protein interactions | 71 | 429 | 5 | 19454 | 50 |
DISC1,ARHGAP24,TMSB4X,FKBP5,PTPN12 |
4.852e-03 | -5.33 | cellular process | biological process | GO:0009987 | 14996 | 47 | 18204 | 49 |
MYO1F,RXRA,BTG1,DNM2,RGL1,FKBP5,ARHGEF18,ZFP36L1,ITGAL,DAB2,SPI1,SEPTIN9,SLC9A7,ARAP1,HCK,CCND2,RBPJ,DOCK8,CD74,MCOLN2,ITGAV,ARHGAP45,BMP2K,PTPN12,TMSB4X,ELF4,WDFY3,GAB1,PTPN6,LRMDA,TFEB,RBM47,DISC1,PLXND1,ITGB2,EHD4,CD68,PTGIR,DOCK2,AKAP13,ARHGAP24,STAB1,SH2B3,PREX1,TLN1,ME1,FYB1 |
4.853e-03 | -5.33 | anatomical structure development | biological process | GO:0048856 | 5207 | 23 | 18204 | 49 |
PTPN12,SH2B3,ITGAV,ARHGAP24,PREX1,RBPJ,DOCK2,CD74,AKAP13,SPI1,ITM2B,RBM47,DAB2,ZFP36L1,TFEB,PLXND1,DISC1,HCK,ITGB2,GAB1,PTPN6,RXRA,DNM2 |
4.872e-03 | -5.32 | Gap junction trafficking and regulation | REACTOME pathways | R-HSA-157858 | 30 | 2 | 10285 | 36 |
DNM2,DAB2 |
4.897e-03 | -5.32 | amide binding | molecular function | GO:0033218 | 254 | 4 | 18094 | 49 |
ITGB2,FKBP5,ITM2B,CD74 |
4.950e-03 | -5.31 | ETS_DOMAIN_3 | prosite domains | PS50061 | 28 | 2 | 12186 | 46 |
SPI1,ELF4 |
4.954e-03 | -5.31 | ETSDOMAIN | prints domains | PR00454 | 28 | 2 | 5227 | 20 |
SPI1,ELF4 |
4.966e-03 | -5.31 | RA_dom | interpro domains | IPR000159 | 39 | 2 | 18521 | 50 |
ARAP1,RGL1 |
4.980e-03 | -5.30 | NR3C2 (nuclear receptor subfamily 3 group C member 2) | protein interactions | 4306 | 41 | 2 | 19454 | 50 |
FKBP5,RXRA |
4.980e-03 | -5.30 | SRGAP3 (SLIT-ROBO Rho GTPase activating protein 3) | protein interactions | 9901 | 41 | 2 | 19454 | 50 |
ARHGAP24,DISC1 |
5.061e-03 | -5.29 | FN1 (fibronectin 1) | protein interactions | 2335 | 830 | 7 | 19454 | 50 |
DAB2,BMP2K,ITGAV,DISC1,TLN1,DNM2,SEPTIN9 |
5.065e-03 | -5.29 | small GTPase-mediated signal transduction | biological process | GO:0007264 | 258 | 4 | 18204 | 49 |
DOCK2,ARHGEF18,RGL1,DOCK8 |
5.104e-03 | -5.28 | cellular response to organic substance | biological process | GO:0071310 | 1716 | 11 | 18204 | 49 |
TMSB4X,HCK,DOCK8,CD74,ZFP36L1,RXRA,CD68,PTPN6,SPI1,GAB1,SH2B3 |
5.122e-03 | -5.27 | integrin alphav-beta1 complex | cellular component | GO:0034682 | 2 | 1 | 19108 | 49 |
ITGAV |
5.122e-03 | -5.27 | integrin alphav-beta5 complex | cellular component | GO:0034684 | 2 | 1 | 19108 | 49 |
ITGAV |
5.122e-03 | -5.27 | integrin alphav-beta8 complex | cellular component | GO:0034686 | 2 | 1 | 19108 | 49 |
ITGAV |
5.122e-03 | -5.27 | integrin alphaM-beta2 complex | cellular component | GO:0034688 | 2 | 1 | 19108 | 49 |
ITGB2 |
5.122e-03 | -5.27 | macrophage migration inhibitory factor receptor complex | cellular component | GO:0035692 | 2 | 1 | 19108 | 49 |
CD74 |
5.122e-03 | -5.27 | integrin alphav-beta6 complex | cellular component | GO:0034685 | 2 | 1 | 19108 | 49 |
ITGAV |
5.122e-03 | -5.27 | integrin alphaX-beta2 complex | cellular component | GO:0034689 | 2 | 1 | 19108 | 49 |
ITGB2 |
5.125e-03 | -5.27 | HTLV-I infection | KEGG pathways | hsa05166 | 256 | 5 | 7161 | 32 |
ITGAL,ITGB2,TLN1,CCND2,SPI1 |
5.125e-03 | -5.27 | HTLV-I infection | KEGG pathways | ko05166 | 256 | 5 | 7161 | 32 |
TLN1,CCND2,ITGAL,ITGB2,SPI1 |
5.134e-03 | -5.27 | ZNF658B (zinc finger protein 658B (pseudogene)) | protein interactions | 401509 | 2 | 1 | 19454 | 50 |
ARHGAP24 |
5.134e-03 | -5.27 | LIPI (lipase I) | protein interactions | 149998 | 2 | 1 | 19454 | 50 |
SEPTIN9 |
5.134e-03 | -5.27 | KIR2DL5A (killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 5A) | protein interactions | 57292 | 2 | 1 | 19454 | 50 |
PTPN6 |
5.134e-03 | -5.27 | Cnot7 (CCR4-NOT transcription complex, subunit 7) | protein interactions | 18983 | 2 | 1 | 19454 | 50 |
BTG1 |
5.134e-03 | -5.27 | MPIG6B (megakaryocyte and platelet inhibitory receptor G6b) | protein interactions | 80739 | 2 | 1 | 19454 | 50 |
PTPN6 |
5.134e-03 | -5.27 | Siglece (sialic acid binding Ig-like lectin E) | protein interactions | 83382 | 2 | 1 | 19454 | 50 |
PTPN6 |
5.134e-03 | -5.27 | ZNF680 (zinc finger protein 680) | protein interactions | 340252 | 2 | 1 | 19454 | 50 |
ARHGAP24 |
5.134e-03 | -5.27 | CUZD1 (CUB and zona pellucida like domains 1) | protein interactions | 50624 | 2 | 1 | 19454 | 50 |
PTPN6 |
5.153e-03 | -5.27 | ITGB5 (integrin subunit beta 5) | protein interactions | 3693 | 136 | 3 | 19454 | 50 |
ITGAV,TLN1,DAB2 |
5.153e-03 | -5.27 | PYGB (glycogen phosphorylase B) | protein interactions | 5834 | 136 | 3 | 19454 | 50 |
ARHGAP24,FYB1,FKBP5 |
5.174e-03 | -5.26 | peptide binding | molecular function | GO:0042277 | 258 | 4 | 18094 | 49 |
CD74,ITGB2,RXRA,ITM2B |
5.187e-03 | -5.26 | cellular response to lipoprotein particle stimulus | biological process | GO:0071402 | 40 | 2 | 18204 | 49 |
CD68,ITGB2 |
5.198e-03 | -5.26 | RDX (radixin) | protein interactions | 5962 | 272 | 4 | 19454 | 50 |
TLN1,ITGB2,SEPTIN9,ARHGAP24 |
5.199e-03 | -5.26 | APP (amyloid beta precursor protein) | protein interactions | 351 | 2342 | 13 | 19454 | 50 |
SEPTIN9,DNM2,ARAP1,HCK,RGL1,ARHGAP24,AKAP13,CD74,FKBP5,DAB2,RBPJ,PTPN12,ITM2B |
5.220e-03 | -5.26 | OAZ3 (ornithine decarboxylase antizyme 3) | protein interactions | 51686 | 42 | 2 | 19454 | 50 |
HEPHL1,ME1 |
5.220e-03 | -5.26 | NSMAF (neutral sphingomyelinase activation associated factor) | protein interactions | 8439 | 42 | 2 | 19454 | 50 |
HEPHL1,DOCK8 |
5.276e-03 | -5.24 | positive regulation of immune effector process | biological process | GO:0002699 | 261 | 4 | 18204 | 49 |
ITGB2,SPI1,PTPN6,CD74 |
5.278e-03 | -5.24 | human chr19p13.2 | chromosome location | human chr19p13.2 | 184 | 3 | 26134 | 50 |
DNM2,ARHGEF18,MYO1F |
5.358e-03 | -5.23 | enzyme activator activity | molecular function | GO:0008047 | 599 | 6 | 18094 | 49 |
ARHGAP24,CCND2,ARAP1,DOCK2,ARHGAP45,PREX1 |
5.370e-03 | -5.23 | regulation of cellular component biogenesis | biological process | GO:0044087 | 1016 | 8 | 18204 | 49 |
TLN1,PREX1,HCK,TMSB4X,ARAP1,ARHGEF18,ARHGAP24,SEPTIN9 |
5.376e-03 | -5.23 | blood vessel lumenization | biological process | GO:0072554 | 2 | 1 | 18204 | 49 |
RBPJ |
5.376e-03 | -5.23 | negative regulation of entry of bacterium into host cell | biological process | GO:2000536 | 2 | 1 | 18204 | 49 |
ITGAV |
5.376e-03 | -5.23 | positive regulation of macrophage migration inhibitory factor signaling pathway | biological process | GO:2000448 | 2 | 1 | 18204 | 49 |
CD74 |
5.376e-03 | -5.23 | regulation of ephrin receptor signaling pathway | biological process | GO:1901187 | 2 | 1 | 18204 | 49 |
RBPJ |
5.376e-03 | -5.23 | negative regulation of dopamine metabolic process | biological process | GO:0045963 | 2 | 1 | 18204 | 49 |
ITGB2 |
5.376e-03 | -5.23 | positive regulation of macrophage inflammatory protein 1 alpha production | biological process | GO:0071642 | 2 | 1 | 18204 | 49 |
MCOLN2 |
5.376e-03 | -5.23 | regulation of prostaglandin-E synthase activity | biological process | GO:2000361 | 2 | 1 | 18204 | 49 |
ITGB2 |
5.376e-03 | -5.23 | memory T cell extravasation | biological process | GO:0035683 | 2 | 1 | 18204 | 49 |
ITGAL |
5.376e-03 | -5.23 | negative regulation of membrane tubulation | biological process | GO:1903526 | 2 | 1 | 18204 | 49 |
DNM2 |
5.376e-03 | -5.23 | arterial endothelial cell fate commitment | biological process | GO:0060844 | 2 | 1 | 18204 | 49 |
RBPJ |
5.376e-03 | -5.23 | regulation of Kit signaling pathway | biological process | GO:1900234 | 2 | 1 | 18204 | 49 |
SH2B3 |
5.376e-03 | -5.23 | regulation of cell adhesion involved in heart morphogenesis | biological process | GO:0061344 | 2 | 1 | 18204 | 49 |
RBPJ |
5.376e-03 | -5.23 | negative regulation of Kit signaling pathway | biological process | GO:1900235 | 2 | 1 | 18204 | 49 |
SH2B3 |
5.376e-03 | -5.23 | negative regulation of neutrophil degranulation | biological process | GO:0043314 | 2 | 1 | 18204 | 49 |
SPI1 |
5.376e-03 | -5.23 | NK T cell activation | biological process | GO:0051132 | 2 | 1 | 18204 | 49 |
ELF4 |
5.376e-03 | -5.23 | pro-T cell differentiation | biological process | GO:0002572 | 2 | 1 | 18204 | 49 |
SPI1 |
5.376e-03 | -5.23 | positive regulation of prostaglandin-E synthase activity | biological process | GO:2000363 | 2 | 1 | 18204 | 49 |
ITGB2 |
5.376e-03 | -5.23 | positive regulation of thyroid hormone mediated signaling pathway | biological process | GO:0002157 | 2 | 1 | 18204 | 49 |
RXRA |
5.376e-03 | -5.23 | negative regulation of catecholamine metabolic process | biological process | GO:0045914 | 2 | 1 | 18204 | 49 |
ITGB2 |
5.376e-03 | -5.23 | synaptic target recognition | biological process | GO:0008039 | 2 | 1 | 18204 | 49 |
PLXND1 |
5.376e-03 | -5.23 | NK T cell proliferation | biological process | GO:0001866 | 2 | 1 | 18204 | 49 |
ELF4 |
5.376e-03 | -5.23 | vesicle scission | biological process | GO:0099050 | 2 | 1 | 18204 | 49 |
DNM2 |
5.390e-03 | -5.22 | endosome | cellular component | GO:0005768 | 1067 | 8 | 19108 | 49 |
CD74,DNM2,SLC9A7,ITM2B,CD68,MCOLN2,ANTXR2,EHD4 |
5.392e-03 | -5.22 | Dab_PTB | interpro domains | IPR048561 | 2 | 1 | 18521 | 50 |
DAB2 |
5.392e-03 | -5.22 | RBP-J/Cbf11/Cbf12_DNA-bd | interpro domains | IPR015351 | 2 | 1 | 18521 | 50 |
RBPJ |
5.392e-03 | -5.22 | Tyr_Pase_non-rcpt_typ-6/11 | interpro domains | IPR012152 | 2 | 1 | 18521 | 50 |
PTPN6 |
5.392e-03 | -5.22 | Beta-trefoil_DNA-bd_dom | interpro domains | IPR015350 | 2 | 1 | 18521 | 50 |
RBPJ |
5.392e-03 | -5.22 | Talin1/2-RS | interpro domains | IPR037438 | 2 | 1 | 18521 | 50 |
TLN1 |
5.392e-03 | -5.22 | Tis11B_N | interpro domains | IPR007635 | 2 | 1 | 18521 | 50 |
ZFP36L1 |
5.392e-03 | -5.22 | CLS_fam | interpro domains | IPR040159 | 2 | 1 | 18521 | 50 |
RBPJ |
5.392e-03 | -5.22 | Nuc_recep-AF1 | interpro domains | IPR021780 | 2 | 1 | 18521 | 50 |
RXRA |
5.392e-03 | -5.22 | Ie/If_SH3 | interpro domains | IPR035507 | 2 | 1 | 18521 | 50 |
MYO1F |
5.392e-03 | -5.22 | RBP-J/Cbf11_DNA-bd_sf | interpro domains | IPR037095 | 2 | 1 | 18521 | 50 |
RBPJ |
5.392e-03 | -5.22 | Anthrax_toxin_rcpt_C | interpro domains | IPR008399 | 2 | 1 | 18521 | 50 |
ANTXR2 |
5.392e-03 | -5.22 | Talin_cent_sf | interpro domains | IPR036476 | 2 | 1 | 18521 | 50 |
TLN1 |
5.392e-03 | -5.22 | BTD_sf | interpro domains | IPR036358 | 2 | 1 | 18521 | 50 |
RBPJ |
5.392e-03 | -5.22 | Talin_cent | interpro domains | IPR015224 | 2 | 1 | 18521 | 50 |
TLN1 |
5.392e-03 | -5.22 | DAB1/2_SBM | interpro domains | IPR048559 | 2 | 1 | 18521 | 50 |
DAB2 |
5.392e-03 | -5.22 | Vinculin-bd_dom | interpro domains | IPR015009 | 2 | 1 | 18521 | 50 |
TLN1 |
5.392e-03 | -5.22 | RBP-Jkappa_IPT | interpro domains | IPR038007 | 2 | 1 | 18521 | 50 |
RBPJ |
5.392e-03 | -5.22 | Talin_R4 | interpro domains | IPR049108 | 2 | 1 | 18521 | 50 |
TLN1 |
5.409e-03 | -5.22 | macrophage migration inhibitory factor binding | molecular function | GO:0035718 | 2 | 1 | 18094 | 49 |
CD74 |
5.419e-03 | -5.22 | upper_aerodigestive_tract | COSMIC cancer mutations | upper_aerodigestive_tract | 13181 | 43 | 16828 | 46 |
SPI1,ITGAL,ME1,TMSB4X,HEPHL1,DNM2,TFEB,STAB1,PREX1,ARAP1,DOCK2,MYO1F,DISC1,FKBP5,ARHGEF18,CD74,AKAP13,ARHGAP24,DAB2,RGL1,SH2B3,GAB1,PTPN12,MCOLN2,CCND2,WDFY3,DOCK8,PLXND1,BMP2K,ELF4,ITGB2,RXRA,ITGAV,HCK,PTGIR,TLN1,SLC9A7,ZFP36L1,RBM47,PTPN6,RBPJ,EHD4,BTG1 |
5.443e-03 | -5.21 | inflammatory response to antigenic stimulus | biological process | GO:0002437 | 41 | 2 | 18204 | 49 |
CD68,RBPJ |
5.443e-03 | -5.21 | antigen processing and presentation of exogenous peptide antigen | biological process | GO:0002478 | 41 | 2 | 18204 | 49 |
DNM2,CD74 |
5.469e-03 | -5.21 | EPO signaling pathway | Pathway Interaction DB | epopathway | 33 | 3 | 2226 | 25 |
SH2B3,GAB1,PTPN6 |
5.471e-03 | -5.21 | FLII (FLII actin remodeling protein) | protein interactions | 2314 | 276 | 4 | 19454 | 50 |
FKBP5,CCND2,RBPJ,DISC1 |
5.494e-03 | -5.20 | negative regulation of cell communication | biological process | GO:0010648 | 1485 | 10 | 18204 | 49 |
SH2B3,PTPN12,PTPN6,SPI1,PTGIR,ITGAV,ARHGAP24,DAB2,CD74,TMSB4X |
5.494e-03 | -5.20 | negative regulation of signaling | biological process | GO:0023057 | 1485 | 10 | 18204 | 49 |
ARHGAP24,DAB2,PTGIR,ITGAV,PTPN6,SPI1,PTPN12,SH2B3,TMSB4X,CD74 |
5.500e-03 | -5.20 | TIG_SUH | pfam domains | PF20144 | 2 | 1 | 17795 | 49 |
RBPJ |
5.500e-03 | -5.20 | DAB2_SBM | pfam domains | PF21792 | 2 | 1 | 17795 | 49 |
DAB2 |
5.500e-03 | -5.20 | Nuc_recep-AF1 | pfam domains | PF11825 | 2 | 1 | 17795 | 49 |
RXRA |
5.500e-03 | -5.20 | Talin_middle | pfam domains | PF09141 | 2 | 1 | 17795 | 49 |
TLN1 |
5.500e-03 | -5.20 | Tis11B_N | pfam domains | PF04553 | 2 | 1 | 17795 | 49 |
ZFP36L1 |
5.500e-03 | -5.20 | Talin_R4 | pfam domains | PF21692 | 2 | 1 | 17795 | 49 |
TLN1 |
5.500e-03 | -5.20 | BTD | pfam domains | PF09270 | 2 | 1 | 17795 | 49 |
RBPJ |
5.500e-03 | -5.20 | LAG1-DNAbind | pfam domains | PF09271 | 2 | 1 | 17795 | 49 |
RBPJ |
5.500e-03 | -5.20 | VBS | pfam domains | PF08913 | 2 | 1 | 17795 | 49 |
TLN1 |
5.500e-03 | -5.20 | Ant_C | pfam domains | PF05586 | 2 | 1 | 17795 | 49 |
ANTXR2 |
5.554e-03 | -5.19 | lytic vacuole membrane | cellular component | GO:0098852 | 446 | 5 | 19108 | 49 |
CD74,DAB2,CD68,TFEB,MCOLN2 |
5.554e-03 | -5.19 | lysosomal membrane | cellular component | GO:0005765 | 446 | 5 | 19108 | 49 |
DAB2,CD74,MCOLN2,CD68,TFEB |
5.611e-03 | -5.18 | cytoskeleton organization | biological process | GO:0007010 | 1251 | 9 | 18204 | 49 |
ARHGEF18,MYO1F,DOCK2,TMSB4X,PREX1,DNM2,TLN1,ARAP1,DISC1 |
5.612e-03 | -5.18 | regulation of actin filament polymerization | biological process | GO:0030833 | 134 | 3 | 18204 | 49 |
TMSB4X,PREX1,HCK |
5.717e-03 | -5.16 | FNBP1L (formin binding protein 1 like) | protein interactions | 54874 | 44 | 2 | 19454 | 50 |
DNM2,RBPJ |
5.717e-03 | -5.16 | ICAM4 (intercellular adhesion molecule 4 (Landsteiner-Wiener blood group)) | protein interactions | 3386 | 44 | 2 | 19454 | 50 |
ITGAV,ITGB2 |
5.717e-03 | -5.16 | FER (FER tyrosine kinase) | protein interactions | 2241 | 44 | 2 | 19454 | 50 |
FKBP5,DNM2 |
5.721e-03 | -5.16 | negative regulation of response to external stimulus | biological process | GO:0032102 | 428 | 5 | 18204 | 49 |
PTPN6,ELF4,SH2B3,TMSB4X,HCK |
5.738e-03 | -5.16 | Signalling by NGF | REACTOME pathways | R-HSA-166520 | 477 | 6 | 10285 | 36 |
AKAP13,PREX1,DNM2,TLN1,GAB1,ARHGEF18 |
5.740e-03 | -5.16 | PTP_cat | interpro domains | IPR000242 | 42 | 2 | 18521 | 50 |
PTPN6,PTPN12 |
5.740e-03 | -5.16 | PSI | interpro domains | IPR016201 | 42 | 2 | 18521 | 50 |
ITGB2,PLXND1 |
5.826e-03 | -5.15 | SKP2 (S-phase kinase associated protein 2) | protein interactions | 6502 | 281 | 4 | 19454 | 50 |
CCND2,DISC1,BTG1,ELF4 |
5.847e-03 | -5.14 | cell-matrix adhesion | biological process | GO:0007160 | 136 | 3 | 18204 | 49 |
ITGAV,ITGAL,ITGB2 |
5.890e-03 | -5.13 | response to wounding | biological process | GO:0009611 | 431 | 5 | 18204 | 49 |
PTPN6,ITGAV,ZFP36L1,TLN1,ARHGAP24 |
5.913e-03 | -5.13 | SH2 domain | gene3d domains | 3.30.505.10 | 111 | 3 | 14470 | 48 |
SH2B3,PTPN6,HCK |
5.952e-03 | -5.12 | Adaptive Immune System | REACTOME pathways | R-HSA-1280218 | 810 | 8 | 10285 | 36 |
PTPN6,GAB1,FYB1,CD74,ITGAL,ITGB2,ITGAV,DNM2 |
5.962e-03 | -5.12 | Y_phosphatase | pfam domains | PF00102 | 42 | 2 | 17795 | 49 |
PTPN12,PTPN6 |
5.967e-03 | -5.12 | cell recognition | biological process | GO:0008037 | 137 | 3 | 18204 | 49 |
DOCK2,PLXND1,DOCK8 |
5.967e-03 | -5.12 | myeloid leukocyte migration | biological process | GO:0097529 | 137 | 3 | 18204 | 49 |
PREX1,ITGB2,MCOLN2 |
5.973e-03 | -5.12 | SPTBN4 (spectrin beta, non-erythrocytic 4) | protein interactions | 57731 | 45 | 2 | 19454 | 50 |
ANTXR2,DISC1 |
5.973e-03 | -5.12 | SMARCAL1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1) | protein interactions | 50485 | 45 | 2 | 19454 | 50 |
FKBP5,RBPJ |
5.973e-03 | -5.12 | ITGAD (integrin subunit alpha D) | protein interactions | 3681 | 45 | 2 | 19454 | 50 |
HEPHL1,ITGB2 |
5.973e-03 | -5.12 | EPOR (erythropoietin receptor) | protein interactions | 2057 | 45 | 2 | 19454 | 50 |
GAB1,PTPN6 |
5.973e-03 | -5.12 | SKAP2 (src kinase associated phosphoprotein 2) | protein interactions | 8935 | 45 | 2 | 19454 | 50 |
HCK,FYB1 |
5.974e-03 | -5.12 | positive regulation of substrate adhesion-dependent cell spreading | biological process | GO:1900026 | 43 | 2 | 18204 | 49 |
PREX1,DAB2 |
6.108e-03 | -5.10 | LCK (LCK proto-oncogene, Src family tyrosine kinase) | protein interactions | 3932 | 455 | 5 | 19454 | 50 |
PTPN6,DNM2,HCK,GAB1,SH2B3 |
6.126e-03 | -5.10 | ETS | smart domains | SM00413 | 28 | 2 | 9717 | 41 |
SPI1,ELF4 |
6.234e-03 | -5.08 | ICAM5 (intercellular adhesion molecule 5) | protein interactions | 7087 | 46 | 2 | 19454 | 50 |
ITGB2,ITGAL |
6.287e-03 | -5.07 | SH3 Domains | gene3d domains | 2.30.30.40 | 223 | 4 | 14470 | 48 |
MYO1F,DOCK2,FYB1,HCK |
6.332e-03 | -5.06 | biliary_tract-gallbladder-carcinoma-adenocarcinoma | COSMIC cancer mutations | biliary_tract-gallbladder-carcinoma-adenocarcinoma | 2821 | 15 | 16828 | 46 |
AKAP13,BMP2K,ARAP1,ZFP36L1,DOCK2,PTPN6,PLXND1,ANTXR2,ITGAV,PTPN12,HCK,SLC9A7,TLN1,ITGAL,ME1 |
6.332e-03 | -5.06 | gallbladder | COSMIC cancer mutations | gallbladder | 2821 | 15 | 16828 | 46 |
PLXND1,PTPN6,ANTXR2,ZFP36L1,DOCK2,ARAP1,AKAP13,BMP2K,ME1,ITGAL,TLN1,SLC9A7,PTPN12,HCK,ITGAV |
6.471e-03 | -5.04 | negative regulation of cellular process | biological process | GO:0048523 | 5320 | 23 | 18204 | 49 |
ITGAV,DAB2,ARHGEF18,ZFP36L1,ARHGAP24,SH2B3,PTPN12,SPI1,ITM2B,PLXND1,ARAP1,HCK,TMSB4X,ELF4,PTGIR,RXRA,CCND2,RBPJ,BTG1,PTPN6,DOCK8,DNM2,CD74 |
6.527e-03 | -5.03 | regulation of leukocyte degranulation | biological process | GO:0043300 | 45 | 2 | 18204 | 49 |
SPI1,ITGB2 |
6.527e-03 | -5.03 | regulation of type I interferon-mediated signaling pathway | biological process | GO:0060338 | 45 | 2 | 18204 | 49 |
RBM47,PTPN6 |
6.550e-03 | -5.03 | phosphatidylinositol binding | molecular function | GO:0035091 | 276 | 4 | 18094 | 49 |
TLN1,WDFY3,ARAP1,DNM2 |
6.569e-03 | -5.03 | response to chemical | biological process | GO:0042221 | 3743 | 18 | 18204 | 49 |
RXRA,PTGIR,CD68,GAB1,DOCK2,PTPN6,DOCK8,CD74,ZFP36L1,DAB2,ITGAV,SPI1,SH2B3,HCK,TMSB4X,PREX1,ITGB2,ME1 |
6.588e-03 | -5.02 | positive regulation of small molecule metabolic process | biological process | GO:0062013 | 142 | 3 | 18204 | 49 |
DAB2,TMSB4X,CD74 |
6.624e-03 | -5.02 | LAG1, DNA binding domain | gene3d domains | 2.60.40.1450 | 2 | 1 | 14470 | 48 |
RBPJ |
6.624e-03 | -5.02 | regulation of cell activation | biological process | GO:0050865 | 630 | 6 | 18204 | 49 |
ZFP36L1,DOCK8,SPI1,PTPN6,CD74,SH2B3 |
6.624e-03 | -5.02 | MCAM (melanoma cell adhesion molecule) | protein interactions | 4162 | 464 | 5 | 19454 | 50 |
ITGAV,GAB1,DAB2,EHD4,LRMDA |
6.660e-03 | -5.01 | positive regulation of leukocyte cell-cell adhesion | biological process | GO:1903039 | 279 | 4 | 18204 | 49 |
PTPN6,CD74,ITGB2,DOCK8 |
6.743e-03 | -5.00 | PFN1 (profilin 1) | protein interactions | 5216 | 466 | 5 | 19454 | 50 |
AKAP13,ARHGAP24,SEPTIN9,DOCK8,DNM2 |
6.772e-03 | -4.99 | FES (FES proto-oncogene, tyrosine kinase) | protein interactions | 2242 | 48 | 2 | 19454 | 50 |
FKBP5,GAB1 |
6.812e-03 | -4.99 | receptor clustering | biological process | GO:0043113 | 46 | 2 | 18204 | 49 |
ITGAL,ITGB2 |
6.812e-03 | -4.99 | endodermal cell differentiation | biological process | GO:0035987 | 46 | 2 | 18204 | 49 |
ITGAV,ITGB2 |
6.863e-03 | -4.98 | carcinoid-endocrine_tumour | COSMIC cancer mutations | carcinoid-endocrine_tumour | 7752 | 30 | 16828 | 46 |
EHD4,AKAP13,FKBP5,BTG1,ZFP36L1,DOCK2,MYO1F,ANTXR2,STAB1,HCK,SLC9A7,TLN1,PREX1,PTGIR,ITM2B,DNM2,RXRA,BMP2K,HEPHL1,ELF4,WDFY3,DOCK8,PLXND1,GAB1,MCOLN2,PTPN12,ITGAL,ME1,RGL1,SH2B3 |
6.937e-03 | -4.97 | regulation of cell migration | biological process | GO:0030334 | 1061 | 8 | 18204 | 49 |
ITGAV,DAB2,GAB1,DOCK8,PLXND1,PREX1,TMSB4X,CD74 |
7.049e-03 | -4.95 | HBZ (hemoglobin subunit zeta) | protein interactions | 3050 | 49 | 2 | 19454 | 50 |
DOCK8,ARHGAP24 |
7.056e-03 | -4.95 | positive regulation of cell communication | biological process | GO:0010647 | 1792 | 11 | 18204 | 49 |
AKAP13,CD74,RXRA,PTPN6,RBPJ,DISC1,DAB2,BMP2K,ITGAV,SPI1,RBM47 |
7.103e-03 | -4.95 | regulation of erythrocyte differentiation | biological process | GO:0045646 | 47 | 2 | 18204 | 49 |
SPI1,ZFP36L1 |
7.103e-03 | -4.95 | labyrinthine layer development | biological process | GO:0060711 | 47 | 2 | 18204 | 49 |
ZFP36L1,RBPJ |
7.103e-03 | -4.95 | T cell selection | biological process | GO:0045058 | 47 | 2 | 18204 | 49 |
DOCK2,CD74 |
7.111e-03 | -4.95 | positive regulation of Wnt signaling pathway | biological process | GO:0030177 | 146 | 3 | 18204 | 49 |
RBPJ,DAB2,DISC1 |
7.116e-03 | -4.95 | VWA | pfam domains | PF00092 | 46 | 2 | 17795 | 49 |
ANTXR2,ITGAL |
7.186e-03 | -4.94 | phosphotyrosine residue binding | molecular function | GO:0001784 | 47 | 2 | 18094 | 49 |
PTPN6,HCK |
7.263e-03 | -4.92 | RPL37 (ribosomal protein L37) | protein interactions | 6167 | 154 | 3 | 19454 | 50 |
HCK,PTPN12,PTPN6 |
7.263e-03 | -4.92 | JAK2 (Janus kinase 2) | protein interactions | 3717 | 154 | 3 | 19454 | 50 |
SH2B3,PTPN12,PTPN6 |
7.317e-03 | -4.92 | Fc gamma R-mediated phagocytosis | KEGG pathways | hsa04666 | 90 | 3 | 7161 | 32 |
DNM2,HCK,DOCK2 |
7.317e-03 | -4.92 | Fc gamma R-mediated phagocytosis | KEGG pathways | ko04666 | 90 | 3 | 7161 | 32 |
DOCK2,HCK,DNM2 |
7.330e-03 | -4.92 | WNK3 (WNK lysine deficient protein kinase 3) | protein interactions | 65267 | 50 | 2 | 19454 | 50 |
BMP2K,ARHGAP24 |
7.412e-03 | -4.90 | skin-trunk-malignant_melanoma-nodular | COSMIC cancer mutations | skin-trunk-malignant_melanoma-nodular | 1291 | 9 | 16828 | 46 |
PTPN12,TFEB,STAB1,FKBP5,DISC1,RBM47,DOCK2,DOCK8,ITGB2 |
7.570e-03 | -4.88 | PPIB (peptidylprolyl isomerase B) | protein interactions | 5479 | 303 | 4 | 19454 | 50 |
DOCK8,PREX1,DNM2,ARHGAP24 |
7.572e-03 | -4.88 | positive regulation of cell development | biological process | GO:0010720 | 458 | 5 | 18204 | 49 |
CD74,SPI1,PLXND1,DISC1,ZFP36L1 |
7.587e-03 | -4.88 | extracellular exosome | cellular component | GO:0070062 | 2175 | 12 | 19108 | 49 |
CD74,DNM2,DOCK2,ITM2B,PTPN6,ITGAL,ARHGEF18,ITGB2,TLN1,ITGAV,FKBP5,EHD4 |
7.598e-03 | -4.88 | SH2 | prosite domains | PS50001 | 107 | 3 | 12186 | 46 |
PTPN6,SH2B3,HCK |
7.617e-03 | -4.88 | APLP1 (amyloid beta precursor like protein 1) | protein interactions | 333 | 51 | 2 | 19454 | 50 |
TMSB4X,DAB2 |
7.658e-03 | -4.87 | placenta development | biological process | GO:0001890 | 150 | 3 | 18204 | 49 |
TFEB,ZFP36L1,RBPJ |
7.674e-03 | -4.87 | MAML1-RBP-Jkappa- ICN1 complex | cellular component | GO:0002193 | 3 | 1 | 19108 | 49 |
RBPJ |
7.674e-03 | -4.87 | alphav-beta3 integrin-HMGB1 complex | cellular component | GO:0035868 | 3 | 1 | 19108 | 49 |
ITGAV |
7.674e-03 | -4.87 | cyclin D2-CDK4 complex | cellular component | GO:0097129 | 3 | 1 | 19108 | 49 |
CCND2 |
7.674e-03 | -4.87 | alphav-beta3 integrin-PKCalpha complex | cellular component | GO:0035866 | 3 | 1 | 19108 | 49 |
ITGAV |
7.674e-03 | -4.87 | integrin alphav-beta3 complex | cellular component | GO:0034683 | 3 | 1 | 19108 | 49 |
ITGAV |
7.691e-03 | -4.87 | CDCP2 (CUB domain containing protein 2) | protein interactions | 200008 | 3 | 1 | 19454 | 50 |
EHD4 |
7.691e-03 | -4.87 | ZNF682 (zinc finger protein 682) | protein interactions | 91120 | 3 | 1 | 19454 | 50 |
ARHGAP24 |
7.691e-03 | -4.87 | SIGLEC11 (sialic acid binding Ig like lectin 11) | protein interactions | 114132 | 3 | 1 | 19454 | 50 |
PTPN6 |
7.691e-03 | -4.87 | ZNF506 (zinc finger protein 506) | protein interactions | 440515 | 3 | 1 | 19454 | 50 |
ARHGAP24 |
7.691e-03 | -4.87 | Srr (serine racemase) | protein interactions | 27364 | 3 | 1 | 19454 | 50 |
DISC1 |
7.691e-03 | -4.87 | Grip1 (glutamate receptor interacting protein 1) | protein interactions | 74053 | 3 | 1 | 19454 | 50 |
RXRA |
7.691e-03 | -4.87 | ZNF540 (zinc finger protein 540) | protein interactions | 163255 | 3 | 1 | 19454 | 50 |
ARHGAP24 |
7.691e-03 | -4.87 | HERC2P2 (HERC2 pseudogene 2) | protein interactions | 400322 | 3 | 1 | 19454 | 50 |
DISC1 |
7.691e-03 | -4.87 | ZNF716 (zinc finger protein 716) | protein interactions | 441234 | 3 | 1 | 19454 | 50 |
ARHGAP24 |
7.691e-03 | -4.87 | ZNF257 (zinc finger protein 257) | protein interactions | 113835 | 3 | 1 | 19454 | 50 |
ARHGAP24 |
7.691e-03 | -4.87 | NKX6-1 (NK6 homeobox 1) | protein interactions | 4825 | 3 | 1 | 19454 | 50 |
RBPJ |
7.691e-03 | -4.87 | Myo6 (myosin VI) | protein interactions | 315840 | 3 | 1 | 19454 | 50 |
DAB2 |
7.699e-03 | -4.87 | Signal Transduction | REACTOME pathways | R-HSA-162582 | 2547 | 16 | 10285 | 36 |
PTPN6,RBPJ,ARAP1,GAB1,ARHGAP45,PTGIR,ARHGAP24,SH2B3,PTPN12,ARHGEF18,TLN1,AKAP13,DNM2,ITGAV,PREX1,RXRA |
7.700e-03 | -4.87 | platelet aggregation | biological process | GO:0070527 | 49 | 2 | 18204 | 49 |
PTPN6,TLN1 |
7.790e-03 | -4.85 | molecular sequestering activity | molecular function | GO:0140313 | 49 | 2 | 18094 | 49 |
TMSB4X,SPI1 |
7.816e-03 | -4.85 | serous_carcinoma | COSMIC cancer mutations | serous_carcinoma | 10987 | 38 | 16828 | 46 |
ANTXR2,RBM47,ZFP36L1,DOCK2,MYO1F,ARAP1,DAB2,ARHGAP24,EHD4,AKAP13,RBPJ,ARHGEF18,FKBP5,DNM2,RXRA,ITGB2,SLC9A7,TLN1,PREX1,PTGIR,HCK,TFEB,STAB1,ITGAV,WDFY3,DOCK8,ELF4,HEPHL1,CD68,BMP2K,RGL1,SH2B3,ME1,ITGAL,SPI1,PTPN12,MCOLN2,GAB1 |
7.857e-03 | -4.85 | Transcriptional misregulation in cancer | KEGG pathways | ko05202 | 179 | 4 | 7161 | 32 |
CCND2,RXRA,BMP2K,SPI1 |
7.857e-03 | -4.85 | Transcriptional misregulation in cancer | KEGG pathways | hsa05202 | 179 | 4 | 7161 | 32 |
SPI1,BMP2K,CCND2,RXRA |
7.890e-03 | -4.84 | negative regulation of defense response | biological process | GO:0031348 | 293 | 4 | 18204 | 49 |
HCK,TMSB4X,ELF4,PTPN6 |
7.928e-03 | -4.84 | COG6 (component of oligomeric golgi complex 6) | protein interactions | 57511 | 159 | 3 | 19454 | 50 |
CD68,TMSB4X,DOCK8 |
7.941e-03 | -4.84 | regulation of actin polymerization or depolymerization | biological process | GO:0008064 | 152 | 3 | 18204 | 49 |
PREX1,TMSB4X,HCK |
7.941e-03 | -4.84 | regulation of lipid transport | biological process | GO:0032368 | 152 | 3 | 18204 | 49 |
DAB2,RXRA,ITGAV |
7.957e-03 | -4.83 | protein domain specific binding | molecular function | GO:0019904 | 651 | 6 | 18094 | 49 |
PTPN6,TLN1,RXRA,PTPN12,PLXND1,DNM2 |
8.007e-03 | -4.83 | antigen processing and presentation of exogenous antigen | biological process | GO:0019884 | 50 | 2 | 18204 | 49 |
DNM2,CD74 |
8.054e-03 | -4.82 | adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process | biological process | GO:0086023 | 3 | 1 | 18204 | 49 |
AKAP13 |
8.054e-03 | -4.82 | regulation of macrophage migration inhibitory factor signaling pathway | biological process | GO:2000446 | 3 | 1 | 18204 | 49 |
CD74 |
8.054e-03 | -4.82 | blood vessel endothelial cell fate commitment | biological process | GO:0060846 | 3 | 1 | 18204 | 49 |
RBPJ |
8.054e-03 | -4.82 | positive regulation of aldosterone secretion | biological process | GO:2000860 | 3 | 1 | 18204 | 49 |
DAB2 |
8.054e-03 | -4.82 | positive regulation of intracellular mRNA localization | biological process | GO:1904582 | 3 | 1 | 18204 | 49 |
ZFP36L1 |
8.054e-03 | -4.82 | positive regulation of aldosterone metabolic process | biological process | GO:0032346 | 3 | 1 | 18204 | 49 |
DAB2 |
8.054e-03 | -4.82 | positive regulation of mineralocorticoid secretion | biological process | GO:2000857 | 3 | 1 | 18204 | 49 |
DAB2 |
8.054e-03 | -4.82 | proepicardium development | biological process | GO:0003342 | 3 | 1 | 18204 | 49 |
ZFP36L1 |
8.054e-03 | -4.82 | cellular response to raffinose | biological process | GO:0097403 | 3 | 1 | 18204 | 49 |
ZFP36L1 |
8.054e-03 | -4.82 | positive regulation of proton-transporting ATP synthase activity, rotational mechanism | biological process | GO:1905273 | 3 | 1 | 18204 | 49 |
TMSB4X |
8.054e-03 | -4.82 | leukocyte migration involved in immune response | biological process | GO:0002522 | 3 | 1 | 18204 | 49 |
HCK |
8.054e-03 | -4.82 | response to raffinose | biological process | GO:1901545 | 3 | 1 | 18204 | 49 |
ZFP36L1 |
8.054e-03 | -4.82 | endothelial to hematopoietic transition | biological process | GO:0098508 | 3 | 1 | 18204 | 49 |
SPI1 |
8.054e-03 | -4.82 | myeloid dendritic cell activation involved in immune response | biological process | GO:0002277 | 3 | 1 | 18204 | 49 |
DOCK2 |
8.054e-03 | -4.82 | pyramidal neuron migration to cerebral cortex | biological process | GO:0021852 | 3 | 1 | 18204 | 49 |
DISC1 |
8.054e-03 | -4.82 | positive regulation of antifungal innate immune response | biological process | GO:1905036 | 3 | 1 | 18204 | 49 |
SPI1 |
8.054e-03 | -4.82 | regulation of myeloid progenitor cell differentiation | biological process | GO:1905453 | 3 | 1 | 18204 | 49 |
SPI1 |
8.054e-03 | -4.82 | blood vessel endothelial cell fate specification | biological process | GO:0097101 | 3 | 1 | 18204 | 49 |
RBPJ |
8.054e-03 | -4.82 | membrane raft polarization | biological process | GO:0001766 | 3 | 1 | 18204 | 49 |
DOCK2 |
8.054e-03 | -4.82 | positive regulation of aldosterone biosynthetic process | biological process | GO:0032349 | 3 | 1 | 18204 | 49 |
DAB2 |
8.054e-03 | -4.82 | positive regulation of clathrin-dependent endocytosis | biological process | GO:2000370 | 3 | 1 | 18204 | 49 |
DAB2 |
8.054e-03 | -4.82 | regulation of proton-transporting ATP synthase activity, rotational mechanism | biological process | GO:1905271 | 3 | 1 | 18204 | 49 |
TMSB4X |
8.054e-03 | -4.82 | regulation of Golgi lumen acidification | biological process | GO:1905526 | 3 | 1 | 18204 | 49 |
SLC9A7 |
8.054e-03 | -4.82 | septum transversum development | biological process | GO:0003343 | 3 | 1 | 18204 | 49 |
ZFP36L1 |
8.054e-03 | -4.82 | monocyte homeostasis | biological process | GO:0035702 | 3 | 1 | 18204 | 49 |
SH2B3 |
8.077e-03 | -4.82 | myeloid cell differentiation | biological process | GO:0030099 | 295 | 4 | 18204 | 49 |
SPI1,PTPN6,RBPJ,SH2B3 |
8.078e-03 | -4.82 | Anthrax_toxin_rcpt_extracel | interpro domains | IPR008400 | 3 | 1 | 18521 | 50 |
ANTXR2 |
8.078e-03 | -4.82 | PTN12/18/22 | interpro domains | IPR047170 | 3 | 1 | 18521 | 50 |
PTPN12 |
8.078e-03 | -4.82 | Malic_N_dom_sf | interpro domains | IPR037062 | 3 | 1 | 18521 | 50 |
ME1 |
8.078e-03 | -4.82 | Malic_OxRdtase | interpro domains | IPR001891 | 3 | 1 | 18521 | 50 |
ME1 |
8.078e-03 | -4.82 | Malic_NAD-bd | interpro domains | IPR012302 | 3 | 1 | 18521 | 50 |
ME1 |
8.078e-03 | -4.82 | ITM2 | interpro domains | IPR040145 | 3 | 1 | 18521 | 50 |
ITM2B |
8.078e-03 | -4.82 | FYB1/2-like | interpro domains | IPR043443 | 3 | 1 | 18521 | 50 |
FYB1 |
8.078e-03 | -4.82 | LAMP_CS | interpro domains | IPR018134 | 3 | 1 | 18521 | 50 |
CD68 |
8.078e-03 | -4.82 | Mucolipin | interpro domains | IPR039031 | 3 | 1 | 18521 | 50 |
MCOLN2 |
8.078e-03 | -4.82 | C2_Dock-C | interpro domains | IPR037808 | 3 | 1 | 18521 | 50 |
DOCK8 |
8.078e-03 | -4.82 | MiT/TFE_N | interpro domains | IPR031867 | 3 | 1 | 18521 | 50 |
TFEB |
8.078e-03 | -4.82 | RII-bd_1 | interpro domains | IPR018459 | 3 | 1 | 18521 | 50 |
AKAP13 |
8.078e-03 | -4.82 | FERM_f0 | interpro domains | IPR032425 | 3 | 1 | 18521 | 50 |
TLN1 |
8.078e-03 | -4.82 | Phe_ZIP | interpro domains | IPR015012 | 3 | 1 | 18521 | 50 |
SH2B3 |
8.078e-03 | -4.82 | hSH3 | interpro domains | IPR029294 | 3 | 1 | 18521 | 50 |
FYB1 |
8.078e-03 | -4.82 | SH2B | interpro domains | IPR030523 | 3 | 1 | 18521 | 50 |
SH2B3 |
8.078e-03 | -4.82 | NHE-6/7/9 | interpro domains | IPR002090 | 3 | 1 | 18521 | 50 |
SLC9A7 |
8.078e-03 | -4.82 | Malic_enzyme_CS | interpro domains | IPR015884 | 3 | 1 | 18521 | 50 |
ME1 |
8.078e-03 | -4.82 | RhoGAP_ARAP | interpro domains | IPR037858 | 3 | 1 | 18521 | 50 |
ARAP1 |
8.078e-03 | -4.82 | TF_Elf_N | interpro domains | IPR022084 | 3 | 1 | 18521 | 50 |
ELF4 |
8.078e-03 | -4.82 | MCLN_ECD | interpro domains | IPR049134 | 3 | 1 | 18521 | 50 |
MCOLN2 |
8.078e-03 | -4.82 | Phe_ZIP_sf | interpro domains | IPR036290 | 3 | 1 | 18521 | 50 |
SH2B3 |
8.078e-03 | -4.82 | Malic_N_dom | interpro domains | IPR012301 | 3 | 1 | 18521 | 50 |
ME1 |
8.078e-03 | -4.82 | ZFP36-like | interpro domains | IPR045877 | 3 | 1 | 18521 | 50 |
ZFP36L1 |
8.103e-03 | -4.82 | vitamin D response element binding | molecular function | GO:0070644 | 3 | 1 | 18094 | 49 |
RXRA |
8.103e-03 | -4.82 | DNA binding domain binding | molecular function | GO:0050692 | 3 | 1 | 18094 | 49 |
RXRA |
8.103e-03 | -4.82 | malate dehydrogenase (decarboxylating) (NADP+) activity | molecular function | GO:0004473 | 3 | 1 | 18094 | 49 |
ME1 |
8.129e-03 | -4.81 | positive regulation of hydrolase activity | biological process | GO:0051345 | 466 | 5 | 18204 | 49 |
ARAP1,ARHGAP45,DOCK8,ARHGAP24,PREX1 |
8.161e-03 | -4.81 | molecular function regulator activity | molecular function | GO:0098772 | 2079 | 12 | 18094 | 49 |
ARAP1,DOCK2,PREX1,ARHGAP24,BMP2K,RGL1,DOCK8,PTGIR,ARHGAP45,AKAP13,CCND2,ARHGEF18 |
8.238e-03 | -4.80 | Malic_M | pfam domains | PF03949 | 3 | 1 | 17795 | 49 |
ME1 |
8.238e-03 | -4.80 | Elf-1_N | pfam domains | PF12310 | 3 | 1 | 17795 | 49 |
ELF4 |
8.238e-03 | -4.80 | Anth_Ig | pfam domains | PF05587 | 3 | 1 | 17795 | 49 |
ANTXR2 |
8.238e-03 | -4.80 | hSH3 | pfam domains | PF14603 | 3 | 1 | 17795 | 49 |
FYB1 |
8.238e-03 | -4.80 | RII_binding_1 | pfam domains | PF10522 | 3 | 1 | 17795 | 49 |
AKAP13 |
8.238e-03 | -4.80 | MCLN_ECD | pfam domains | PF21381 | 3 | 1 | 17795 | 49 |
MCOLN2 |
8.238e-03 | -4.80 | MITF_TFEB_C_3_N | pfam domains | PF15951 | 3 | 1 | 17795 | 49 |
TFEB |
8.238e-03 | -4.80 | FERM_f0 | pfam domains | PF16511 | 3 | 1 | 17795 | 49 |
TLN1 |
8.238e-03 | -4.80 | malic | pfam domains | PF00390 | 3 | 1 | 17795 | 49 |
ME1 |
8.238e-03 | -4.80 | Phe_ZIP | pfam domains | PF08916 | 3 | 1 | 17795 | 49 |
SH2B3 |
8.343e-03 | -4.79 | KLRC1 (killer cell lectin like receptor C1) | protein interactions | 3821 | 162 | 3 | 19454 | 50 |
PTPN6,WDFY3,DNM2 |
8.373e-03 | -4.78 | ACTN1 (actinin alpha 1) | protein interactions | 87 | 312 | 4 | 19454 | 50 |
TLN1,PTPN6,DISC1,ARHGAP24 |
8.377e-03 | -4.78 | regulation of actin filament length | biological process | GO:0030832 | 155 | 3 | 18204 | 49 |
TMSB4X,PREX1,HCK |
8.421e-03 | -4.78 | BTD | smart domains | SM01268 | 2 | 1 | 9717 | 41 |
RBPJ |
8.421e-03 | -4.78 | LAG1_DNAbind | smart domains | SM01267 | 2 | 1 | 9717 | 41 |
RBPJ |
8.484e-03 | -4.77 | IKBIP (IKBKB interacting protein) | protein interactions | 121457 | 163 | 3 | 19454 | 50 |
DISC1,ANTXR2,DNM2 |
8.497e-03 | -4.77 | NONO (non-POU domain containing octamer binding) | protein interactions | 4841 | 493 | 5 | 19454 | 50 |
ARHGAP24,RXRA,RBPJ,SPI1,DAB2 |
8.507e-03 | -4.77 | EPM2A (EPM2A glucan phosphatase, laforin) | protein interactions | 7957 | 54 | 2 | 19454 | 50 |
FKBP5,PREX1 |
8.523e-03 | -4.77 | YWHAE (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon) | protein interactions | 7531 | 1150 | 8 | 19454 | 50 |
SH2B3,ARHGAP45,TFEB,GAB1,DISC1,ZFP36L1,AKAP13,CD74 |
8.536e-03 | -4.76 | RA | prosite domains | PS50200 | 37 | 2 | 12186 | 46 |
ARAP1,RGL1 |
8.536e-03 | -4.76 | TYR_PHOSPHATASE_PTP | prosite domains | PS50055 | 37 | 2 | 12186 | 46 |
PTPN12,PTPN6 |
8.550e-03 | -4.76 | PRTYPHPHTASE | prints domains | PR00700 | 37 | 2 | 5227 | 20 |
PTPN6,PTPN12 |
8.578e-03 | -4.76 | regulation of immune system process | biological process | GO:0002682 | 1584 | 10 | 18204 | 49 |
CD74,FYB1,DOCK8,HCK,ITGB2,SPI1,RBM47,PTPN6,CD68,ZFP36L1 |
8.638e-03 | -4.75 | ERK1 and ERK2 cascade | biological process | GO:0070371 | 52 | 2 | 18204 | 49 |
ITGAV,ZFP36L1 |
8.638e-03 | -4.75 | iron ion transport | biological process | GO:0006826 | 52 | 2 | 18204 | 49 |
DNM2,HEPHL1 |
8.675e-03 | -4.75 | negative regulation of cytoskeleton organization | biological process | GO:0051494 | 157 | 3 | 18204 | 49 |
TMSB4X,ARHGEF18,ARAP1 |
8.710e-03 | -4.74 | growth cone | cellular component | GO:0030426 | 165 | 3 | 19108 | 49 |
PREX1,DNM2,DISC1 |
8.761e-03 | -4.74 | secretory granule membrane | cellular component | GO:0030667 | 317 | 4 | 19108 | 49 |
ITGAL,CD68,ITGAV,ITGB2 |
8.793e-03 | -4.73 | prostate-carcinoma | COSMIC cancer mutations | prostate-carcinoma | 9000 | 33 | 16828 | 46 |
DOCK2,MYO1F,ZFP36L1,PTPN6,RBM47,AKAP13,EHD4,ARHGEF18,RBPJ,DAB2,BTG1,ARHGAP24,RXRA,ITGAV,TFEB,HCK,STAB1,SLC9A7,TLN1,PTGIR,PREX1,WDFY3,DOCK8,PLXND1,HEPHL1,ELF4,ITGAL,ME1,RGL1,GAB1,MCOLN2,PTPN12,CCND2 |
8.926e-03 | -4.72 | CBL (Cbl proto-oncogene) | protein interactions | 867 | 499 | 5 | 19454 | 50 |
ITGAV,FYB1,ARHGAP45,HCK,PTPN6 |
9.053e-03 | -4.70 | intracellular non-membrane-bounded organelle | cellular component | GO:0043232 | 5729 | 23 | 19108 | 49 |
AKAP13,SEPTIN9,DAB2,RBPJ,DNM2,TFEB,MYO1F,PTPN12,HCK,PTPN6,DISC1,FYB1,WDFY3,TMSB4X,ARHGAP24,SPI1,TLN1,RXRA,ELF4,DOCK2,ZFP36L1,CCND2,ARHGEF18 |
9.094e-03 | -4.70 | non-membrane-bounded organelle | cellular component | GO:0043228 | 5731 | 23 | 19108 | 49 |
TFEB,MYO1F,DAB2,DNM2,RBPJ,AKAP13,SEPTIN9,DISC1,PTPN6,PTPN12,HCK,SPI1,ARHGAP24,WDFY3,TMSB4X,FYB1,ZFP36L1,CCND2,ARHGEF18,DOCK2,RXRA,ELF4,TLN1 |
9.125e-03 | -4.70 | LETMD1 (LETM1 domain containing 1) | protein interactions | 25875 | 56 | 2 | 19454 | 50 |
MCOLN2,HCK |
9.125e-03 | -4.70 | TEDC1 (tubulin epsilon and delta complex 1) | protein interactions | 283643 | 56 | 2 | 19454 | 50 |
FKBP5,DISC1 |
9.140e-03 | -4.70 | PPARA activates gene expression | REACTOME pathways | R-HSA-1989781 | 124 | 3 | 10285 | 36 |
ME1,RXRA,RGL1 |
9.145e-03 | -4.69 | secretory granule lumen | cellular component | GO:0034774 | 321 | 4 | 19108 | 49 |
TMSB4X,ARHGAP45,DOCK2,PTPN6 |
9.209e-03 | -4.69 | SH2 | smart domains | SM00252 | 103 | 3 | 9717 | 41 |
SH2B3,HCK,PTPN6 |
9.212e-03 | -4.69 | KLK10 (kallikrein related peptidase 10) | protein interactions | 5655 | 168 | 3 | 19454 | 50 |
PTPN6,MYO1F,ITGB2 |
9.231e-03 | -4.69 | ACTA1 (actin alpha 1, skeletal muscle) | protein interactions | 58 | 321 | 4 | 19454 | 50 |
DNM2,TLN1,SEPTIN9,TMSB4X |
9.290e-03 | -4.68 | negative regulation of supramolecular fiber organization | biological process | GO:1902904 | 161 | 3 | 18204 | 49 |
ARAP1,TMSB4X,ARHGEF18 |
9.301e-03 | -4.68 | regulation of response to external stimulus | biological process | GO:0032101 | 1116 | 8 | 18204 | 49 |
ELF4,CD74,TMSB4X,HCK,SH2B3,SPI1,PTPN6,RBM47 |
9.361e-03 | -4.67 | H2BC5 (H2B clustered histone 5) | protein interactions | 3017 | 169 | 3 | 19454 | 50 |
ARHGAP24,DNM2,TLN1 |
9.378e-03 | -4.67 | organelle membrane | cellular component | GO:0031090 | 3742 | 17 | 19108 | 49 |
STAB1,ANTXR2,WDFY3,EHD4,DNM2,ITM2B,DAB2,CD68,TFEB,MCOLN2,ITGB2,ITGAV,ARAP1,CD74,SLC9A7,CCND2,ITGAL |
9.442e-03 | -4.66 | ICAM2 (intercellular adhesion molecule 2) | protein interactions | 3384 | 57 | 2 | 19454 | 50 |
ITM2B,ITGB2 |
9.442e-03 | -4.66 | PRKCQ (protein kinase C theta) | protein interactions | 5588 | 57 | 2 | 19454 | 50 |
FKBP5,FYB1 |
9.442e-03 | -4.66 | PTPRC (protein tyrosine phosphatase receptor type C) | protein interactions | 5788 | 57 | 2 | 19454 | 50 |
PTPN6,ITGAL |
9.442e-03 | -4.66 | RBSN (rabenosyn, RAB effector) | protein interactions | 64145 | 57 | 2 | 19454 | 50 |
DISC1,EHD4 |
9.446e-03 | -4.66 | site of polarized growth | cellular component | GO:0030427 | 170 | 3 | 19108 | 49 |
DISC1,DNM2,PREX1 |
9.513e-03 | -4.66 | PLOD2 (procollagen-lysine,2-oxoglutarate 5-dioxygenase 2) | protein interactions | 5352 | 170 | 3 | 19454 | 50 |
PTPN12,TLN1,ARHGAP24 |
9.592e-03 | -4.65 | regulation of cell motility | biological process | GO:2000145 | 1122 | 8 | 18204 | 49 |
PREX1,TMSB4X,DOCK8,PLXND1,CD74,DAB2,ITGAV,GAB1 |
9.619e-03 | -4.64 | SH3 | prosite domains | PS50002 | 222 | 4 | 12186 | 46 |
MYO1F,FYB1,DOCK2,HCK |
9.623e-03 | -4.64 | cellular response to chemical stimulus | biological process | GO:0070887 | 2411 | 13 | 18204 | 49 |
PTPN6,GAB1,RXRA,CD68,CD74,DOCK8,SPI1,SH2B3,ZFP36L1,PREX1,TMSB4X,ITGB2,HCK |
9.625e-03 | -4.64 | morphogenesis of an epithelial sheet | biological process | GO:0002011 | 55 | 2 | 18204 | 49 |
ARHGAP24,ITGAV |
9.625e-03 | -4.64 | neutrophil chemotaxis | biological process | GO:0030593 | 55 | 2 | 18204 | 49 |
PREX1,ITGB2 |
9.641e-03 | -4.64 | cytoplasmic vesicle lumen | cellular component | GO:0060205 | 326 | 4 | 19108 | 49 |
ARHGAP45,TMSB4X,PTPN6,DOCK2 |
9.674e-03 | -4.64 | RHOH (ras homolog family member H) | protein interactions | 399 | 509 | 5 | 19454 | 50 |
ITGAV,PREX1,DAB2,EHD4,ITM2B |
9.731e-03 | -4.63 | PXN (paxillin) | protein interactions | 5829 | 326 | 4 | 19454 | 50 |
HCK,PTPN12,TLN1,ITGAV |
9.743e-03 | -4.63 | vesicle lumen | cellular component | GO:0031983 | 327 | 4 | 19108 | 49 |
TMSB4X,ARHGAP45,PTPN6,DOCK2 |
9.755e-03 | -4.63 | Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha) | REACTOME pathways | R-HSA-400206 | 127 | 3 | 10285 | 36 |
ME1,RXRA,RGL1 |
9.763e-03 | -4.63 | LRCH1 (leucine rich repeats and calponin homology domain containing 1) | protein interactions | 23143 | 58 | 2 | 19454 | 50 |
DOCK8,HEPHL1 |
9.763e-03 | -4.63 | Sec24c (SEC24 homolog C, COPII coat complex component) | protein interactions | 218811 | 58 | 2 | 19454 | 50 |
BMP2K,DAB2 |
9.763e-03 | -4.63 | PPWD1 (peptidylprolyl isomerase domain and WD repeat containing 1) | protein interactions | 23398 | 58 | 2 | 19454 | 50 |
ME1,FKBP5 |
9.811e-03 | -4.62 | tube morphogenesis | biological process | GO:0035239 | 685 | 6 | 18204 | 49 |
ZFP36L1,ARHGAP24,ITGAV,GAB1,RBPJ,PLXND1 |
9.819e-03 | -4.62 | ROCK1 (Rho associated coiled-coil containing protein kinase 1) | protein interactions | 6093 | 172 | 3 | 19454 | 50 |
TLN1,ARHGAP24,GAB1 |
9.919e-03 | -4.61 | - | gene3d domains | 6.10.140.110 | 3 | 1 | 14470 | 48 |
SH2B3 |
9.919e-03 | -4.61 | Malic enzyme, N-terminal domain | gene3d domains | 3.40.50.10380 | 3 | 1 | 14470 | 48 |
ME1 |
9.950e-03 | -4.61 | CAV1 (caveolin 1) | protein interactions | 857 | 719 | 6 | 19454 | 50 |
PTPN6,TMSB4X,SEPTIN9,ITM2B,GAB1,ITGAV |
9.964e-03 | -4.61 | modulation by symbiont of entry into host | biological process | GO:0052372 | 56 | 2 | 18204 | 49 |
ITGAV,CD74 |
9.964e-03 | -4.61 | leukocyte cell-cell adhesion | biological process | GO:0007159 | 56 | 2 | 18204 | 49 |
ITGB2,ITGAL |
9.964e-03 | -4.61 | endoderm formation | biological process | GO:0001706 | 56 | 2 | 18204 | 49 |
ITGAV,ITGB2 |
9.964e-03 | -4.61 | negative regulation of leukocyte apoptotic process | biological process | GO:2000107 | 56 | 2 | 18204 | 49 |
DOCK8,CD74 |
9.975e-03 | -4.61 | ALDH18A1 (aldehyde dehydrogenase 18 family member A1) | protein interactions | 5832 | 173 | 3 | 19454 | 50 |
DOCK8,PREX1,ARHGAP24 |
9.975e-03 | -4.61 | RARA (retinoic acid receptor alpha) | protein interactions | 5914 | 173 | 3 | 19454 | 50 |
RXRA,BTG1,SPI1 |
1.004e-02 | -4.60 | NCOR1 (nuclear receptor corepressor 1) | protein interactions | 9611 | 329 | 4 | 19454 | 50 |
CCND2,RBPJ,RXRA,ITGAV |
1.005e-02 | -4.60 | tube development | biological process | GO:0035295 | 903 | 7 | 18204 | 49 |
PLXND1,GAB1,PTPN6,RBPJ,ZFP36L1,ARHGAP24,ITGAV |
1.007e-02 | -4.60 | SH3 | smart domains | SM00326 | 202 | 4 | 9717 | 41 |
FYB1,HCK,DOCK2,MYO1F |
1.007e-02 | -4.60 | regulation of cell differentiation | biological process | GO:0045595 | 1622 | 10 | 18204 | 49 |
CD74,PLXND1,DISC1,RBPJ,SPI1,BTG1,PTPN6,ITGAV,DAB2,ZFP36L1 |
1.009e-02 | -4.60 | CD82 (CD82 molecule) | protein interactions | 3732 | 59 | 2 | 19454 | 50 |
ITGB2,ITGAL |
1.013e-02 | -4.59 | KAT2A (lysine acetyltransferase 2A) | protein interactions | 2648 | 174 | 3 | 19454 | 50 |
RBPJ,CCND2,ELF4 |
1.013e-02 | -4.59 | phospholipid binding | molecular function | GO:0005543 | 489 | 5 | 18094 | 49 |
DNM2,PREX1,WDFY3,TLN1,ARAP1 |
1.017e-02 | -4.59 | RHOA (ras homolog family member A) | protein interactions | 387 | 1186 | 8 | 19454 | 50 |
DNM2,PREX1,AKAP13,GAB1,ITGAV,ARHGEF18,DAB2,PTPN12 |
1.022e-02 | -4.58 | alphav-beta3 integrin-IGF-1-IGF1R complex | cellular component | GO:0035867 | 4 | 1 | 19108 | 49 |
ITGAV |
1.022e-02 | -4.58 | central region of growth cone | cellular component | GO:0090724 | 4 | 1 | 19108 | 49 |
DISC1 |
1.023e-02 | -4.58 | positive regulation of cell differentiation | biological process | GO:0045597 | 906 | 7 | 18204 | 49 |
DISC1,PLXND1,CD74,ZFP36L1,DAB2,BTG1,SPI1 |
1.024e-02 | -4.58 | DMP1 (dentin matrix acidic phosphoprotein 1) | protein interactions | 1758 | 4 | 1 | 19454 | 50 |
CCND2 |
1.024e-02 | -4.58 | ZNF749 (zinc finger protein 749) | protein interactions | 388567 | 4 | 1 | 19454 | 50 |
ARHGAP24 |
1.024e-02 | -4.58 | Fndc5 (fibronectin type III domain containing 5) | protein interactions | 384061 | 4 | 1 | 19454 | 50 |
ITGAV |
1.024e-02 | -4.58 | H1-10-AS1 (H1-10 antisense RNA 1) | protein interactions | 339942 | 4 | 1 | 19454 | 50 |
PTPN6 |
1.024e-02 | -4.58 | ZNF615 (zinc finger protein 615) | protein interactions | 284370 | 4 | 1 | 19454 | 50 |
ARHGAP24 |
1.024e-02 | -4.58 | ZNF879 (zinc finger protein 879) | protein interactions | 345462 | 4 | 1 | 19454 | 50 |
ARHGAP24 |
1.024e-02 | -4.58 | MGAT3 (beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase) | protein interactions | 4248 | 4 | 1 | 19454 | 50 |
DISC1 |
1.024e-02 | -4.58 | Map6 (microtubule-associated protein 6) | protein interactions | 29457 | 4 | 1 | 19454 | 50 |
PLXND1 |
1.024e-02 | -4.58 | FBXO41 (F-box protein 41) | protein interactions | 150726 | 4 | 1 | 19454 | 50 |
DISC1 |
1.030e-02 | -4.58 | cellular response to growth factor stimulus | biological process | GO:0071363 | 494 | 5 | 18204 | 49 |
ZFP36L1,DAB2,EHD4,PTPN12,GAB1 |
1.031e-02 | -4.57 | regulation of myeloid leukocyte mediated immunity | biological process | GO:0002886 | 57 | 2 | 18204 | 49 |
SPI1,ITGB2 |
1.031e-02 | -4.57 | regulation of lymphocyte apoptotic process | biological process | GO:0070228 | 57 | 2 | 18204 | 49 |
DOCK8,CD74 |
1.033e-02 | -4.57 | thyroid | COSMIC cancer mutations | thyroid | 9867 | 35 | 16828 | 46 |
ITGAV,STAB1,TFEB,PREX1,PTGIR,SLC9A7,TLN1,ITGB2,RXRA,DNM2,ARHGEF18,FKBP5,RBPJ,CD74,EHD4,AKAP13,DAB2,ARAP1,ZFP36L1,DOCK2,MYO1F,RBM47,ANTXR2,GAB1,MCOLN2,SPI1,ITGAL,RGL1,SH2B3,BMP2K,HEPHL1,ELF4,WDFY3,DOCK8,PLXND1 |
1.035e-02 | -4.57 | salivary_gland-carcinoma-adenoid_cystic_carcinoma | COSMIC cancer mutations | salivary_gland-carcinoma-adenoid_cystic_carcinoma | 488 | 5 | 16828 | 46 |
TLN1,SLC9A7,ITM2B,ZFP36L1,DOCK8 |
1.042e-02 | -4.56 | MITF (melanocyte inducing transcription factor) | protein interactions | 4286 | 60 | 2 | 19454 | 50 |
SPI1,TFEB |
1.054e-02 | -4.55 | PTPc | smart domains | SM00194 | 37 | 2 | 9717 | 41 |
PTPN12,PTPN6 |
1.061e-02 | -4.55 | PIP (prolactin induced protein) | protein interactions | 5304 | 177 | 3 | 19454 | 50 |
SPI1,RBM47,ARHGAP24 |
1.064e-02 | -4.54 | regulation of anatomical structure size | biological process | GO:0090066 | 498 | 5 | 18204 | 49 |
DISC1,DNM2,TMSB4X,HCK,PREX1 |
1.070e-02 | -4.54 | negative regulation of apoptotic process | biological process | GO:0043066 | 914 | 7 | 18204 | 49 |
PLXND1,DOCK8,HCK,CD74,ITGAV,CCND2,DAB2 |
1.072e-02 | -4.54 | negative regulation of mast cell activation involved in immune response | biological process | GO:0033007 | 4 | 1 | 18204 | 49 |
PTPN6 |
1.072e-02 | -4.54 | regulation of mature B cell apoptotic process | biological process | GO:0002905 | 4 | 1 | 18204 | 49 |
CD74 |
1.072e-02 | -4.54 | inner ear receptor cell fate commitment | biological process | GO:0060120 | 4 | 1 | 18204 | 49 |
RBPJ |
1.072e-02 | -4.54 | endothelial cell fate specification | biological process | GO:0060847 | 4 | 1 | 18204 | 49 |
RBPJ |
1.072e-02 | -4.54 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway | biological process | GO:2000587 | 4 | 1 | 18204 | 49 |
PTPN12 |
1.072e-02 | -4.54 | club cell differentiation | biological process | GO:0060486 | 4 | 1 | 18204 | 49 |
RBPJ |
1.072e-02 | -4.54 | positive regulation of neutrophil degranulation | biological process | GO:0043315 | 4 | 1 | 18204 | 49 |
ITGB2 |
1.072e-02 | -4.54 | auditory receptor cell fate commitment | biological process | GO:0009912 | 4 | 1 | 18204 | 49 |
RBPJ |
1.072e-02 | -4.54 | positive regulation of establishment of T cell polarity | biological process | GO:1903905 | 4 | 1 | 18204 | 49 |
DOCK8 |
1.072e-02 | -4.54 | negative regulation of dendritic cell antigen processing and presentation | biological process | GO:0002605 | 4 | 1 | 18204 | 49 |
CD68 |
1.072e-02 | -4.54 | respiratory burst after phagocytosis | biological process | GO:0045728 | 4 | 1 | 18204 | 49 |
HCK |
1.072e-02 | -4.54 | dichotomous subdivision of terminal units involved in salivary gland branching | biological process | GO:0060666 | 4 | 1 | 18204 | 49 |
PLXND1 |
1.072e-02 | -4.54 | negative regulation of mature B cell apoptotic process | biological process | GO:0002906 | 4 | 1 | 18204 | 49 |
CD74 |
1.072e-02 | -4.54 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell | biological process | GO:0002291 | 4 | 1 | 18204 | 49 |
ITGAL |
1.072e-02 | -4.54 | positive regulation of steroid hormone biosynthetic process | biological process | GO:0090031 | 4 | 1 | 18204 | 49 |
DAB2 |
1.072e-02 | -4.54 | positive regulation of microglial cell mediated cytotoxicity | biological process | GO:1904151 | 4 | 1 | 18204 | 49 |
SPI1 |
1.072e-02 | -4.54 | regulation of intracellular mRNA localization | biological process | GO:1904580 | 4 | 1 | 18204 | 49 |
ZFP36L1 |
1.076e-02 | -4.53 | FAS1_dom_sf | interpro domains | IPR036378 | 4 | 1 | 18521 | 50 |
STAB1 |
1.076e-02 | -4.53 | Beta-thymosin | interpro domains | IPR001152 | 4 | 1 | 18521 | 50 |
TMSB4X |
1.076e-02 | -4.53 | Cu-oxidase_C | interpro domains | IPR011706 | 4 | 1 | 18521 | 50 |
HEPHL1 |
1.076e-02 | -4.53 | DUF5600 | interpro domains | IPR040990 | 4 | 1 | 18521 | 50 |
EHD4 |
1.076e-02 | -4.53 | ILWEQ_dom | interpro domains | IPR002558 | 4 | 1 | 18521 | 50 |
TLN1 |
1.076e-02 | -4.53 | FAS1_domain | interpro domains | IPR000782 | 4 | 1 | 18521 | 50 |
STAB1 |
1.076e-02 | -4.53 | Gab1-4-like | interpro domains | IPR046355 | 4 | 1 | 18521 | 50 |
GAB1 |
1.076e-02 | -4.53 | BTG | interpro domains | IPR033332 | 4 | 1 | 18521 | 50 |
BTG1 |
1.076e-02 | -4.53 | Cu_oxidase_Cu_BS | interpro domains | IPR002355 | 4 | 1 | 18521 | 50 |
HEPHL1 |
1.076e-02 | -4.53 | Beta-thymosin_sf | interpro domains | IPR038386 | 4 | 1 | 18521 | 50 |
TMSB4X |
1.076e-02 | -4.53 | I/LWEQ_dom_sf | interpro domains | IPR035964 | 4 | 1 | 18521 | 50 |
TLN1 |
1.076e-02 | -4.53 | MiT/TFE_C | interpro domains | IPR021802 | 4 | 1 | 18521 | 50 |
TFEB |
1.076e-02 | -4.53 | Retinoid-X_rcpt/HNF4 | interpro domains | IPR000003 | 4 | 1 | 18521 | 50 |
RXRA |
1.076e-02 | -4.53 | ATF1 (activating transcription factor 1) | protein interactions | 466 | 61 | 2 | 19454 | 50 |
RBPJ,SPI1 |
1.076e-02 | -4.53 | negative regulation of MAPK cascade | biological process | GO:0043409 | 170 | 3 | 18204 | 49 |
PTPN6,SH2B3,DAB2 |
1.078e-02 | -4.53 | wound healing | biological process | GO:0042060 | 321 | 4 | 18204 | 49 |
ARHGAP24,TLN1,ITGAV,PTPN6 |
1.079e-02 | -4.53 | malic enzyme activity | molecular function | GO:0004470 | 4 | 1 | 18094 | 49 |
ME1 |
1.079e-02 | -4.53 | stem cell factor receptor binding | molecular function | GO:0005173 | 4 | 1 | 18094 | 49 |
SH2B3 |
1.079e-02 | -4.53 | oxaloacetate decarboxylase activity | molecular function | GO:0008948 | 4 | 1 | 18094 | 49 |
ME1 |
1.085e-02 | -4.52 | extracellular vesicle | cellular component | GO:1903561 | 2278 | 12 | 19108 | 49 |
ARHGEF18,ITGAL,DOCK2,DNM2,CD74,PTPN6,ITM2B,EHD4,FKBP5,ITGB2,ITGAV,TLN1 |
1.089e-02 | -4.52 | extracellular organelle | cellular component | GO:0043230 | 2279 | 12 | 19108 | 49 |
ITGAL,ARHGEF18,ITM2B,PTPN6,CD74,DNM2,DOCK2,FKBP5,EHD4,TLN1,ITGAV,ITGB2 |
1.089e-02 | -4.52 | extracellular membrane-bounded organelle | cellular component | GO:0065010 | 2279 | 12 | 19108 | 49 |
ITGAV,TLN1,ITGB2,EHD4,FKBP5,PTPN6,ITM2B,DOCK2,DNM2,CD74,ARHGEF18,ITGAL |
1.089e-02 | -4.52 | haematopoietic_and_lymphoid_tissue-other-idiopathic_erythrocytosis | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-other-idiopathic_erythrocytosis | 4 | 1 | 16828 | 46 |
SH2B3 |
1.089e-02 | -4.52 | idiopathic_erythrocytosis | COSMIC cancer mutations | idiopathic_erythrocytosis | 4 | 1 | 16828 | 46 |
SH2B3 |
1.089e-02 | -4.52 | CAPZA1 (capping actin protein of muscle Z-line subunit alpha 1) | protein interactions | 829 | 337 | 4 | 19454 | 50 |
ARAP1,DNM2,DISC1,RXRA |
1.089e-02 | -4.52 | RHBDD1 (rhomboid domain containing 1) | protein interactions | 84236 | 337 | 4 | 19454 | 50 |
MYO1F,TLN1,ITGB2,MCOLN2 |
1.094e-02 | -4.52 | CAP1 (cyclase associated actin cytoskeleton regulatory protein 1) | protein interactions | 10487 | 179 | 3 | 19454 | 50 |
SEPTIN9,ARHGAP24,FKBP5 |
1.097e-02 | -4.51 | Fasciclin | pfam domains | PF02469 | 4 | 1 | 17795 | 49 |
STAB1 |
1.097e-02 | -4.51 | TPR_6 | pfam domains | PF13174 | 4 | 1 | 17795 | 49 |
FKBP5 |
1.097e-02 | -4.51 | Thymosin | pfam domains | PF01290 | 4 | 1 | 17795 | 49 |
TMSB4X |
1.097e-02 | -4.51 | DUF5600 | pfam domains | PF18150 | 4 | 1 | 17795 | 49 |
EHD4 |
1.097e-02 | -4.51 | DUF3371 | pfam domains | PF11851 | 4 | 1 | 17795 | 49 |
TFEB |
1.097e-02 | -4.51 | I_LWEQ | pfam domains | PF01608 | 4 | 1 | 17795 | 49 |
TLN1 |
1.097e-02 | -4.51 | Cu-oxidase_2 | pfam domains | PF07731 | 4 | 1 | 17795 | 49 |
HEPHL1 |
1.100e-02 | -4.51 | AP2B1 (adaptor related protein complex 2 subunit beta 1) | protein interactions | 163 | 338 | 4 | 19454 | 50 |
DAB2,FKBP5,BMP2K,ARHGAP24 |
1.100e-02 | -4.51 | ERBB3 (erb-b2 receptor tyrosine kinase 3) | protein interactions | 2065 | 338 | 4 | 19454 | 50 |
SH2B3,PTPN6,PTPN12,HCK |
1.104e-02 | -4.51 | specific granule lumen | cellular component | GO:0035580 | 62 | 2 | 19108 | 49 |
PTPN6,DOCK2 |
1.122e-02 | -4.49 | UBA1 (ubiquitin like modifier activating enzyme 1) | protein interactions | 7317 | 340 | 4 | 19454 | 50 |
ARHGAP24,CCND2,TLN1,DOCK8 |
1.126e-02 | -4.49 | regulation of lymphocyte activation | biological process | GO:0051249 | 505 | 5 | 18204 | 49 |
ZFP36L1,DOCK8,PTPN6,SPI1,CD74 |
1.126e-02 | -4.49 | regulation of phosphate metabolic process | biological process | GO:0019220 | 1154 | 8 | 18204 | 49 |
PTPN6,CCND2,DAB2,EHD4,CD74,ME1,ITGB2,TMSB4X |
1.127e-02 | -4.49 | PPP5C (protein phosphatase 5 catalytic subunit) | protein interactions | 5536 | 181 | 3 | 19454 | 50 |
DISC1,RXRA,FKBP5 |
1.128e-02 | -4.48 | LAMP_2 | prosite domains | PS00311 | 3 | 1 | 12186 | 46 |
CD68 |
1.128e-02 | -4.48 | MALIC_ENZYMES | prosite domains | PS00331 | 3 | 1 | 12186 | 46 |
ME1 |
1.128e-02 | -4.48 | MULTICOPPER_OXIDASE2 | prosite domains | PS00080 | 3 | 1 | 12186 | 46 |
HEPHL1 |
1.131e-02 | -4.48 | regulation of phosphorus metabolic process | biological process | GO:0051174 | 1155 | 8 | 18204 | 49 |
DAB2,CCND2,PTPN6,TMSB4X,ITGB2,ME1,CD74,EHD4 |
1.137e-02 | -4.48 | positive regulation of cytokine-mediated signaling pathway | biological process | GO:0001961 | 60 | 2 | 18204 | 49 |
CD74,RBM47 |
1.143e-02 | -4.47 | human chr6q14.2 | chromosome location | human chr6q14.2 | 6 | 1 | 26134 | 50 |
ME1 |
1.144e-02 | -4.47 | MALOXRDTASE | prints domains | PR00072 | 3 | 1 | 5227 | 20 |
ME1 |
1.144e-02 | -4.47 | NAHEXCHNGR6 | prints domains | PR01088 | 3 | 1 | 5227 | 20 |
SLC9A7 |
1.144e-02 | -4.47 | DDX11 (DEAD/H-box helicase 11) | protein interactions | 1663 | 63 | 2 | 19454 | 50 |
FKBP5,WDFY3 |
1.145e-02 | -4.47 | TOP3B (DNA topoisomerase III beta) | protein interactions | 8940 | 1465 | 9 | 19454 | 50 |
TLN1,ARAP1,PREX1,WDFY3,PLXND1,SH2B3,TFEB,RBM47,AKAP13 |
1.145e-02 | -4.47 | TERF1 (telomeric repeat binding factor 1) | protein interactions | 7013 | 342 | 4 | 19454 | 50 |
DOCK2,ARHGEF18,ZFP36L1,BMP2K |
1.151e-02 | -4.46 | protein phosphorylated amino acid binding | molecular function | GO:0045309 | 60 | 2 | 18094 | 49 |
HCK,PTPN6 |
1.153e-02 | -4.46 | response to endogenous stimulus | biological process | GO:0009719 | 1402 | 9 | 18204 | 49 |
GAB1,PTPN12,ZFP36L1,DAB2,RXRA,CD68,EHD4,ME1,ITGB2 |
1.160e-02 | -4.46 | positive regulation of cell-cell adhesion | biological process | GO:0022409 | 328 | 4 | 18204 | 49 |
DOCK8,ITGB2,CD74,PTPN6 |
1.160e-02 | -4.46 | positive regulation of lymphocyte activation | biological process | GO:0051251 | 328 | 4 | 18204 | 49 |
SPI1,PTPN6,CD74,DOCK8 |
1.161e-02 | -4.46 | HCK (HCK proto-oncogene, Src family tyrosine kinase) | protein interactions | 3055 | 183 | 3 | 19454 | 50 |
GAB1,DNM2,HCK |
1.161e-02 | -4.46 | DEK (DEK proto-oncogene) | protein interactions | 7913 | 183 | 3 | 19454 | 50 |
ARHGAP24,PTPN12,RBPJ |
1.161e-02 | -4.46 | GTF3C4 (general transcription factor IIIC subunit 4) | protein interactions | 9329 | 183 | 3 | 19454 | 50 |
ARHGAP24,EHD4,RBPJ |
1.164e-02 | -4.45 | regulation of interleukin-6 production | biological process | GO:0032675 | 175 | 3 | 18204 | 49 |
CD74,ELF4,PTPN6 |
1.168e-02 | -4.45 | INSR (insulin receptor) | protein interactions | 3643 | 344 | 4 | 19454 | 50 |
PTPN6,PTPN12,GAB1,ITGAV |
1.170e-02 | -4.45 | ruffle | cellular component | GO:0001726 | 184 | 3 | 19108 | 49 |
ITGAV,TLN1,ARHGAP45 |
1.172e-02 | -4.45 | regulation of leukocyte differentiation | biological process | GO:1902105 | 329 | 4 | 18204 | 49 |
ZFP36L1,SPI1,PTPN6,CD74 |
1.174e-02 | -4.44 | aorta development | biological process | GO:0035904 | 61 | 2 | 18204 | 49 |
RBPJ,PLXND1 |
1.179e-02 | -4.44 | LRCH2 (leucine rich repeats and calponin homology domain containing 2) | protein interactions | 57631 | 64 | 2 | 19454 | 50 |
DOCK8,DOCK2 |
1.179e-02 | -4.44 | TPM3 (tropomyosin 3) | protein interactions | 7170 | 345 | 4 | 19454 | 50 |
FKBP5,RXRA,SEPTIN9,DISC1 |
1.181e-02 | -4.44 | Tyr_Pase_cat | interpro domains | IPR003595 | 61 | 2 | 18521 | 50 |
PTPN12,PTPN6 |
1.181e-02 | -4.44 | C1-like_sf | interpro domains | IPR046349 | 61 | 2 | 18521 | 50 |
ARHGAP45,AKAP13 |
1.182e-02 | -4.44 | regulation of locomotion | biological process | GO:0040012 | 1164 | 8 | 18204 | 49 |
ITGAV,DAB2,GAB1,PLXND1,DOCK8,TMSB4X,PREX1,CD74 |
1.190e-02 | -4.43 | circulatory system development | biological process | GO:0072359 | 933 | 7 | 18204 | 49 |
AKAP13,PLXND1,ZFP36L1,ARHGAP24,ITGAV,GAB1,RBPJ |
1.195e-02 | -4.43 | SMAP2 (small ArfGAP2) | protein interactions | 64744 | 185 | 3 | 19454 | 50 |
DAB2,RBM47,BMP2K |
1.196e-02 | -4.43 | regulation of small molecule metabolic process | biological process | GO:0062012 | 331 | 4 | 18204 | 49 |
CD74,DAB2,TMSB4X,ME1 |
1.211e-02 | -4.41 | regulation of substrate adhesion-dependent cell spreading | biological process | GO:1900024 | 62 | 2 | 18204 | 49 |
DAB2,PREX1 |
1.211e-02 | -4.41 | positive regulation of myeloid leukocyte differentiation | biological process | GO:0002763 | 62 | 2 | 18204 | 49 |
CD74,ZFP36L1 |
1.215e-02 | -4.41 | RPS6KA6 (ribosomal protein S6 kinase A6) | protein interactions | 27330 | 65 | 2 | 19454 | 50 |
RBPJ,RXRA |
1.226e-02 | -4.40 | SH3_2 | pfam domains | PF07653 | 61 | 2 | 17795 | 49 |
DOCK2,FYB1 |
1.238e-02 | -4.39 | EPHA2 (EPH receptor A2) | protein interactions | 1969 | 350 | 4 | 19454 | 50 |
HCK,CCND2,ITGAV,GAB1 |
1.250e-02 | -4.38 | HLA-DRB3 (major histocompatibility complex, class II, DR beta 3) | protein interactions | 3125 | 66 | 2 | 19454 | 50 |
CD74,ITM2B |
1.261e-02 | -4.37 | Malic_M | smart domains | SM00919 | 3 | 1 | 9717 | 41 |
ME1 |
1.261e-02 | -4.37 | malic | smart domains | SM01274 | 3 | 1 | 9717 | 41 |
ME1 |
1.263e-02 | -4.37 | regulation of immune response | biological process | GO:0050776 | 944 | 7 | 18204 | 49 |
FYB1,CD74,ITGB2,HCK,SPI1,PTPN6,RBM47 |
1.276e-02 | -4.36 | apolipoprotein B mRNA editing enzyme complex | cellular component | GO:0030895 | 5 | 1 | 19108 | 49 |
RBM47 |
1.276e-02 | -4.36 | alpha-beta T cell receptor complex | cellular component | GO:0042105 | 5 | 1 | 19108 | 49 |
PTPN6 |
1.277e-02 | -4.36 | negative regulation of programmed cell death | biological process | GO:0043069 | 946 | 7 | 18204 | 49 |
CD74,HCK,PLXND1,DOCK8,DAB2,CCND2,ITGAV |
1.279e-02 | -4.36 | ADCY10 (adenylate cyclase 10) | protein interactions | 55811 | 5 | 1 | 19454 | 50 |
PTGIR |
1.279e-02 | -4.36 | ZNF836 (zinc finger protein 836) | protein interactions | 162962 | 5 | 1 | 19454 | 50 |
ARHGAP24 |
1.279e-02 | -4.36 | TRPM6 (transient receptor potential cation channel subfamily M member 6) | protein interactions | 140803 | 5 | 1 | 19454 | 50 |
ARHGAP24 |
1.279e-02 | -4.36 | Calu (calumenin) | protein interactions | 12321 | 5 | 1 | 19454 | 50 |
SEPTIN9 |
1.279e-02 | -4.36 | ZNF93 (zinc finger protein 93) | protein interactions | 81931 | 5 | 1 | 19454 | 50 |
ARHGAP24 |
1.279e-02 | -4.36 | POU2F3 (POU class 2 homeobox 3) | protein interactions | 25833 | 5 | 1 | 19454 | 50 |
ARHGAP24 |
1.279e-02 | -4.36 | ZNF571 (zinc finger protein 571) | protein interactions | 51276 | 5 | 1 | 19454 | 50 |
ARHGAP24 |
1.281e-02 | -4.36 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm | 7307 | 28 | 16828 | 46 |
CCND2,GAB1,PTPN12,MCOLN2,ME1,SH2B3,RGL1,HEPHL1,TMSB4X,PLXND1,WDFY3,DOCK8,PREX1,SLC9A7,ITGAV,STAB1,TFEB,RXRA,DNM2,ITGB2,BTG1,DAB2,FKBP5,AKAP13,EHD4,DOCK2,ZFP36L1,MYO1F |
1.281e-02 | -4.36 | regulation of hydrolase activity | biological process | GO:0051336 | 726 | 6 | 18204 | 49 |
ARHGAP24,ARHGAP45,PREX1,PLXND1,DOCK8,ARAP1 |
1.286e-02 | -4.35 | TRIP6 (thyroid hormone receptor interactor 6) | protein interactions | 7205 | 354 | 4 | 19454 | 50 |
TMSB4X,HCK,TLN1,PTPN6 |
1.287e-02 | -4.35 | MIOS (meiosis regulator for oocyte development) | protein interactions | 54468 | 67 | 2 | 19454 | 50 |
ARHGAP24,RXRA |
1.287e-02 | -4.35 | ASAP1 (ArfGAP with SH3 domain, ankyrin repeat and PH domain 1) | protein interactions | 50807 | 67 | 2 | 19454 | 50 |
HCK,PTPN12 |
1.287e-02 | -4.35 | STX16 (syntaxin 16) | protein interactions | 8675 | 67 | 2 | 19454 | 50 |
PTPN12,MCOLN2 |
1.291e-02 | -4.35 | VIRMA (vir like m6A methyltransferase associated) | protein interactions | 25962 | 2914 | 14 | 19454 | 50 |
SEPTIN9,PREX1,DNM2,AKAP13,DISC1,PLXND1,TLN1,WDFY3,ITGAV,RGL1,BMP2K,GAB1,RBM47,ARHGEF18 |
1.291e-02 | -4.35 | upper_aerodigestive_tract-mouth-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-mouth-carcinoma-squamous_cell_carcinoma | 6953 | 27 | 16828 | 46 |
PLXND1,TMSB4X,WDFY3,HEPHL1,ME1,CCND2,PTPN12,MCOLN2,GAB1,PTPN6,DISC1,RBM47,MYO1F,ZFP36L1,DOCK2,ARAP1,AKAP13,RBPJ,ARHGEF18,DNM2,RXRA,ITGB2,TLN1,PREX1,STAB1,HCK,ITGAV |
1.312e-02 | -4.33 | cell-substrate adhesion | biological process | GO:0031589 | 183 | 3 | 18204 | 49 |
ITGAV,ITGB2,ITGAL |
1.312e-02 | -4.33 | regulation of lipid localization | biological process | GO:1905952 | 183 | 3 | 18204 | 49 |
ITGAV,DAB2,RXRA |
1.314e-02 | -4.33 | response to growth factor | biological process | GO:0070848 | 525 | 5 | 18204 | 49 |
PTPN12,EHD4,GAB1,ZFP36L1,DAB2 |
1.320e-02 | -4.33 | Single helix bin | gene3d domains | 1.20.5.520 | 4 | 1 | 14470 | 48 |
TMSB4X |
1.320e-02 | -4.33 | FAS1 domain | gene3d domains | 2.30.180.10 | 4 | 1 | 14470 | 48 |
STAB1 |
1.320e-02 | -4.33 | Talin, central domain | gene3d domains | 1.20.1420.10 | 4 | 1 | 14470 | 48 |
TLN1 |
1.324e-02 | -4.32 | PTOV1 (PTOV1 extended AT-hook containing adaptor protein) | protein interactions | 53635 | 68 | 2 | 19454 | 50 |
RBPJ,FKBP5 |
1.324e-02 | -4.32 | CDKL2 (cyclin dependent kinase like 2) | protein interactions | 8999 | 68 | 2 | 19454 | 50 |
FKBP5,MYO1F |
1.325e-02 | -4.32 | regulation of biological process involved in symbiotic interaction | biological process | GO:0043903 | 65 | 2 | 18204 | 49 |
CD74,ITGAV |
1.327e-02 | -4.32 | response to stress | biological process | GO:0006950 | 3388 | 16 | 18204 | 49 |
MCOLN2,CD74,RBPJ,PTPN6,PTGIR,CD68,ITGB2,TLN1,HCK,STAB1,SPI1,ITGAV,ARHGAP24,TFEB,ZFP36L1,ITGAL |
1.339e-02 | -4.31 | negative regulation of Rac protein signal transduction | biological process | GO:0035021 | 5 | 1 | 18204 | 49 |
ARHGAP24 |
1.339e-02 | -4.31 | regulation of antifungal innate immune response | biological process | GO:1905034 | 5 | 1 | 18204 | 49 |
SPI1 |
1.339e-02 | -4.31 | regulation of mast cell activation involved in immune response | biological process | GO:0033006 | 5 | 1 | 18204 | 49 |
PTPN6 |
1.339e-02 | -4.31 | negative regulation of adipose tissue development | biological process | GO:1904178 | 5 | 1 | 18204 | 49 |
SPI1 |
1.339e-02 | -4.31 | epididymis development | biological process | GO:1905867 | 5 | 1 | 18204 | 49 |
PTPN6 |
1.339e-02 | -4.31 | regulation of microglial cell mediated cytotoxicity | biological process | GO:1904149 | 5 | 1 | 18204 | 49 |
SPI1 |
1.339e-02 | -4.31 | membrane tubulation | biological process | GO:0097749 | 5 | 1 | 18204 | 49 |
DNM2 |
1.339e-02 | -4.31 | negative regulation of lipoprotein metabolic process | biological process | GO:0050748 | 5 | 1 | 18204 | 49 |
ITGAV |
1.339e-02 | -4.31 | positive regulation of cell proliferation involved in heart morphogenesis | biological process | GO:2000138 | 5 | 1 | 18204 | 49 |
RBPJ |
1.339e-02 | -4.31 | transforming growth factor beta production | biological process | GO:0071604 | 5 | 1 | 18204 | 49 |
ITGAV |
1.339e-02 | -4.31 | natural killer cell proliferation | biological process | GO:0001787 | 5 | 1 | 18204 | 49 |
ELF4 |
1.339e-02 | -4.31 | thrombopoietin-mediated signaling pathway | biological process | GO:0038163 | 5 | 1 | 18204 | 49 |
SH2B3 |
1.339e-02 | -4.31 | regulation of membrane tubulation | biological process | GO:1903525 | 5 | 1 | 18204 | 49 |
DNM2 |
1.339e-02 | -4.31 | epidermal cell fate specification | biological process | GO:0009957 | 5 | 1 | 18204 | 49 |
RBPJ |
1.343e-02 | -4.31 | Cu_oxidase_CS | interpro domains | IPR033138 | 5 | 1 | 18521 | 50 |
HEPHL1 |
1.343e-02 | -4.31 | Lysosome-assoc_membr_glycop | interpro domains | IPR002000 | 5 | 1 | 18521 | 50 |
CD68 |
1.343e-02 | -4.31 | Cu-oxidase-like_N | interpro domains | IPR011707 | 5 | 1 | 18521 | 50 |
HEPHL1 |
1.343e-02 | -4.31 | Lamp2-like_luminal | interpro domains | IPR048528 | 5 | 1 | 18521 | 50 |
CD68 |
1.343e-02 | -4.31 | HnRNP_R/Q_splicing_fac | interpro domains | IPR006535 | 5 | 1 | 18521 | 50 |
RBM47 |
1.343e-02 | -4.31 | EHD_N | interpro domains | IPR031692 | 5 | 1 | 18521 | 50 |
EHD4 |
1.343e-02 | -4.31 | DOCK_N | interpro domains | IPR032376 | 5 | 1 | 18521 | 50 |
DOCK2 |
1.343e-02 | -4.31 | DOCK_N_sub1 | interpro domains | IPR042455 | 5 | 1 | 18521 | 50 |
DOCK2 |
1.344e-02 | -4.31 | PSI | smart domains | SM00423 | 42 | 2 | 9717 | 41 |
ITGB2,PLXND1 |
1.347e-02 | -4.31 | NAADP-sensitive calcium-release channel activity | molecular function | GO:0072345 | 5 | 1 | 18094 | 49 |
MCOLN2 |
1.347e-02 | -4.31 | neuregulin binding | molecular function | GO:0038132 | 5 | 1 | 18094 | 49 |
ITGAV |
1.347e-02 | -4.31 | C-X3-C chemokine binding | molecular function | GO:0019960 | 5 | 1 | 18094 | 49 |
ITGAV |
1.355e-02 | -4.30 | negative regulation of immune system process | biological process | GO:0002683 | 529 | 5 | 18204 | 49 |
SPI1,PTPN6,CD74,HCK,CD68 |
1.358e-02 | -4.30 | Rap1 signaling pathway | KEGG pathways | hsa04015 | 210 | 4 | 7161 | 32 |
TLN1,FYB1,ITGAL,ITGB2 |
1.358e-02 | -4.30 | Rap1 signaling pathway | KEGG pathways | ko04015 | 210 | 4 | 7161 | 32 |
ITGB2,ITGAL,FYB1,TLN1 |
1.359e-02 | -4.30 | cell development | biological process | GO:0048468 | 2236 | 12 | 18204 | 49 |
CD74,DNM2,DOCK2,PTPN6,RBPJ,PREX1,PLXND1,DISC1,SPI1,RBM47,SH2B3,ZFP36L1 |
1.361e-02 | -4.30 | EVL (Enah/Vasp-like) | protein interactions | 51466 | 69 | 2 | 19454 | 50 |
FYB1,HCK |
1.361e-02 | -4.30 | PABPC3 (poly(A) binding protein cytoplasmic 3) | protein interactions | 5042 | 69 | 2 | 19454 | 50 |
GAB1,ARHGAP24 |
1.364e-02 | -4.29 | Signaling by ERBB2 | REACTOME pathways | R-HSA-1227986 | 51 | 2 | 10285 | 36 |
GAB1,PTPN12 |
1.364e-02 | -4.29 | homotypic cell-cell adhesion | biological process | GO:0034109 | 66 | 2 | 18204 | 49 |
PTPN6,TLN1 |
1.364e-02 | -4.29 | peptidyl-tyrosine phosphorylation | biological process | GO:0018108 | 66 | 2 | 18204 | 49 |
HCK,PTPN6 |
1.369e-02 | -4.29 | EHD_N | pfam domains | PF16880 | 5 | 1 | 17795 | 49 |
EHD4 |
1.369e-02 | -4.29 | Cu-oxidase_3 | pfam domains | PF07732 | 5 | 1 | 17795 | 49 |
HEPHL1 |
1.369e-02 | -4.29 | Lamp | pfam domains | PF01299 | 5 | 1 | 17795 | 49 |
CD68 |
1.369e-02 | -4.29 | DOCK_N | pfam domains | PF16172 | 5 | 1 | 17795 | 49 |
DOCK2 |
1.372e-02 | -4.29 | PE/DAG-bd | interpro domains | IPR002219 | 66 | 2 | 18521 | 50 |
ARHGAP45,AKAP13 |
1.376e-02 | -4.29 | CD2AP (CD2 associated protein) | protein interactions | 23607 | 195 | 3 | 19454 | 50 |
SEPTIN9,HCK,DNM2 |
1.380e-02 | -4.28 | Regulation of actin cytoskeleton | KEGG pathways | ko04810 | 211 | 4 | 7161 | 32 |
ITGAV,ITGB2,ITGAL,TMSB4X |
1.380e-02 | -4.28 | Regulation of actin cytoskeleton | KEGG pathways | hsa04810 | 211 | 4 | 7161 | 32 |
TMSB4X,ITGAL,ITGB2,ITGAV |
1.382e-02 | -4.28 | Regulation of RhoA activity | Pathway Interaction DB | rhoa_reg_pathway | 46 | 3 | 2226 | 25 |
AKAP13,ARAP1,ARHGEF18 |
1.386e-02 | -4.28 | PSMD3 (proteasome 26S subunit, non-ATPase 3) | protein interactions | 5709 | 362 | 4 | 19454 | 50 |
ARHGAP24,CD74,CCND2,PTPN6 |
1.393e-02 | -4.27 | Scavenging by Class H Receptors | REACTOME pathways | R-HSA-3000497 | 4 | 1 | 10285 | 36 |
STAB1 |
1.395e-02 | -4.27 | BLK (BLK proto-oncogene, Src family tyrosine kinase) | protein interactions | 640 | 196 | 3 | 19454 | 50 |
GAB1,HCK,FKBP5 |
1.399e-02 | -4.27 | IL6ST (interleukin 6 cytokine family signal transducer) | protein interactions | 3572 | 70 | 2 | 19454 | 50 |
HCK,PTPN6 |
1.399e-02 | -4.27 | KRT36 (keratin 36) | protein interactions | 8689 | 70 | 2 | 19454 | 50 |
HCK,TMSB4X |
1.404e-02 | -4.27 | positive regulation of response to cytokine stimulus | biological process | GO:0060760 | 67 | 2 | 18204 | 49 |
RBM47,CD74 |
1.414e-02 | -4.26 | RNF20 (ring finger protein 20) | protein interactions | 56254 | 197 | 3 | 19454 | 50 |
RBPJ,DISC1,ARHGAP24 |
1.417e-02 | -4.26 | CDK1 (cyclin dependent kinase 1) | protein interactions | 983 | 560 | 5 | 19454 | 50 |
DNM2,FKBP5,DAB2,CCND2,PTPN6 |
1.437e-02 | -4.24 | MAPK4 (mitogen-activated protein kinase 4) | protein interactions | 5596 | 71 | 2 | 19454 | 50 |
GAB1,FKBP5 |
1.438e-02 | -4.24 | ANXA2 (annexin A2) | protein interactions | 302 | 366 | 4 | 19454 | 50 |
DISC1,AKAP13,DOCK8,TFEB |
1.444e-02 | -4.24 | negative regulation of leukocyte mediated immunity | biological process | GO:0002704 | 68 | 2 | 18204 | 49 |
SPI1,PTPN6 |
1.444e-02 | -4.24 | negative regulation of interleukin-6 production | biological process | GO:0032715 | 68 | 2 | 18204 | 49 |
PTPN6,ELF4 |
1.444e-02 | -4.24 | cell-cell recognition | biological process | GO:0009988 | 68 | 2 | 18204 | 49 |
DOCK2,DOCK8 |
1.444e-02 | -4.24 | peptidyl-tyrosine modification | biological process | GO:0018212 | 68 | 2 | 18204 | 49 |
PTPN6,HCK |
1.448e-02 | -4.23 | primitive_neuroectodermal_tumour-medulloblastoma | COSMIC cancer mutations | primitive_neuroectodermal_tumour-medulloblastoma | 15350 | 46 | 16828 | 46 |
ITM2B,DNM2,STAB1,TFEB,PREX1,ARAP1,DOCK2,MYO1F,DISC1,AKAP13,ARHGEF18,FKBP5,CD74,DAB2,ARHGAP24,ITGAL,SPI1,ME1,TMSB4X,HEPHL1,ITGB2,RXRA,ITGAV,HCK,TLN1,SLC9A7,PTGIR,ZFP36L1,PTPN6,RBM47,ANTXR2,EHD4,RBPJ,BTG1,SH2B3,RGL1,GAB1,MCOLN2,PTPN12,CCND2,DOCK8,WDFY3,PLXND1,CD68,BMP2K,ELF4 |
1.451e-02 | -4.23 | SMAD2 (SMAD family member 2) | protein interactions | 4087 | 367 | 4 | 19454 | 50 |
DOCK8,DAB2,RXRA,ANTXR2 |
1.476e-02 | -4.22 | Ppp1cb (protein phosphatase 1 catalytic subunit beta) | protein interactions | 19046 | 72 | 2 | 19454 | 50 |
BMP2K,DAB2 |
1.476e-02 | -4.22 | JMJD1C (jumonji domain containing 1C) | protein interactions | 221037 | 72 | 2 | 19454 | 50 |
RBPJ,RXRA |
1.491e-02 | -4.21 | DBN1 (drebrin 1) | protein interactions | 1627 | 370 | 4 | 19454 | 50 |
BMP2K,DISC1,ARHGAP24,DAB2 |
1.492e-02 | -4.21 | PTDSS1 (phosphatidylserine synthase 1) | protein interactions | 9791 | 201 | 3 | 19454 | 50 |
PTPN6,RBM47,HEPHL1 |
1.502e-02 | -4.20 | I_LWEQ | prosite domains | PS50945 | 4 | 1 | 12186 | 46 |
TLN1 |
1.502e-02 | -4.20 | THYMOSIN_B4 | prosite domains | PS00500 | 4 | 1 | 12186 | 46 |
TMSB4X |
1.502e-02 | -4.20 | FAS1 | prosite domains | PS50213 | 4 | 1 | 12186 | 46 |
STAB1 |
1.502e-02 | -4.20 | LAMP_3 | prosite domains | PS51407 | 4 | 1 | 12186 | 46 |
CD68 |
1.512e-02 | -4.19 | SGTB (small glutamine rich tetratricopeptide repeat co-chaperone beta) | protein interactions | 54557 | 202 | 3 | 19454 | 50 |
WDFY3,TLN1,CD68 |
1.512e-02 | -4.19 | regulation of angiogenesis | biological process | GO:0045765 | 355 | 4 | 18204 | 49 |
PLXND1,STAB1,GAB1,BTG1 |
1.512e-02 | -4.19 | positive regulation of hemopoiesis | biological process | GO:1903708 | 193 | 3 | 18204 | 49 |
ZFP36L1,CD74,SPI1 |
1.512e-02 | -4.19 | positive regulation of leukocyte differentiation | biological process | GO:1902107 | 193 | 3 | 18204 | 49 |
ZFP36L1,CD74,SPI1 |
1.515e-02 | -4.19 | FSD1 (fibronectin type III and SPRY domain containing 1) | protein interactions | 79187 | 73 | 2 | 19454 | 50 |
EHD4,DISC1 |
1.515e-02 | -4.19 | STAMBPL1 (STAM binding protein like 1) | protein interactions | 57559 | 73 | 2 | 19454 | 50 |
RBM47,BMP2K |
1.515e-02 | -4.19 | PANK4 (pantothenate kinase 4 (inactive)) | protein interactions | 55229 | 73 | 2 | 19454 | 50 |
ARHGAP24,PTPN6 |
1.518e-02 | -4.19 | NHLRC2 (NHL repeat containing 2) | protein interactions | 374354 | 372 | 4 | 19454 | 50 |
AKAP13,TLN1,TFEB,MYO1F |
1.521e-02 | -4.19 | lamellipodium | cellular component | GO:0030027 | 203 | 3 | 19108 | 49 |
PLXND1,DOCK8,ITGAV |
1.521e-02 | -4.19 | endocytic vesicle membrane | cellular component | GO:0030666 | 203 | 3 | 19108 | 49 |
STAB1,DNM2,CD74 |
1.522e-02 | -4.19 | LYSASSOCTDMP | prints domains | PR00336 | 4 | 1 | 5227 | 20 |
CD68 |
1.522e-02 | -4.19 | RETINOIDXR | prints domains | PR00545 | 4 | 1 | 5227 | 20 |
RXRA |
1.526e-02 | -4.18 | antigen processing and presentation of peptide antigen | biological process | GO:0048002 | 70 | 2 | 18204 | 49 |
DNM2,CD74 |
1.529e-02 | -4.18 | Atg12-Atg5-Atg16 complex | cellular component | GO:0034274 | 6 | 1 | 19108 | 49 |
WDFY3 |
1.529e-02 | -4.18 | mRNA editing complex | cellular component | GO:0045293 | 6 | 1 | 19108 | 49 |
RBM47 |
1.531e-02 | -4.18 | MYO6 (myosin VI) | protein interactions | 4646 | 373 | 4 | 19454 | 50 |
SEPTIN9,BMP2K,DOCK8,DAB2 |
1.531e-02 | -4.18 | DPYSL2 (dihydropyrimidinase like 2) | protein interactions | 1808 | 203 | 3 | 19454 | 50 |
SEPTIN9,DISC1,PREX1 |
1.532e-02 | -4.18 | Nme7 (NME/NM23 family member 7) | protein interactions | 171567 | 6 | 1 | 19454 | 50 |
TMSB4X |
1.532e-02 | -4.18 | CD300LF (CD300 molecule like family member f) | protein interactions | 146722 | 6 | 1 | 19454 | 50 |
PTPN6 |
1.532e-02 | -4.18 | Ncoa2 (nuclear receptor coactivator 2) | protein interactions | 17978 | 6 | 1 | 19454 | 50 |
RXRA |
1.532e-02 | -4.18 | ITGAX (integrin subunit alpha X) | protein interactions | 3687 | 6 | 1 | 19454 | 50 |
ITGB2 |
1.532e-02 | -4.18 | ZNF311 (zinc finger protein 311) | protein interactions | 282890 | 6 | 1 | 19454 | 50 |
ARHGAP24 |
1.532e-02 | -4.18 | echA1 (enoyl-CoA hydratase EchA1) | protein interactions | 886723 | 6 | 1 | 19454 | 50 |
PTPN6 |
1.552e-02 | -4.17 | amb2 Integrin signaling | Pathway Interaction DB | amb2_neutrophils_pathway | 48 | 3 | 2226 | 25 |
ITGB2,TLN1,HCK |
1.554e-02 | -4.16 | EEF1A1P5 (eukaryotic translation elongation factor 1 alpha 1 pseudogene 5) | protein interactions | 158078 | 74 | 2 | 19454 | 50 |
CCND2,ARHGAP24 |
1.568e-02 | -4.16 | localization within membrane | biological process | GO:0051668 | 549 | 5 | 18204 | 49 |
FYB1,DOCK2,EHD4,ITGB2,ITGAL |
1.572e-02 | -4.15 | UTRN (utrophin) | protein interactions | 7402 | 205 | 3 | 19454 | 50 |
DISC1,MCOLN2,PTPN12 |
1.579e-02 | -4.15 | IL-6 signaling pathway | WikiPathways | WP364 | 43 | 2 | 5310 | 24 |
HCK,GAB1 |
1.594e-02 | -4.14 | MTX3 (metaxin 3) | protein interactions | 345778 | 75 | 2 | 19454 | 50 |
PTGIR,CD68 |
1.594e-02 | -4.14 | AKT3 (AKT serine/threonine kinase 3) | protein interactions | 10000 | 75 | 2 | 19454 | 50 |
DAB2,FKBP5 |
1.594e-02 | -4.14 | PDAP1 (PDGFA associated protein 1) | protein interactions | 11333 | 75 | 2 | 19454 | 50 |
DISC1,CD74 |
1.597e-02 | -4.14 | negative regulation of immune response | biological process | GO:0050777 | 197 | 3 | 18204 | 49 |
HCK,PTPN6,SPI1 |
1.599e-02 | -4.14 | positive regulation of cell projection organization | biological process | GO:0031346 | 361 | 4 | 18204 | 49 |
ARAP1,DISC1,PLXND1,SEPTIN9 |
1.604e-02 | -4.13 | regulation of aldosterone secretion | biological process | GO:2000858 | 6 | 1 | 18204 | 49 |
DAB2 |
1.604e-02 | -4.13 | hair follicle maturation | biological process | GO:0048820 | 6 | 1 | 18204 | 49 |
RBPJ |
1.604e-02 | -4.13 | positive regulation of prostaglandin biosynthetic process | biological process | GO:0031394 | 6 | 1 | 18204 | 49 |
CD74 |
1.604e-02 | -4.13 | arterial endothelial cell differentiation | biological process | GO:0060842 | 6 | 1 | 18204 | 49 |
RBPJ |
1.604e-02 | -4.13 | endocardium morphogenesis | biological process | GO:0003160 | 6 | 1 | 18204 | 49 |
RBPJ |
1.604e-02 | -4.13 | negative regulation of amine metabolic process | biological process | GO:0033239 | 6 | 1 | 18204 | 49 |
ITGB2 |
1.604e-02 | -4.13 | regulation of establishment of T cell polarity | biological process | GO:1903903 | 6 | 1 | 18204 | 49 |
DOCK8 |
1.604e-02 | -4.13 | membrane raft distribution | biological process | GO:0031580 | 6 | 1 | 18204 | 49 |
DOCK2 |
1.604e-02 | -4.13 | positive regulation of chemokine (C-C motif) ligand 5 production | biological process | GO:0071651 | 6 | 1 | 18204 | 49 |
MCOLN2 |
1.604e-02 | -4.13 | positive regulation of vitamin D receptor signaling pathway | biological process | GO:0070564 | 6 | 1 | 18204 | 49 |
RXRA |
1.604e-02 | -4.13 | regulation of macrophage inflammatory protein 1 alpha production | biological process | GO:0071640 | 6 | 1 | 18204 | 49 |
MCOLN2 |
1.604e-02 | -4.13 | regulation of mineralocorticoid secretion | biological process | GO:2000855 | 6 | 1 | 18204 | 49 |
DAB2 |
1.604e-02 | -4.13 | regulation of defense response to fungus | biological process | GO:1900150 | 6 | 1 | 18204 | 49 |
SPI1 |
1.604e-02 | -4.13 | radial glia-guided pyramidal neuron migration | biological process | GO:0140650 | 6 | 1 | 18204 | 49 |
DISC1 |
1.604e-02 | -4.13 | negative regulation of protein localization to chromatin | biological process | GO:0120186 | 6 | 1 | 18204 | 49 |
SPI1 |
1.604e-02 | -4.13 | apolipoprotein A-I-mediated signaling pathway | biological process | GO:0038027 | 6 | 1 | 18204 | 49 |
ITGAV |
1.604e-02 | -4.13 | oncogene-induced cell senescence | biological process | GO:0090402 | 6 | 1 | 18204 | 49 |
SPI1 |
1.609e-02 | -4.13 | Dynamin_stalk | interpro domains | IPR000375 | 6 | 1 | 18521 | 50 |
DNM2 |
1.609e-02 | -4.13 | BTG-like_sf | interpro domains | IPR036054 | 6 | 1 | 18521 | 50 |
BTG1 |
1.609e-02 | -4.13 | Dynamin_GTPase_CS | interpro domains | IPR019762 | 6 | 1 | 18521 | 50 |
DNM2 |
1.609e-02 | -4.13 | DOCK_C/D_N | interpro domains | IPR021816 | 6 | 1 | 18521 | 50 |
DOCK8 |
1.609e-02 | -4.13 | Integrin_bsu_cyt_dom | interpro domains | IPR014836 | 6 | 1 | 18521 | 50 |
ITGB2 |
1.609e-02 | -4.13 | GED_dom | interpro domains | IPR020850 | 6 | 1 | 18521 | 50 |
DNM2 |
1.609e-02 | -4.13 | Anti_prolifrtn | interpro domains | IPR002087 | 6 | 1 | 18521 | 50 |
BTG1 |
1.609e-02 | -4.13 | GED | interpro domains | IPR003130 | 6 | 1 | 18521 | 50 |
DNM2 |
1.609e-02 | -4.13 | negative regulation of protein binding | biological process | GO:0032091 | 72 | 2 | 18204 | 49 |
DISC1,DAB2 |
1.609e-02 | -4.13 | positive regulation of chemokine production | biological process | GO:0032722 | 72 | 2 | 18204 | 49 |
CD74,MCOLN2 |
1.613e-02 | -4.13 | positive regulation of leukocyte activation | biological process | GO:0002696 | 362 | 4 | 18204 | 49 |
PTPN6,SPI1,CD74,DOCK8 |
1.614e-02 | -4.13 | oxidoreductase activity, acting on metal ions, oxygen as acceptor | molecular function | GO:0016724 | 6 | 1 | 18094 | 49 |
HEPHL1 |
1.614e-02 | -4.13 | ferroxidase activity | molecular function | GO:0004322 | 6 | 1 | 18094 | 49 |
HEPHL1 |
1.614e-02 | -4.13 | extracellular matrix protein binding | molecular function | GO:1990430 | 6 | 1 | 18094 | 49 |
ITGAV |
1.614e-02 | -4.13 | retinoic acid-responsive element binding | molecular function | GO:0044323 | 6 | 1 | 18094 | 49 |
RXRA |
1.614e-02 | -4.13 | LIM domain binding | molecular function | GO:0030274 | 6 | 1 | 18094 | 49 |
TLN1 |
1.614e-02 | -4.13 | type 1 angiotensin receptor binding | molecular function | GO:0031702 | 6 | 1 | 18094 | 49 |
ARAP1 |
1.614e-02 | -4.13 | NFAT protein binding | molecular function | GO:0051525 | 6 | 1 | 18094 | 49 |
SPI1 |
1.622e-02 | -4.12 | molecular transducer activity | molecular function | GO:0060089 | 1474 | 9 | 18094 | 49 |
PTGIR,CD74,ITGAV,PLXND1,ITGAL,PTPN6,RXRA,ITGB2,ANTXR2 |
1.622e-02 | -4.12 | signaling receptor activity | molecular function | GO:0038023 | 1474 | 9 | 18094 | 49 |
PLXND1,ITGAV,CD74,PTGIR,ANTXR2,ITGB2,RXRA,ITGAL,PTPN6 |
1.623e-02 | -4.12 | positive regulation of cell population proliferation | biological process | GO:0008284 | 992 | 7 | 18204 | 49 |
HCK,DISC1,CD74,CCND2,ITGAV,PTPN6,RBPJ |
1.635e-02 | -4.11 | PGM3 (phosphoglucomutase 3) | protein interactions | 5238 | 76 | 2 | 19454 | 50 |
ARHGAP24,DISC1 |
1.641e-02 | -4.11 | Integrin_b_cyt | pfam domains | PF08725 | 6 | 1 | 17795 | 49 |
ITGB2 |
1.641e-02 | -4.11 | GED | pfam domains | PF02212 | 6 | 1 | 17795 | 49 |
DNM2 |
1.641e-02 | -4.11 | BTG | pfam domains | PF07742 | 6 | 1 | 17795 | 49 |
BTG1 |
1.641e-02 | -4.11 | Integrin_B_tail | pfam domains | PF07965 | 6 | 1 | 17795 | 49 |
ITGB2 |
1.641e-02 | -4.11 | Dynamin_M | pfam domains | PF01031 | 6 | 1 | 17795 | 49 |
DNM2 |
1.641e-02 | -4.11 | PH_BEACH | pfam domains | PF14844 | 6 | 1 | 17795 | 49 |
WDFY3 |
1.641e-02 | -4.11 | DOCK_C-D_N | pfam domains | PF11878 | 6 | 1 | 17795 | 49 |
DOCK8 |
1.643e-02 | -4.11 | regulation of vasculature development | biological process | GO:1901342 | 364 | 4 | 18204 | 49 |
STAB1,BTG1,GAB1,PLXND1 |
1.647e-02 | -4.11 | protein-macromolecule adaptor activity | molecular function | GO:0030674 | 989 | 7 | 18094 | 49 |
AKAP13,RBM47,FKBP5,SH2B3,BTG1,DAB2,GAB1 |
1.648e-02 | -4.11 | - | gene3d domains | 1.10.268.20 | 5 | 1 | 14470 | 48 |
EHD4 |
1.648e-02 | -4.11 | Dedicator of cytokinesis N-terminal subdomain | gene3d domains | 1.20.1270.350 | 5 | 1 | 14470 | 48 |
DOCK2 |
1.652e-02 | -4.10 | regulation of ERBB signaling pathway | biological process | GO:1901184 | 73 | 2 | 18204 | 49 |
PTPN12,RBPJ |
1.652e-02 | -4.10 | vasculogenesis | biological process | GO:0001570 | 73 | 2 | 18204 | 49 |
ITGAV,ZFP36L1 |
1.652e-02 | -4.10 | receptor internalization | biological process | GO:0031623 | 73 | 2 | 18204 | 49 |
DNM2,ITGB2 |
1.652e-02 | -4.10 | regulation of myoblast differentiation | biological process | GO:0045661 | 73 | 2 | 18204 | 49 |
BTG1,ZFP36L1 |
1.652e-02 | -4.10 | endothelial cell migration | biological process | GO:0043542 | 73 | 2 | 18204 | 49 |
PLXND1,GAB1 |
1.668e-02 | -4.09 | clathrin-coated pit | cellular component | GO:0005905 | 77 | 2 | 19108 | 49 |
DAB2,DNM2 |
1.676e-02 | -4.09 | TNS3 (tensin 3) | protein interactions | 64759 | 77 | 2 | 19454 | 50 |
GAB1,PTPN12 |
1.676e-02 | -4.09 | SNX18 (sorting nexin 18) | protein interactions | 112574 | 77 | 2 | 19454 | 50 |
DNM2,DISC1 |
1.677e-02 | -4.09 | ILWEQ | smart domains | SM00307 | 4 | 1 | 9717 | 41 |
TLN1 |
1.677e-02 | -4.09 | THY | smart domains | SM00152 | 4 | 1 | 9717 | 41 |
TMSB4X |
1.677e-02 | -4.09 | FAS1 | smart domains | SM00554 | 4 | 1 | 9717 | 41 |
STAB1 |
1.684e-02 | -4.08 | leukocyte activation involved in immune response | biological process | GO:0002366 | 201 | 3 | 18204 | 49 |
ITGAL,DOCK2,CD74 |
1.695e-02 | -4.08 | chaperone-mediated protein folding | biological process | GO:0061077 | 74 | 2 | 18204 | 49 |
FKBP5,CD74 |
1.695e-02 | -4.08 | Factors involved in megakaryocyte development and platelet production | REACTOME pathways | R-HSA-983231 | 156 | 3 | 10285 | 36 |
DOCK8,DOCK2,SH2B3 |
1.697e-02 | -4.08 | mantle_cell_lymphoma | COSMIC cancer mutations | mantle_cell_lymphoma | 2849 | 14 | 16828 | 46 |
PREX1,STAB1,MCOLN2,TFEB,GAB1,RGL1,ME1,ARHGAP24,ELF4,ARHGEF18,AKAP13,DOCK2,MYO1F,WDFY3 |
1.705e-02 | -4.07 | Tyr_Pase_AS | interpro domains | IPR016130 | 74 | 2 | 18521 | 50 |
PTPN12,PTPN6 |
1.706e-02 | -4.07 | regulation of protein polymerization | biological process | GO:0032271 | 202 | 3 | 18204 | 49 |
HCK,TMSB4X,PREX1 |
1.709e-02 | -4.07 | human chr12q24.12 | chromosome location | human chr12q24.12 | 9 | 1 | 26134 | 50 |
SH2B3 |
1.720e-02 | -4.06 | urinary_tract-bladder-carcinoma-transitional_cell_carcinoma | COSMIC cancer mutations | urinary_tract-bladder-carcinoma-transitional_cell_carcinoma | 6040 | 24 | 16828 | 46 |
ELF4,DAB2,FKBP5,ARHGEF18,AKAP13,RBM47,PLXND1,ARAP1,MYO1F,ZFP36L1,WDFY3,DOCK2,DOCK8,PREX1,SLC9A7,TLN1,ITGAV,HCK,PTPN12,STAB1,RXRA,DNM2,ITM2B,ITGAL |
1.728e-02 | -4.06 | transitional_cell_carcinoma | COSMIC cancer mutations | transitional_cell_carcinoma | 6042 | 24 | 16828 | 46 |
PLXND1,DOCK8,WDFY3,ELF4,ITGAL,PTPN12,RBM47,ARAP1,MYO1F,ZFP36L1,DOCK2,DAB2,AKAP13,ARHGEF18,FKBP5,DNM2,RXRA,ITM2B,TLN1,SLC9A7,PREX1,ITGAV,HCK,STAB1 |
1.732e-02 | -4.06 | positive regulation of metabolic process | biological process | GO:0009893 | 3796 | 17 | 18204 | 49 |
RBPJ,RXRA,CCND2,CD74,MCOLN2,DNM2,SPI1,RBM47,DAB2,ZFP36L1,TFEB,EHD4,ELF4,ITGB2,TMSB4X,DISC1,ARAP1 |
1.738e-02 | -4.05 | MET activates PTPN11 | REACTOME pathways | R-HSA-8865999 | 5 | 1 | 10285 | 36 |
GAB1 |
1.738e-02 | -4.05 | NOSTRIN mediated eNOS trafficking | REACTOME pathways | R-HSA-203641 | 5 | 1 | 10285 | 36 |
DNM2 |
1.739e-02 | -4.05 | DCAF6 (DDB1 and CUL4 associated factor 6) | protein interactions | 55827 | 213 | 3 | 19454 | 50 |
DOCK8,WDFY3,DAB2 |
1.740e-02 | -4.05 | defense response to other organism | biological process | GO:0098542 | 1006 | 7 | 18204 | 49 |
MCOLN2,CD74,HCK,PTPN6,RBPJ,STAB1,TFEB |
1.742e-02 | -4.05 | positive regulation of response to external stimulus | biological process | GO:0032103 | 564 | 5 | 18204 | 49 |
TMSB4X,HCK,CD74,SPI1,RBM47 |
1.748e-02 | -4.05 | VWF_A | interpro domains | IPR002035 | 75 | 2 | 18521 | 50 |
ITGAL,ANTXR2 |
1.774e-02 | -4.03 | cell activation involved in immune response | biological process | GO:0002263 | 205 | 3 | 18204 | 49 |
ITGAL,CD74,DOCK2 |
1.782e-02 | -4.03 | regulation of axon extension | biological process | GO:0030516 | 76 | 2 | 18204 | 49 |
DISC1,DNM2 |
1.786e-02 | -4.03 | LAIR1 (leukocyte associated immunoglobulin like receptor 1) | protein interactions | 3903 | 7 | 1 | 19454 | 50 |
PTPN6 |
1.786e-02 | -4.03 | NSUN7 (NOP2/Sun RNA methyltransferase family member 7) | protein interactions | 79730 | 7 | 1 | 19454 | 50 |
PTPN6 |
1.786e-02 | -4.03 | ZCCHC24 (zinc finger CCHC-type containing 24) | protein interactions | 219654 | 7 | 1 | 19454 | 50 |
RBM47 |
1.786e-02 | -4.03 | ZNF501 (zinc finger protein 501) | protein interactions | 115560 | 7 | 1 | 19454 | 50 |
ARHGAP24 |
1.786e-02 | -4.03 | ZNF701 (zinc finger protein 701) | protein interactions | 55762 | 7 | 1 | 19454 | 50 |
ARHGAP24 |
1.786e-02 | -4.03 | MYT1L (myelin transcription factor 1 like) | protein interactions | 23040 | 7 | 1 | 19454 | 50 |
DISC1 |
1.786e-02 | -4.03 | Gadd45b (growth arrest and DNA-damage-inducible 45 beta) | protein interactions | 17873 | 7 | 1 | 19454 | 50 |
RXRA |
1.786e-02 | -4.03 | XKR8 (XK related 8) | protein interactions | 55113 | 7 | 1 | 19454 | 50 |
PTGIR |
1.786e-02 | -4.03 | SIGLEC9 (sialic acid binding Ig like lectin 9) | protein interactions | 27180 | 7 | 1 | 19454 | 50 |
PTPN6 |
1.804e-02 | -4.01 | MAGED2 (MAGE family member D2) | protein interactions | 10916 | 216 | 3 | 19454 | 50 |
FKBP5,PTPN6,DOCK8 |
1.809e-02 | -4.01 | BAG2 (BAG cochaperone 2) | protein interactions | 9532 | 596 | 5 | 19454 | 50 |
DISC1,TLN1,TFEB,EHD4,HCK |
1.809e-02 | -4.01 | AKT1 (AKT serine/threonine kinase 1) | protein interactions | 207 | 596 | 5 | 19454 | 50 |
ZFP36L1,GAB1,PREX1,CCND2,FKBP5 |
1.818e-02 | -4.01 | kinase binding | molecular function | GO:0019900 | 780 | 6 | 18094 | 49 |
PTPN6,ITGB2,BTG1,CCND2,ITGAV,SH2B3 |
1.820e-02 | -4.01 | RPS27A (ribosomal protein S27a) | protein interactions | 6233 | 393 | 4 | 19454 | 50 |
DOCK8,RBM47,GAB1,ARHGAP24 |
1.826e-02 | -4.00 | PLS3 (plastin 3) | protein interactions | 5358 | 217 | 3 | 19454 | 50 |
TLN1,ARHGAP24,SEPTIN9 |
1.827e-02 | -4.00 | positive regulation of axonogenesis | biological process | GO:0050772 | 77 | 2 | 18204 | 49 |
DISC1,PLXND1 |
1.827e-02 | -4.00 | positive regulation of small GTPase mediated signal transduction | biological process | GO:0051057 | 77 | 2 | 18204 | 49 |
AKAP13,ITGAV |
1.836e-02 | -4.00 | plasma membrane protein complex | cellular component | GO:0098797 | 600 | 5 | 19108 | 49 |
CD74,ITGB2,PTPN6,ITGAV,ITGAL |
1.840e-02 | -4.00 | regulation of leukocyte activation | biological process | GO:0002694 | 572 | 5 | 18204 | 49 |
DOCK8,ZFP36L1,CD74,SPI1,PTPN6 |
1.849e-02 | -3.99 | external side of plasma membrane | cellular component | GO:0009897 | 396 | 4 | 19108 | 49 |
ITGAV,CD74,ITGB2,ITGAL |
1.866e-02 | -3.98 | MAPK3 (mitogen-activated protein kinase 3) | protein interactions | 5595 | 396 | 4 | 19454 | 50 |
RXRA,GAB1,ITGAV,FKBP5 |
1.869e-02 | -3.98 | cellular response to interleukin-3 | biological process | GO:0036016 | 7 | 1 | 18204 | 49 |
SH2B3 |
1.869e-02 | -3.98 | negative regulation of ruffle assembly | biological process | GO:1900028 | 7 | 1 | 18204 | 49 |
ARHGAP24 |
1.869e-02 | -3.98 | positive regulation of corticosteroid hormone secretion | biological process | GO:2000848 | 7 | 1 | 18204 | 49 |
DAB2 |
1.869e-02 | -3.98 | regulation of thyroid hormone mediated signaling pathway | biological process | GO:0002155 | 7 | 1 | 18204 | 49 |
RXRA |
1.869e-02 | -3.98 | membrane raft localization | biological process | GO:0051665 | 7 | 1 | 18204 | 49 |
DOCK2 |
1.869e-02 | -3.98 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay | biological process | GO:0031086 | 7 | 1 | 18204 | 49 |
ZFP36L1 |
1.869e-02 | -3.98 | macropinocytosis | biological process | GO:0044351 | 7 | 1 | 18204 | 49 |
DOCK2 |
1.869e-02 | -3.98 | regulation of entry of bacterium into host cell | biological process | GO:2000535 | 7 | 1 | 18204 | 49 |
ITGAV |
1.869e-02 | -3.98 | TRAIL-activated apoptotic signaling pathway | biological process | GO:0036462 | 7 | 1 | 18204 | 49 |
SPI1 |
1.869e-02 | -3.98 | response to interleukin-3 | biological process | GO:0036015 | 7 | 1 | 18204 | 49 |
SH2B3 |
1.869e-02 | -3.98 | delamination | biological process | GO:0060232 | 7 | 1 | 18204 | 49 |
SPI1 |
1.869e-02 | -3.98 | chorio-allantoic fusion | biological process | GO:0060710 | 7 | 1 | 18204 | 49 |
ZFP36L1 |
1.869e-02 | -3.98 | positive regulation of transcription of Notch receptor target | biological process | GO:0007221 | 7 | 1 | 18204 | 49 |
RBPJ |
1.869e-02 | -3.98 | regulation of isomerase activity | biological process | GO:0010911 | 7 | 1 | 18204 | 49 |
ITGB2 |
1.869e-02 | -3.98 | positive regulation of isomerase activity | biological process | GO:0010912 | 7 | 1 | 18204 | 49 |
ITGB2 |
1.869e-02 | -3.98 | positive regulation of dendritic cell antigen processing and presentation | biological process | GO:0002606 | 7 | 1 | 18204 | 49 |
CD74 |
1.872e-02 | -3.98 | negative regulation of tumor necrosis factor production | biological process | GO:0032720 | 78 | 2 | 18204 | 49 |
PTPN6,ELF4 |
1.874e-02 | -3.98 | MULTICOPPER_OXIDASE1 | prosite domains | PS00079 | 5 | 1 | 12186 | 46 |
HEPHL1 |
1.875e-02 | -3.98 | Integrin_bsu_tail | interpro domains | IPR012896 | 7 | 1 | 18521 | 50 |
ITGB2 |
1.875e-02 | -3.98 | Dynamin | interpro domains | IPR022812 | 7 | 1 | 18521 | 50 |
DNM2 |
1.875e-02 | -3.98 | Alpha-catenin/vinculin-like_sf | interpro domains | IPR036723 | 7 | 1 | 18521 | 50 |
TLN1 |
1.875e-02 | -3.98 | Integrin_bsu_tail_dom_sf | interpro domains | IPR036349 | 7 | 1 | 18521 | 50 |
ITGB2 |
1.875e-02 | -3.98 | MYSc_Myo1 | interpro domains | IPR036072 | 7 | 1 | 18521 | 50 |
MYO1F |
1.875e-02 | -3.98 | Dynamin_GTPase | interpro domains | IPR001401 | 7 | 1 | 18521 | 50 |
DNM2 |
1.881e-02 | -3.97 | MHC class II protein binding | molecular function | GO:0042289 | 7 | 1 | 18094 | 49 |
CD74 |
1.881e-02 | -3.97 | LBD domain binding | molecular function | GO:0050693 | 7 | 1 | 18094 | 49 |
RXRA |
1.881e-02 | -3.97 | clathrin-coated vesicle | cellular component | GO:0030136 | 220 | 3 | 19108 | 49 |
CD74,DNM2,DAB2 |
1.883e-02 | -3.97 | negative regulation of cell population proliferation | biological process | GO:0008285 | 791 | 6 | 18204 | 49 |
RBPJ,SH2B3,PTPN6,BTG1,PTGIR,DAB2 |
1.886e-02 | -3.97 | LINC00839 (long intergenic non-protein coding RNA 839) | protein interactions | 84856 | 82 | 2 | 19454 | 50 |
AKAP13,SEPTIN9 |
1.886e-02 | -3.97 | MEF2D (myocyte enhancer factor 2D) | protein interactions | 4209 | 82 | 2 | 19454 | 50 |
RXRA,RBPJ |
1.893e-02 | -3.97 | CDK5 (cyclin dependent kinase 5) | protein interactions | 1020 | 220 | 3 | 19454 | 50 |
FKBP5,CCND2,TLN1 |
1.909e-02 | -3.96 | positive regulation of cell activation | biological process | GO:0050867 | 381 | 4 | 18204 | 49 |
DOCK8,PTPN6,SPI1,CD74 |
1.917e-02 | -3.95 | myeloid cell development | biological process | GO:0061515 | 79 | 2 | 18204 | 49 |
SH2B3,PTPN6 |
1.917e-02 | -3.95 | positive regulation of blood vessel endothelial cell migration | biological process | GO:0043536 | 79 | 2 | 18204 | 49 |
GAB1,TMSB4X |
1.925e-02 | -3.95 | Signaling events mediated by Stem cell factor receptor (c-Kit) | Pathway Interaction DB | kitpathway | 52 | 3 | 2226 | 25 |
PTPN6,SH2B3,GAB1 |
1.925e-02 | -3.95 | RHOB (ras homolog family member B) | protein interactions | 388 | 832 | 6 | 19454 | 50 |
AKAP13,ANTXR2,ITGAV,GAB1,ARHGEF18,DAB2 |
1.930e-02 | -3.95 | WH_DNA-bd_sf | interpro domains | IPR036390 | 211 | 3 | 18521 | 50 |
PREX1,SPI1,ELF4 |
1.930e-02 | -3.95 | NEXN (nexilin F-actin binding protein) | protein interactions | 91624 | 83 | 2 | 19454 | 50 |
ARHGAP24,DISC1 |
1.930e-02 | -3.95 | TUT4 (terminal uridylyl transferase 4) | protein interactions | 23318 | 83 | 2 | 19454 | 50 |
FKBP5,RBM47 |
1.930e-02 | -3.95 | N4BP2 (NEDD4 binding protein 2) | protein interactions | 55728 | 83 | 2 | 19454 | 50 |
RBM47,DISC1 |
1.930e-02 | -3.95 | WDR70 (WD repeat domain 70) | protein interactions | 55100 | 83 | 2 | 19454 | 50 |
RBPJ,ARHGAP24 |
1.939e-02 | -3.94 | YWHAQ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta) | protein interactions | 10971 | 1076 | 7 | 19454 | 50 |
DISC1,ZFP36L1,GAB1,CD74,AKAP13,TFEB,TLN1 |
1.959e-02 | -3.93 | mouth | COSMIC cancer mutations | mouth | 9004 | 32 | 16828 | 46 |
HEPHL1,TMSB4X,PLXND1,DOCK8,WDFY3,CCND2,GAB1,MCOLN2,PTPN12,ME1,BTG1,ARHGEF18,RBPJ,CD74,EHD4,AKAP13,RBM47,DISC1,PTPN6,ARAP1,DOCK2,MYO1F,ZFP36L1,PTGIR,PREX1,TLN1,ITGAV,STAB1,HCK,RXRA,DNM2,ITGB2 |
1.959e-02 | -3.93 | regulation of leukocyte cell-cell adhesion | biological process | GO:1903037 | 384 | 4 | 18204 | 49 |
DOCK8,ITGB2,CD74,PTPN6 |
1.962e-02 | -3.93 | TGM1 (transglutaminase 1) | protein interactions | 7051 | 223 | 3 | 19454 | 50 |
ARHGAP24,TLN1,DOCK2 |
1.962e-02 | -3.93 | FGFR2 (fibroblast growth factor receptor 2) | protein interactions | 2263 | 223 | 3 | 19454 | 50 |
PTPN6,DNM2,PTPN12 |
1.963e-02 | -3.93 | negative regulation of tumor necrosis factor superfamily cytokine production | biological process | GO:1903556 | 80 | 2 | 18204 | 49 |
ELF4,PTPN6 |
1.974e-02 | -3.93 | PPARA (peroxisome proliferator activated receptor alpha) | protein interactions | 5465 | 84 | 2 | 19454 | 50 |
RXRA,AKAP13 |
1.974e-02 | -3.93 | NFKBIB (NFKB inhibitor beta) | protein interactions | 4793 | 84 | 2 | 19454 | 50 |
RXRA,FKBP5 |
1.974e-02 | -3.93 | KRTAP3-1 (keratin associated protein 3-1) | protein interactions | 83896 | 84 | 2 | 19454 | 50 |
DOCK2,HCK |
1.974e-02 | -3.93 | NCAPG2 (non-SMC condensin II complex subunit G2) | protein interactions | 54892 | 84 | 2 | 19454 | 50 |
FKBP5,ARHGAP24 |
1.974e-02 | -3.92 | - | gene3d domains | 2.40.160.110 | 6 | 1 | 14470 | 48 |
CD68 |
1.974e-02 | -3.92 | I/LWEQ domain | gene3d domains | 1.20.1410.10 | 6 | 1 | 14470 | 48 |
TLN1 |
1.974e-02 | -3.92 | Dynamin, middle domain | gene3d domains | 1.20.120.1240 | 6 | 1 | 14470 | 48 |
DNM2 |
1.974e-02 | -3.92 | Anti-proliferative protein, N-terminal domain | gene3d domains | 3.90.640.90 | 6 | 1 | 14470 | 48 |
BTG1 |
1.976e-02 | -3.92 | CAPZA2 (capping actin protein of muscle Z-line subunit alpha 2) | protein interactions | 830 | 403 | 4 | 19454 | 50 |
HEPHL1,BMP2K,DAB2,ARAP1 |
1.985e-02 | -3.92 | negative regulation of cell activation | biological process | GO:0050866 | 214 | 3 | 18204 | 49 |
PTPN6,SH2B3,CD74 |
1.991e-02 | -3.92 | CLTC (clathrin heavy chain) | protein interactions | 1213 | 611 | 5 | 19454 | 50 |
BMP2K,TLN1,DAB2,EHD4,DNM2 |
1.996e-02 | -3.91 | Malaria | KEGG pathways | ko05144 | 49 | 2 | 7161 | 32 |
ITGAL,ITGB2 |
1.996e-02 | -3.91 | Malaria | KEGG pathways | hsa05144 | 49 | 2 | 7161 | 32 |
ITGB2,ITGAL |
2.009e-02 | -3.91 | outflow tract morphogenesis | biological process | GO:0003151 | 81 | 2 | 18204 | 49 |
PLXND1,RBPJ |
2.015e-02 | -3.90 | ZF_DAG_PE_1 | prosite domains | PS00479 | 58 | 2 | 12186 | 46 |
AKAP13,ARHGAP45 |
2.018e-02 | -3.90 | CREM (cAMP responsive element modulator) | protein interactions | 1390 | 85 | 2 | 19454 | 50 |
RBPJ,SPI1 |
2.018e-02 | -3.90 | ZAP70 (zeta chain of T cell receptor associated protein kinase 70) | protein interactions | 7535 | 85 | 2 | 19454 | 50 |
PTPN6,SH2B3 |
2.019e-02 | -3.90 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | 3511 | 16 | 16828 | 46 |
CCND2,TFEB,HCK,HEPHL1,DAB2,ELF4,BTG1,AKAP13,EHD4,CD74,RBM47,ANTXR2,TMSB4X,DOCK8,ZFP36L1,WDFY3 |
2.019e-02 | -3.90 | chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | COSMIC cancer mutations | chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | 3511 | 16 | 16828 | 46 |
CCND2,TFEB,HCK,HEPHL1,DAB2,ELF4,BTG1,AKAP13,EHD4,CD74,RBM47,ANTXR2,TMSB4X,DOCK8,ZFP36L1,WDFY3 |
2.023e-02 | -3.90 | IL-3 Signaling Pathway | WikiPathways | WP286 | 49 | 2 | 5310 | 24 |
PTPN6,HCK |
2.032e-02 | -3.90 | PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2) | protein interactions | 5296 | 226 | 3 | 19454 | 50 |
HCK,STAB1,GAB1 |
2.034e-02 | -3.90 | regulation of myeloid cell differentiation | biological process | GO:0045637 | 216 | 3 | 18204 | 49 |
SPI1,CD74,ZFP36L1 |
2.034e-02 | -3.90 | cell chemotaxis | biological process | GO:0060326 | 216 | 3 | 18204 | 49 |
GAB1,ITGB2,PREX1 |
2.038e-02 | -3.89 | ZNF28 (zinc finger protein 28) | protein interactions | 7576 | 8 | 1 | 19454 | 50 |
ARHGAP24 |
2.038e-02 | -3.89 | OSGEPL1 (O-sialoglycoprotein endopeptidase like 1) | protein interactions | 64172 | 8 | 1 | 19454 | 50 |
MCOLN2 |
2.038e-02 | -3.89 | ZNF236 (zinc finger protein 236) | protein interactions | 7776 | 8 | 1 | 19454 | 50 |
ARHGAP24 |
2.038e-02 | -3.89 | Prkca (protein kinase C, alpha) | protein interactions | 24680 | 8 | 1 | 19454 | 50 |
AKAP13 |
2.038e-02 | -3.89 | LILRB1 (leukocyte immunoglobulin like receptor B1) | protein interactions | 10859 | 8 | 1 | 19454 | 50 |
PTPN6 |
2.038e-02 | -3.89 | KMO (kynurenine 3-monooxygenase) | protein interactions | 8564 | 8 | 1 | 19454 | 50 |
DISC1 |
2.038e-02 | -3.89 | ZNF568 (zinc finger protein 568) | protein interactions | 374900 | 8 | 1 | 19454 | 50 |
ARHGAP24 |
2.038e-02 | -3.89 | TREML1 (triggering receptor expressed on myeloid cells like 1) | protein interactions | 340205 | 8 | 1 | 19454 | 50 |
PTPN6 |
2.038e-02 | -3.89 | SLC9A7 (solute carrier family 9 member A7) | protein interactions | 84679 | 8 | 1 | 19454 | 50 |
SLC9A7 |
2.038e-02 | -3.89 | CD1D (CD1d molecule) | protein interactions | 912 | 8 | 1 | 19454 | 50 |
CD74 |
2.042e-02 | -3.89 | BAG3 (BAG cochaperone 3) | protein interactions | 9531 | 615 | 5 | 19454 | 50 |
GAB1,DOCK8,FKBP5,DNM2,WDFY3 |
2.055e-02 | -3.88 | PRKCD (protein kinase C delta) | protein interactions | 5580 | 227 | 3 | 19454 | 50 |
PTPN6,ITGB2,DAB2 |
2.056e-02 | -3.88 | granulocyte chemotaxis | biological process | GO:0071621 | 82 | 2 | 18204 | 49 |
ITGB2,PREX1 |
2.056e-02 | -3.88 | T cell activation involved in immune response | biological process | GO:0002286 | 82 | 2 | 18204 | 49 |
ITGAL,CD74 |
2.056e-02 | -3.88 | regulation of bone mineralization | biological process | GO:0030500 | 82 | 2 | 18204 | 49 |
BMP2K,RXRA |
2.057e-02 | -3.88 | Natural killer cell mediated cytotoxicity | KEGG pathways | hsa04650 | 132 | 3 | 7161 | 32 |
PTPN6,ITGB2,ITGAL |
2.057e-02 | -3.88 | Natural killer cell mediated cytotoxicity | KEGG pathways | ko04650 | 132 | 3 | 7161 | 32 |
ITGAL,ITGB2,PTPN6 |
2.061e-02 | -3.88 | regulation of immune effector process | biological process | GO:0002697 | 390 | 4 | 18204 | 49 |
CD74,SPI1,PTPN6,ITGB2 |
2.082e-02 | -3.87 | CD22 mediated BCR regulation | REACTOME pathways | R-HSA-5690714 | 6 | 1 | 10285 | 36 |
PTPN6 |
2.082e-02 | -3.87 | MET activates PI3K/AKT signaling | REACTOME pathways | R-HSA-8851907 | 6 | 1 | 10285 | 36 |
GAB1 |
2.103e-02 | -3.86 | PCNT (pericentrin) | protein interactions | 5116 | 229 | 3 | 19454 | 50 |
DNM2,DISC1,SEPTIN9 |
2.103e-02 | -3.86 | PCMT1 (protein-L-isoaspartate (D-aspartate) O-methyltransferase) | protein interactions | 5110 | 229 | 3 | 19454 | 50 |
ARHGAP24,AKAP13,DOCK8 |
2.103e-02 | -3.86 | positive regulation of B cell activation | biological process | GO:0050871 | 83 | 2 | 18204 | 49 |
CD74,SPI1 |
2.108e-02 | -3.86 | MYH7 (myosin heavy chain 7) | protein interactions | 4625 | 87 | 2 | 19454 | 50 |
RBPJ,DISC1 |
2.108e-02 | -3.86 | GK (glycerol kinase) | protein interactions | 2710 | 87 | 2 | 19454 | 50 |
PTGIR,RXRA |
2.115e-02 | -3.86 | supramolecular fiber organization | biological process | GO:0097435 | 593 | 5 | 18204 | 49 |
MYO1F,ARAP1,TMSB4X,PREX1,DNM2 |
2.129e-02 | -3.85 | PDGFR-beta signaling pathway | Pathway Interaction DB | pdgfrbpathway | 54 | 3 | 2226 | 25 |
GAB1,DNM2,HCK |
2.134e-02 | -3.85 | regulation of aldosterone biosynthetic process | biological process | GO:0032347 | 8 | 1 | 18204 | 49 |
DAB2 |
2.134e-02 | -3.85 | negative regulation of erythrocyte differentiation | biological process | GO:0045647 | 8 | 1 | 18204 | 49 |
ZFP36L1 |
2.134e-02 | -3.85 | dorsal aorta morphogenesis | biological process | GO:0035912 | 8 | 1 | 18204 | 49 |
RBPJ |
2.134e-02 | -3.85 | regulation of platelet-derived growth factor receptor-beta signaling pathway | biological process | GO:2000586 | 8 | 1 | 18204 | 49 |
PTPN12 |
2.134e-02 | -3.85 | dichotomous subdivision of an epithelial terminal unit | biological process | GO:0060600 | 8 | 1 | 18204 | 49 |
PLXND1 |
2.134e-02 | -3.85 | regulation of NADP metabolic process | biological process | GO:1902031 | 8 | 1 | 18204 | 49 |
ME1 |
2.134e-02 | -3.85 | regulation of aldosterone metabolic process | biological process | GO:0032344 | 8 | 1 | 18204 | 49 |
DAB2 |
2.134e-02 | -3.85 | positive regulation of unsaturated fatty acid biosynthetic process | biological process | GO:2001280 | 8 | 1 | 18204 | 49 |
CD74 |
2.134e-02 | -3.85 | regulation of cellular pH reduction | biological process | GO:0032847 | 8 | 1 | 18204 | 49 |
SLC9A7 |
2.134e-02 | -3.85 | endothelial cell fate commitment | biological process | GO:0060839 | 8 | 1 | 18204 | 49 |
RBPJ |
2.134e-02 | -3.85 | negative regulation of low-density lipoprotein receptor activity | biological process | GO:1905598 | 8 | 1 | 18204 | 49 |
ITGAV |
2.134e-02 | -3.85 | positive regulation of ligase activity | biological process | GO:0051351 | 8 | 1 | 18204 | 49 |
TMSB4X |
2.134e-02 | -3.85 | positive regulation of non-motile cilium assembly | biological process | GO:1902857 | 8 | 1 | 18204 | 49 |
SEPTIN9 |
2.134e-02 | -3.85 | regulation of keratinocyte apoptotic process | biological process | GO:1902172 | 8 | 1 | 18204 | 49 |
ZFP36L1 |
2.134e-02 | -3.85 | T cell extravasation | biological process | GO:0072683 | 8 | 1 | 18204 | 49 |
ITGAL |
2.134e-02 | -3.85 | G protein-coupled receptor signaling pathway involved in heart process | biological process | GO:0086103 | 8 | 1 | 18204 | 49 |
AKAP13 |
2.134e-02 | -3.85 | Immune System | REACTOME pathways | R-HSA-168256 | 2101 | 13 | 10285 | 36 |
ARHGAP45,GAB1,PTPN6,ITGAL,DOCK2,CD68,TLN1,ITGAV,DNM2,ITGB2,FYB1,CD74,HCK |
2.140e-02 | -3.84 | Integrin_beta_N | interpro domains | IPR033760 | 8 | 1 | 18521 | 50 |
ITGB2 |
2.140e-02 | -3.84 | Prostanoid_rcpt | interpro domains | IPR008365 | 8 | 1 | 18521 | 50 |
PTGIR |
2.140e-02 | -3.84 | Integrin_bsu_VWA | interpro domains | IPR002369 | 8 | 1 | 18521 | 50 |
ITGB2 |
2.140e-02 | -3.84 | TIG1_plexin | interpro domains | IPR041019 | 8 | 1 | 18521 | 50 |
PLXND1 |
2.140e-02 | -3.84 | Myosin_TH1 | interpro domains | IPR010926 | 8 | 1 | 18521 | 50 |
MYO1F |
2.140e-02 | -3.84 | PH-BEACH_dom | interpro domains | IPR023362 | 8 | 1 | 18521 | 50 |
WDFY3 |
2.146e-02 | -3.84 | CD4 receptor binding | molecular function | GO:0042609 | 8 | 1 | 18094 | 49 |
CD74 |
2.146e-02 | -3.84 | malate dehydrogenase activity | molecular function | GO:0016615 | 8 | 1 | 18094 | 49 |
ME1 |
2.146e-02 | -3.84 | phosphorylation-dependent protein binding | molecular function | GO:0140031 | 8 | 1 | 18094 | 49 |
PTPN6 |
2.151e-02 | -3.84 | NBPF19 (NBPF member 19) | protein interactions | 101060226 | 231 | 3 | 19454 | 50 |
DOCK2,ITGB2,HCK |
2.153e-02 | -3.84 | PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) | protein interactions | 5291 | 88 | 2 | 19454 | 50 |
HCK,SEPTIN9 |
2.157e-02 | -3.84 | YTHDC1 (YTH N6-methyladenosine RNA binding protein C1) | protein interactions | 91746 | 414 | 4 | 19454 | 50 |
AKAP13,FYB1,RBM47,SPI1 |
2.159e-02 | -3.84 | CSK (C-terminal Src kinase) | protein interactions | 1445 | 854 | 6 | 19454 | 50 |
GAB1,DISC1,MCOLN2,DAB2,PTPN12,HCK |
2.174e-02 | -3.83 | EGFR (epidermal growth factor receptor) | protein interactions | 1956 | 3105 | 14 | 19454 | 50 |
ITGAV,GAB1,FKBP5,ARHGEF18,HCK,ITGB2,PTPN6,TLN1,PTPN12,DAB2,SH2B3,SEPTIN9,DNM2,EHD4 |
2.182e-02 | -3.82 | Myosin_TH1 | pfam domains | PF06017 | 8 | 1 | 17795 | 49 |
MYO1F |
2.182e-02 | -3.82 | PSI_integrin | pfam domains | PF17205 | 8 | 1 | 17795 | 49 |
ITGB2 |
2.182e-02 | -3.82 | Integrin_beta | pfam domains | PF00362 | 8 | 1 | 17795 | 49 |
ITGB2 |
2.182e-02 | -3.82 | TIG_plexin | pfam domains | PF17960 | 8 | 1 | 17795 | 49 |
PLXND1 |
2.199e-02 | -3.82 | SLC25A41 (solute carrier family 25 member 41) | protein interactions | 284427 | 89 | 2 | 19454 | 50 |
DAB2,BMP2K |
2.199e-02 | -3.82 | GPX4 (glutathione peroxidase 4) | protein interactions | 2879 | 89 | 2 | 19454 | 50 |
PTPN12,ME1 |
2.212e-02 | -3.81 | RHOJ (ras homolog family member J) | protein interactions | 57381 | 628 | 5 | 19454 | 50 |
EHD4,ITM2B,DOCK8,ITGAV,GAB1 |
2.224e-02 | -3.81 | EIF3L (eukaryotic translation initiation factor 3 subunit L) | protein interactions | 51386 | 234 | 3 | 19454 | 50 |
ARHGAP24,CD74,DNM2 |
2.224e-02 | -3.81 | JAK1 (Janus kinase 1) | protein interactions | 3716 | 234 | 3 | 19454 | 50 |
GAB1,DISC1,PTPN6 |
2.241e-02 | -3.80 | large_intestine-colon | COSMIC cancer mutations | large_intestine-colon | 1291 | 8 | 16828 | 46 |
ARHGAP24,PREX1,TLN1,PTPN6,HEPHL1,DOCK2,STAB1,ITGAL |
2.244e-02 | -3.80 | BTG_2 | prosite domains | PS01203 | 6 | 1 | 12186 | 46 |
BTG1 |
2.244e-02 | -3.80 | G_DYNAMIN_1 | prosite domains | PS00410 | 6 | 1 | 12186 | 46 |
DNM2 |
2.244e-02 | -3.80 | GED | prosite domains | PS51388 | 6 | 1 | 12186 | 46 |
DNM2 |
2.244e-02 | -3.80 | BTG_1 | prosite domains | PS00960 | 6 | 1 | 12186 | 46 |
BTG1 |
2.247e-02 | -3.80 | positive regulation of lipid transport | biological process | GO:0032370 | 86 | 2 | 18204 | 49 |
DAB2,RXRA |
2.251e-02 | -3.79 | trunk | COSMIC cancer mutations | trunk | 3554 | 16 | 16828 | 46 |
ITGB2,ITGAL,TLN1,PTPN12,TFEB,HCK,STAB1,RBM47,DISC1,DOCK8,MYO1F,DOCK2,WDFY3,HEPHL1,DAB2,FKBP5 |
2.255e-02 | -3.79 | regulation of growth | biological process | GO:0040008 | 603 | 5 | 18204 | 49 |
RBPJ,BTG1,DISC1,DNM2,DAB2 |
2.255e-02 | -3.79 | regulation of cell growth | biological process | GO:0001558 | 401 | 4 | 18204 | 49 |
DISC1,DNM2,DAB2,BTG1 |
2.260e-02 | -3.79 | Tyr_Pase_dom | interpro domains | IPR000387 | 86 | 2 | 18521 | 50 |
PTPN12,PTPN6 |
2.272e-02 | -3.78 | human chr4q21.23 | chromosome location | human chr4q21.23 | 12 | 1 | 26134 | 50 |
WDFY3 |
2.274e-02 | -3.78 | CTSL (cathepsin L) | protein interactions | 1514 | 236 | 3 | 19454 | 50 |
RXRA,CD74,ITM2B |
2.275e-02 | -3.78 | ANTIPRLFBTG1 | prints domains | PR00310 | 6 | 1 | 5227 | 20 |
BTG1 |
2.285e-02 | -3.78 | unconventional myosin complex | cellular component | GO:0016461 | 9 | 1 | 19108 | 49 |
MYO1F |
2.290e-02 | -3.78 | NIM1K (NIM1 serine/threonine protein kinase) | protein interactions | 167359 | 9 | 1 | 19454 | 50 |
SEPTIN9 |
2.290e-02 | -3.78 | SEMA3A (semaphorin 3A) | protein interactions | 10371 | 9 | 1 | 19454 | 50 |
DISC1 |
2.290e-02 | -3.78 | ZNF766 (zinc finger protein 766) | protein interactions | 90321 | 9 | 1 | 19454 | 50 |
ARHGAP24 |
2.290e-02 | -3.78 | KLRA1P (killer cell lectin like receptor A1, pseudogene) | protein interactions | 10748 | 9 | 1 | 19454 | 50 |
PTPN6 |
2.290e-02 | -3.78 | KLB (klotho beta) | protein interactions | 152831 | 9 | 1 | 19454 | 50 |
ARHGAP24 |
2.290e-02 | -3.78 | CLEC4F (C-type lectin domain family 4 member F) | protein interactions | 165530 | 9 | 1 | 19454 | 50 |
ITGAV |
2.290e-02 | -3.78 | PPFIA4 (PTPRF interacting protein alpha 4) | protein interactions | 8497 | 9 | 1 | 19454 | 50 |
DISC1 |
2.290e-02 | -3.78 | PCNX4 (pecanex 4) | protein interactions | 64430 | 9 | 1 | 19454 | 50 |
DISC1 |
2.290e-02 | -3.78 | HLA-DMA (major histocompatibility complex, class II, DM alpha) | protein interactions | 3108 | 9 | 1 | 19454 | 50 |
CD74 |
2.290e-02 | -3.78 | RBM46 (RNA binding motif protein 46) | protein interactions | 166863 | 9 | 1 | 19454 | 50 |
RBM47 |
2.290e-02 | -3.78 | LILRB2 (leukocyte immunoglobulin like receptor B2) | protein interactions | 10288 | 9 | 1 | 19454 | 50 |
PTPN6 |
2.292e-02 | -3.78 | TMEM179B (transmembrane protein 179B) | protein interactions | 374395 | 91 | 2 | 19454 | 50 |
PTGIR,CD68 |
2.292e-02 | -3.78 | TRMT6 (tRNA methyltransferase 6 non-catalytic subunit) | protein interactions | 51605 | 91 | 2 | 19454 | 50 |
FKBP5,SEPTIN9 |
2.292e-02 | -3.78 | TRIO (trio Rho guanine nucleotide exchange factor) | protein interactions | 7204 | 91 | 2 | 19454 | 50 |
DISC1,DAB2 |
2.292e-02 | -3.78 | AMIGO1 (adhesion molecule with Ig like domain 1) | protein interactions | 57463 | 91 | 2 | 19454 | 50 |
DNM2,ITM2B |
2.308e-02 | -3.77 | LAMP1 (lysosomal associated membrane protein 1) | protein interactions | 3916 | 635 | 5 | 19454 | 50 |
ARHGAP24,DISC1,ITGAV,ITM2B,EHD4 |
2.320e-02 | -3.76 | Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin | SMPDB pathways | SMP0000354 | 8 | 1 | 1369 | 4 |
PTGIR |
2.320e-02 | -3.76 | Transfer of Acetyl Groups into Mitochondria | SMPDB pathways | SMP0000466 | 8 | 1 | 1369 | 4 |
ME1 |
2.324e-02 | -3.76 | MBNL1 (muscleblind like splicing regulator 1) | protein interactions | 4154 | 238 | 3 | 19454 | 50 |
DNM2,RBM47,HEPHL1 |
2.335e-02 | -3.76 | prostate-carcinoma-adenocarcinoma | COSMIC cancer mutations | prostate-carcinoma-adenocarcinoma | 12379 | 40 | 16828 | 46 |
ITM2B,ITGB2,RXRA,DNM2,TFEB,STAB1,ITGAV,PREX1,PTGIR,TLN1,SLC9A7,MYO1F,DOCK2,ZFP36L1,ARAP1,ANTXR2,RBM47,PTPN6,DISC1,ARHGEF18,FKBP5,EHD4,AKAP13,ARHGAP24,DAB2,SPI1,ITGAL,SH2B3,RGL1,ME1,MCOLN2,PTPN12,GAB1,CCND2,WDFY3,DOCK8,PLXND1,BMP2K,ELF4,HEPHL1 |
2.339e-02 | -3.76 | KDM5B (lysine demethylase 5B) | protein interactions | 10765 | 92 | 2 | 19454 | 50 |
BMP2K,ELF4 |
2.341e-02 | -3.75 | immune response-activating cell surface receptor signaling pathway | biological process | GO:0002429 | 228 | 3 | 18204 | 49 |
PTPN6,FYB1,HCK |
2.348e-02 | -3.75 | RANBP9 (RAN binding protein 9) | protein interactions | 10048 | 425 | 4 | 19454 | 50 |
DISC1,ITGAL,ARHGAP24,ITGB2 |
2.348e-02 | -3.75 | Semaphorin interactions | REACTOME pathways | R-HSA-373755 | 68 | 2 | 10285 | 36 |
PLXND1,TLN1 |
2.350e-02 | -3.75 | TBP (TATA-box binding protein) | protein interactions | 6908 | 239 | 3 | 19454 | 50 |
SPI1,RBPJ,RXRA |
2.353e-02 | -3.75 | ZF_DAG_PE_2 | prosite domains | PS50081 | 63 | 2 | 12186 | 46 |
ARHGAP45,AKAP13 |
2.368e-02 | -3.74 | regulation of plasma membrane bounded cell projection assembly | biological process | GO:0120032 | 229 | 3 | 18204 | 49 |
SEPTIN9,ARHGAP24,ARAP1 |
2.370e-02 | -3.74 | pancreas-carcinoid-endocrine_tumour | COSMIC cancer mutations | pancreas-carcinoid-endocrine_tumour | 7250 | 27 | 16828 | 46 |
MYO1F,DOCK2,ZFP36L1,ANTXR2,FKBP5,AKAP13,EHD4,BTG1,ITM2B,RXRA,DNM2,STAB1,PTGIR,PREX1,SLC9A7,TLN1,WDFY3,PLXND1,ELF4,HEPHL1,ITGAL,RGL1,SH2B3,ME1,PTPN12,MCOLN2,GAB1 |
2.387e-02 | -3.74 | LRRC8E (leucine rich repeat containing 8 VRAC subunit E) | protein interactions | 80131 | 93 | 2 | 19454 | 50 |
PTGIR,ARHGAP24 |
2.387e-02 | -3.74 | TEX11 (testis expressed 11) | protein interactions | 56159 | 93 | 2 | 19454 | 50 |
CCND2,CD74 |
2.387e-02 | -3.74 | UTP25 (UTP25 small subunit processome component) | protein interactions | 27042 | 93 | 2 | 19454 | 50 |
BMP2K,PREX1 |
2.395e-02 | -3.73 | positive regulation of lipid biosynthetic process | biological process | GO:0046889 | 89 | 2 | 18204 | 49 |
DAB2,CD74 |
2.395e-02 | -3.73 | regulation of leukocyte apoptotic process | biological process | GO:2000106 | 89 | 2 | 18204 | 49 |
CD74,DOCK8 |
2.397e-02 | -3.73 | antibacterial innate immune response | biological process | GO:0140367 | 9 | 1 | 18204 | 49 |
TFEB |
2.397e-02 | -3.73 | regulation of mRNA 3'-end processing | biological process | GO:0031440 | 9 | 1 | 18204 | 49 |
ZFP36L1 |
2.397e-02 | -3.73 | respiratory burst involved in defense response | biological process | GO:0002679 | 9 | 1 | 18204 | 49 |
HCK |
2.397e-02 | -3.73 | peroxisome proliferator activated receptor signaling pathway | biological process | GO:0035357 | 9 | 1 | 18204 | 49 |
RXRA |
2.397e-02 | -3.73 | positive regulation of antigen processing and presentation | biological process | GO:0002579 | 9 | 1 | 18204 | 49 |
CD74 |
2.397e-02 | -3.73 | establishment of T cell polarity | biological process | GO:0001768 | 9 | 1 | 18204 | 49 |
DOCK2 |
2.397e-02 | -3.73 | negative regulation of inflammatory response to wounding | biological process | GO:0106015 | 9 | 1 | 18204 | 49 |
PTPN6 |
2.397e-02 | -3.73 | regulation of ligase activity | biological process | GO:0051340 | 9 | 1 | 18204 | 49 |
TMSB4X |
2.397e-02 | -3.73 | mesendoderm development | biological process | GO:0048382 | 9 | 1 | 18204 | 49 |
ZFP36L1 |
2.397e-02 | -3.73 | positive regulation of hormone biosynthetic process | biological process | GO:0046886 | 9 | 1 | 18204 | 49 |
DAB2 |
2.397e-02 | -3.73 | negative regulation of chemokine-mediated signaling pathway | biological process | GO:0070100 | 9 | 1 | 18204 | 49 |
SH2B3 |
2.397e-02 | -3.73 | regulation of protein localization to chromatin | biological process | GO:1905634 | 9 | 1 | 18204 | 49 |
SPI1 |
2.397e-02 | -3.73 | malate metabolic process | biological process | GO:0006108 | 9 | 1 | 18204 | 49 |
ME1 |
2.397e-02 | -3.73 | positive regulation of early endosome to late endosome transport | biological process | GO:2000643 | 9 | 1 | 18204 | 49 |
DAB2 |
2.397e-02 | -3.73 | regulation of sarcomere organization | biological process | GO:0060297 | 9 | 1 | 18204 | 49 |
AKAP13 |
2.397e-02 | -3.73 | negative regulation of antigen processing and presentation | biological process | GO:0002578 | 9 | 1 | 18204 | 49 |
CD68 |
2.397e-02 | -3.73 | positive regulation of Wnt signaling pathway, planar cell polarity pathway | biological process | GO:2000096 | 9 | 1 | 18204 | 49 |
DAB2 |
2.404e-02 | -3.73 | BRICHOS_dom | interpro domains | IPR007084 | 9 | 1 | 18521 | 50 |
ITM2B |
2.404e-02 | -3.73 | BEACH_dom_sf | interpro domains | IPR036372 | 9 | 1 | 18521 | 50 |
WDFY3 |
2.404e-02 | -3.73 | Aminoacid_DH-like_N_sf | interpro domains | IPR046346 | 9 | 1 | 18521 | 50 |
ME1 |
2.404e-02 | -3.73 | BEACH_dom | interpro domains | IPR000409 | 9 | 1 | 18521 | 50 |
WDFY3 |
2.404e-02 | -3.73 | Integrin_bsu | interpro domains | IPR015812 | 9 | 1 | 18521 | 50 |
ITGB2 |
2.404e-02 | -3.73 | Plexin_RBD | interpro domains | IPR046800 | 9 | 1 | 18521 | 50 |
PLXND1 |
2.404e-02 | -3.73 | NaH_exchanger | interpro domains | IPR004709 | 9 | 1 | 18521 | 50 |
SLC9A7 |
2.404e-02 | -3.73 | Plexin_cytoplasmic_RasGAP_dom | interpro domains | IPR013548 | 9 | 1 | 18521 | 50 |
PLXND1 |
2.412e-02 | -3.72 | angiotensin receptor binding | molecular function | GO:0031701 | 9 | 1 | 18094 | 49 |
ARAP1 |
2.422e-02 | -3.72 | regulation of cell projection assembly | biological process | GO:0060491 | 231 | 3 | 18204 | 49 |
ARHGAP24,ARAP1,SEPTIN9 |
2.425e-02 | -3.72 | Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | REACTOME pathways | R-HSA-210744 | 7 | 1 | 10285 | 36 |
RBPJ |
2.435e-02 | -3.72 | KANSL1 (KAT8 regulatory NSL complex subunit 1) | protein interactions | 284058 | 94 | 2 | 19454 | 50 |
ELF4,DISC1 |
2.436e-02 | -3.71 | regulation of cell development | biological process | GO:0060284 | 839 | 6 | 18204 | 49 |
PTPN6,SPI1,CD74,ZFP36L1,DISC1,PLXND1 |
2.446e-02 | -3.71 | regulation of Rho protein signal transduction | biological process | GO:0035023 | 90 | 2 | 18204 | 49 |
ARHGEF18,AKAP13 |
2.446e-02 | -3.71 | regulation of purine nucleotide metabolic process | biological process | GO:1900542 | 90 | 2 | 18204 | 49 |
TMSB4X,ME1 |
2.452e-02 | -3.71 | Plexin_cytopl | pfam domains | PF08337 | 9 | 1 | 17795 | 49 |
PLXND1 |
2.452e-02 | -3.71 | Beach | pfam domains | PF02138 | 9 | 1 | 17795 | 49 |
WDFY3 |
2.452e-02 | -3.71 | BRICHOS | pfam domains | PF04089 | 9 | 1 | 17795 | 49 |
ITM2B |
2.452e-02 | -3.71 | Plexin_RBD | pfam domains | PF20170 | 9 | 1 | 17795 | 49 |
PLXND1 |
2.470e-02 | -3.70 | WH-like_DNA-bd_sf | interpro domains | IPR036388 | 232 | 3 | 18521 | 50 |
ELF4,PREX1,SPI1 |
2.475e-02 | -3.70 | KRT40 (keratin 40) | protein interactions | 125115 | 432 | 4 | 19454 | 50 |
HCK,DOCK2,DOCK8,TMSB4X |
2.480e-02 | -3.70 | Staphylococcus aureus infection | KEGG pathways | hsa05150 | 55 | 2 | 7161 | 32 |
ITGAL,ITGB2 |
2.480e-02 | -3.70 | Staphylococcus aureus infection | KEGG pathways | ko05150 | 55 | 2 | 7161 | 32 |
ITGAL,ITGB2 |
2.483e-02 | -3.70 | PSTPIP1 (proline-serine-threonine phosphatase interacting protein 1) | protein interactions | 9051 | 95 | 2 | 19454 | 50 |
DNM2,PTPN12 |
2.487e-02 | -3.69 | regulation of defense response | biological process | GO:0031347 | 843 | 6 | 18204 | 49 |
ELF4,HCK,TMSB4X,SPI1,PTPN6,RBM47 |
2.495e-02 | -3.69 | axon | cellular component | GO:0030424 | 650 | 5 | 19108 | 49 |
WDFY3,PREX1,PLXND1,DNM2,DISC1 |
2.496e-02 | -3.69 | regulation of nucleotide metabolic process | biological process | GO:0006140 | 91 | 2 | 18204 | 49 |
TMSB4X,ME1 |
2.505e-02 | -3.69 | PAICS (phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase) | protein interactions | 10606 | 245 | 3 | 19454 | 50 |
PTPN12,FKBP5,DOCK8 |
2.506e-02 | -3.69 | GED | smart domains | SM00302 | 6 | 1 | 9717 | 41 |
DNM2 |
2.506e-02 | -3.69 | Integrin_b_cyt | smart domains | SM01241 | 6 | 1 | 9717 | 41 |
ITGB2 |
2.506e-02 | -3.69 | btg1 | smart domains | SM00099 | 6 | 1 | 9717 | 41 |
BTG1 |
2.529e-02 | -3.68 | TRIM67 (tripartite motif containing 67) | protein interactions | 440730 | 4804 | 19 | 19454 | 50 |
PTPN12,DISC1,AKAP13,DNM2,ARAP1,EHD4,PREX1,SEPTIN9,FKBP5,RBPJ,ARHGEF18,BMP2K,ANTXR2,ITGAV,ME1,WDFY3,CCND2,TLN1,TMSB4X |
2.534e-02 | -3.68 | Cell adhesion molecules (CAMs) | KEGG pathways | ko04514 | 143 | 3 | 7161 | 32 |
ITGB2,ITGAV,ITGAL |
2.534e-02 | -3.68 | Cell adhesion molecules (CAMs) | KEGG pathways | hsa04514 | 143 | 3 | 7161 | 32 |
ITGAL,ITGB2,ITGAV |
2.537e-02 | -3.67 | HNRNPL (heterogeneous nuclear ribonucleoprotein L) | protein interactions | 3191 | 1958 | 10 | 19454 | 50 |
DAB2,FKBP5,SLC9A7,ARHGEF18,RBM47,ARHGAP24,AKAP13,ARAP1,SEPTIN9,RXRA |
2.541e-02 | -3.67 | ANGPTL3 (angiopoietin like 3) | protein interactions | 27329 | 10 | 1 | 19454 | 50 |
ITGAV |
2.541e-02 | -3.67 | CDKL4 (cyclin dependent kinase like 4) | protein interactions | 344387 | 10 | 1 | 19454 | 50 |
FKBP5 |
2.541e-02 | -3.67 | OR51E2 (olfactory receptor family 51 subfamily E member 2) | protein interactions | 81285 | 10 | 1 | 19454 | 50 |
HEPHL1 |
2.541e-02 | -3.67 | SIGLEC10 (sialic acid binding Ig like lectin 10) | protein interactions | 89790 | 10 | 1 | 19454 | 50 |
PTPN6 |
2.541e-02 | -3.67 | PRTG (protogenin) | protein interactions | 283659 | 10 | 1 | 19454 | 50 |
DISC1 |
2.541e-02 | -3.67 | PGA4 (pepsinogen A4) | protein interactions | 643847 | 10 | 1 | 19454 | 50 |
CD74 |
2.541e-02 | -3.67 | P2rx7 (purinergic receptor P2X 7) | protein interactions | 29665 | 10 | 1 | 19454 | 50 |
ITGB2 |
2.541e-02 | -3.67 | SIGLEC7 (sialic acid binding Ig like lectin 7) | protein interactions | 27036 | 10 | 1 | 19454 | 50 |
PTPN6 |
2.541e-02 | -3.67 | ZNF852 (zinc finger protein 852) | protein interactions | 285346 | 10 | 1 | 19454 | 50 |
ARHGAP24 |
2.541e-02 | -3.67 | HEPN1 (hepatocellular carcinoma, down-regulated 1) | protein interactions | 641654 | 10 | 1 | 19454 | 50 |
HEPHL1 |
2.541e-02 | -3.67 | METTL26 (methyltransferase like 26) | protein interactions | 84326 | 10 | 1 | 19454 | 50 |
DISC1 |
2.541e-02 | -3.67 | DMTF1 (cyclin D binding myb like transcription factor 1) | protein interactions | 9988 | 10 | 1 | 19454 | 50 |
CCND2 |
2.541e-02 | -3.67 | FCER2 (Fc epsilon receptor II) | protein interactions | 2208 | 10 | 1 | 19454 | 50 |
ITGB2 |
2.541e-02 | -3.67 | NRAP (nebulin related anchoring protein) | protein interactions | 4892 | 10 | 1 | 19454 | 50 |
TLN1 |
2.541e-02 | -3.67 | CDH4 (cadherin 4) | protein interactions | 1002 | 10 | 1 | 19454 | 50 |
RBPJ |
2.541e-02 | -3.67 | ZNF589 (zinc finger protein 589) | protein interactions | 51385 | 10 | 1 | 19454 | 50 |
RBPJ |
2.541e-02 | -3.67 | ZNF606 (zinc finger protein 606) | protein interactions | 80095 | 10 | 1 | 19454 | 50 |
ARHGAP24 |
2.541e-02 | -3.67 | KCNN3 (potassium calcium-activated channel subfamily N member 3) | protein interactions | 3782 | 10 | 1 | 19454 | 50 |
DNM2 |
2.541e-02 | -3.67 | SPAG11A (sperm associated antigen 11A) | protein interactions | 653423 | 10 | 1 | 19454 | 50 |
ITGAV |
2.547e-02 | -3.67 | ATG16L1 (autophagy related 16 like 1) | protein interactions | 55054 | 1138 | 7 | 19454 | 50 |
TFEB,DOCK2,AKAP13,TLN1,WDFY3,DNM2,ARHGAP45 |
2.548e-02 | -3.67 | positive regulation of transporter activity | biological process | GO:0032411 | 92 | 2 | 18204 | 49 |
TMSB4X,RXRA |
2.548e-02 | -3.67 | response to chemokine | biological process | GO:1990868 | 92 | 2 | 18204 | 49 |
SH2B3,DOCK8 |
2.548e-02 | -3.67 | cellular response to chemokine | biological process | GO:1990869 | 92 | 2 | 18204 | 49 |
DOCK8,SH2B3 |
2.573e-02 | -3.66 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | 3608 | 16 | 16828 | 46 |
HEPHL1,BTG1,AKAP13,CD74,PLXND1,ZFP36L1,DOCK2,WDFY3,CCND2,PTPN12,HCK,MCOLN2,GAB1,ITGAV,ME1,ITM2B |
2.581e-02 | -3.66 | CPNE2 (copine 2) | protein interactions | 221184 | 97 | 2 | 19454 | 50 |
SEPTIN9,RBM47 |
2.581e-02 | -3.66 | Tpm1 (tropomyosin 1, alpha) | protein interactions | 22003 | 97 | 2 | 19454 | 50 |
DAB2,BMP2K |
2.585e-02 | -3.66 | SYK (spleen associated tyrosine kinase) | protein interactions | 6850 | 248 | 3 | 19454 | 50 |
PTPN6,ITGB2,GAB1 |
2.599e-02 | -3.65 | regulation of stress fiber assembly | biological process | GO:0051492 | 93 | 2 | 18204 | 49 |
ARHGEF18,ARAP1 |
2.599e-02 | -3.65 | regulation of extent of cell growth | biological process | GO:0061387 | 93 | 2 | 18204 | 49 |
DNM2,DISC1 |
2.605e-02 | -3.65 | GBF1 (golgi brefeldin A resistant guanine nucleotide exchange factor 1) | protein interactions | 8729 | 439 | 4 | 19454 | 50 |
SEPTIN9,DAB2,PTPN6,TLN1 |
2.625e-02 | -3.64 | cell surface | cellular component | GO:0009986 | 896 | 6 | 19108 | 49 |
ITGAL,ANTXR2,ITGB2,CD74,ITGAV,TLN1 |
2.628e-02 | -3.64 | phosphoprotein binding | molecular function | GO:0051219 | 93 | 2 | 18094 | 49 |
HCK,PTPN6 |
2.630e-02 | -3.64 | stomach | COSMIC cancer mutations | stomach | 15550 | 46 | 16828 | 46 |
GAB1,PTPN12,MCOLN2,CCND2,RGL1,SH2B3,BMP2K,CD68,ELF4,DOCK8,WDFY3,PLXND1,ITGAV,HCK,PTGIR,TLN1,SLC9A7,ITGB2,RXRA,RBPJ,EHD4,BTG1,ZFP36L1,RBM47,ANTXR2,PTPN6,SPI1,ITGAL,ME1,HEPHL1,TMSB4X,STAB1,TFEB,PREX1,ITM2B,DNM2,ARHGEF18,FKBP5,CD74,AKAP13,ARHGAP24,DAB2,ARAP1,DOCK2,MYO1F,DISC1 |
2.631e-02 | -3.64 | PRPSAP2 (phosphoribosyl pyrophosphate synthetase associated protein 2) | protein interactions | 5636 | 98 | 2 | 19454 | 50 |
PTPN12,HCK |
2.639e-02 | -3.63 | VWFA | prosite domains | PS50234 | 67 | 2 | 12186 | 46 |
ANTXR2,ITGAL |
2.644e-02 | -3.63 | RHOQ (ras homolog family member Q) | protein interactions | 23433 | 441 | 4 | 19454 | 50 |
DOCK8,ITM2B,GAB1,ITGAV |
2.649e-02 | -3.63 | DYNAMIN | prints domains | PR00195 | 7 | 1 | 5227 | 20 |
DNM2 |
2.660e-02 | -3.63 | positive regulation of fibroblast apoptotic process | biological process | GO:2000271 | 10 | 1 | 18204 | 49 |
BTG1 |
2.660e-02 | -3.63 | integrin activation | biological process | GO:0033622 | 10 | 1 | 18204 | 49 |
TLN1 |
2.660e-02 | -3.63 | positive regulation of ATP biosynthetic process | biological process | GO:2001171 | 10 | 1 | 18204 | 49 |
TMSB4X |
2.660e-02 | -3.63 | dorsal aorta development | biological process | GO:0035907 | 10 | 1 | 18204 | 49 |
RBPJ |
2.660e-02 | -3.63 | establishment of lymphocyte polarity | biological process | GO:0001767 | 10 | 1 | 18204 | 49 |
DOCK2 |
2.660e-02 | -3.63 | cellular response to X-ray | biological process | GO:0071481 | 10 | 1 | 18204 | 49 |
CCND2 |
2.660e-02 | -3.63 | negative regulation of mast cell activation | biological process | GO:0033004 | 10 | 1 | 18204 | 49 |
PTPN6 |
2.660e-02 | -3.63 | cellular response to salt stress | biological process | GO:0071472 | 10 | 1 | 18204 | 49 |
ZFP36L1 |
2.660e-02 | -3.63 | sequestering of actin monomers | biological process | GO:0042989 | 10 | 1 | 18204 | 49 |
TMSB4X |
2.660e-02 | -3.63 | regulation of vitamin D receptor signaling pathway | biological process | GO:0070562 | 10 | 1 | 18204 | 49 |
RXRA |
2.660e-02 | -3.63 | sebaceous gland development | biological process | GO:0048733 | 10 | 1 | 18204 | 49 |
RBPJ |
2.660e-02 | -3.63 | transferrin transport | biological process | GO:0033572 | 10 | 1 | 18204 | 49 |
DNM2 |
2.660e-02 | -3.63 | synaptic vesicle budding from presynaptic endocytic zone membrane | biological process | GO:0016185 | 10 | 1 | 18204 | 49 |
DNM2 |
2.660e-02 | -3.63 | endothelial cell chemotaxis | biological process | GO:0035767 | 10 | 1 | 18204 | 49 |
GAB1 |
2.660e-02 | -3.63 | aggrephagy | biological process | GO:0035973 | 10 | 1 | 18204 | 49 |
WDFY3 |
2.662e-02 | -3.63 | metal ion transport | biological process | GO:0030001 | 630 | 5 | 18204 | 49 |
MCOLN2,DNM2,HEPHL1,SLC9A7,ITGAV |
2.668e-02 | -3.62 | Plexin | interpro domains | IPR031148 | 10 | 1 | 18521 | 50 |
PLXND1 |
2.668e-02 | -3.62 | Cyclins_cyclin-box | interpro domains | IPR048258 | 10 | 1 | 18521 | 50 |
CCND2 |
2.669e-02 | -3.62 | microvillus | cellular component | GO:0005902 | 99 | 2 | 19108 | 49 |
ITGAV,MYO1F |
2.676e-02 | -3.62 | prostaglandin receptor activity | molecular function | GO:0004955 | 10 | 1 | 18094 | 49 |
PTGIR |
2.676e-02 | -3.62 | AP-2 adaptor complex binding | molecular function | GO:0035612 | 10 | 1 | 18094 | 49 |
BMP2K |
2.676e-02 | -3.62 | FK506 binding | molecular function | GO:0005528 | 10 | 1 | 18094 | 49 |
FKBP5 |
2.680e-02 | -3.62 | Flnb (filamin, beta) | protein interactions | 286940 | 99 | 2 | 19454 | 50 |
DAB2,BMP2K |
2.680e-02 | -3.62 | PRPSAP1 (phosphoribosyl pyrophosphate synthetase associated protein 1) | protein interactions | 5635 | 99 | 2 | 19454 | 50 |
HCK,PTPN12 |
2.680e-02 | -3.62 | LMTK2 (lemur tyrosine kinase 2) | protein interactions | 22853 | 99 | 2 | 19454 | 50 |
PTPN12,PTPN6 |
2.704e-02 | -3.61 | transition metal ion transport | biological process | GO:0000041 | 95 | 2 | 18204 | 49 |
HEPHL1,DNM2 |
2.715e-02 | -3.61 | haematopoietic_and_lymphoid_tissue | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue | 14368 | 44 | 16828 | 46 |
AKAP13,ARHGEF18,FKBP5,CD74,DAB2,ARHGAP24,ARAP1,DOCK2,MYO1F,TFEB,STAB1,PREX1,ITM2B,DNM2,HEPHL1,TMSB4X,ITGAL,SPI1,ME1,EHD4,BTG1,ZFP36L1,PTPN6,RBM47,ANTXR2,ITGAV,HCK,SLC9A7,TLN1,PTGIR,ITGB2,RXRA,CD68,BMP2K,ELF4,DOCK8,WDFY3,PLXND1,GAB1,PTPN12,MCOLN2,CCND2,SH2B3,RGL1 |
2.717e-02 | -3.61 | MYH9 (myosin heavy chain 9) | protein interactions | 4627 | 663 | 5 | 19454 | 50 |
PTPN6,DAB2,RXRA,ARHGAP24,BMP2K |
2.717e-02 | -3.61 | PTPc_motif | smart domains | SM00404 | 61 | 2 | 9717 | 41 |
PTPN6,PTPN12 |
2.718e-02 | -3.61 | regulation of hemopoiesis | biological process | GO:1903706 | 425 | 4 | 18204 | 49 |
ZFP36L1,SPI1,PTPN6,CD74 |
2.720e-02 | -3.60 | EF-hand_4 | pfam domains | PF12763 | 10 | 1 | 17795 | 49 |
EHD4 |
2.731e-02 | -3.60 | SKIC3 (SKI3 subunit of superkiller complex) | protein interactions | 9652 | 100 | 2 | 19454 | 50 |
FKBP5,TLN1 |
2.731e-02 | -3.60 | TTI1 (TELO2 interacting protein 1) | protein interactions | 9675 | 100 | 2 | 19454 | 50 |
CD68,FKBP5 |
2.731e-02 | -3.60 | LRCH3 (leucine rich repeats and calponin homology domain containing 3) | protein interactions | 84859 | 100 | 2 | 19454 | 50 |
DOCK8,SEPTIN9 |
2.731e-02 | -3.60 | SUFU (SUFU negative regulator of hedgehog signaling) | protein interactions | 51684 | 100 | 2 | 19454 | 50 |
DISC1,RBPJ |
2.731e-02 | -3.60 | ANXA6 (annexin A6) | protein interactions | 309 | 100 | 2 | 19454 | 50 |
DOCK8,ARHGAP24 |
2.737e-02 | -3.60 | response to lipid | biological process | GO:0033993 | 862 | 6 | 18204 | 49 |
HCK,CD68,PTGIR,ZFP36L1,DAB2,RXRA |
2.737e-02 | -3.60 | Viral myocarditis | KEGG pathways | hsa05416 | 58 | 2 | 7161 | 32 |
ITGAL,ITGB2 |
2.747e-02 | -3.59 | Endocytosis | KEGG pathways | hsa04144 | 260 | 4 | 7161 | 32 |
EHD4,ARAP1,DAB2,DNM2 |
2.747e-02 | -3.59 | Endocytosis | KEGG pathways | ko04144 | 260 | 4 | 7161 | 32 |
EHD4,ARAP1,DNM2,DAB2 |
2.748e-02 | -3.59 | STX17 (syntaxin 17) | protein interactions | 55014 | 254 | 3 | 19454 | 50 |
PTPN12,ME1,HEPHL1 |
2.752e-02 | -3.59 | plasma membrane bounded cell projection | cellular component | GO:0120025 | 2285 | 11 | 19108 | 49 |
PREX1,SEPTIN9,ARHGAP45,DOCK8,WDFY3,TLN1,ITGAV,MYO1F,PLXND1,DNM2,DISC1 |
2.756e-02 | -3.59 | negative regulation of response to wounding | biological process | GO:1903035 | 96 | 2 | 18204 | 49 |
SH2B3,PTPN6 |
2.756e-02 | -3.59 | regulation of stem cell proliferation | biological process | GO:0072091 | 96 | 2 | 18204 | 49 |
RBPJ,ZFP36L1 |
2.767e-02 | -3.59 | Cross-presentation of particulate exogenous antigens (phagosomes) | REACTOME pathways | R-HSA-1236973 | 8 | 1 | 10285 | 36 |
ITGAV |
2.779e-02 | -3.58 | PINK1 (PTEN induced kinase 1) | protein interactions | 65018 | 667 | 5 | 19454 | 50 |
SEPTIN9,HEPHL1,FKBP5,EHD4,TLN1 |
2.780e-02 | -3.58 | regulation of inflammatory response | biological process | GO:0050727 | 428 | 4 | 18204 | 49 |
PTPN6,ELF4,TMSB4X,HCK |
2.781e-02 | -3.58 | PRKCG (protein kinase C gamma) | protein interactions | 5582 | 101 | 2 | 19454 | 50 |
ITGB2,DAB2 |
2.781e-02 | -3.58 | KDELR2 (KDEL endoplasmic reticulum protein retention receptor 2) | protein interactions | 11014 | 101 | 2 | 19454 | 50 |
HEPHL1,CCND2 |
2.781e-02 | -3.58 | DYNC1I1 (dynein cytoplasmic 1 intermediate chain 1) | protein interactions | 1780 | 101 | 2 | 19454 | 50 |
DISC1,DNM2 |
2.792e-02 | -3.58 | LAT2 (linker for activation of T cells family member 2) | protein interactions | 7462 | 11 | 1 | 19454 | 50 |
GAB1 |
2.792e-02 | -3.58 | FMO1 (flavin containing dimethylaniline monoxygenase 1) | protein interactions | 2326 | 11 | 1 | 19454 | 50 |
TLN1 |
2.792e-02 | -3.58 | CCDC141 (coiled-coil domain containing 141) | protein interactions | 285025 | 11 | 1 | 19454 | 50 |
DISC1 |
2.792e-02 | -3.58 | Fcho2 (FCH domain only 2) | protein interactions | 218503 | 11 | 1 | 19454 | 50 |
DAB2 |
2.792e-02 | -3.58 | ZNF726 (zinc finger protein 726) | protein interactions | 730087 | 11 | 1 | 19454 | 50 |
ARHGAP24 |
2.792e-02 | -3.58 | NYAP1 (neuronal tyrosine phosphorylated phosphoinositide-3-kinase adaptor 1) | protein interactions | 222950 | 11 | 1 | 19454 | 50 |
TLN1 |
2.792e-02 | -3.58 | RGCC (regulator of cell cycle) | protein interactions | 28984 | 11 | 1 | 19454 | 50 |
TLN1 |
2.792e-02 | -3.58 | MS4A7 (membrane spanning 4-domains A7) | protein interactions | 58475 | 11 | 1 | 19454 | 50 |
ITGB2 |
2.813e-02 | -3.57 | anaplastic_carcinoma | COSMIC cancer mutations | anaplastic_carcinoma | 856 | 6 | 16828 | 46 |
DOCK2,DOCK8,PTGIR,ELF4,DAB2,HEPHL1 |
2.813e-02 | -3.57 | thyroid-carcinoma-anaplastic_carcinoma | COSMIC cancer mutations | thyroid-carcinoma-anaplastic_carcinoma | 856 | 6 | 16828 | 46 |
PTGIR,HEPHL1,DAB2,ELF4,DOCK2,DOCK8 |
2.819e-02 | -3.57 | KRT31 (keratin 31) | protein interactions | 3881 | 450 | 4 | 19454 | 50 |
TMSB4X,HCK,DOCK2,ITGB2 |
2.825e-02 | -3.57 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-mantle_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-mantle_cell_lymphoma | 2737 | 13 | 16828 | 46 |
GAB1,STAB1,MCOLN2,AKAP13,TFEB,ARHGEF18,PREX1,ARHGAP24,MYO1F,DOCK2,WDFY3,ME1,RGL1 |
2.832e-02 | -3.56 | human chr9p24.3 | chromosome location | human chr9p24.3 | 15 | 1 | 26134 | 50 |
DOCK8 |
2.832e-02 | -3.56 | human chr12q21.33 | chromosome location | human chr12q21.33 | 15 | 1 | 26134 | 50 |
BTG1 |
2.832e-02 | -3.56 | FASLG (Fas ligand) | protein interactions | 356 | 102 | 2 | 19454 | 50 |
HCK,FYB1 |
2.832e-02 | -3.56 | GRAP2 (GRB2 related adaptor protein 2) | protein interactions | 9402 | 102 | 2 | 19454 | 50 |
DNM2,GAB1 |
2.832e-02 | -3.56 | NFYA (nuclear transcription factor Y subunit alpha) | protein interactions | 4800 | 102 | 2 | 19454 | 50 |
ME1,SPI1 |
2.832e-02 | -3.56 | NTNG1 (netrin G1) | protein interactions | 22854 | 102 | 2 | 19454 | 50 |
TLN1,EHD4 |
2.842e-02 | -3.56 | RHOF (ras homolog family member F, filopodia associated) | protein interactions | 54509 | 671 | 5 | 19454 | 50 |
EHD4,DAB2,DOCK8,GAB1,ITGAV |
2.853e-02 | -3.56 | bone-femur-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-femur-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 633 | 5 | 16828 | 46 |
ELF4,HEPHL1,PREX1,STAB1,AKAP13 |
2.858e-02 | -3.56 | CDK9 (cyclin dependent kinase 9) | protein interactions | 1025 | 672 | 5 | 19454 | 50 |
SEPTIN9,FKBP5,DNM2,HCK,PTPN6 |
2.877e-02 | -3.55 | regulation of leukocyte mediated immunity | biological process | GO:0002703 | 247 | 3 | 18204 | 49 |
ITGB2,SPI1,PTPN6 |
2.879e-02 | -3.55 | FLOT1 (flotillin 1) | protein interactions | 10211 | 453 | 4 | 19454 | 50 |
DISC1,ELF4,GAB1,SEPTIN9 |
2.884e-02 | -3.55 | GADD45A (growth arrest and DNA damage inducible alpha) | protein interactions | 1647 | 103 | 2 | 19454 | 50 |
RBPJ,RXRA |
2.886e-02 | -3.55 | prostate | COSMIC cancer mutations | prostate | 13883 | 43 | 16828 | 46 |
DOCK8,WDFY3,PLXND1,BMP2K,HEPHL1,ELF4,ITGAL,SPI1,ME1,RGL1,SH2B3,GAB1,PTPN12,MCOLN2,CCND2,ARAP1,MYO1F,ZFP36L1,DOCK2,DISC1,PTPN6,RBM47,ANTXR2,AKAP13,EHD4,FKBP5,ARHGEF18,RBPJ,DAB2,BTG1,ARHGAP24,ITM2B,ITGB2,DNM2,RXRA,ITGAV,STAB1,TFEB,HCK,TLN1,SLC9A7,PREX1,PTGIR |
2.893e-02 | -3.54 | BTG Family Proteins and Cell Cycle Regulation | SMPDB pathways | SMP0063773 | 10 | 1 | 1369 | 4 |
BTG1 |
2.900e-02 | -3.54 | PSMC5 (proteasome 26S subunit, ATPase 5) | protein interactions | 5705 | 454 | 4 | 19454 | 50 |
PTPN6,TLN1,CCND2,RXRA |
2.917e-02 | -3.53 | Integrin_B_tail | smart domains | SM01242 | 7 | 1 | 9717 | 41 |
ITGB2 |
2.917e-02 | -3.53 | DYNc | smart domains | SM00053 | 7 | 1 | 9717 | 41 |
DNM2 |
2.917e-02 | -3.53 | activation of GTPase activity | biological process | GO:0090630 | 99 | 2 | 18204 | 49 |
ARHGAP45,ARHGAP24 |
2.922e-02 | -3.53 | negative regulation of myeloid leukocyte mediated immunity | biological process | GO:0002887 | 11 | 1 | 18204 | 49 |
SPI1 |
2.922e-02 | -3.53 | blood vessel endothelial cell differentiation | biological process | GO:0060837 | 11 | 1 | 18204 | 49 |
RBPJ |
2.922e-02 | -3.53 | pyramidal neuron development | biological process | GO:0021860 | 11 | 1 | 18204 | 49 |
DISC1 |
2.922e-02 | -3.53 | negative regulation of humoral immune response mediated by circulating immunoglobulin | biological process | GO:0002924 | 11 | 1 | 18204 | 49 |
PTPN6 |
2.922e-02 | -3.53 | regulation of non-motile cilium assembly | biological process | GO:1902855 | 11 | 1 | 18204 | 49 |
SEPTIN9 |
2.922e-02 | -3.53 | synaptic vesicle budding | biological process | GO:0070142 | 11 | 1 | 18204 | 49 |
DNM2 |
2.922e-02 | -3.53 | negative regulation of platelet aggregation | biological process | GO:0090331 | 11 | 1 | 18204 | 49 |
SH2B3 |
2.922e-02 | -3.53 | positive regulation of steroid hormone secretion | biological process | GO:2000833 | 11 | 1 | 18204 | 49 |
DAB2 |
2.922e-02 | -3.53 | regulation of chemokine (C-C motif) ligand 5 production | biological process | GO:0071649 | 11 | 1 | 18204 | 49 |
MCOLN2 |
2.922e-02 | -3.53 | cardiac muscle cell myoblast differentiation | biological process | GO:0060379 | 11 | 1 | 18204 | 49 |
RBPJ |
2.922e-02 | -3.53 | pericyte cell differentiation | biological process | GO:1904238 | 11 | 1 | 18204 | 49 |
SPI1 |
2.922e-02 | -3.53 | secondary heart field specification | biological process | GO:0003139 | 11 | 1 | 18204 | 49 |
RBPJ |
2.923e-02 | -3.53 | Signaling by SCF-KIT | REACTOME pathways | R-HSA-1433557 | 337 | 4 | 10285 | 36 |
SH2B3,PTPN6,GAB1,TLN1 |
2.931e-02 | -3.53 | Integrin_alpha_Ig-like_3 | interpro domains | IPR048286 | 11 | 1 | 18521 | 50 |
ITGAV |
2.931e-02 | -3.53 | PKD1_2_channel | interpro domains | IPR013122 | 11 | 1 | 18521 | 50 |
MCOLN2 |
2.931e-02 | -3.53 | Cation/H_exchanger_CPA1 | interpro domains | IPR018422 | 11 | 1 | 18521 | 50 |
SLC9A7 |
2.931e-02 | -3.53 | EH_dom | interpro domains | IPR000261 | 11 | 1 | 18521 | 50 |
EHD4 |
2.940e-02 | -3.53 | complement component C3b binding | molecular function | GO:0001851 | 11 | 1 | 18094 | 49 |
ITGB2 |
2.940e-02 | -3.53 | nitric-oxide synthase binding | molecular function | GO:0050998 | 11 | 1 | 18094 | 49 |
CD74 |
2.940e-02 | -3.53 | T cell receptor binding | molecular function | GO:0042608 | 11 | 1 | 18094 | 49 |
DOCK2 |
2.940e-02 | -3.53 | STAT family protein binding | molecular function | GO:0097677 | 11 | 1 | 18094 | 49 |
SPI1 |
2.940e-02 | -3.53 | prostanoid receptor activity | molecular function | GO:0004954 | 11 | 1 | 18094 | 49 |
PTGIR |
2.947e-02 | -3.52 | BEACH domain | gene3d domains | 1.10.1540.10 | 9 | 1 | 14470 | 48 |
WDFY3 |
2.956e-02 | -3.52 | positive regulation of cellular component organization | biological process | GO:0051130 | 1122 | 7 | 18204 | 49 |
DOCK2,SEPTIN9,DAB2,HCK,DISC1,PLXND1,ARAP1 |
2.981e-02 | -3.51 | PH_BEACH | prosite domains | PS51783 | 8 | 1 | 12186 | 46 |
WDFY3 |
2.981e-02 | -3.51 | TH1 | prosite domains | PS51757 | 8 | 1 | 12186 | 46 |
MYO1F |
2.988e-02 | -3.51 | TRIP10 (thyroid hormone receptor interactor 10) | protein interactions | 9322 | 105 | 2 | 19454 | 50 |
DNM2,RXRA |
2.988e-02 | -3.51 | XPNPEP1 (X-prolyl aminopeptidase 1) | protein interactions | 7511 | 105 | 2 | 19454 | 50 |
DISC1,RBPJ |
2.988e-02 | -3.51 | Integrin_A_Ig_3 | pfam domains | PF20806 | 11 | 1 | 17795 | 49 |
ITGAV |
2.988e-02 | -3.51 | PKD_channel | pfam domains | PF08016 | 11 | 1 | 17795 | 49 |
MCOLN2 |
3.005e-02 | -3.50 | protein tyrosine phosphatase activity | molecular function | GO:0004725 | 100 | 2 | 18094 | 49 |
PTPN6,PTPN12 |
3.013e-02 | -3.50 | trans-Golgi network | cellular component | GO:0005802 | 264 | 3 | 19108 | 49 |
SLC9A7,CD74,ARAP1 |
3.014e-02 | -3.50 | TYR_PHOSPHATASE_1 | prosite domains | PS00383 | 72 | 2 | 12186 | 46 |
PTPN12,PTPN6 |
3.016e-02 | -3.50 | PML (PML nuclear body scaffold) | protein interactions | 5371 | 923 | 6 | 19454 | 50 |
DNM2,SPI1,TLN1,SEPTIN9,ELF4,RXRA |
3.022e-02 | -3.50 | INTEGRINB | prints domains | PR01186 | 8 | 1 | 5227 | 20 |
ITGB2 |
3.022e-02 | -3.50 | PROSTANOIDR | prints domains | PR01788 | 8 | 1 | 5227 | 20 |
PTGIR |
3.023e-02 | -3.50 | IGF1R (insulin like growth factor 1 receptor) | protein interactions | 3480 | 460 | 4 | 19454 | 50 |
ITGAV,GAB1,PTPN6,PTPN12 |
3.027e-02 | -3.50 | platelet activation | biological process | GO:0030168 | 101 | 2 | 18204 | 49 |
PTPN6,TLN1 |
3.033e-02 | -3.50 | PFKP (phosphofructokinase, platelet) | protein interactions | 5214 | 264 | 3 | 19454 | 50 |
GAB1,ARHGAP24,PTPN6 |
3.038e-02 | -3.49 | FBXW7 (F-box and WD repeat domain containing 7) | protein interactions | 55294 | 1181 | 7 | 19454 | 50 |
FKBP5,SPI1,BTG1,ITGAV,DISC1,AKAP13,DNM2 |
3.040e-02 | -3.49 | HSP90AB2P (heat shock protein 90 alpha family class B member 2, pseudogene) | protein interactions | 391634 | 106 | 2 | 19454 | 50 |
HCK,FKBP5 |
3.040e-02 | -3.49 | SGCA (sarcoglycan alpha) | protein interactions | 6442 | 106 | 2 | 19454 | 50 |
DNM2,ITM2B |
3.042e-02 | -3.49 | FCRL5 (Fc receptor like 5) | protein interactions | 83416 | 12 | 1 | 19454 | 50 |
ME1 |
3.042e-02 | -3.49 | ZNF91 (zinc finger protein 91) | protein interactions | 7644 | 12 | 1 | 19454 | 50 |
ARHGAP24 |
3.042e-02 | -3.49 | AMPD3 (adenosine monophosphate deaminase 3) | protein interactions | 272 | 12 | 1 | 19454 | 50 |
ITGB2 |
3.042e-02 | -3.49 | C8orf76 (chromosome 8 open reading frame 76) | protein interactions | 84933 | 12 | 1 | 19454 | 50 |
DISC1 |
3.042e-02 | -3.49 | PNMT (phenylethanolamine N-methyltransferase) | protein interactions | 5409 | 12 | 1 | 19454 | 50 |
HCK |
3.042e-02 | -3.49 | TM7SF2 (transmembrane 7 superfamily member 2) | protein interactions | 7108 | 12 | 1 | 19454 | 50 |
DISC1 |
3.042e-02 | -3.49 | RWDD1 (RWD domain containing 1) | protein interactions | 51389 | 12 | 1 | 19454 | 50 |
CD74 |
3.042e-02 | -3.49 | PDE6G (phosphodiesterase 6G) | protein interactions | 5148 | 12 | 1 | 19454 | 50 |
DNM2 |
3.042e-02 | -3.49 | ANO5 (anoctamin 5) | protein interactions | 203859 | 12 | 1 | 19454 | 50 |
PTGIR |
3.042e-02 | -3.49 | TENM4 (teneurin transmembrane protein 4) | protein interactions | 26011 | 12 | 1 | 19454 | 50 |
DOCK2 |
3.042e-02 | -3.49 | TNXB (tenascin XB) | protein interactions | 7148 | 12 | 1 | 19454 | 50 |
SEPTIN9 |
3.042e-02 | -3.49 | LOC102724560 (cystathionine beta-synthase like) | protein interactions | 102724560 | 12 | 1 | 19454 | 50 |
ARHGAP24 |
3.042e-02 | -3.49 | SSTR2 (somatostatin receptor 2) | protein interactions | 6752 | 12 | 1 | 19454 | 50 |
PTPN6 |
3.042e-02 | -3.49 | ROBO4 (roundabout guidance receptor 4) | protein interactions | 54538 | 12 | 1 | 19454 | 50 |
RXRA |
3.042e-02 | -3.49 | PTPN20 (protein tyrosine phosphatase non-receptor type 20) | protein interactions | 26095 | 12 | 1 | 19454 | 50 |
PTPN6 |
3.042e-02 | -3.49 | NUDT4 (nudix hydrolase 4) | protein interactions | 11163 | 12 | 1 | 19454 | 50 |
DISC1 |
3.042e-02 | -3.49 | THAP2 (THAP domain containing 2) | protein interactions | 83591 | 12 | 1 | 19454 | 50 |
PTPN12 |
3.042e-02 | -3.49 | Cep350 (centrosomal protein 350) | protein interactions | 74081 | 12 | 1 | 19454 | 50 |
TLN1 |
3.042e-02 | -3.49 | ITGB6 (integrin subunit beta 6) | protein interactions | 3694 | 12 | 1 | 19454 | 50 |
ITGAV |
3.042e-02 | -3.49 | ABCB5 (ATP binding cassette subfamily B member 5) | protein interactions | 340273 | 12 | 1 | 19454 | 50 |
CCND2 |
3.042e-02 | -3.49 | ROPN1L (rhophilin associated tail protein 1 like) | protein interactions | 83853 | 12 | 1 | 19454 | 50 |
CD74 |
3.042e-02 | -3.49 | ZNF235 (zinc finger protein 235) | protein interactions | 9310 | 12 | 1 | 19454 | 50 |
ARHGAP24 |
3.042e-02 | -3.49 | FUT4 (fucosyltransferase 4) | protein interactions | 2526 | 12 | 1 | 19454 | 50 |
ITGB2 |
3.042e-02 | -3.49 | ZNF268 (zinc finger protein 268) | protein interactions | 10795 | 12 | 1 | 19454 | 50 |
RBPJ |
3.044e-02 | -3.49 | Prot-tyrosine_phosphatase-like | interpro domains | IPR029021 | 101 | 2 | 18521 | 50 |
PTPN6,PTPN12 |
3.056e-02 | -3.49 | C1 | smart domains | SM00109 | 65 | 2 | 9717 | 41 |
AKAP13,ARHGAP45 |
3.062e-02 | -3.49 | OSBPL8 (oxysterol binding protein like 8) | protein interactions | 114882 | 265 | 3 | 19454 | 50 |
PTGIR,CD74,DISC1 |
3.071e-02 | -3.48 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia | 10418 | 35 | 16828 | 46 |
DAB2,ARHGAP24,AKAP13,EHD4,ARHGEF18,FKBP5,CD74,PTPN6,ANTXR2,ARAP1,DOCK2,MYO1F,SLC9A7,TLN1,PREX1,ITGAV,STAB1,DNM2,RXRA,HEPHL1,ELF4,CD68,BMP2K,PLXND1,DOCK8,WDFY3,CCND2,GAB1,MCOLN2,PTPN12,ME1,RGL1,SH2B3,ITGAL,SPI1 |
3.071e-02 | -3.48 | acute_myeloid_leukaemia | COSMIC cancer mutations | acute_myeloid_leukaemia | 10418 | 35 | 16828 | 46 |
ITGAV,STAB1,PREX1,TLN1,SLC9A7,RXRA,DNM2,ARHGEF18,FKBP5,CD74,EHD4,AKAP13,ARHGAP24,DAB2,ARAP1,MYO1F,DOCK2,ANTXR2,PTPN6,GAB1,MCOLN2,PTPN12,CCND2,SPI1,ITGAL,ME1,SH2B3,RGL1,BMP2K,CD68,HEPHL1,ELF4,DOCK8,WDFY3,PLXND1 |
3.082e-02 | -3.48 | artery development | biological process | GO:0060840 | 102 | 2 | 18204 | 49 |
RBPJ,PLXND1 |
3.082e-02 | -3.48 | alpha-beta T cell activation | biological process | GO:0046631 | 102 | 2 | 18204 | 49 |
ELF4,DOCK2 |
3.093e-02 | -3.48 | TFAP2A (transcription factor AP-2 alpha) | protein interactions | 7020 | 107 | 2 | 19454 | 50 |
DAB2,RBPJ |
3.093e-02 | -3.48 | POLR3C (RNA polymerase III subunit C) | protein interactions | 10623 | 107 | 2 | 19454 | 50 |
DISC1,RBPJ |
3.093e-02 | -3.48 | APLP2 (amyloid beta precursor like protein 2) | protein interactions | 334 | 107 | 2 | 19454 | 50 |
DAB2,DISC1 |
3.101e-02 | -3.47 | regulation of neuron projection development | biological process | GO:0010975 | 443 | 4 | 18204 | 49 |
PREX1,DAB2,DISC1,PLXND1 |
3.103e-02 | -3.47 | Nectin adhesion pathway | Pathway Interaction DB | nectin_pathway | 25 | 2 | 2226 | 25 |
ITGAV,TLN1 |
3.108e-02 | -3.47 | Prostanoid ligand receptors | REACTOME pathways | R-HSA-391908 | 9 | 1 | 10285 | 36 |
PTGIR |
3.108e-02 | -3.47 | Sodium/Proton exchangers | REACTOME pathways | R-HSA-425986 | 9 | 1 | 10285 | 36 |
SLC9A7 |
3.108e-02 | -3.47 | PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | REACTOME pathways | R-HSA-8849469 | 9 | 1 | 10285 | 36 |
ARAP1 |
3.114e-02 | -3.47 | soft_tissue-blood_vessel-angiosarcoma | COSMIC cancer mutations | soft_tissue-blood_vessel-angiosarcoma | 2192 | 11 | 16828 | 46 |
ITGAL,ME1,PTPN12,GAB1,ITGAV,SLC9A7,TLN1,DOCK2,PLXND1,AKAP13,ARHGAP24 |
3.114e-02 | -3.47 | angiosarcoma | COSMIC cancer mutations | angiosarcoma | 2192 | 11 | 16828 | 46 |
ITGAV,GAB1,PTPN12,AKAP13,ARHGAP24,TLN1,SLC9A7,DOCK2,ITGAL,ME1,PLXND1 |
3.120e-02 | -3.47 | positive regulation of T cell activation | biological process | GO:0050870 | 255 | 3 | 18204 | 49 |
DOCK8,PTPN6,CD74 |
3.138e-02 | -3.46 | regulation of biomineral tissue development | biological process | GO:0070167 | 103 | 2 | 18204 | 49 |
RXRA,BMP2K |
3.147e-02 | -3.46 | CDK15 (cyclin dependent kinase 15) | protein interactions | 65061 | 108 | 2 | 19454 | 50 |
FKBP5,ME1 |
3.147e-02 | -3.46 | PTK7 (protein tyrosine kinase 7 (inactive)) | protein interactions | 5754 | 108 | 2 | 19454 | 50 |
PTPN6,PTPN12 |
3.147e-02 | -3.46 | PYGL (glycogen phosphorylase L) | protein interactions | 5836 | 108 | 2 | 19454 | 50 |
FKBP5,ARHGAP24 |
3.151e-02 | -3.46 | VCL (vinculin) | protein interactions | 7414 | 268 | 3 | 19454 | 50 |
ARHGAP24,TLN1,PTPN12 |
3.151e-02 | -3.46 | NSUN2 (NOP2/Sun RNA methyltransferase 2) | protein interactions | 54888 | 268 | 3 | 19454 | 50 |
TLN1,FKBP5,ARHGAP24 |
3.151e-02 | -3.46 | protein complex oligomerization | biological process | GO:0051259 | 256 | 3 | 18204 | 49 |
CD74,EHD4,ME1 |
3.156e-02 | -3.46 | Ig_E-set | interpro domains | IPR014756 | 103 | 2 | 18521 | 50 |
PLXND1,RBPJ |
3.159e-02 | -3.45 | adenoid_cystic_carcinoma | COSMIC cancer mutations | adenoid_cystic_carcinoma | 1123 | 7 | 16828 | 46 |
ITM2B,ZFP36L1,DOCK8,AKAP13,BTG1,SLC9A7,TLN1 |
3.160e-02 | -3.45 | clear_cell_renal_cell_carcinoma | COSMIC cancer mutations | clear_cell_renal_cell_carcinoma | 13924 | 43 | 16828 | 46 |
BTG1,ARHGAP24,DAB2,ARHGEF18,FKBP5,CD74,RBPJ,AKAP13,EHD4,RBM47,ANTXR2,DISC1,PTPN6,ARAP1,ZFP36L1,MYO1F,DOCK2,PTGIR,PREX1,SLC9A7,TLN1,ITGAV,HCK,STAB1,TFEB,RXRA,DNM2,ITM2B,ITGB2,HEPHL1,ELF4,BMP2K,PLXND1,WDFY3,DOCK8,CCND2,GAB1,MCOLN2,PTPN12,ME1,RGL1,SPI1,ITGAL |
3.160e-02 | -3.45 | kidney-carcinoma-clear_cell_renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-clear_cell_renal_cell_carcinoma | 13924 | 43 | 16828 | 46 |
ITGAL,SPI1,ME1,HEPHL1,STAB1,TFEB,PREX1,ITM2B,DNM2,AKAP13,ARHGEF18,FKBP5,CD74,DAB2,ARHGAP24,ARAP1,MYO1F,DOCK2,DISC1,GAB1,PTPN12,MCOLN2,CCND2,RGL1,BMP2K,ELF4,DOCK8,WDFY3,PLXND1,ITGAV,HCK,SLC9A7,TLN1,PTGIR,ITGB2,RXRA,EHD4,RBPJ,BTG1,ZFP36L1,PTPN6,RBM47,ANTXR2 |
3.160e-02 | -3.45 | acute_lymphoblastic_leukaemia | COSMIC cancer mutations | acute_lymphoblastic_leukaemia | 2197 | 11 | 16828 | 46 |
HCK,TFEB,STAB1,BMP2K,DAB2,HEPHL1,ARHGAP24,BTG1,ITGAL,SPI1,PLXND1 |
3.172e-02 | -3.45 | anatomical structure morphogenesis | biological process | GO:0009653 | 2225 | 11 | 18204 | 49 |
ITGAV,ARHGAP24,ZFP36L1,SPI1,PLXND1,ITGB2,RBPJ,PTPN6,DOCK2,GAB1,DNM2 |
3.181e-02 | -3.45 | AP2A1 (adaptor related protein complex 2 subunit alpha 1) | protein interactions | 160 | 269 | 3 | 19454 | 50 |
BMP2K,DAB2,DNM2 |
3.184e-02 | -3.45 | lymphoid progenitor cell differentiation | biological process | GO:0002320 | 12 | 1 | 18204 | 49 |
SPI1 |
3.184e-02 | -3.45 | regulation of chemokine-mediated signaling pathway | biological process | GO:0070099 | 12 | 1 | 18204 | 49 |
SH2B3 |
3.184e-02 | -3.45 | heart field specification | biological process | GO:0003128 | 12 | 1 | 18204 | 49 |
RBPJ |
3.184e-02 | -3.45 | regulation of prostaglandin biosynthetic process | biological process | GO:0031392 | 12 | 1 | 18204 | 49 |
CD74 |
3.184e-02 | -3.45 | endocardium development | biological process | GO:0003157 | 12 | 1 | 18204 | 49 |
RBPJ |
3.184e-02 | -3.45 | cytidine to uridine editing | biological process | GO:0016554 | 12 | 1 | 18204 | 49 |
RBM47 |
3.184e-02 | -3.45 | endothelial tube morphogenesis | biological process | GO:0061154 | 12 | 1 | 18204 | 49 |
RBPJ |
3.184e-02 | -3.45 | regulation of inflammatory response to wounding | biological process | GO:0106014 | 12 | 1 | 18204 | 49 |
PTPN6 |
3.184e-02 | -3.45 | morphogenesis of an endothelium | biological process | GO:0003159 | 12 | 1 | 18204 | 49 |
RBPJ |
3.184e-02 | -3.45 | regulation of timing of cell differentiation | biological process | GO:0048505 | 12 | 1 | 18204 | 49 |
RBPJ |
3.186e-02 | -3.45 | PML body | cellular component | GO:0016605 | 109 | 2 | 19108 | 49 |
WDFY3,ELF4 |
3.187e-02 | -3.45 | TUBA1A (tubulin alpha 1a) | protein interactions | 7846 | 692 | 5 | 19454 | 50 |
TLN1,FKBP5,CD74,BTG1,ARHGAP24 |
3.189e-02 | -3.45 | Signaling events mediated by VEGFR1 and VEGFR2 | Pathway Interaction DB | vegfr1_2_pathway | 63 | 3 | 2226 | 25 |
GAB1,PTPN6,ITGAV |
3.194e-02 | -3.44 | epithelial cell migration | biological process | GO:0010631 | 104 | 2 | 18204 | 49 |
GAB1,PLXND1 |
3.194e-02 | -3.44 | positive regulation of ubiquitin-dependent protein catabolic process | biological process | GO:2000060 | 104 | 2 | 18204 | 49 |
DAB2,DISC1 |
3.194e-02 | -3.44 | regulation of chemokine production | biological process | GO:0032642 | 104 | 2 | 18204 | 49 |
MCOLN2,CD74 |
3.194e-02 | -3.44 | protein polymerization | biological process | GO:0051258 | 104 | 2 | 18204 | 49 |
DNM2,PREX1 |
3.200e-02 | -3.44 | MBP (myelin basic protein) | protein interactions | 4155 | 109 | 2 | 19454 | 50 |
BMP2K,ARHGAP24 |
3.200e-02 | -3.44 | NT5C2 (5'-nucleotidase, cytosolic II) | protein interactions | 22978 | 109 | 2 | 19454 | 50 |
ELF4,EHD4 |
3.203e-02 | -3.44 | MAP-kinase scaffold activity | molecular function | GO:0005078 | 12 | 1 | 18094 | 49 |
AKAP13 |
3.203e-02 | -3.44 | vinculin binding | molecular function | GO:0017166 | 12 | 1 | 18094 | 49 |
TLN1 |
3.203e-02 | -3.44 | macrolide binding | molecular function | GO:0005527 | 12 | 1 | 18094 | 49 |
FKBP5 |
3.203e-02 | -3.44 | semaphorin receptor activity | molecular function | GO:0017154 | 12 | 1 | 18094 | 49 |
PLXND1 |
3.211e-02 | -3.44 | PTCH1 (patched 1) | protein interactions | 5727 | 270 | 3 | 19454 | 50 |
PLXND1,ITGAV,CD74 |
3.213e-02 | -3.44 | VCAM1 (vascular cell adhesion molecule 1) | protein interactions | 7412 | 469 | 4 | 19454 | 50 |
DNM2,ARAP1,WDFY3,TLN1 |
3.231e-02 | -3.43 | von Willebrand factor, type A domain | gene3d domains | 3.40.50.410 | 85 | 2 | 14470 | 48 |
ITGB2,ANTXR2 |
3.232e-02 | -3.43 | bone-sacrum-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-sacrum-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 12 | 1 | 16828 | 46 |
STAB1 |
3.235e-02 | -3.43 | H2AC4 (H2A clustered histone 4) | protein interactions | 8335 | 470 | 4 | 19454 | 50 |
DNM2,EHD4,CCND2,PTPN6 |
3.235e-02 | -3.43 | regulation of innate immune response | biological process | GO:0045088 | 449 | 4 | 18204 | 49 |
PTPN6,RBM47,SPI1,HCK |
3.251e-02 | -3.43 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | biological process | GO:0090100 | 105 | 2 | 18204 | 49 |
RBPJ,DAB2 |
3.251e-02 | -3.43 | positive regulation of myeloid cell differentiation | biological process | GO:0045639 | 105 | 2 | 18204 | 49 |
CD74,ZFP36L1 |
3.251e-02 | -3.43 | response to type II interferon | biological process | GO:0034341 | 105 | 2 | 18204 | 49 |
CD74,HCK |
3.251e-02 | -3.43 | antigen processing and presentation | biological process | GO:0019882 | 105 | 2 | 18204 | 49 |
CD74,DNM2 |
3.254e-02 | -3.43 | CFTR (CF transmembrane conductance regulator) | protein interactions | 1080 | 1469 | 8 | 19454 | 50 |
TLN1,DNM2,CD68,SEPTIN9,TFEB,DAB2,ANTXR2,ITGAV |
3.256e-02 | -3.42 | intracellular organelle | cellular component | GO:0043229 | 13594 | 41 | 19108 | 49 |
PTPN12,HCK,ITGB2,ARHGAP45,ARAP1,DISC1,PTPN6,BTG1,CD74,ME1,STAB1,FKBP5,SEPTIN9,AKAP13,BMP2K,ITM2B,DAB2,RBPJ,DNM2,TFEB,MYO1F,CD68,TLN1,ITGAV,RXRA,ELF4,SLC9A7,RBM47,DOCK2,ZFP36L1,ARHGEF18,ITGAL,CCND2,FYB1,EHD4,TMSB4X,WDFY3,ANTXR2,ARHGAP24,MCOLN2,SPI1 |
3.269e-02 | -3.42 | Cytochrome c1, transmembrane anchor, C-terminal | gene3d domains | 1.20.5.100 | 10 | 1 | 14470 | 48 |
ITGB2 |
3.269e-02 | -3.42 | - | gene3d domains | 6.10.140.1330 | 10 | 1 | 14470 | 48 |
SLC9A7 |
3.281e-02 | -3.42 | distal axon | cellular component | GO:0150034 | 273 | 3 | 19108 | 49 |
PREX1,DNM2,DISC1 |
3.284e-02 | -3.42 | semaphorin receptor complex | cellular component | GO:0002116 | 13 | 1 | 19108 | 49 |
PLXND1 |
3.291e-02 | -3.41 | Septin2 (septin 2) | protein interactions | 18000 | 13 | 1 | 19454 | 50 |
SEPTIN9 |
3.291e-02 | -3.41 | PLEKHH1 (pleckstrin homology, MyTH4 and FERM domain containing H1) | protein interactions | 57475 | 13 | 1 | 19454 | 50 |
FKBP5 |
3.291e-02 | -3.41 | SEMA4A (semaphorin 4A) | protein interactions | 64218 | 13 | 1 | 19454 | 50 |
PLXND1 |
3.291e-02 | -3.41 | PRRX1 (paired related homeobox 1) | protein interactions | 5396 | 13 | 1 | 19454 | 50 |
FKBP5 |
3.291e-02 | -3.41 | FCRL3 (Fc receptor like 3) | protein interactions | 115352 | 13 | 1 | 19454 | 50 |
PTPN6 |
3.291e-02 | -3.41 | CRYGC (crystallin gamma C) | protein interactions | 1420 | 13 | 1 | 19454 | 50 |
DISC1 |
3.291e-02 | -3.41 | C1orf74 (chromosome 1 open reading frame 74) | protein interactions | 148304 | 13 | 1 | 19454 | 50 |
HCK |
3.291e-02 | -3.41 | PPP1R2B (PPP1R2 family member B) | protein interactions | 153743 | 13 | 1 | 19454 | 50 |
BMP2K |
3.291e-02 | -3.41 | Notch1 (notch 1) | protein interactions | 18128 | 13 | 1 | 19454 | 50 |
RBPJ |
3.291e-02 | -3.41 | ZNF718 (zinc finger protein 718) | protein interactions | 255403 | 13 | 1 | 19454 | 50 |
ARHGAP24 |
3.293e-02 | -3.41 | blood_vessel | COSMIC cancer mutations | blood_vessel | 2211 | 11 | 16828 | 46 |
GAB1,ITGAV,PTPN12,SLC9A7,TLN1,ITGAL,ME1,AKAP13,ARHGAP24,DOCK2,PLXND1 |
3.307e-02 | -3.41 | regulation of actin filament bundle assembly | biological process | GO:0032231 | 106 | 2 | 18204 | 49 |
ARHGEF18,ARAP1 |
3.309e-02 | -3.41 | PLP1 (proteolipid protein 1) | protein interactions | 5354 | 111 | 2 | 19454 | 50 |
CD74,ITGAV |
3.327e-02 | -3.40 | INB | smart domains | SM00187 | 8 | 1 | 9717 | 41 |
ITGB2 |
3.329e-02 | -3.40 | regulation of MAPK cascade | biological process | GO:0043408 | 669 | 5 | 18204 | 49 |
DAB2,PTPN6,SPI1,SH2B3,CD74 |
3.341e-02 | -3.40 | immune response-regulating cell surface receptor signaling pathway | biological process | GO:0002768 | 262 | 3 | 18204 | 49 |
HCK,PTPN6,FYB1 |
3.348e-02 | -3.40 | BRICHOS | prosite domains | PS50869 | 9 | 1 | 12186 | 46 |
ITM2B |
3.348e-02 | -3.40 | INTEGRIN_BETA | prosite domains | PS00243 | 9 | 1 | 12186 | 46 |
ITGB2 |
3.348e-02 | -3.40 | BEACH | prosite domains | PS50197 | 9 | 1 | 12186 | 46 |
WDFY3 |
3.349e-02 | -3.40 | embryonic organ development | biological process | GO:0048568 | 454 | 4 | 18204 | 49 |
TFEB,ZFP36L1,SH2B3,RBPJ |
3.363e-02 | -3.39 | MCAT (malonyl-CoA-acyl carrier protein transacylase) | protein interactions | 27349 | 112 | 2 | 19454 | 50 |
TFEB,ITGAV |
3.363e-02 | -3.39 | SARS1 (seryl-tRNA synthetase 1) | protein interactions | 6301 | 112 | 2 | 19454 | 50 |
EHD4,ARHGAP24 |
3.363e-02 | -3.39 | C10orf88 (chromosome 10 open reading frame 88) | protein interactions | 80007 | 112 | 2 | 19454 | 50 |
RBM47,BMP2K |
3.365e-02 | -3.39 | T cell receptor signaling pathway | biological process | GO:0050852 | 107 | 2 | 18204 | 49 |
PTPN6,FYB1 |
3.365e-02 | -3.39 | epithelium migration | biological process | GO:0090132 | 107 | 2 | 18204 | 49 |
GAB1,PLXND1 |
3.369e-02 | -3.39 | XPO1 (exportin 1) | protein interactions | 7514 | 1479 | 8 | 19454 | 50 |
DOCK8,SEPTIN9,TFEB,DAB2,RBPJ,BMP2K,ZFP36L1,ARHGAP24 |
3.377e-02 | -3.39 | salivary_gland | COSMIC cancer mutations | salivary_gland | 1139 | 7 | 16828 | 46 |
DOCK8,ZFP36L1,ITM2B,AKAP13,SLC9A7,TLN1,BTG1 |
3.394e-02 | -3.38 | NAHEXCHNGR | prints domains | PR01084 | 9 | 1 | 5227 | 20 |
SLC9A7 |
3.394e-02 | -3.38 | FLNB (filamin B) | protein interactions | 2317 | 276 | 3 | 19454 | 50 |
PTPN12,FKBP5,SEPTIN9 |
3.418e-02 | -3.38 | CARS1 (cysteinyl-tRNA synthetase 1) | protein interactions | 833 | 113 | 2 | 19454 | 50 |
ARHGAP24,TLN1 |
3.422e-02 | -3.37 | cardiac septum development | biological process | GO:0003279 | 108 | 2 | 18204 | 49 |
PLXND1,RBPJ |
3.435e-02 | -3.37 | NTRK1 (neurotrophic receptor tyrosine kinase 1) | protein interactions | 4914 | 2058 | 10 | 19454 | 50 |
GAB1,ITGAV,FKBP5,PTPN12,SEPTIN9,TLN1,PTPN6,DNM2,ARAP1,EHD4 |
3.443e-02 | -3.37 | Protein tyrosine phosphatase superfamily | gene3d domains | 3.90.190.10 | 88 | 2 | 14470 | 48 |
PTPN12,PTPN6 |
3.444e-02 | -3.37 | epithelial to mesenchymal transition involved in endocardial cushion formation | biological process | GO:0003198 | 13 | 1 | 18204 | 49 |
RBPJ |
3.444e-02 | -3.37 | type II interferon-mediated signaling pathway | biological process | GO:0060333 | 13 | 1 | 18204 | 49 |
HCK |
3.444e-02 | -3.37 | cardioblast differentiation | biological process | GO:0010002 | 13 | 1 | 18204 | 49 |
RBPJ |
3.444e-02 | -3.37 | atrioventricular canal development | biological process | GO:0036302 | 13 | 1 | 18204 | 49 |
RBPJ |
3.444e-02 | -3.37 | negative regulation of homotypic cell-cell adhesion | biological process | GO:0034111 | 13 | 1 | 18204 | 49 |
SH2B3 |
3.444e-02 | -3.37 | positive regulation of cyclin-dependent protein serine/threonine kinase activity | biological process | GO:0045737 | 13 | 1 | 18204 | 49 |
CCND2 |
3.444e-02 | -3.37 | defense response to tumor cell | biological process | GO:0002357 | 13 | 1 | 18204 | 49 |
SPI1 |
3.444e-02 | -3.37 | negative regulation of leukocyte degranulation | biological process | GO:0043301 | 13 | 1 | 18204 | 49 |
SPI1 |
3.444e-02 | -3.37 | positive regulation of osteoblast proliferation | biological process | GO:0033690 | 13 | 1 | 18204 | 49 |
ITGAV |
3.444e-02 | -3.37 | regulation of development, heterochronic | biological process | GO:0040034 | 13 | 1 | 18204 | 49 |
RBPJ |
3.447e-02 | -3.37 | MET receptor recycling | REACTOME pathways | R-HSA-8875656 | 10 | 1 | 10285 | 36 |
GAB1 |
3.447e-02 | -3.37 | Signaling by FGFR3 fusions in cancer | REACTOME pathways | R-HSA-8853334 | 10 | 1 | 10285 | 36 |
GAB1 |
3.447e-02 | -3.37 | SH3_1 | pfam domains | PF00018 | 106 | 2 | 17795 | 49 |
HCK,MYO1F |
3.454e-02 | -3.37 | G_SEPTIN_dom | interpro domains | IPR030379 | 13 | 1 | 18521 | 50 |
SEPTIN9 |
3.454e-02 | -3.37 | Septin | interpro domains | IPR016491 | 13 | 1 | 18521 | 50 |
SEPTIN9 |
3.459e-02 | -3.36 | plasma membrane raft | cellular component | GO:0044853 | 114 | 2 | 19108 | 49 |
HCK,ITGB2 |
3.465e-02 | -3.36 | insulin-like growth factor I binding | molecular function | GO:0031994 | 13 | 1 | 18094 | 49 |
ITGAV |
3.474e-02 | -3.36 | THBS1 (thrombospondin 1) | protein interactions | 7057 | 114 | 2 | 19454 | 50 |
ITGAV,DISC1 |
3.474e-02 | -3.36 | UBE2L6 (ubiquitin conjugating enzyme E2 L6) | protein interactions | 9246 | 114 | 2 | 19454 | 50 |
DNM2,SEPTIN9 |
3.488e-02 | -3.36 | IRS4 (insulin receptor substrate 4) | protein interactions | 8471 | 279 | 3 | 19454 | 50 |
PTPN6,FKBP5,ARHGAP24 |
3.490e-02 | -3.36 | morphogenesis of an epithelium | biological process | GO:0002009 | 460 | 4 | 18204 | 49 |
RBPJ,ARHGAP24,PLXND1,ITGAV |
3.502e-02 | -3.35 | VWA | smart domains | SM00327 | 70 | 2 | 9717 | 41 |
ITGAL,ANTXR2 |
3.522e-02 | -3.35 | Septin | pfam domains | PF00735 | 13 | 1 | 17795 | 49 |
SEPTIN9 |
3.532e-02 | -3.34 | septin complex | cellular component | GO:0031105 | 14 | 1 | 19108 | 49 |
SEPTIN9 |
3.532e-02 | -3.34 | uropod | cellular component | GO:0001931 | 14 | 1 | 19108 | 49 |
DNM2 |
3.532e-02 | -3.34 | septin ring | cellular component | GO:0005940 | 14 | 1 | 19108 | 49 |
SEPTIN9 |
3.537e-02 | -3.34 | protein localization to membrane | biological process | GO:0072657 | 462 | 4 | 18204 | 49 |
EHD4,FYB1,ITGAL,ITGB2 |
3.540e-02 | -3.34 | Septin7 (septin 7) | protein interactions | 235072 | 14 | 1 | 19454 | 50 |
SEPTIN9 |
3.540e-02 | -3.34 | MS4A2 (membrane spanning 4-domains A2) | protein interactions | 2206 | 14 | 1 | 19454 | 50 |
PTPN6 |
3.540e-02 | -3.34 | TFEC (transcription factor EC) | protein interactions | 22797 | 14 | 1 | 19454 | 50 |
TFEB |
3.540e-02 | -3.34 | Tecpr2 (tectonin beta-propeller repeat containing 2) | protein interactions | 104859 | 14 | 1 | 19454 | 50 |
WDFY3 |
3.540e-02 | -3.34 | CSH2 (chorionic somatomammotropin hormone 2) | protein interactions | 1443 | 14 | 1 | 19454 | 50 |
PTPN12 |
3.540e-02 | -3.34 | PTF1A (pancreas associated transcription factor 1a) | protein interactions | 256297 | 14 | 1 | 19454 | 50 |
RBPJ |
3.540e-02 | -3.34 | DNAJC27 (DnaJ heat shock protein family (Hsp40) member C27) | protein interactions | 51277 | 14 | 1 | 19454 | 50 |
FKBP5 |
3.540e-02 | -3.34 | ZFP2 (ZFP2 zinc finger protein) | protein interactions | 80108 | 14 | 1 | 19454 | 50 |
PTPN12 |
3.540e-02 | -3.34 | LY6G5C (lymphocyte antigen 6 family member G5C) | protein interactions | 80741 | 14 | 1 | 19454 | 50 |
ITGAV |
3.540e-02 | -3.34 | ST13P4 (ST13, Hsp70 interacting protein pseudogene 4) | protein interactions | 145165 | 14 | 1 | 19454 | 50 |
CCND2 |
3.540e-02 | -3.34 | AZIN2 (antizyme inhibitor 2) | protein interactions | 113451 | 14 | 1 | 19454 | 50 |
TLN1 |
3.540e-02 | -3.34 | Septin11 (septin 11) | protein interactions | 52398 | 14 | 1 | 19454 | 50 |
SEPTIN9 |
3.554e-02 | -3.34 | regulation of protein phosphorylation | biological process | GO:0001932 | 917 | 6 | 18204 | 49 |
CCND2,ITGB2,DAB2,PTPN6,CD74,EHD4 |
3.558e-02 | -3.34 | STIP1 (stress induced phosphoprotein 1) | protein interactions | 10963 | 960 | 6 | 19454 | 50 |
DNM2,FKBP5,TLN1,DOCK8,ARHGAP24,ME1 |
3.559e-02 | -3.34 | side of membrane | cellular component | GO:0098552 | 715 | 5 | 19108 | 49 |
ITGAL,ITGAV,ITGB2,CD74,HCK |
3.567e-02 | -3.33 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-angioimmunoblastic_T_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-angioimmunoblastic_T_cell_lymphoma | 265 | 3 | 16828 | 46 |
HCK,SH2B3,BTG1 |
3.573e-02 | -3.33 | positive regulation of cellular metabolic process | biological process | GO:0031325 | 3164 | 14 | 18204 | 49 |
EHD4,ELF4,ITGB2,TMSB4X,RBM47,SPI1,TFEB,DAB2,MCOLN2,CD74,DNM2,RBPJ,CCND2,RXRA |
3.574e-02 | -3.33 | human chr2q32.1 | chromosome location | human chr2q32.1 | 19 | 1 | 26134 | 50 |
ITGAV |
3.574e-02 | -3.33 | human chr15q25.3 | chromosome location | human chr15q25.3 | 19 | 1 | 26134 | 50 |
AKAP13 |
3.574e-02 | -3.33 | human chrXq26.1 | chromosome location | human chrXq26.1 | 19 | 1 | 26134 | 50 |
ELF4 |
3.583e-02 | -3.33 | KRT34 (keratin 34) | protein interactions | 3885 | 282 | 3 | 19454 | 50 |
TMSB4X,HCK,DOCK2 |
3.586e-02 | -3.33 | GGA1 (golgi associated, gamma adaptin ear containing, ARF binding protein 1) | protein interactions | 26088 | 116 | 2 | 19454 | 50 |
DNM2,STAB1 |
3.586e-02 | -3.33 | SUCLG1 (succinate-CoA ligase GDP/ADP-forming subunit alpha) | protein interactions | 8802 | 116 | 2 | 19454 | 50 |
SEPTIN9,ARHGAP24 |
3.590e-02 | -3.33 | regulation of response to stress | biological process | GO:0080134 | 1431 | 8 | 18204 | 49 |
SH2B3,RBM47,PTPN6,SPI1,TMSB4X,HCK,ELF4,CD74 |
3.598e-02 | -3.32 | negative regulation of binding | biological process | GO:0051100 | 111 | 2 | 18204 | 49 |
DAB2,DISC1 |
3.598e-02 | -3.32 | positive regulation of lipid localization | biological process | GO:1905954 | 111 | 2 | 18204 | 49 |
DAB2,RXRA |
3.635e-02 | -3.31 | YWHAB (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta) | protein interactions | 7529 | 965 | 6 | 19454 | 50 |
ZFP36L1,GAB1,CD74,AKAP13,ITGB2,TFEB |
3.642e-02 | -3.31 | LAMC1 (laminin subunit gamma 1) | protein interactions | 3915 | 117 | 2 | 19454 | 50 |
ANTXR2,DISC1 |
3.642e-02 | -3.31 | SYT6 (synaptotagmin 6) | protein interactions | 148281 | 117 | 2 | 19454 | 50 |
DNM2,EHD4 |
3.657e-02 | -3.31 | extrinsic apoptotic signaling pathway | biological process | GO:0097191 | 112 | 2 | 18204 | 49 |
SPI1,ITGAV |
3.664e-02 | -3.31 | positive regulation of macromolecule metabolic process | biological process | GO:0010604 | 3485 | 15 | 18204 | 49 |
CD74,MCOLN2,DNM2,RBPJ,RXRA,CCND2,ELF4,EHD4,DISC1,ARAP1,SPI1,RBM47,ZFP36L1,DAB2,TFEB |
3.699e-02 | -3.30 | SAMD1 (sterile alpha motif domain containing 1) | protein interactions | 90378 | 118 | 2 | 19454 | 50 |
TLN1,RBPJ |
3.703e-02 | -3.30 | angioimmunoblastic_T_cell_lymphoma | COSMIC cancer mutations | angioimmunoblastic_T_cell_lymphoma | 269 | 3 | 16828 | 46 |
BTG1,SH2B3,HCK |
3.704e-02 | -3.30 | negative regulation of macrophage derived foam cell differentiation | biological process | GO:0010745 | 14 | 1 | 18204 | 49 |
ITGAV |
3.704e-02 | -3.30 | ventricular trabecula myocardium morphogenesis | biological process | GO:0003222 | 14 | 1 | 18204 | 49 |
RBPJ |
3.704e-02 | -3.30 | interleukin-6-mediated signaling pathway | biological process | GO:0070102 | 14 | 1 | 18204 | 49 |
SPI1 |
3.704e-02 | -3.30 | positive regulation of purine nucleotide biosynthetic process | biological process | GO:1900373 | 14 | 1 | 18204 | 49 |
TMSB4X |
3.704e-02 | -3.30 | positive regulation of receptor recycling | biological process | GO:0001921 | 14 | 1 | 18204 | 49 |
ARAP1 |
3.704e-02 | -3.30 | regulation of podosome assembly | biological process | GO:0071801 | 14 | 1 | 18204 | 49 |
HCK |
3.704e-02 | -3.30 | positive regulation by symbiont of entry into host | biological process | GO:0075294 | 14 | 1 | 18204 | 49 |
CD74 |
3.704e-02 | -3.30 | regulation of unsaturated fatty acid biosynthetic process | biological process | GO:2001279 | 14 | 1 | 18204 | 49 |
CD74 |
3.704e-02 | -3.30 | positive regulation of nucleotide biosynthetic process | biological process | GO:0030810 | 14 | 1 | 18204 | 49 |
TMSB4X |
3.704e-02 | -3.30 | cellular response to oxidised low-density lipoprotein particle stimulus | biological process | GO:0140052 | 14 | 1 | 18204 | 49 |
CD68 |
3.704e-02 | -3.30 | positive regulation of viral entry into host cell | biological process | GO:0046598 | 14 | 1 | 18204 | 49 |
CD74 |
3.713e-02 | -3.29 | CYCLINS | prosite domains | PS00292 | 10 | 1 | 12186 | 46 |
CCND2 |
3.715e-02 | -3.29 | Ras_G-nucl-exch_fac_CS | interpro domains | IPR019804 | 14 | 1 | 18521 | 50 |
RGL1 |
3.715e-02 | -3.29 | Cation/H_exchanger | interpro domains | IPR006153 | 14 | 1 | 18521 | 50 |
SLC9A7 |
3.715e-02 | -3.29 | Link_dom | interpro domains | IPR000538 | 14 | 1 | 18521 | 50 |
STAB1 |
3.717e-02 | -3.29 | tissue migration | biological process | GO:0090130 | 113 | 2 | 18204 | 49 |
GAB1,PLXND1 |
3.717e-02 | -3.29 | regulation of regulated secretory pathway | biological process | GO:1903305 | 113 | 2 | 18204 | 49 |
SPI1,ITGB2 |
3.717e-02 | -3.29 | positive regulation of plasma membrane bounded cell projection assembly | biological process | GO:0120034 | 113 | 2 | 18204 | 49 |
SEPTIN9,ARAP1 |
3.727e-02 | -3.29 | potassium:proton antiporter activity | molecular function | GO:0015386 | 14 | 1 | 18094 | 49 |
SLC9A7 |
3.736e-02 | -3.29 | BRICHOS | smart domains | SM01039 | 9 | 1 | 9717 | 41 |
ITM2B |
3.736e-02 | -3.29 | Beach | smart domains | SM01026 | 9 | 1 | 9717 | 41 |
WDFY3 |
3.747e-02 | -3.28 | adrenal_cortical_carcinoma | COSMIC cancer mutations | adrenal_cortical_carcinoma | 2256 | 11 | 16828 | 46 |
PTGIR,PTPN12,STAB1,MCOLN2,RXRA,ITGAL,EHD4,PLXND1,PTPN6,DOCK8,DOCK2 |
3.756e-02 | -3.28 | KMT2B (lysine methyltransferase 2B) | protein interactions | 9757 | 119 | 2 | 19454 | 50 |
RBPJ,ELF4 |
3.757e-02 | -3.28 | myelodysplastic-myeloproliferative_neoplasm-unclassifiable | COSMIC cancer mutations | myelodysplastic-myeloproliferative_neoplasm-unclassifiable | 112 | 2 | 16828 | 46 |
SPI1,SH2B3 |
3.757e-02 | -3.28 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelodysplastic-myeloproliferative_neoplasm-unclassifiable | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelodysplastic-myeloproliferative_neoplasm-unclassifiable | 112 | 2 | 16828 | 46 |
SH2B3,SPI1 |
3.759e-02 | -3.28 | human chr12p13.32 | chromosome location | human chr12p13.32 | 20 | 1 | 26134 | 50 |
CCND2 |
3.780e-02 | -3.28 | cell trailing edge | cellular component | GO:0031254 | 15 | 1 | 19108 | 49 |
DNM2 |
3.785e-02 | -3.27 | Import of palmitoyl-CoA into the mitochondrial matrix | REACTOME pathways | R-HSA-200425 | 11 | 1 | 10285 | 36 |
RXRA |
3.785e-02 | -3.27 | MET activates RAP1 and RAC1 | REACTOME pathways | R-HSA-8875555 | 11 | 1 | 10285 | 36 |
GAB1 |
3.785e-02 | -3.27 | Signaling by FGFR4 in disease | REACTOME pathways | R-HSA-5655291 | 11 | 1 | 10285 | 36 |
GAB1 |
3.788e-02 | -3.27 | HOXA11 (homeobox A11) | protein interactions | 3207 | 15 | 1 | 19454 | 50 |
RBPJ |
3.788e-02 | -3.27 | UCP3 (uncoupling protein 3) | protein interactions | 7352 | 15 | 1 | 19454 | 50 |
RBM47 |
3.788e-02 | -3.27 | ZNF813 (zinc finger protein 813) | protein interactions | 126017 | 15 | 1 | 19454 | 50 |
ARHGAP24 |
3.788e-02 | -3.27 | ANGPT2 (angiopoietin 2) | protein interactions | 285 | 15 | 1 | 19454 | 50 |
ITGAV |
3.788e-02 | -3.27 | ASCL4 (achaete-scute family bHLH transcription factor 4) | protein interactions | 121549 | 15 | 1 | 19454 | 50 |
DNM2 |
3.788e-02 | -3.27 | CASTOR1 (cytosolic arginine sensor for mTORC1 subunit 1) | protein interactions | 652968 | 15 | 1 | 19454 | 50 |
RXRA |
3.788e-02 | -3.27 | ZNF616 (zinc finger protein 616) | protein interactions | 90317 | 15 | 1 | 19454 | 50 |
ARHGAP24 |
3.788e-02 | -3.27 | OLFM3 (olfactomedin 3) | protein interactions | 118427 | 15 | 1 | 19454 | 50 |
EHD4 |
3.788e-02 | -3.27 | ZNF714 (zinc finger protein 714) | protein interactions | 148206 | 15 | 1 | 19454 | 50 |
ARHGAP24 |
3.788e-02 | -3.27 | Xlink | pfam domains | PF00193 | 14 | 1 | 17795 | 49 |
STAB1 |
3.788e-02 | -3.27 | Na_H_Exchanger | pfam domains | PF00999 | 14 | 1 | 17795 | 49 |
SLC9A7 |
3.814e-02 | -3.27 | HOXB9 (homeobox B9) | protein interactions | 3219 | 120 | 2 | 19454 | 50 |
RBPJ,BTG1 |
3.814e-02 | -3.27 | FNBP1 (formin binding protein 1) | protein interactions | 23048 | 120 | 2 | 19454 | 50 |
DNM2,RBPJ |
3.814e-02 | -3.27 | CD79B (CD79b molecule) | protein interactions | 974 | 120 | 2 | 19454 | 50 |
PTPN6,WDFY3 |
3.862e-02 | -3.25 | stomach-adenocarcinoma | COSMIC cancer mutations | stomach-adenocarcinoma | 4101 | 17 | 16828 | 46 |
FKBP5,AKAP13,DAB2,DOCK2,DOCK8,MYO1F,WDFY3,ZFP36L1,STAB1,TFEB,MCOLN2,ITGAV,GAB1,PREX1,TLN1,ITM2B,RXRA |
3.868e-02 | -3.25 | positive regulation of phosphate metabolic process | biological process | GO:0045937 | 697 | 5 | 18204 | 49 |
CCND2,TMSB4X,DAB2,EHD4,CD74 |
3.868e-02 | -3.25 | positive regulation of phosphorus metabolic process | biological process | GO:0010562 | 697 | 5 | 18204 | 49 |
CCND2,TMSB4X,DAB2,CD74,EHD4 |
3.910e-02 | -3.24 | Alpha-catenin/vinculin-like | gene3d domains | 1.20.120.230 | 12 | 1 | 14470 | 48 |
TLN1 |
3.934e-02 | -3.24 | SH3DOMAIN | prints domains | PR00452 | 83 | 2 | 5227 | 20 |
MYO1F,HCK |
3.935e-02 | -3.24 | perinuclear region of cytoplasm | cellular component | GO:0048471 | 735 | 5 | 19108 | 49 |
DISC1,DAB2,SEPTIN9,PREX1,EHD4 |
3.942e-02 | -3.23 | secretory | COSMIC cancer mutations | secretory | 115 | 2 | 16828 | 46 |
WDFY3,ARHGAP24 |
3.942e-02 | -3.23 | meninges-meningioma-secretory | COSMIC cancer mutations | meninges-meningioma-secretory | 115 | 2 | 16828 | 46 |
WDFY3,ARHGAP24 |
3.964e-02 | -3.23 | negative regulation of androgen receptor signaling pathway | biological process | GO:0060766 | 15 | 1 | 18204 | 49 |
DAB2 |
3.964e-02 | -3.23 | negative regulation of B cell apoptotic process | biological process | GO:0002903 | 15 | 1 | 18204 | 49 |
CD74 |
3.964e-02 | -3.23 | negative regulation of DNA damage response, signal transduction by p53 class mediator | biological process | GO:0043518 | 15 | 1 | 18204 | 49 |
CD74 |
3.964e-02 | -3.23 | positive regulation of hormone metabolic process | biological process | GO:0032352 | 15 | 1 | 18204 | 49 |
DAB2 |
3.964e-02 | -3.23 | regulation of steroid hormone biosynthetic process | biological process | GO:0090030 | 15 | 1 | 18204 | 49 |
DAB2 |
3.964e-02 | -3.23 | p38MAPK cascade | biological process | GO:0038066 | 15 | 1 | 18204 | 49 |
ZFP36L1 |
3.964e-02 | -3.23 | pyramidal neuron differentiation | biological process | GO:0021859 | 15 | 1 | 18204 | 49 |
DISC1 |
3.964e-02 | -3.23 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | biological process | GO:1900153 | 15 | 1 | 18204 | 49 |
ZFP36L1 |
3.964e-02 | -3.23 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | biological process | GO:1902166 | 15 | 1 | 18204 | 49 |
CD74 |
3.964e-02 | -3.23 | positive regulation of monocyte chemotactic protein-1 production | biological process | GO:0071639 | 15 | 1 | 18204 | 49 |
MCOLN2 |
3.964e-02 | -3.23 | negative regulation of immunoglobulin mediated immune response | biological process | GO:0002890 | 15 | 1 | 18204 | 49 |
PTPN6 |
3.964e-02 | -3.23 | epithelial cell fate commitment | biological process | GO:0072148 | 15 | 1 | 18204 | 49 |
RBPJ |
3.964e-02 | -3.23 | positive regulation of endothelial cell chemotaxis | biological process | GO:2001028 | 15 | 1 | 18204 | 49 |
TMSB4X |
3.964e-02 | -3.23 | positive regulation of non-canonical Wnt signaling pathway | biological process | GO:2000052 | 15 | 1 | 18204 | 49 |
DAB2 |
3.964e-02 | -3.23 | negative regulation of B cell mediated immunity | biological process | GO:0002713 | 15 | 1 | 18204 | 49 |
PTPN6 |
3.975e-02 | -3.23 | PPIase_FKBP_dom | interpro domains | IPR001179 | 15 | 1 | 18521 | 50 |
FKBP5 |
3.988e-02 | -3.22 | nuclear vitamin D receptor binding | molecular function | GO:0042809 | 15 | 1 | 18094 | 49 |
RXRA |
3.988e-02 | -3.22 | cyclin-dependent protein serine/threonine kinase activator activity | molecular function | GO:0061575 | 15 | 1 | 18094 | 49 |
CCND2 |
3.988e-02 | -3.22 | icosanoid receptor activity | molecular function | GO:0004953 | 15 | 1 | 18094 | 49 |
PTGIR |
3.988e-02 | -3.22 | low-density lipoprotein particle receptor activity | molecular function | GO:0005041 | 15 | 1 | 18094 | 49 |
STAB1 |
3.988e-02 | -3.22 | 1-phosphatidylinositol binding | molecular function | GO:0005545 | 15 | 1 | 18094 | 49 |
WDFY3 |
3.988e-02 | -3.22 | GNAQ (G protein subunit alpha q) | protein interactions | 2776 | 123 | 2 | 19454 | 50 |
AKAP13,PTGIR |
3.988e-02 | -3.22 | UBASH3A (ubiquitin associated and SH3 domain containing A) | protein interactions | 53347 | 123 | 2 | 19454 | 50 |
DNM2,DISC1 |
3.996e-02 | -3.22 | TYR_PHOSPHATASE_2 | prosite domains | PS50056 | 84 | 2 | 12186 | 46 |
PTPN12,PTPN6 |
4.002e-02 | -3.22 | calcium channel activity | molecular function | GO:0005262 | 117 | 2 | 18094 | 49 |
ITGAV,MCOLN2 |
4.011e-02 | -3.22 | RUNX1 (RUNX family transcription factor 1) | protein interactions | 861 | 295 | 3 | 19454 | 50 |
ELF4,SPI1,CCND2 |
4.016e-02 | -3.21 | Platelet homeostasis | REACTOME pathways | R-HSA-418346 | 91 | 2 | 10285 | 36 |
PTGIR,PTPN6 |
4.021e-02 | -3.21 | multicellular organismal process | biological process | GO:0032501 | 6177 | 23 | 18204 | 49 |
DISC1,PLXND1,ITGB2,ITM2B,SPI1,TFEB,ZFP36L1,ITGAL,DNM2,PTPN6,GAB1,ELF4,PREX1,TLN1,SH2B3,ITGAV,ARHGAP24,CD74,DOCK8,AKAP13,RBPJ,DOCK2,CCND2 |
4.024e-02 | -3.21 | skin-hip-malignant_melanoma | COSMIC cancer mutations | skin-hip-malignant_melanoma | 15 | 1 | 16828 | 46 |
HEPHL1 |
4.027e-02 | -3.21 | septin cytoskeleton | cellular component | GO:0032156 | 16 | 1 | 19108 | 49 |
SEPTIN9 |
4.027e-02 | -3.21 | T cell receptor complex | cellular component | GO:0042101 | 16 | 1 | 19108 | 49 |
PTPN6 |
4.035e-02 | -3.21 | SETDB2 (SET domain bifurcated histone lysine methyltransferase 2) | protein interactions | 83852 | 16 | 1 | 19454 | 50 |
HEPHL1 |
4.035e-02 | -3.21 | GPNMB (glycoprotein nmb) | protein interactions | 10457 | 16 | 1 | 19454 | 50 |
TFEB |
4.035e-02 | -3.21 | DGKQ (diacylglycerol kinase theta) | protein interactions | 1609 | 16 | 1 | 19454 | 50 |
EHD4 |
4.035e-02 | -3.21 | GMPR2 (guanosine monophosphate reductase 2) | protein interactions | 51292 | 16 | 1 | 19454 | 50 |
ARHGAP24 |
4.035e-02 | -3.21 | ZSCAN4 (zinc finger and SCAN domain containing 4) | protein interactions | 201516 | 16 | 1 | 19454 | 50 |
HCK |
4.035e-02 | -3.21 | SPANXN5 (SPANX family member N5) | protein interactions | 494197 | 16 | 1 | 19454 | 50 |
EHD4 |
4.035e-02 | -3.21 | IL1RL2 (interleukin 1 receptor like 2) | protein interactions | 8808 | 16 | 1 | 19454 | 50 |
MYO1F |
4.035e-02 | -3.21 | MAML2 (mastermind like transcriptional coactivator 2) | protein interactions | 84441 | 16 | 1 | 19454 | 50 |
RBPJ |
4.035e-02 | -3.21 | CASTOR2 (cytosolic arginine sensor for mTORC1 subunit 2) | protein interactions | 729438 | 16 | 1 | 19454 | 50 |
RXRA |
4.035e-02 | -3.21 | AKAP6 (A-kinase anchoring protein 6) | protein interactions | 9472 | 16 | 1 | 19454 | 50 |
DISC1 |
4.035e-02 | -3.21 | SYTL2 (synaptotagmin like 2) | protein interactions | 54843 | 16 | 1 | 19454 | 50 |
SEPTIN9 |
4.035e-02 | -3.21 | TNFRSF25 (TNF receptor superfamily member 25) | protein interactions | 8718 | 16 | 1 | 19454 | 50 |
PTPN6 |
4.035e-02 | -3.21 | PIPOX (pipecolic acid and sarcosine oxidase) | protein interactions | 51268 | 16 | 1 | 19454 | 50 |
FKBP5 |
4.037e-02 | -3.21 | protein kinase binding | molecular function | GO:0019901 | 701 | 5 | 18094 | 49 |
CCND2,ITGAV,ITGB2,SH2B3,PTPN6 |
4.053e-02 | -3.21 | FKBP_C | pfam domains | PF00254 | 15 | 1 | 17795 | 49 |
FKBP5 |
4.058e-02 | -3.20 | regulation of organelle organization | biological process | GO:0033043 | 1201 | 7 | 18204 | 49 |
HCK,PREX1,TMSB4X,ARAP1,AKAP13,ARHGEF18,SEPTIN9 |
4.073e-02 | -3.20 | PPAR signaling pathway | KEGG pathways | ko03320 | 72 | 2 | 7161 | 32 |
RXRA,ME1 |
4.073e-02 | -3.20 | Leishmaniasis | KEGG pathways | hsa05140 | 72 | 2 | 7161 | 32 |
ITGB2,PTPN6 |
4.073e-02 | -3.20 | PPAR signaling pathway | KEGG pathways | hsa03320 | 72 | 2 | 7161 | 32 |
RXRA,ME1 |
4.073e-02 | -3.20 | Leishmaniasis | KEGG pathways | ko05140 | 72 | 2 | 7161 | 32 |
ITGB2,PTPN6 |
4.076e-02 | -3.20 | EH | prosite domains | PS50031 | 11 | 1 | 12186 | 46 |
EHD4 |
4.085e-02 | -3.20 | Axon guidance | REACTOME pathways | R-HSA-422475 | 549 | 5 | 10285 | 36 |
PLXND1,ITGAV,DNM2,TLN1,GAB1 |
4.126e-02 | -3.19 | response to steroid hormone | biological process | GO:0048545 | 285 | 3 | 18204 | 49 |
DAB2,ZFP36L1,RXRA |
4.150e-02 | -3.18 | Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain | gene3d domains | 1.10.10.10 | 232 | 3 | 14470 | 48 |
SPI1,PREX1,ELF4 |
4.166e-02 | -3.18 | IFT74 (intraflagellar transport 74) | protein interactions | 80173 | 126 | 2 | 19454 | 50 |
SEPTIN9,DISC1 |
4.166e-02 | -3.18 | GET3 (guided entry of tail-anchored proteins factor 3, ATPase) | protein interactions | 439 | 126 | 2 | 19454 | 50 |
CCND2,DISC1 |
4.166e-02 | -3.18 | SYP (synaptophysin) | protein interactions | 6855 | 126 | 2 | 19454 | 50 |
GAB1,HEPHL1 |
4.193e-02 | -3.17 | skin-mucosal-malignant_melanoma | COSMIC cancer mutations | skin-mucosal-malignant_melanoma | 2009 | 10 | 16828 | 46 |
ME1,RBM47,RXRA,ITGAL,DAB2,CCND2,ELF4,TFEB,PTPN12,HCK |
4.193e-02 | -3.17 | mucosal | COSMIC cancer mutations | mucosal | 2009 | 10 | 16828 | 46 |
CCND2,ELF4,DAB2,HCK,TFEB,PTPN12,RBM47,ME1,RXRA,ITGAL |
4.198e-02 | -3.17 | regulation of canonical NF-kappaB signal transduction | biological process | GO:0043122 | 287 | 3 | 18204 | 49 |
CD74,AKAP13,TMSB4X |
4.207e-02 | -3.17 | negative regulation of immune effector process | biological process | GO:0002698 | 121 | 2 | 18204 | 49 |
SPI1,PTPN6 |
4.211e-02 | -3.17 | cell-cell junction | cellular component | GO:0005911 | 513 | 4 | 19108 | 49 |
ARHGAP24,PTPN6,TLN1,GAB1 |
4.223e-02 | -3.16 | regulation of adipose tissue development | biological process | GO:1904177 | 16 | 1 | 18204 | 49 |
SPI1 |
4.223e-02 | -3.16 | regulation of corticosteroid hormone secretion | biological process | GO:2000846 | 16 | 1 | 18204 | 49 |
DAB2 |
4.223e-02 | -3.16 | neutrophil homeostasis | biological process | GO:0001780 | 16 | 1 | 18204 | 49 |
SH2B3 |
4.223e-02 | -3.16 | regulation of Wnt signaling pathway, planar cell polarity pathway | biological process | GO:2000095 | 16 | 1 | 18204 | 49 |
DAB2 |
4.223e-02 | -3.16 | positive regulation of B cell differentiation | biological process | GO:0045579 | 16 | 1 | 18204 | 49 |
SPI1 |
4.223e-02 | -3.16 | branching involved in salivary gland morphogenesis | biological process | GO:0060445 | 16 | 1 | 18204 | 49 |
PLXND1 |
4.223e-02 | -3.16 | positive regulation of cyclin-dependent protein kinase activity | biological process | GO:1904031 | 16 | 1 | 18204 | 49 |
CCND2 |
4.223e-02 | -3.16 | cardiac left ventricle morphogenesis | biological process | GO:0003214 | 16 | 1 | 18204 | 49 |
RBPJ |
4.223e-02 | -3.16 | regulation of ATP biosynthetic process | biological process | GO:2001169 | 16 | 1 | 18204 | 49 |
TMSB4X |
4.234e-02 | -3.16 | positive regulation of innate immune response | biological process | GO:0045089 | 288 | 3 | 18204 | 49 |
HCK,RBM47,SPI1 |
4.248e-02 | -3.16 | sodium:proton antiporter activity | molecular function | GO:0015385 | 16 | 1 | 18094 | 49 |
SLC9A7 |
4.248e-02 | -3.16 | femur | COSMIC cancer mutations | femur | 1197 | 7 | 16828 | 46 |
RBM47,STAB1,AKAP13,HEPHL1,ELF4,DAB2,PREX1 |
4.251e-02 | -3.16 | HSPA6 (heat shock protein family A (Hsp70) member 6) | protein interactions | 3310 | 302 | 3 | 19454 | 50 |
TLN1,HCK,PTPN12 |
4.270e-02 | -3.15 | formation of primary germ layer | biological process | GO:0001704 | 122 | 2 | 18204 | 49 |
ITGAV,ITGB2 |
4.271e-02 | -3.15 | tissue development | biological process | GO:0009888 | 1757 | 9 | 18204 | 49 |
AKAP13,PLXND1,HCK,ITGB2,ITGAV,ARHGAP24,ZFP36L1,DAB2,RBPJ |
4.273e-02 | -3.15 | MHC class II protein complex | cellular component | GO:0042613 | 17 | 1 | 19108 | 49 |
CD74 |
4.282e-02 | -3.15 | SLAMF6 (SLAM family member 6) | protein interactions | 114836 | 17 | 1 | 19454 | 50 |
PTPN6 |
4.282e-02 | -3.15 | NOTCH4 (notch receptor 4) | protein interactions | 4855 | 17 | 1 | 19454 | 50 |
RBPJ |
4.282e-02 | -3.15 | LY6D (lymphocyte antigen 6 family member D) | protein interactions | 8581 | 17 | 1 | 19454 | 50 |
MCOLN2 |
4.282e-02 | -3.15 | CSH1 (chorionic somatomammotropin hormone 1) | protein interactions | 1442 | 17 | 1 | 19454 | 50 |
PTPN12 |
4.282e-02 | -3.15 | ZNF557 (zinc finger protein 557) | protein interactions | 79230 | 17 | 1 | 19454 | 50 |
ARHGAP24 |
4.282e-02 | -3.15 | ARPP19 (cAMP regulated phosphoprotein 19) | protein interactions | 10776 | 17 | 1 | 19454 | 50 |
ME1 |
4.282e-02 | -3.15 | SEPSECS (Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase) | protein interactions | 51091 | 17 | 1 | 19454 | 50 |
RBPJ |
4.282e-02 | -3.15 | PLCE1 (phospholipase C epsilon 1) | protein interactions | 51196 | 17 | 1 | 19454 | 50 |
FKBP5 |
4.282e-02 | -3.15 | STK32A (serine/threonine kinase 32A) | protein interactions | 202374 | 17 | 1 | 19454 | 50 |
FKBP5 |
4.282e-02 | -3.15 | LRRC3 (leucine rich repeat containing 3) | protein interactions | 81543 | 17 | 1 | 19454 | 50 |
SEPTIN9 |
4.282e-02 | -3.15 | OLFM1 (olfactomedin 1) | protein interactions | 10439 | 17 | 1 | 19454 | 50 |
DISC1 |
4.282e-02 | -3.15 | Lrr1 (leucine rich repeat protein 1) | protein interactions | 69706 | 17 | 1 | 19454 | 50 |
WDFY3 |
4.282e-02 | -3.15 | AOC1 (amine oxidase copper containing 1) | protein interactions | 26 | 17 | 1 | 19454 | 50 |
DNM2 |
4.282e-02 | -3.15 | DNALI1 (dynein axonemal light intermediate chain 1) | protein interactions | 7802 | 17 | 1 | 19454 | 50 |
DNM2 |
4.286e-02 | -3.15 | BTK (Bruton tyrosine kinase) | protein interactions | 695 | 128 | 2 | 19454 | 50 |
HCK,GAB1 |
4.286e-02 | -3.15 | GAB2 (GRB2 associated binding protein 2) | protein interactions | 9846 | 128 | 2 | 19454 | 50 |
PTPN6,GAB1 |
4.293e-02 | -3.15 | diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | diffuse_large_B_cell_lymphoma | 4151 | 17 | 16828 | 46 |
CCND2,GAB1,ITGAV,PTPN12,MCOLN2,HCK,DNM2,ME1,ITM2B,HEPHL1,BTG1,AKAP13,CD74,PLXND1,WDFY3,DOCK2,ZFP36L1 |
4.311e-02 | -3.14 | human chr14q24.1 | chromosome location | human chr14q24.1 | 23 | 1 | 26134 | 50 |
ZFP36L1 |
4.318e-02 | -3.14 | Cyclin_C | pfam domains | PF02984 | 16 | 1 | 17795 | 49 |
CCND2 |
4.340e-02 | -3.14 | Primary Focal Segmental Glomerulosclerosis FSGS | WikiPathways | WP2572 | 74 | 2 | 5310 | 24 |
ITGAV,TLN1 |
4.346e-02 | -3.14 | COL8A1 (collagen type VIII alpha 1 chain) | protein interactions | 1295 | 129 | 2 | 19454 | 50 |
DISC1,BMP2K |
4.346e-02 | -3.14 | CHD7 (chromodomain helicase DNA binding protein 7) | protein interactions | 55636 | 129 | 2 | 19454 | 50 |
RBPJ,FKBP5 |
4.397e-02 | -3.12 | cardiocyte differentiation | biological process | GO:0035051 | 124 | 2 | 18204 | 49 |
RBPJ,AKAP13 |
4.397e-02 | -3.12 | positive regulation of lipid metabolic process | biological process | GO:0045834 | 124 | 2 | 18204 | 49 |
CD74,DAB2 |
4.407e-02 | -3.12 | KIF3A (kinesin family member 3A) | protein interactions | 11127 | 130 | 2 | 19454 | 50 |
HEPHL1,DISC1 |
4.415e-02 | -3.12 | establishment of localization | biological process | GO:0051234 | 3887 | 16 | 18204 | 49 |
DOCK2,MYO1F,CD68,CD74,MCOLN2,HEPHL1,DNM2,STAB1,ITGAV,DAB2,ITGAL,ZFP36L1,EHD4,SLC9A7,ITGB2,HCK |
4.427e-02 | -3.12 | EIF3B (eukaryotic translation initiation factor 3 subunit B) | protein interactions | 8662 | 307 | 3 | 19454 | 50 |
CCND2,ARHGAP24,CD74 |
4.433e-02 | -3.12 | Vitamin D Metabolism | WikiPathways | WP1531 | 10 | 1 | 5310 | 24 |
RXRA |
4.433e-02 | -3.12 | Liver X Receptor Pathway | WikiPathways | WP2874 | 10 | 1 | 5310 | 24 |
RXRA |
4.439e-02 | -3.11 | LINK_1 | prosite domains | PS01241 | 12 | 1 | 12186 | 46 |
STAB1 |
4.451e-02 | -3.11 | bone-humerus-chondrosarcoma | COSMIC cancer mutations | bone-humerus-chondrosarcoma | 123 | 2 | 16828 | 46 |
HEPHL1,ME1 |
4.459e-02 | -3.11 | Uptake and function of anthrax toxins | REACTOME pathways | R-HSA-5210891 | 13 | 1 | 10285 | 36 |
ANTXR2 |
4.459e-02 | -3.11 | Notch-HLH transcription pathway | REACTOME pathways | R-HSA-350054 | 13 | 1 | 10285 | 36 |
RBPJ |
4.459e-02 | -3.11 | NOTCH2 intracellular domain regulates transcription | REACTOME pathways | R-HSA-2197563 | 13 | 1 | 10285 | 36 |
RBPJ |
4.459e-02 | -3.11 | FCGR activation | REACTOME pathways | R-HSA-2029481 | 13 | 1 | 10285 | 36 |
HCK |
4.461e-02 | -3.11 | regulation of cell-matrix adhesion | biological process | GO:0001952 | 125 | 2 | 18204 | 49 |
DISC1,TLN1 |
4.468e-02 | -3.11 | LGALS7 (galectin 7) | protein interactions | 3963 | 131 | 2 | 19454 | 50 |
DOCK8,GAB1 |
4.481e-02 | -3.11 | protein trimerization | biological process | GO:0070206 | 17 | 1 | 18204 | 49 |
CD74 |
4.481e-02 | -3.11 | regulation of proton transport | biological process | GO:0010155 | 17 | 1 | 18204 | 49 |
TMSB4X |
4.481e-02 | -3.11 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | biological process | GO:1902165 | 17 | 1 | 18204 | 49 |
CD74 |
4.481e-02 | -3.11 | negative regulation of humoral immune response | biological process | GO:0002921 | 17 | 1 | 18204 | 49 |
PTPN6 |
4.481e-02 | -3.11 | regulation of plasma membrane organization | biological process | GO:1903729 | 17 | 1 | 18204 | 49 |
DNM2 |
4.481e-02 | -3.11 | response to hepatocyte growth factor | biological process | GO:0035728 | 17 | 1 | 18204 | 49 |
GAB1 |
4.481e-02 | -3.11 | specification of animal organ identity | biological process | GO:0010092 | 17 | 1 | 18204 | 49 |
RBPJ |
4.481e-02 | -3.11 | regulation of lipoprotein metabolic process | biological process | GO:0050746 | 17 | 1 | 18204 | 49 |
ITGAV |
4.493e-02 | -3.10 | regulation of ERK1 and ERK2 cascade | biological process | GO:0070372 | 295 | 3 | 18204 | 49 |
CD74,PTPN6,DAB2 |
4.493e-02 | -3.10 | Cyclin_C-dom | interpro domains | IPR004367 | 17 | 1 | 18521 | 50 |
CCND2 |
4.493e-02 | -3.10 | Thyroglobulin_1_sf | interpro domains | IPR036857 | 17 | 1 | 18521 | 50 |
CD74 |
4.493e-02 | -3.10 | Thyroglobulin_1 | interpro domains | IPR000716 | 17 | 1 | 18521 | 50 |
CD74 |
4.494e-02 | -3.10 | human chr4p15.2 | chromosome location | human chr4p15.2 | 24 | 1 | 26134 | 50 |
RBPJ |
4.499e-02 | -3.10 | STK11 (serine/threonine kinase 11) | protein interactions | 6794 | 309 | 3 | 19454 | 50 |
SEPTIN9,FKBP5,CCND2 |
4.507e-02 | -3.10 | oxidoreductase activity, acting on metal ions | molecular function | GO:0016722 | 17 | 1 | 18094 | 49 |
HEPHL1 |
4.507e-02 | -3.10 | low-density lipoprotein particle binding | molecular function | GO:0030169 | 17 | 1 | 18094 | 49 |
STAB1 |
4.507e-02 | -3.10 | transmembrane receptor protein tyrosine phosphatase activity | molecular function | GO:0005001 | 17 | 1 | 18094 | 49 |
PTPN6 |
4.507e-02 | -3.10 | transmembrane receptor protein tyrosine kinase adaptor activity | molecular function | GO:0005068 | 17 | 1 | 18094 | 49 |
SH2B3 |
4.507e-02 | -3.10 | transmembrane receptor protein phosphatase activity | molecular function | GO:0019198 | 17 | 1 | 18094 | 49 |
PTPN6 |
4.515e-02 | -3.10 | skin-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-carcinoma-squamous_cell_carcinoma | 493 | 4 | 16828 | 46 |
SH2B3,CCND2,BMP2K,ZFP36L1 |
4.519e-02 | -3.10 | filopodium membrane | cellular component | GO:0031527 | 18 | 1 | 19108 | 49 |
ITGAV |
4.529e-02 | -3.09 | ZNF100 (zinc finger protein 100) | protein interactions | 163227 | 18 | 1 | 19454 | 50 |
ARHGAP24 |
4.529e-02 | -3.09 | Chmp6 (charged multivesicular body protein 6) | protein interactions | 208092 | 18 | 1 | 19454 | 50 |
PTPN6 |
4.529e-02 | -3.09 | ADO (2-aminoethanethiol dioxygenase) | protein interactions | 84890 | 18 | 1 | 19454 | 50 |
DISC1 |
4.529e-02 | -3.09 | NAALADL2 (N-acetylated alpha-linked acidic dipeptidase like 2) | protein interactions | 254827 | 18 | 1 | 19454 | 50 |
ITM2B |
4.529e-02 | -3.09 | DCAF17 (DDB1 and CUL4 associated factor 17) | protein interactions | 80067 | 18 | 1 | 19454 | 50 |
PREX1 |
4.529e-02 | -3.09 | TM4SF20 (transmembrane 4 L six family member 20) | protein interactions | 79853 | 18 | 1 | 19454 | 50 |
CD74 |
4.529e-02 | -3.09 | ZNF365 (zinc finger protein 365) | protein interactions | 22891 | 18 | 1 | 19454 | 50 |
DISC1 |
4.529e-02 | -3.09 | B3GAT2 (beta-1,3-glucuronyltransferase 2) | protein interactions | 135152 | 18 | 1 | 19454 | 50 |
SEPTIN9 |
4.529e-02 | -3.09 | AK9 (adenylate kinase 9) | protein interactions | 221264 | 18 | 1 | 19454 | 50 |
ARHGAP24 |
4.529e-02 | -3.09 | Numb (NUMB endocytic adaptor protein) | protein interactions | 18222 | 18 | 1 | 19454 | 50 |
BMP2K |
4.529e-02 | -3.09 | SRR (serine racemase) | protein interactions | 63826 | 18 | 1 | 19454 | 50 |
DISC1 |
4.529e-02 | -3.09 | SPARCL1 (SPARC like 1) | protein interactions | 8404 | 18 | 1 | 19454 | 50 |
DISC1 |
4.529e-02 | -3.09 | GALM (galactose mutarotase) | protein interactions | 130589 | 18 | 1 | 19454 | 50 |
AKAP13 |
4.530e-02 | -3.09 | TXNDC12 (thioredoxin domain containing 12) | protein interactions | 51060 | 132 | 2 | 19454 | 50 |
HCK,TLN1 |
4.530e-02 | -3.09 | TINF2 (TERF1 interacting nuclear factor 2) | protein interactions | 26277 | 132 | 2 | 19454 | 50 |
ZFP36L1,FKBP5 |
4.531e-02 | -3.09 | ovary-other-neoplasm | COSMIC cancer mutations | ovary-other-neoplasm | 12717 | 40 | 16828 | 46 |
DOCK8,WDFY3,PLXND1,ELF4,HEPHL1,ITGAL,SH2B3,RGL1,ME1,PTPN12,MCOLN2,GAB1,CCND2,MYO1F,DOCK2,ZFP36L1,ARAP1,PTPN6,ANTXR2,RBM47,AKAP13,EHD4,CD74,RBPJ,ARHGEF18,FKBP5,DAB2,BTG1,ITM2B,ITGB2,DNM2,RXRA,TFEB,STAB1,HCK,ITGAV,TLN1,SLC9A7,PREX1,PTGIR |
4.547e-02 | -3.09 | EH | smart domains | SM00027 | 11 | 1 | 9717 | 41 |
EHD4 |
4.547e-02 | -3.09 | Cupredoxins - blue copper proteins | gene3d domains | 2.60.40.420 | 14 | 1 | 14470 | 48 |
HEPHL1 |
4.549e-02 | -3.09 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-chronic_eosinophilic_leukaemia-hypereosinophilic_syndrome | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-chronic_eosinophilic_leukaemia-hypereosinophilic_syndrome | 17 | 1 | 16828 | 46 |
SH2B3 |
4.549e-02 | -3.09 | chronic_eosinophilic_leukaemia-hypereosinophilic_syndrome | COSMIC cancer mutations | chronic_eosinophilic_leukaemia-hypereosinophilic_syndrome | 17 | 1 | 16828 | 46 |
SH2B3 |
4.579e-02 | -3.08 | late endosome | cellular component | GO:0005770 | 312 | 3 | 19108 | 49 |
CD74,CD68,MCOLN2 |
4.581e-02 | -3.08 | Thyroglobulin_1 | pfam domains | PF00086 | 17 | 1 | 17795 | 49 |
CD74 |
4.582e-02 | -3.08 | EZR (ezrin) | protein interactions | 7430 | 526 | 4 | 19454 | 50 |
ARHGAP24,SEPTIN9,GAB1,PTPN12 |
4.590e-02 | -3.08 | regulation of myeloid leukocyte differentiation | biological process | GO:0002761 | 127 | 2 | 18204 | 49 |
CD74,ZFP36L1 |
4.591e-02 | -3.08 | PLAUR (plasminogen activator, urokinase receptor) | protein interactions | 5329 | 133 | 2 | 19454 | 50 |
HCK,ITGB2 |
4.591e-02 | -3.08 | CBS (cystathionine beta-synthase) | protein interactions | 875 | 133 | 2 | 19454 | 50 |
ARHGAP24,PREX1 |
4.591e-02 | -3.08 | DUT (deoxyuridine triphosphatase) | protein interactions | 1854 | 133 | 2 | 19454 | 50 |
TLN1,FKBP5 |
4.615e-02 | -3.08 | skin-malignant_melanoma | COSMIC cancer mutations | skin-malignant_melanoma | 15741 | 46 | 16828 | 46 |
BMP2K,CD68,ELF4,WDFY3,DOCK8,PLXND1,GAB1,MCOLN2,PTPN12,CCND2,SH2B3,RGL1,RBPJ,EHD4,BTG1,ZFP36L1,RBM47,ANTXR2,PTPN6,ITGAV,HCK,PTGIR,SLC9A7,TLN1,ITGB2,RXRA,HEPHL1,TMSB4X,SPI1,ITGAL,ME1,FKBP5,ARHGEF18,CD74,AKAP13,ARHGAP24,DAB2,ARAP1,MYO1F,DOCK2,DISC1,STAB1,TFEB,PREX1,ITM2B,DNM2 |
4.641e-02 | -3.07 | negative regulation of multicellular organismal process | biological process | GO:0051241 | 1237 | 7 | 18204 | 49 |
RBPJ,SH2B3,STAB1,PTPN6,SPI1,ELF4,CD74 |
4.655e-02 | -3.07 | regulation of protein binding | biological process | GO:0043393 | 128 | 2 | 18204 | 49 |
DAB2,DISC1 |
4.657e-02 | -3.07 | kidney-other-neoplasm | COSMIC cancer mutations | kidney-other-neoplasm | 10653 | 35 | 16828 | 46 |
ARAP1,DOCK2,MYO1F,ANTXR2,EHD4,AKAP13,ARHGEF18,FKBP5,DAB2,BTG1,ARHGAP24,ITM2B,ITGB2,DNM2,RXRA,ITGAV,HCK,STAB1,TLN1,SLC9A7,PREX1,PTGIR,WDFY3,DOCK8,PLXND1,HEPHL1,ELF4,ITGAL,ME1,RGL1,SH2B3,GAB1,MCOLN2,PTPN12,CCND2 |
4.671e-02 | -3.06 | Chemokine signaling pathway | KEGG pathways | ko04062 | 182 | 3 | 7161 | 32 |
DOCK2,HCK,PREX1 |
4.671e-02 | -3.06 | Chemokine signaling pathway | KEGG pathways | hsa04062 | 182 | 3 | 7161 | 32 |
DOCK2,HCK,PREX1 |
4.714e-02 | -3.05 | leg | COSMIC cancer mutations | leg | 969 | 6 | 16828 | 46 |
SLC9A7,HCK,STAB1,AKAP13,PTPN12,WDFY3 |
4.716e-02 | -3.05 | EML4 (EMAP like 4) | protein interactions | 27436 | 135 | 2 | 19454 | 50 |
FKBP5,TFEB |
4.716e-02 | -3.05 | JAK3 (Janus kinase 3) | protein interactions | 3718 | 135 | 2 | 19454 | 50 |
FKBP5,PTPN6 |
4.716e-02 | -3.05 | Myo1c (myosin IC) | protein interactions | 17913 | 135 | 2 | 19454 | 50 |
DAB2,BMP2K |
4.717e-02 | -3.05 | STAT1 (signal transducer and activator of transcription 1) | protein interactions | 6772 | 315 | 3 | 19454 | 50 |
RXRA,ITGAV,ARHGAP24 |
4.717e-02 | -3.05 | FLT3 (fms related receptor tyrosine kinase 3) | protein interactions | 2322 | 315 | 3 | 19454 | 50 |
PTPN6,HCK,PTPN12 |
4.738e-02 | -3.05 | copper ion transport | biological process | GO:0006825 | 18 | 1 | 18204 | 49 |
HEPHL1 |
4.738e-02 | -3.05 | negative regulation of platelet activation | biological process | GO:0010544 | 18 | 1 | 18204 | 49 |
SH2B3 |
4.738e-02 | -3.05 | retinoic acid receptor signaling pathway | biological process | GO:0048384 | 18 | 1 | 18204 | 49 |
RXRA |
4.738e-02 | -3.05 | regulation of dopamine metabolic process | biological process | GO:0042053 | 18 | 1 | 18204 | 49 |
ITGB2 |
4.738e-02 | -3.05 | positive regulation of superoxide anion generation | biological process | GO:0032930 | 18 | 1 | 18204 | 49 |
ITGB2 |
4.738e-02 | -3.05 | clathrin coat assembly | biological process | GO:0048268 | 18 | 1 | 18204 | 49 |
DAB2 |
4.738e-02 | -3.05 | positive regulation of type 2 immune response | biological process | GO:0002830 | 18 | 1 | 18204 | 49 |
CD74 |
4.738e-02 | -3.05 | regulation of catecholamine metabolic process | biological process | GO:0042069 | 18 | 1 | 18204 | 49 |
ITGB2 |
4.738e-02 | -3.05 | regulation of humoral immune response mediated by circulating immunoglobulin | biological process | GO:0002923 | 18 | 1 | 18204 | 49 |
PTPN6 |
4.738e-02 | -3.05 | heart formation | biological process | GO:0060914 | 18 | 1 | 18204 | 49 |
RBPJ |
4.752e-02 | -3.05 | PPIase_dom_sf | interpro domains | IPR046357 | 18 | 1 | 18521 | 50 |
FKBP5 |
4.752e-02 | -3.05 | EGF_dom | interpro domains | IPR024731 | 18 | 1 | 18521 | 50 |
STAB1 |
4.760e-02 | -3.04 | immune response-activating signaling pathway | biological process | GO:0002757 | 302 | 3 | 18204 | 49 |
PTPN6,FYB1,HCK |
4.766e-02 | -3.04 | lipoprotein particle receptor activity | molecular function | GO:0030228 | 18 | 1 | 18094 | 49 |
STAB1 |
4.766e-02 | -3.04 | intracellularly gated calcium channel activity | molecular function | GO:0015278 | 18 | 1 | 18094 | 49 |
MCOLN2 |
4.766e-02 | -3.04 | clathrin adaptor activity | molecular function | GO:0035615 | 18 | 1 | 18094 | 49 |
DAB2 |
4.774e-02 | -3.04 | ZNF138 (zinc finger protein 138) | protein interactions | 7697 | 19 | 1 | 19454 | 50 |
ARHGAP24 |
4.774e-02 | -3.04 | PDIK1L (PDLIM1 interacting kinase 1 like) | protein interactions | 149420 | 19 | 1 | 19454 | 50 |
FKBP5 |
4.774e-02 | -3.04 | MAML3 (mastermind like transcriptional coactivator 3) | protein interactions | 55534 | 19 | 1 | 19454 | 50 |
RBPJ |
4.774e-02 | -3.04 | NHERF4 (NHERF family PDZ scaffold protein 4) | protein interactions | 79849 | 19 | 1 | 19454 | 50 |
PTGIR |
4.774e-02 | -3.04 | MCOLN1 (mucolipin TRP cation channel 1) | protein interactions | 57192 | 19 | 1 | 19454 | 50 |
MCOLN2 |
4.774e-02 | -3.04 | CRYBB1 (crystallin beta B1) | protein interactions | 1414 | 19 | 1 | 19454 | 50 |
DISC1 |
4.774e-02 | -3.04 | PEX2 (peroxisomal biogenesis factor 2) | protein interactions | 5828 | 19 | 1 | 19454 | 50 |
PTPN6 |
4.774e-02 | -3.04 | ZNF197 (zinc finger protein 197) | protein interactions | 10168 | 19 | 1 | 19454 | 50 |
DISC1 |
4.774e-02 | -3.04 | COL4A4 (collagen type IV alpha 4 chain) | protein interactions | 1286 | 19 | 1 | 19454 | 50 |
ANTXR2 |
4.779e-02 | -3.04 | EMSY (EMSY transcriptional repressor, BRCA2 interacting) | protein interactions | 56946 | 136 | 2 | 19454 | 50 |
ELF4,DISC1 |
4.779e-02 | -3.04 | ROCK2 (Rho associated coiled-coil containing protein kinase 2) | protein interactions | 9475 | 136 | 2 | 19454 | 50 |
TLN1,AKAP13 |
4.779e-02 | -3.04 | NR2F2 (nuclear receptor subfamily 2 group F member 2) | protein interactions | 7026 | 136 | 2 | 19454 | 50 |
PTGIR,RBPJ |
4.786e-02 | -3.04 | negative regulation of T cell activation | biological process | GO:0050868 | 130 | 2 | 18204 | 49 |
PTPN6,CD74 |
4.793e-02 | -3.04 | Retrograde neurotrophin signalling | REACTOME pathways | R-HSA-177504 | 14 | 1 | 10285 | 36 |
DNM2 |
4.793e-02 | -3.04 | Regulation of pyruvate dehydrogenase (PDH) complex | REACTOME pathways | R-HSA-204174 | 14 | 1 | 10285 | 36 |
RXRA |
4.793e-02 | -3.04 | Regulation of IFNG signaling | REACTOME pathways | R-HSA-877312 | 14 | 1 | 10285 | 36 |
PTPN6 |
4.795e-02 | -3.04 | thyroid-other-neoplasm | COSMIC cancer mutations | thyroid-other-neoplasm | 7637 | 27 | 16828 | 46 |
STAB1,TFEB,ITGAV,TLN1,SLC9A7,PTGIR,PREX1,ITGB2,DNM2,RXRA,AKAP13,EHD4,ARHGEF18,FKBP5,DAB2,ZFP36L1,DOCK2,MYO1F,ARAP1,GAB1,ITGAL,RGL1,SH2B3,BMP2K,HEPHL1,DOCK8,PLXND1 |
4.800e-02 | -3.04 | G_SEPTIN | prosite domains | PS51719 | 13 | 1 | 12186 | 46 |
SEPTIN9 |
4.819e-02 | -3.03 | innate immune response | biological process | GO:0045087 | 741 | 5 | 18204 | 49 |
MCOLN2,CD74,PTPN6,TFEB,HCK |
4.835e-02 | -3.03 | coated vesicle | cellular component | GO:0030135 | 319 | 3 | 19108 | 49 |
DAB2,CD74,DNM2 |
4.837e-02 | -3.03 | stomach-carcinoma-adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-adenocarcinoma | 15150 | 45 | 16828 | 46 |
SH2B3,RGL1,CCND2,PTPN12,MCOLN2,GAB1,PLXND1,DOCK8,WDFY3,ELF4,BMP2K,CD68,RXRA,ITGB2,PTGIR,TLN1,SLC9A7,HCK,ITGAV,ANTXR2,RBM47,PTPN6,BTG1,RBPJ,EHD4,ME1,SPI1,ITGAL,TMSB4X,HEPHL1,DNM2,ITM2B,PREX1,TFEB,STAB1,DISC1,DOCK2,MYO1F,ARAP1,ARHGAP24,DAB2,CD74,FKBP5,ARHGEF18,AKAP13 |
4.838e-02 | -3.03 | heat shock protein binding | molecular function | GO:0031072 | 130 | 2 | 18094 | 49 |
FKBP5,ITGB2 |
4.844e-02 | -3.03 | EGF_3 | pfam domains | PF12947 | 18 | 1 | 17795 | 49 |
STAB1 |
4.846e-02 | -3.03 | L1CAM interactions | REACTOME pathways | R-HSA-373760 | 101 | 2 | 10285 | 36 |
DNM2,ITGAV |
4.852e-02 | -3.03 | mesoderm development | biological process | GO:0007498 | 131 | 2 | 18204 | 49 |
HCK,ZFP36L1 |
4.879e-02 | -3.02 | transport | biological process | GO:0006810 | 3615 | 15 | 18204 | 49 |
DNM2,HEPHL1,CD74,MCOLN2,MYO1F,DOCK2,ITGB2,HCK,SLC9A7,EHD4,DAB2,ITGAL,ZFP36L1,ITGAV,STAB1 |
4.881e-02 | -3.02 | EPO Signaling Pathway | SMPDB pathways | SMP0069678 | 17 | 1 | 1369 | 4 |
PTPN6 |
4.883e-02 | -3.02 | haematopoietic_neoplasm | COSMIC cancer mutations | haematopoietic_neoplasm | 11082 | 36 | 16828 | 46 |
ARAP1,DOCK2,MYO1F,ANTXR2,PTPN6,ARHGEF18,FKBP5,CD74,AKAP13,EHD4,ARHGAP24,DAB2,RXRA,DNM2,ITGAV,HCK,STAB1,PREX1,SLC9A7,TLN1,DOCK8,WDFY3,PLXND1,BMP2K,CD68,HEPHL1,ELF4,SPI1,ITGAL,ME1,RGL1,SH2B3,GAB1,PTPN12,MCOLN2,CCND2 |
4.884e-02 | -3.02 | clathrin-coated vesicle membrane | cellular component | GO:0030665 | 138 | 2 | 19108 | 49 |
CD74,DAB2 |
4.905e-02 | -3.01 | OR2A4 (olfactory receptor family 2 subfamily A member 4) | protein interactions | 79541 | 138 | 2 | 19454 | 50 |
ME1,HEPHL1 |
4.905e-02 | -3.01 | FUT8 (fucosyltransferase 8) | protein interactions | 2530 | 138 | 2 | 19454 | 50 |
MCOLN2,ITGAV |
4.905e-02 | -3.01 | TENT5C (terminal nucleotidyltransferase 5C) | protein interactions | 54855 | 138 | 2 | 19454 | 50 |
EHD4,SEPTIN9 |
4.916e-02 | -3.01 | defense response to bacterium | biological process | GO:0042742 | 306 | 3 | 18204 | 49 |
TFEB,STAB1,RBPJ |
4.918e-02 | -3.01 | regulation of mRNA processing | biological process | GO:0050684 | 132 | 2 | 18204 | 49 |
ZFP36L1,RBM47 |
4.918e-02 | -3.01 | positive regulation of proteolysis involved in protein catabolic process | biological process | GO:1903052 | 132 | 2 | 18204 | 49 |
DAB2,DISC1 |
4.943e-02 | -3.01 | BAP1 (BRCA1 associated protein 1) | protein interactions | 8314 | 1313 | 7 | 19454 | 50 |
DNM2,TLN1,SEPTIN9,ELF4,FKBP5,ZFP36L1,ME1 |
4.943e-02 | -3.01 | regulation of phosphorylation | biological process | GO:0042325 | 994 | 6 | 18204 | 49 |
CD74,EHD4,PTPN6,CCND2,ITGB2,DAB2 |
4.968e-02 | -3.00 | NEFM (neurofilament medium chain) | protein interactions | 4741 | 139 | 2 | 19454 | 50 |
PTPN12,DISC1 |
4.968e-02 | -3.00 | IFT20 (intraflagellar transport 20) | protein interactions | 90410 | 139 | 2 | 19454 | 50 |
DISC1,PTPN12 |
4.968e-02 | -3.00 | NAA15 (N-alpha-acetyltransferase 15, NatA auxiliary subunit) | protein interactions | 80155 | 139 | 2 | 19454 | 50 |
RBPJ,ARHGAP24 |
4.977e-02 | -3.00 | ITGB1 (integrin subunit beta 1) | protein interactions | 3688 | 322 | 3 | 19454 | 50 |
RXRA,ITGAV,TLN1 |
4.985e-02 | -3.00 | positive regulation of endothelial cell migration | biological process | GO:0010595 | 133 | 2 | 18204 | 49 |
GAB1,TMSB4X |
4.995e-02 | -3.00 | base conversion or substitution editing | biological process | GO:0016553 | 19 | 1 | 18204 | 49 |
RBM47 |
4.995e-02 | -3.00 | regulation of early endosome to late endosome transport | biological process | GO:2000641 | 19 | 1 | 18204 | 49 |
DAB2 |
4.995e-02 | -3.00 | detection of temperature stimulus involved in sensory perception of pain | biological process | GO:0050965 | 19 | 1 | 18204 | 49 |
DISC1 |
4.995e-02 | -3.00 | positive regulation of endothelial cell differentiation | biological process | GO:0045603 | 19 | 1 | 18204 | 49 |
BTG1 |
4.995e-02 | -3.00 | protein localization to cell-cell junction | biological process | GO:0150105 | 19 | 1 | 18204 | 49 |
ARHGEF18 |
4.995e-02 | -3.00 | regulation of cell proliferation involved in heart morphogenesis | biological process | GO:2000136 | 19 | 1 | 18204 | 49 |
RBPJ |
4.995e-02 | -3.00 | adenylate cyclase-activating adrenergic receptor signaling pathway | biological process | GO:0071880 | 19 | 1 | 18204 | 49 |
AKAP13 |
4.995e-02 | -3.00 | regulation of mast cell activation | biological process | GO:0033003 | 19 | 1 | 18204 | 49 |
PTPN6 |
4.995e-02 | -3.00 | negative regulation of amyloid precursor protein biosynthetic process | biological process | GO:0042985 | 19 | 1 | 18204 | 49 |
ITM2B |
4.995e-02 | -3.00 | 3'-UTR-mediated mRNA destabilization | biological process | GO:0061158 | 19 | 1 | 18204 | 49 |
ZFP36L1 |
4.995e-02 | -3.00 | regulation of B cell apoptotic process | biological process | GO:0002902 | 19 | 1 | 18204 | 49 |
CD74 |